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 i  
Abstract 
The binding of polar organic molecules in water is one of the most difficult problems in molecular 
recognition. Carbohydrates are especially challenging targets, given their complex, hydromimetic and 
subtly variable structures. As a result, carbohydrate-binding proteins such as lectins often display low 
affinities and moderate selectivities, especially when compared to other classes of small molecule 
binding proteins. ‘Synthetic lectin’ mimics have been reported for several years, but have typically 
been still weaker, with previous approaches generally consisting of macrocycles employing aromatic 












This project aimed to investigate a new type of synthetic lectin employing bis-urea spacer units. 
Incorporation of this urea spacer design into anthracene tetraurea 1 afforded good affinities and 
selectivities, comparable to natural lectins, for cellodextrin oligosaccharide substrates (such as D-
cellotriose 2). The potential of the urea spacer was fully realised when incorporated into 
triethylbenzene hexaurea 3 however, which shows binding affinities and selectivities for D-glucose 4 
that far exceed any previous synthetic system. Receptor 3 even continues to function in complex 
biological media (such as human blood serum), enabling preliminary proof of concept for 3 acting as a 
D-glucose 4 sensor. The performance of 3 even surpasses most natural systems (such as lectins) and 
therefore can be considered the first true example of a synthetic biomimetic receptor for D-glucose.
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Chapter 1 - Introduction 
1.1 Carbohydrates and their recognition by natural and synthetic lectins 
The class of organic molecules known as carbohydrates are ubiquitous throughout nature (Figure 1). 
They provide the main source of energy for many organisms (D-glucose 4), act as key components in 
biological systems such as DNA (2-deoxy-D-ribose) and deliver macroscopic structural rigidity when 
incorporated into biopolymers (D-cellulose 8and D-chitin 9).1,2 In addition to these classical roles, 
saccharide chains of varying lengths can contain an extraordinary amount of information for biological 
systems. Combining the subtle stereochemical variance of monosaccharides with possible substitution 
at any of the hydroxyls, differing rings sizes, glycosidic linkage positions and branching of saccharide 
chains results in a wealth of potential structural diversity. As a result of this a sequence of six 
monosaccharides produces more than 1012 different potential oligosaccharides. Comparatively six 
nucleotides generates only 4096 nucleotide sequences and six amino acids produces 6 × 107 possible 
combinations of polypeptide.3,4 It should be of no surprise then that the recognition of characteristic 
sugar chains is instrumental in numerous biological processes, such as cell to cell recognition, protein 
transport and infection by pathogens. Such processes are mediated by proteins known as lectins that 
can selectively recognise and bind carbohydrates in a non-covalent manner.5,6 
 
Figure 1 Examples of carbohydrates commonly found in nature: D-glucose 4, D-galactose 5, D-mannose 6, N-
acetyl-D-glucosamine 7, D-cellulose 8 and D-chitin 9. 
The affinities and selectivity achieved by natural lectins is impressive when considering the subtle 
structural variance of carbohydrates. The single stereochemical difference seen for D-glucose 4, D-
galactose 5 and D-mannose 6 results in completely different functions in biology and yet, are very 
similar in the overall structure of the molecule. The other key consideration is the aqueous medium 
that biology operates in. Carbohydrates have an outer surface of hydroxyl groups that effectively 
camouflage the core carbon ring from the polar solvent. This results in most carbohydrates being 
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hydromimetic (resembling water), thus making the distinction between the substrate and the solvent 
by the lectin all the more challenging (Figure 2).7,8  
 
Figure 2 Hydromimetic nature of β-D-glucose, where the outer hydroxyls resemble water. 
This high degree of selectivity observed in lectins is achieved through highly complementary binding 
sites, each specifically tailored to a particular carbohydrate. Multiple chemical interactions are present 
in the binding site. Hydrogen bonding between the sugar hydroxyls and appropriately oriented polar 
residues (such as arginine and aspartic acid) are used in conjunction with CH-π interactions between 
the aliphatic parts of the carbohydrate and apolar aromatic residues (such as tyrosine and 
phenylalanine). Electrostatic and charge-dipole interactions having been observed in the binding sites 
of some proteins as well. Lectins typically feature shallow binding pockets and thus the sugar isn’t 
typically fully encapsulated unless bound in a protein dimer (Figure 3), so residues are often orientated 
to be substrate specific to maximise binding interactions.9,10 
 
Figure 3 Schematic of simple lectin binding sites for glucose, displaying the general orientation of chemical 
interactions: apolar interactions (usually CH-π, blue) and polar hydrogen bonding (red). Two types of binding site 
are also shown, firstly partial encapsulation (left) and full encapsulation by protein dimerisation (right). 
While good substrate selectivity is known for natural lectins, relatively weak affinities are also observed 
with association constants (Ka) of 103-104 M-1 being typical.11,12 This highlights the inherent challenges 
of binding carbohydrates in water (structural diversity and solvent competitiveness), and nature 
sometimes compensates for this through modification of the sugar via phosphorylation or chelation 
with metals (such as manganese or calcium, as seen for C-type lectins).9,13 It is these moderate affinities 
however that provides an opportunity to outperform nature through design and synthesis of a 
‘synthetic lectin’. However, replicating the highly defined binding sites of natural lectins and the innate 
difficulty of binding carbohydrates in water poses significant challenges. A synthetically accessible host 
molecule that is capable of selectively binding a target carbohydrate with good affinity would be of 
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𝛥𝐺 =  −𝑅𝑇 ln 𝐾𝑎  
substantial interest; with a host of applications possible such as blood glucose monitoring for diabetes, 
tumour recognition and potentially new approaches for drug delivery.14,15 
1.2 Association constants and rates of exchange 
The complexation of a guest (i.e. a carbohydrate) to a certain receptor is governed by the following 
equilibrium (Equation 1)16: 
           (Eqn. 1) 
 
The association of a free guest (G) to a free host molecule (H) to give a host-guest complex (HG), and 
its associated binding affinity, is determined by the association constant (Ka) – the greater this value 
the more favourable the equilibrium is towards forming the HG complex. This association constant can 
therefore be expressed in terms of concentrations of [HG], [H] and [G] (Equation 2). The dissociation 
constant (Kd) is the reciprocal of the association constant, but is more commonly used in biological 
contexts (Equation 3).16 The vast majority of the work outlined in this thesis will discuss binding 
affinities in terms of association constants (Ka). 
     (Eqn. 2)     (Eqn. 3) 
 
Association constants (Ka) are expressed in units of per molar (M-1), but can be expressed in Gibb’s free 
energy of binding (ΔG) and thus joules per mole (J mol-1) using equation 4: 
           (Eqn. 4) 
Calculation of association constants is therefore dependent on determining the concentrations of 
[HG], [H] and [G] when known concentrations of host and guest are mixed together. This is typically 
ascertained through titration of known concentrations of guest into host (or vice versa), with the 
concentration of host-guest complex determined at each point in the titration through analysis of the 
experimental data. A combined mixture of host and guest is typically titrated into host, in order to 
keep the concentration of host constant while the concentration of guest steadily increases throughout 
the titration.16 
The most typically used method for determination of association constants is an NMR spectroscopy 
titration, as this method can also give critical information about binding kinetics and structural 
information of the host-guest complex. The exact method used to extract the association constant 
from experimental NMR titration data is dependent on the exchange rate (kex) of free guest with guest 
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 𝐺 =   𝐺 𝑡𝑜𝑡𝑎𝑙 − [𝐻𝐺] 
bound to the host, which is related to binding affinity (Ka), temperature of the system and several other 
factors. How fast or slow this rate of exchange is relative to the difference between the frequency 
(chemical shifts in hertz) of bound and unbound forms of the host (Δω = ωHG-ωH) can result in several 
different outcomes observed in NMR titration spectra (Figure 4).17  
If rate of exchange is much faster than the difference in frequency between the bound and unbound 
species (fast exchange, Equation 5), then a time averaged spectrum is obtained – where separate 
signals for both host (δH) and host-guest (δHG) coalesce into one signal (δobs, Equation 6). The mole 
fractions of each species (Equations 7 and 8) then determine the chemical shift of this averaged 
signal.16 
 
           (Eqn. 5)  
           (Eqn. 6) 
     (Eqn. 7)      (Eqn. 8) 
 
This is observed during a NMR titration, where addition of guest to host causes a change in chemical 
shift (Δδobs) for the host signals. At each point in the titration, the chemical shift of the host-guest 
complex (δHG) is a representation of the mole fraction of the host-guest complex (XHG) and thus can be 
used to calculate the concentration of host-guest complex ([HG], Equations 9, 12 and 13). This can in 
turn be used to determine the remaining concentrations of free host ([H]) and free guest ([G]) using 
equations 10 and 11, and inputting these values into Equation 2 can yield an association constant (Ka).16 
           (Eqn. 9) 
 
     (Eqn. 10)      (Eqn. 11) 
 
           (Eqn. 12) 
 
           (Eqn. 13) 
 
 𝐻 =   𝐻 𝑡𝑜𝑡𝑎𝑙 − [𝐻𝐺] 
𝛿𝑜𝑏𝑠 =  𝛿𝐻






 𝐻𝐺 =  
 𝐻 𝑡𝑜𝑡𝑎𝑙 (𝛿𝑜𝑏𝑠 − 𝛿𝐻)
(𝛿𝐻𝐺 − 𝛿𝐻)
 
𝐹𝑎𝑠𝑡 𝐸𝑥𝑐ℎ𝑎𝑛𝑔𝑒, 𝐾𝑒𝑥  ≫ 𝛥𝜔 
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𝑆𝑙𝑜𝑤 𝐸𝑥𝑐ℎ𝑎𝑛𝑔𝑒, 𝐾𝑒𝑥  ≪ 𝛥𝜔 
 𝐻𝐺 =  
𝐼𝑛𝑡𝐻𝐺
𝐼𝑛𝑡𝐻𝐺 + 𝐼𝑛𝑡𝐻
  × [𝐻]𝑡𝑜𝑡𝑎𝑙  
A very different scenario is observed when a host guest system operates with ‘slow exchange’ kinetics. 
This occurs when the rate of exchange between bound and unbound guests is much slower than the 
difference in frequency between bound and unbound species (Equation 14). This results in observation 
of two discreet signals for both bound and unbound species of host, with signals relating to the host-
guest complex (HG) increasing in intensity as more of the host becomes bound by guest during a 
titration, until the host is saturated with guest and only signals pertaining to the host-guest complex 
remain. Determination of association constant (Ka) is therefore determined by integration of host-
guest signals (IntHG) relative to those of the free host (IntH). This ratio can be used to determine the 
concentration of host-guest complex ([HG], Equation 15), and thus [H] and [G] at each point in the 
titration. Inputting these values into equation 2 as for fast exchange systems yields the association 
constant (Ka).16 
 
           (Eqn. 14) 
           (Eqn. 15) 
 
However, if the rate of exchange (kex) is similar or equal to the difference in frequency of bound and 
unbound host species (Δω), then a combination of the effects from fast and slow exchange spectra are 
observed – termed ‘intermediate exchange’. This ultimately results in significant line broadening of 
host signals as guest is added, until the host signals end up with very large spectral line widths 
(sometimes completely unobservable in a spectrum) upon saturation with guest. This usually means 
that no association constant (Ka) can be determined from the experimental data and an alternative 


















Figure 4 Partial 1H NMR spectra displaying examples of host-guest systems in different exchange rate regimes: 
fast exchange (A), intermediate exchange (B) and slow exchange (C). 
If a secondary method is required to determine binding affinities, theoretically any measurable output 
that changes upon formation of a host-guest complex can be used. Some common methods used 
include UV-vis or fluorescence spectroscopy titrations, whereby the change in absorbance or emission 
intensity (ΔI) is measured as a host molecule becomes complexed to a guest. The change in this 
‘observable’ value (i.e. Iobs for UV-vis or fluorescence) can be used to calculate [HG] and thus Ka in much 
the same way as changes in chemical shift (δobs) were used in fast exchange systems in NMR titrations.16 
The majority of the above discussion pertains to a 1:1 binding stoichiometry, where one host binds to 
one guest. If multiple binding stoichiometries were observed, such as one host binding two guests, 
then the equations used to calculate [HG] and thus association constant (Ka) would be much more 
complicated. However, the vast majority of the work discussed in thesis will be related to 1:1 binding 
stoichiometries. Therefore discussion relating to multiple binding stoichiometries will not covered in 
great detail in this thesis. 
Fast Exchange 
kEx >> Δω 
Intermediate Exchange 
kEx ≈ Δω 
Slow Exchange 
kEx << Δω 
A B C Increasing [HG] 
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1.3 Carbohydrate recognition by synthetic lectins in organic media 
The binding of carbohydrates through non-covalent interactions by a synthetic receptor is more easily 
attainable in organic solvents than in water, as the competitive nature of the solvent is less of a 
consideration.18 The more manageable solubility of the receptor is also of benefit. With no competition 
from the background solvent, the H-bond interactions between polar groups and the carbohydrate 
becomes the predominant factor in acquiring good affinities in more apolar media.19 Thus 
arrangement of potential H-bond donors must be carefully considered to maximise favourable 
interactions. The poor solubility demonstrated by some carbohydrates in organic solvents also requires 
the receptor to encapsulate and essentially solubilise the substrate, although modification to the sugar 
with aliphatic solubilising groups can circumvent this (such as for octyl glucosides 11 and 12, Figure 5). 
While not fully representative of carbohydrate recognition in water, investigations in apolar solvents 
can allude to potentially active supramolecular architectures that could be developed further to 
function in an aqueous environment. 
One of the earliest examples was reported by Aoyama and co-workers, where calixarene 10 was shown 
to bind octyl glucosides 11 and 12 via a 2:1 host to guest encapsulation in chloroform (Figure 5). 
Association constants of 3 × 108 M-2 were obtained, with the sugar bound by complementary hydrogen 
bonds between hydroxyl groups of both the substrate and receptor. Future modification to the 
calixarene scaffold with anionic appendages enabled solubility in aqueous media although a reduction 
in affinity accompanied this, most likely a result of competitive solvent binding.20 
 
Figure 5 Calixarene 10 synthesised by Aoyama and co-workers showed evidence of binding octyl D-glucosides (α 
= 11 β = 12) in chloroform via dimerisation of the receptor to encapsulate the sugar (R = C11H23).20 
Another early example was macrocyclic cholaphane 13 reported by the Davis group, which was able 
to extract methyl β-D-glucoside 14 from water into chloroform (Figure 6). The rigid steroidal backbone, 
derived from cholic acid, demonstrated a degree of pre-organisation. This conformational inflexibility 
forced the axial H-bond donor hydroxyls to be orientated towards the substrate binding site, resulting 




Figure 6 Macrocycle 13 synthesised by Davis and co-workers, which was shown to extract methyl-β-D-glucoside 
14 from aqueous solutions in chloroform.21, 
More recently Roelens et al have demonstrated that podand 15 binds octyl β-D-glucoside 12 strongly 
in both 1:1 and 2:1 receptor/substrate stoichiometries in chloroform (Figure 7). The high degree of 
pre-organisation is achieved through the 1,3,5-ethyl groups sterically locking the H-bond accepting 
pyrrole moieties in a tripodal arrangement.22 This design was then developed further to cryptand 16, 
increasing the degree of pre-organisation. This effectively generated a cavity that can fully encapsulate 
the sugar in a 1:1 binding fashion. This delivered an improved Ka of 4 × 104 M-1 for 12 in chloroform, 
but also increased selectivity to just the β-anomer with no binding observed for the α-anomer.23 
 
Figure 7 Synthesis and development of podand 12 to cryptand 13 and the resultant increase in pre-organisation 
by Roelens and co-workers. Both receptors show good affinities for octyl β-D-glucoside 9 in chloroform.22,23 
The same 1,3,5-triethyl benzene scaffold was also incorporated into a several receptor designs by 
Mazik and co-workers, with both acyclic and monocyclic variants reported (Figure 8). These also 
showed appreciable affinities for their corresponding guests, with acyclic receptor 17 affording an 
affinity of Ka ~1.3 × 105 M-1 for 12 in anhydrous chloroform, with two receptors binding to one guest.24 
Evolution of this design to a monocyclic receptor improved affinities, where receptor 18 provided a Ka 
of ~3 × 105 M-1 towards 12 in chloroform.25 Small additions of water or DMSO severely reduced the 










Figure 8 Carbohydrate receptors reported by Mazik et al, both of which incorporate the 1,3,5-triethylbenzene 
scaffold. Acyclic receptor 17 and monocyclic receptor 18 both display affinities for 12 of Ka > 105 M-1 in 
chloroform.24,25 
Helical oligoamide 19 was also recently reported by Huc and colleagues to display excellent selectivity 
and affinities for D-fructose 20 over other common monosaccharides (Figure 9). Association constants 
of ~3 × 104 M-1 were consistently obtained for several variations of the foldamer in a 4:1 mixture of 
chloroform/DMSO. This activity is a result of the oligoamide elegantly coiling around the substrate in 
a helical fashion, encapsulating the sugar and delivering both H-bond donors and acceptors where 
required. Each iteration of the oligoamide was generated via repeated modulation of the amide 
backbone in conjunction with molecular modelling to further refine each design. This process was 











Figure 9 Helical foldamer 19 reported by Huc et al shows good selectivity and affinity for D-fructose 20 in 4:1 
chloroform/DMSO. The oligoamide helically encapsulates the substrate, providing H-bond donors and acceptors 
where appropriate. Figure reproduced with permission from Nature Publishing Group.26 
1.4 Carbohydrate recognition by synthetic lectins in aqueous media 
Selectively binding carbohydrates is significantly more difficult in water than in apolar organic solvents. 
This is due to the competitive association of water molecules in the receptor binding site, which often 
becomes solvated with a network of water molecules.18 The receptor must then possess sufficient 
affinity for a substrate to favourably displace these water molecules into the bulk solution. To achieve 
this in an aqueous environment means that corresponding interactions to accommodate all regions of 
the carbohydrate must be incorporated into the binding pocket, as hydrogen bonding is difficult to 
utilise as the dominant interaction. The other key obstacle is that the receptor must be sufficiently 
soluble in water and still be able to maintain a defined binding site. Self-binding and aggregation must 
not occur, as well as the binding site being sufficiently rigid to prevent collapse of the cavity and thus 
obstruct entry of the substrate. With this in mind, it is unsurprising that few examples exist of synthetic 







Figure 10 Anthracenyl boronic acid based receptors 21 and 22 synthesised by Yoon and Czarnik. Receptor 23 was 
reported by Shinkai and co-workers, and demonstrated improved selectivity for D-glucose as well operation over 
a broader pH range.28,29 
While such challenges are apparent for non-covalent recognition systems, they can be mitigated by 
using a reversible covalent reaction to bind substrates. The most prevalent example to exploit this 
methodology is the reversible interaction of 1,2 and 1,3-diols with aryl boronic acids.30 Early examples 
by Yoon and Czarnik demonstrated that anthracenyl boronic acids 21 and 22 provided a direct 
fluorescence response upon binding carbohydrates (Figure 10).28 Selectivity was increased upon 
modification of these earlier designs by Shinkai et al to allow partial encapsulation of the sugar in a 
shallow binding site, with complementary CH-π interactions provided by the anthracene which also 
delivered a measurable fluorescence output (receptor 23, Figure 10).29 While good affinities for 
carbohydrates with boronic acids are possible, good selectivities can be difficult to achieve, as boronic 
acids complex polyols in general.31 Another consideration is that the equilibrium of the diol co-
ordination to boron is highly pH sensitive, generally favouring pH ranges above physiological levels (pH 
~9-10), although this can be relieved somewhat by pendant Lewis bases (such as the tertiary amines 
seen for 23).32 
Novel receptor designs based upon non-covalent interactions are rare however. The majority of 
examples focus on rigid cage-like structures that maintain a centre cavity for the substrate to occupy. 
These ‘temple’ style receptors employ complementary apolar and polar interactions, and generally 
correlate best to all equatorial substrates, such as β-D-glucose (Figure 11), which can be considered as 
having separate polar and apolar regions (Figure 2). There are two key interactions involved: CH-π 
interactions between the axial hydrogens of the sugar and the aromatic surfaces of the receptor 
accompany hydrogen bonds between the equatorial ring of hydroxyls and the polar spacer units. This 
simplified schematic allows a degree of modularity when designing a receptor and the Davis group has 




Figure 11 Simple schematic of a ‘temple’ style receptor designed to bind β-D-glucose. Complementary 
interactions between apolar (blue) and polar (red) regions of both the substrate and receptor are shown in the 
binding cavity. 
 
Figure 12 Synthetic lectin 24 reported by the Davis group, showing excellent selectivity for N-acetyl-D-
glucosamine 7 when R = H.33 Installation of alkoxy substituents increased affinity for 4 and decreased it for 7¸with 
the optimum binding observed when R = OPr.34 
Macrocycle 24 (R = H) was an early attempt in the Davis group to replicate the temple design as a 
molecular architecture (Figure 12). The biphenyl ceiling and floor is designed to be flush against the 
sugar to provide CH-π interactions with the axial hydrogens of the substrate. The isophthalamide 
spacer units provide structural rigidity to maintain the open cavity as well as hydrogen bonding 
interactions with the equatorial hydroxyls of the carbohydrate. Water solubility was achieved through 
pendant tris-carboxylate chains on each spacer unit, yielding a total of twelve negative charges that 
make the molecule sufficiently polar to dissolve in aqueous media. This design was found to be very 
selective for β-N-acetylglucosamine 7, affording a Ka of 630 M-1.33 This is very comparable to natural 
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lectin wheat germ agglutinin, which has an affinity for 7 of Ka ~ 730 M-1. Modification of the biphenyl 
to accommodate terminal alkoxy groups decreased selectivity for 7 but increased selectivity for β-D-
glucose 4, with the propoxy derivative (R = OPr, OC3H7) proving the most effective with a Ka of 60 M-
1.34 This is believed to be primarily due to the alkoxy chains pointing inward towards the cavity, thus 
altering the cavity size and shape. 
Evolution of the temple design led to the synthesis of simplified anthracene receptor 25 (Figure 13). 
This new design was significantly more synthetically accessible than previous iterations and could be 
accessed after just five steps, which is fifteen less than the synthetic route for 24. Despite this dramatic 
simplification there was no loss in performance, with 25 selectively binding β-D-glucose with a Ka of 
56 M-1 in water.35 This new receptor opted to substitute out the biphenyl surfaces for anthracene. 
Biphenyl units have a tendency to twist out of the plane with respect to one another due to steric clash 
of the ortho hydrogens. The rationale with this new design was that the condensed aromatic surfaces 
would thus provide a more consistent interaction surface for axial hydrogens of the sugar as no such 
distortion would now be possible. 
 
Figure 13 Simplified anthracene based receptor 25, which shows comparable performance to 24 for binding β-
D-glucose 4 in water.35 
Receptor 25 also halved the number of polar spacer units from four to two, which resulted in a much 
more flexible molecule. A balance of flexibility and pre-organisation is required for good binding 
affinities, and it was found that 25 adopted a partially open conformation in solution. Entry of a 
substrate into the cavity then induces a conformational change which opens up the binding site to fully 
encapsulate the sugar. Anthracene is inherently fluorescent and this conformational change upon 
binding induced a fluorescent response that was quantifiable and proportional to the degree of 
substrate bound within the cavity. This enables a secondary method of sensing glucose binding within 
the receptor and suggests potential for 25 in the application of glucose monitoring for diabetes.35 
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Extension of the solubilising group to larger dendrimers for 25 increased affinities for β-D-glucose 4, 
with 2nd generation “medium-medium” dendritic solubilising group 26 (known within the Davis group 
as G2MM) providing an improved Ka of 90 M-1 in water (Figure 14). A high affinity and selectivity was 
observed for charged substrates such as D-glucosamine 28, with 26 giving a binding affinity of Ka ~ 
2400 M-1. Extension to higher order dendrimers only appeared to increase this observed affinity and 
selectivity. Dendrimer 27 affords a Ka of ~7000 M-1 for 28 and shows reduced affinity for D-glucose 4. 
The affinities observed for 26 and 27 with D-glucosamine 28 are speculated to result from strong 
charge-charge interactions, which is now possible due to the increased length of the solubilising 
chains. The terminal carboxylates are now able to enter the cavity and form a salt bridge with the 
charged groups on the sugar. The larger dendrimers are believed to be under less strain, as well as 
featuring more carboxylate groups, when forming this salt bridge and thus are capable of higher 
affinities.36 
 
Figure 14 Extension of the dendrimer to G2MM solubilising group 26 and larger dendrimers 27 increases 
selectivity and affinity for charged sugar D-glucosamine 28 in water.36 
While receptors 24 and 25 showed good activity for monosaccharides, larger substrates did not display 
good affinities. Receptors 29 and 30 were based upon 24 but utilised meta and para-terphenyl surfaces 
to extend the cavity horizontally, increasing the cavity size to accommodate larger sugars (Figure 15). 
Indeed, both showed good selectivities for disaccharides but 30 bound substrates with much greater 
affinity (~5 times stronger binding than for 29). Receptor 30 afforded a Ka of 3300 M-1 for D-cellobiose 
31, which is very comparable to the typical binding strength that natural lectins possess (Ka ~ 103-104 
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M-1). Despite this apparent strong binding, further extension of the cavity horizontally to bind larger 
substrates is not practical and was predicted to result in too much flexibility, making it more difficult 
to maintain a defined cavity. Therefore such designs are limited to receptors akin to that of 30.37,38 
 
Figure 15 Terphenyl based receptors 29 and 30 feature extended cavities designed to accommodate larger 
substrates. Receptor 30 shows excellent selectivity and affinity for several key disaccharides including D-
cellobiose 31.37, 38 
The limitations of substrate size for 29 and 30 were eventually overcome via a new method of binding. 
Pyrene based receptor 32 features a three isophthalamide pillar arrangement to support the open 
cavity between two pyrene surfaces (Figure 16). While displaying only moderate binding for 
monosaccharides, the receptor showed strong affinity for D-cellobiose 31 with a Ka of ~5700 M-1; 
almost a two fold increase over terphenyl receptor 30. Cellulose derived oligosaccharides of increasing 
chain length were then subjected to binding strength investigations and it was found that D-
cellotetraose 33 had the strongest affinity with a Ka of ~15,000 M-1. Longer oligosaccharides were 
tested, but a reduction of association constant to Ka ~9,000 M-1 was observed and this was speculated 






Figure 16 Three pillar pyrene based receptor 32 was shown to be have very high affinities for cellulose derived 
oligosaccharides (such as D-cellotetraose 33). It is believed the sugar based polymer chain threads through the 
cavity until the most optimal configuration is achieved.39 
Extensive NMR spectroscopy studies and molecular modelling suggested that the oligosaccharide 
chain threads through the cavity and then rests with the middle glycosidic bond in the centre of the 
binding site (Figure 17). The terminal monomers are then solvated by the water or have additional 
interactions with the dendrimer solubilising groups. Once the sugar chain threads into the receptor, 
interactions are possible with any of the monomers but were least favoured with the terminal sugar 
units according to NOESY NMR spectroscopy. Once the oligosaccharide enters the cavity it can then 
thread through the cavity until the most optimal interactions are achieved (in this case, the middle of 




Figure 17 Molecular modelling of pyrene receptor 32 and D-cellopentaose, where optimal binding takes place at 






Figure 18 Analysis of receptor 32 and D-cellulose (left), and 32 and D-chitosan (right) using AFM. Observed height 
profiles for observed protrusions are consistent with receptor threaded onto polysaccharides.39 
With threading of oligosaccharides now established, the threading of polysaccharides was 
investigated. A solution of 32 and D-cellulose in 1M NaOH, and a mildly acidic (~pH 6) solution of 32 
and D-chitosan were studied by AFM for any evidence of threading (Figure 18). The height profiles for 
observed protrusions were consistent with the polysaccharides threading through the receptor cavity, 
and not with the receptor simply lying on top of the polymer surface. Control samples of the 
polysaccharides without receptor 32, were shown to adopt coiled aggregates and not the strands (D-
cellulose) or plates (D-chitosan) observed when receptor was also present. This would suggest that the 
bound receptor interferes with the self-association and folding of the substrates. D-Chitosan and 
receptor 32 were also found to be soluble across a broad pH range (pH 1-11), whereas the separate 
components are not, implying a mutual solubility was achieved as the host-guest pair. This result is the 












Figure 19 Racemic mixture of chiral receptors 34a and 34b showed unprecedented enantioselective recognition 
of N-acetyl-D-glucosamine 7, with one diastereomer binding 16 times more strongly than the other. R= water 
solubilising group.40 
More recently, chirality was incorporated into receptor design, with synthetic lectins 34a and 34b 
isolated as racemic mixture (Figure 19). No separation of the enantiomers was possible, but 
characteristic signals in 1H NMR allowed quantification of binding affinities for both receptors to 
different guests. Most notable was the enantiospecific recognition of N-acetyl-D-glucosamine 7, where 
one receptor bound 7 16 times stronger than the other. These synthetic lectins are the first examples 
of synthetic receptors showing enantiodiscrimination in water through non-covalent interactions. 
Receptors 34a and 34b also reported generally unprecedented affinities for several monosaccharides 
in water. These chiral synthetic lectins suggest that introducing chirality into the receptor design can 
improve complementarity towards carbohydrate substrates and thus bring receptor performance ever 
closer to biomimicry of natural lectins.40 
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Chapter 2 – Tetra Alkoxy Ester Anthracene Receptor 
2.1 Polysaccharides as a Target Guest Substrate 
D-Cellulose 8 is the most abundant organic molecule on Earth, acting as an important structural 
component of the primary cell wall in many green plants and algae.2 Equally considerable is D-chitin 9 
which is the second most abundant biopolymer and a major constituent of fungi and invertebrate 
exoskeletons.41 This makes both polysaccharides an almost inexhaustible source of carbon when 
selectively degraded to their corresponding monomer units using enzymes or reagents.42,43 D-cellulose 
8 can be converted to D-glucose 4 which is valued by the fuel and food industry, whereas D-chitin 9 
can be converted to N-acetyl-D-glucosamine 7 which has potential applications in medicine (Figure 
20).44 The main drawback to taking advantage of these materials is that cellulose and chitin do not 
dissolve in a neutral aqueous environment, making the polymeric material difficult to manipulate and 
process efficiently. Current chemical processing methods require elevated temperatures and extreme 
pH ranges.45 Therefore a host molecule that assists in the solubility of these polysaccharides in a 
neutral aqueous environment would allow enzymes or reagents that could convert the polymeric 
scaffolds to their equivalent monomers under mild conditions. Receptor 32 (Figure 16) has already 
proven capable of threading oligosaccharides through the binding cavity but is not very synthetically 
accessible.39 Receptors of alternate design that are more synthetically accessible could thread onto 
polysaccharide chains such as cellulose 8 and chitin 9. It is envisaged that such receptors would form 
pseudo rotaxanes upon binding with the polymer chain and that several receptors per polymer could 
solubilise the polysaccharide under mild aqueous conditions. 
 
Figure 20 The most abundant biopolymers: D-cellulose 8 and D-chitin 9 and their corresponding monomers D-
glucose 4 and N-acetyl-D-glucosamine 7. 
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2.2 Receptor Design and Retrosynthetic Analysis 
The main aim of this project was to design and develop novel receptors that are capable of binding 
oligo and polysaccharides by threading of the polymer chain through the cavity. As shown before, 
receptor 32 showed strong binding affinities for oligosaccharides derived from β-1,4 polysaccharides 
such as cellulose and chitosan, where the sugar chain was believed to thread through the central cavity 
(Figure 21).39 This new found activity was not observed for previous systems, such as for receptors 24 
and 25.33,35 This was postulated to be due to 32 having a slightly larger cavity which allows the terminal 
sugar to enter and then thread through until optimal interactions are achieved at the central glycoside 
bridge. Despite the promising results obtained for 32, the receptor itself was not trivial to synthesise 
as it requires a number of synthetic steps and functional group transformations (>20 steps), not all of 












Figure 21 Simplification of 32 to tetraurea 35 which takes inspiration from 25, where R indicates modification 
points that could aid solubility or binding in water. Receptor 25 shows very weak or no binding to 









Figure 22 Comparison of bis-amide (left, 10 bonds) and bis-urea (centre, 11 bonds) spacer units. Hypothesised 
hydrogen bonding array provided by the bis-urea spacer towards a diol motif commonly found in carbohydrates 
(right). 
Taking inspiration from the relatively simple synthetic route towards 25 (when compared to 32), the 
design for tetraurea 35 was proposed (Figure 21). The increased cavity size of 35 was to be achieved 
through lengthening of the polar spacer units by one bond length, progressing from a bis-amide to a 
bis-urea motif (Figure 22). While the bis-urea spacer enlarges the cavity, it would also effectively 
double the number of H-bond donors that are directed towards the hydroxyl groups of the sugar 
substrate within the binding site (Figure 22). The favourable intermolecular hydrogen bonds between 
the ureas and the oxygen lone pairs of the sugar were observed through Monte Carlo Molecular 
Mechanics (MCMM) which modelled the complex of the receptor and cellotetraose (Figure 23), which 
demonstrated hydrogen bonding with the central hydroxyls of the oligosaccharide chain once in the 
cavity. Variation of the H-bond donors has not yet been investigated for these temple style receptors 
and so the impact of this change upon receptor conformation and binding to smaller substrates (such 
as D-glucose) will also be explored. The bis-urea spacer unit also holds the aromatic surfaces further 
apart: approximately 8.5 Å, which is close to ideal for accommodating a carbohydrate. This increased 
distance is also significantly larger than that required for π-π stacking of aromatics (~7 Å) and was 
predicted to disfavour the binding of aromatic guests. The strong binding of small aromatics is a known 
problem for the selectivity of carbohydrate receptor 25, which has a smaller distance between the 
aromatic surfaces. The anthracene units of 35 run parallel with the polysaccharide to maximise CH-π 









Figure 23 Monte Carlo Molecular Mechanics (MCMM) of the tetraurea anthracene 35 and D-cellotetraose 33, 
showing the urea hydrogen bonds and the central hydroxyls near the glycosidic bond (dashed lines). Force field 
used: OPLS2005 with aqueous GB/SA solvation. 
Initial synthetic efforts targeted receptors of the design 36 (Scheme 1). These feature four alkoxy 
carboxylate groups per anthracene, eight in total per receptor, to aid solubility in aqueous media. The 
classical temple systems, such as 25, featured the solubilising groups on the polar linkers. These 
anthracene systems were water soluble with as few as six carboxylate groups, so it was rationalised 
that eight carboxylates for 36 would provide sufficient solubility of the receptor in water. Attachment 
of the solubilising groups to the anthracene (in the case of 36) was to allow development of 



















Scheme 1. Retrosynthetic analysis of tetraurea macrocycle to anthracene diamine (X = suitable leaving group, 
e.g. OC6F5, Cl etc.). 
The key step in the synthesis of 36 was formation of the tert-butyl protected macrocycle 37, which 
involves cyclisation of 1,2-phenylene diamine 38 and an activated amide/carbamate 40 or isocyanate 
intermediate 39 to install the urea functionality (Scheme 1). These isocyanates or activated 
amides/carbamates are synthesised after functional group conversion from the corresponding 
anthracene diamine 41. A synthetic route towards 41 had already been established previously in the 
Davis group (Scheme 2), although yields for reduction of azide 42 to amine 41 were poor (~30%).46 
Therefore further optimisation of this step was considered desirable during the synthesis to maintain 
efficiency of material. Once the protected macrocycle 37 can be synthesised, deprotection of the tert-
butyl esters to the carboxylate via acid and subsequent neutralisation to neutral pH yields the water 




Scheme 2. Retrosynthetic analysis of the tetra ester anthracene diamine 41 
It should be noted that the reverse route which features a 1,2-diisocyanatobenzene 49 and the 
anthracene diamine 41 (Scheme 3) was hypothesised to not be viable, due to the inherent instability 
of 49. Literature regarding 49 was scarce but suggests issues with polymerisation and intramolecular 
cyclisation (Scheme 4).47 Unpublished work within the Davis group reinforces this hypothesis, as Boc 
protected carbamate 53 was shown to unintentionally cyclise through reaction with the adjacent 
imidazole urea (Scheme 5).48 Both of these functional groups are less reactive than the equivalent 
amine and isocyanate present on intermediate 50. It was therefore predicted that similar, if not worse 

























Scheme 5. Cyclisation of tert-butyl carbamate 53 onto imidazole urea to give cyclic urea 54 and imidazole 55, as 








Scheme 6. (i) H2SO4, MeCN, -10 °C, 2h, 61%; (ii) BBr3, CH2Cl2, reflux, 16h, 79%. 
Initial construction of the anthracene scaffold 46 was carried out by a condensation between 1,2-
dimethoxybenzene 47 and acetaldehyde 48 in concentrated sulfuric acid (Scheme 6). It was found that 
maintaining a temperature below 0 °C was crucial to preventing polymerisation and thus increase the 
yield. The resultant crude mixture obtained was highly insoluble and proved difficult to purify. 
Purification by flash column chromatography using chloroform as an eluent was somewhat successful, 
although had to be performed in batches on large scale due to insolubility. Demethylation of 46 to 








Scheme 7. (i) tert-butyl bromoacetate, K2CO3, THF, reflux, 16h, 67%; (ii) NBS, ABCN, DCM, reflux, 1h, 98%. 
Alkylation of 45 with tert-butyl bromoacetate in basic conditions then delivered tetra ester 44 in good 
yield after column chromatography (Scheme 7). A radical bromination of 44 with N-bromosuccinimide 
and radical initiator ABCN then afforded the dibromide 43 in quantitative yield. No further purification 
was necessary after extraction of the bromide using dichloromethane and washing with aqueous base 











Scheme 8. (i) NaN3, MeCN, reflux, 3h, 98%; (ii) PMe3, H2O, THF, rt, 16h, 98%. 
The corresponding diazido anthracene 42 was then obtained through SN2 substitution of the bromide 
43 with sodium azide, which was obtained in a near quantitative yield (Scheme 8). The crude azide 42 
was then converted to the desired diamine 41 in a quantitative yield via a Staudinger reaction using 
trimethylphosphine in THF. It was found that using a great excess (up to 20 equivalents) of phosphine 
was needed to drive the reaction to completion and overcome the poor yield previously reported for 
this transformation. The residual trimethylphosphine oxide was also easily removed by sublimation via 





Scheme 9. (i) Triphosgene, NaHCO3 (aqueous, 0.1 M), CH2Cl2, 0 °C, 30 min, 96%. 
With diamine 41 in hand, the next stage was to convert it to either an isocyanate 39 or activated 
amide/carbamate 40, which would allow access to the macrocycle upon reaction with 1,2-phenylene 
diamine 38 (Scheme 1). It was decided to pursue the isocyanate route initially, as the group had 
previously experienced success in their use for urea bond formation in the synthesis of anion 
transporters. Anthracene diamine 41 was then exposed to previously reported conditions that make 
use of a biphasic solvent system (Scheme 9), which afforded diisocyanate 39 in an excellent yield with 
no further purification necessary. A very clear shift downfield of the methylene peak adjacent to 
nitrogen was observed in the 1H NMR, but the isocyanate carbon itself proved too weak to be observed 
by 13C NMR. The NCO functional group showed a reasonably strong characteristic infra-red stretch at 
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~2250 cm-1 however, and this was used to confirm the presence of the isocyanate functional group. 
While the product obtained was a solid, it showed slow degradation in air and hydrolysis in solution 
over time. Storage under nitrogen in the solid state at 0 °C was necessary if kept for periods of time 












Scheme 10. Attempted Macrocyclisation with diisocyanate 39 and two different diamino benzenes 38 and 56. 
Initial attempts to cyclise 39 with 1,2-diamino-4,5-difluorobenzene 56 were unsuccessful (Scheme 10, 
R’ = F), with none of macrocycle 57 observed in the crude reaction mixture (by 1H NMR or mass 
spectrometry) or after purification by reverse phase HPLC. The fluorinated diamine 56 was initially 
chosen with the intent that the fluorine would allow easy identification and characterisation of the 
product by 1H and 19F NMR. It was afterwards postulated that the negatively inductive effects of 
fluorine could reduce the nucleophilicity of the diamine, especially once one of the amines had formed 
a urea to make the half macrocycle. The reaction was then repeated with 1,2-phenylene diamine 38 
(R’ = H, Scheme 10), but again no macrocycle 37 was observed or isolated. Surprisingly, efforts to 
synthesise the half receptor 59 also failed using one equivalent of the diisocyanate 39 and 2 
equivalents of diamine 38 (Scheme 10). This lack of reactivity towards the isocyanate was unexpected. 
It was initially rationalised that either the tert-butyl esters make the approach towards the isocyanate 
too hindered for the diamine or that once a monourea is formed the resultant molecule becomes less 








Scheme 11. (i) Aniline, CH2Cl2, rt, 16h, 61 = 85%, 62 = 82%. 
To probe this apparent unreactive nature of the isocyanate, test reactions were undertaken to simulate 
formation of the half macrocycle. Simple diisocyanate anthracene 60 (R = H, Scheme 11) was 
synthesised from the corresponding diamine, which was prepared from literature procedure.49 
Conversion of this anthracene diamine to the isocyanate 60 was carried using the same procedure as 
for 39 (Scheme 9), and was then reacted with aniline in dichloromethane. After stirring for 16 hours 
bis-urea 61 precipitated out in an excellent yield. 61 proved to be highly insoluble in most organic 
solvents, except in more polar media such as DMSO or pyridine and this would indicate that insolubility 
of the macrocyclic intermediates could be a problem. The formation of this bis-urea however does 
suggest that the isocyanate was sufficiently electrophilic to react with the diamine, at least to form the 
half macrocycle, and that perhaps the steric hindrance of the tert-butyl esters could also be an issue. 
To probe this hypothesis, 39 was then reacted with aniline in dichloromethane. Resultant isolation of 
62 then appeared to disprove this, but its high degree of insolubility like 61 would agree with the 






Scheme 12. (i) 1,2-phenylenediamine 38, CH2Cl2, rt, 1h, 87%. 
Synthesis of the half macrocycle 59 was now a priority, so that its solubility could be better investigated 
and thus a more appropriate solvent be chosen for the macrocycle formation. Addition of diisocyanate 
39 to a large excess of diamine 38 (~20 equivalents, with previous attempts using <3 equivalents) 
afforded half receptor 59 in an excellent yield (Scheme 12). The large excess of diamine 38 was 
designed to maximise the exposure of isocyanate 39 to diamine and limit any potential reaction of half 
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receptor with isocyanate. As expected, 59 also proved very insoluble in most organic solvents, but 








Table 1. Solvents and conditions screened for macrocyclisation of 59 and 39. 
Entry Solvent Isolated 
Yield (%) 
Conditions Comments 
1 CH2Cl2 0 rt, 3 days Minor isocyanate hydrolysis, 
half receptor recovered. 
2 CH2Cl2 0 DIPEA, rt, 1 day Same as entry 1, isocyanate 
hydrolysed faster. 
3 CH2Cl2 0 reflux, 7 days Same as entry 1 
 
4 THF 0 reflux, 3 days Same as entry 1, half receptor 
less soluble. 
5 DMF - rt, 16h Consumption of half receptor, 
no separation by HPLC. 
6 CH2Cl2:pyridine 
(5:1) 
<10% rt, <3h Macrocycle observed in mass 





Several solvents and conditions were screened to promote formation of the target macrocycle 37 from 
half receptor 59 and diisocyanate 39 (Table 1). All reactions were performed at relatively high 
concentrations (5 mM) to promote any sign of reactivity, whereas macrocyclisation formations 
typically use more dilute conditions, such as 1-0.1 mM, to favour intramolecular cyclisation. Initially 
dichloromethane was chosen as a solvent to confirm the hypothesis that solubility of 59 was the 
limiting factor (entry 1, Table 1). Indeed, only a small amount of hydrolysis of isocyanate 39 was 
observed, with the half macrocycle 59 being recovered afterwards. Addition of the base DIPEA (entry 
2, Table 1) appeared to have no effect, except to accelerate the hydrolysis of the isocyanate 39. 
Refluxing the reaction mixture in dichloromethane (entry 3, Table 1) still showed the presence of 39 
and 59 after one week. Interestingly, addition of hexyl isocyanate to half receptor 59 in 
dichloromethane gave the corresponding tetraurea demonstrating that the half receptor was 
sufficiently nucleophilic. This might suggest any macrocyclic intermediates formed during entries 1-3 
are probably too insoluble to allow the reaction to proceed to completion. More polar solvents were 
then screened, but 59 appeared even less soluble in THF than dichloromethane and even upon 
refluxing no consumption of 59 was seen. Half macrocycle 59 proved to be highly soluble in DMF (entry 
5, Table 1) and was fully consumed after 16 hours at room temperature. Subsequent purification by 
preparative reverse phase HPLC proved non-trivial compared to previous macrocyclic systems in the 
group and it was eventually evident that a complex mixture of products had been obtained.  
Half receptor 59 was already known to be very soluble in pyridine which was to be the next solvent 
system to be investigated, and it was eventually found that addition of half receptor 59 in pyridine to 
a dilute solution of isocyanate 39 in dichloromethane (final pyridine to CH2Cl2, 1:5) showed complete 
consumption of both starting materials in under 3 hours, with new fluorescent compounds clearly 
visible by TLC. While this improved rate of reactivity could be attributed to improved solubility, pyridine 
is also known to act as a nucleophilic catalyst for acylation and could be activating the isocyanate via 
a pyridinium intermediate – thus increasing the electrophilicity at the isocyanate carbon, although 
some previous work disputes this hypothesis and suggests pyridine is merely acting as a base.50 
Analysis of the crude reaction mixture by mass spectrometry confirmed the presence of the target 
macrocycle 37. Initial purification by column chromatography and then analysis of this mixture by 
reverse phase HPLC suggested there were 3 major products (Figure 20) with similar retention times: 









Figure 24. Reverse phase HPLC traces of the partially purified reaction mixtures to form macrocycle 37, using 
reaction conditions outlined in entry 6, Table 1. The difference in reaction concentration can be seen, with a 
much cleaner reaction being obtained upon dilution of the reaction from 5mM (top) to 0.5 mM (bottom). 
Detection wavelengths of 370 nm were used to detect anthracene. Each run was performed using different 
eluent gradients, hence the differing retention times. Stationary phase: analytical scale C18, flow rate: 1 mL/min, 
eluents: acetone/water. 
These test macrocyclisations were performed relatively concentrated (5 mM), so dilution of the 
reaction mixture (0.1-1 mM) was expected to favour the intramolecular cyclisation that leads to the 
target macrocycle 37. Indeed, such a result was obtained upon dilution to 0.5 mM, as seen in the much 
cleaner HPLC trace obtained (Figure 24). Macrocycle 37 was then isolated by preparative HPLC in a 
moderate yield of 40%. Tetraurea 37 proved more soluble than half receptor 59 but displayed 
aggregation in most deuterated solvents during characterisation, even upon dilution. Using (CD3)2CO 
as a solvent was found to give the 1H NMR spectrum with the sharpest signals, although some peaks 
relating to the spacer aromatics were still heavily broadened. This could be due to slow conformational 
exchange caused by hydrogen bonding taking place between the ureas on the spacer units.  
 
 
Scheme 13. Diels-Alder addition of singlet oxygen to anthracene. 
Also evident was partial oxidation of one or both of the anthracene units over time, a result of a Diels-
Alder addition of singlet oxygen that forms an irreversible peroxide bridge across the central aromatic 
ring (Scheme 13).51 The mono-oxidised and bis-oxidised species were both observed using mass 
spectrometry, which would suggest they are relatively stable being able to survive the high energy 
environment during mass spectrometry. Such oxidation was observed to get progressively worse in a 
matter of hours during characterisation. Previous studies in the literature have demonstrated that the 
lifetime of singlet oxygen decreases significantly in protic solvents (such as methanol and water) due 
5 mM reaction 
0.5 mM reaction 
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to H-bond stabilisation, and that deuteration increases the lifetime.52,53 Therefore aprotic NMR 
solvents such as CDCl3 and (CD3)2CO are predicted to show increased rates of oxidation of anthracenes. 
Oxidation of anthracene has been prevalent in previous electron rich anthracene based systems in the 
Davis group46, but was not observed in this system until now. It was also not clear when this oxidation 
had taken place, so future efforts in synthesising 37 made sure to remove all oxygen from the system 
and minimise its time spent in solution. This resulted in removal of the flash column from the 
purification step and purification of the crude product only by preparative reverse phase HPLC as soon 








Scheme 14. (i) 43, CH2Cl2 and pyridine (10:1), 16h, rt, 56%. 
Further optimisation led to a reduction of pyridine used, from 5:1 (CH2Cl2:pyridine) to 10:1. This final 
optimised procedure (Scheme 14) afforded 37 in 56% yield, a relatively high yield when compared to 
previous macrocyclisations in the group (typically <20%).35,36 This might be due to the much faster 
cyclisation rate for 37 than for previous systems, thus preferentially forming the desired macrocycle 
before any side reactions or degradation of starting materials can occur. It was also be noted that a 
macrocyclisation (i.e. 2+2) between diisocyanate 39 and 1,2-phenylene diamine 38 in a 10:1 mixture 
of dichloromethane and pyridine was attempted. This yielded mostly half receptor 59 (>70%) and very 
little macrocycle 37 (<10%). It was not immediately clear why more of macrocycle 37 was not formed, 
but it was decided that the synthetic route via the half receptor was the best solution regardless, and 
the most efficient practically and chemically. 
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2.4 Attempts to access the water soluble macrocycle and investigations into macrocycle stability 
Now that the protected macrocycle 37 was in hand, deprotection of the tert-butyl esters affords the 
water soluble macrocycle 36 (Scheme 15). Once in water, oxidation of anthracene was expected to be 
no longer be an issue due to the stabilisation of singlet oxygen through H-bond donation from 
water.52,53 However, initial deprotection attempts using TFA (50% v/v) in dichloromethane, followed by 
neutralisation to pH 7 with aqueous sodium hydroxide, gave a fluorescent water soluble product that 









Scheme 15 (i) TFA (50% v/v), CH2Cl2, rt, 16h; (ii) NaOH (aq), H2O. Desired macrocycle 36 not observed. 
The 1H NMR spectrum in D2O of the major products was initially hard to interpret, but it was clear the 
product was no longer symmetrical. Particularly evident were an increased number of signals in the 
aromatic region (δ 7-7.8 ppm), as well as complex new signals in the aliphatic regions (δ 0.5-4 ppm). 
The broad residual water peak at 4.79 ppm obscured the region where the anthracenyl and carboxyl 
methylene signals are usually observed, which meant that all structural information was to be 
garnered from the aromatic region of the spectrum. Interestingly, sequential additions of CD3OD 
resulted in an increase in resolution of signals in the aromatic region, until at 100% CD3OD the 
spectrum in Figure 25 was obtained. The majority of NMR analysis was thus carried out in CD3OD due 













Figure 25 Partial 1H NMR spectra (400 MHz, 298 K) of the major product using conditions in Scheme 15, focusing 
on the aromatic region (δ 6.7-8.1 ppm). Increased resolution of peaks can be seen using CD3OD (top) as a solvent 
when compared to using D2O (bottom) as a solvent. 
Extensive NMR analysis using 1D and 2D NMR characterisation techniques confirmed that the 
deprotection had reached ‘completion’, with no evidence for any tert-butyl groups to still be present. 
The increased resolution of the spectra in methanol compared to water could infer intermolecular 
aggregation or slow conformational exchange was occurring in water. This was disproven however 
when dilution (to less than 0.1 mM) and variable temperature (20-80 °C) studies in both solvents 
suggested the asymmetry was not a result of aggregation or of conformational origin. Another 
hypothesis was that the tert-butyl cations generated during the deprotection were potentially 
interfering with the reaction.54 Commonly used cation scavenger triethylsilane was tested but the 
same complex product was consistently obtained. Any reaction products were not detected by mass 
spectrometry due to the presumed difficulty of accelerating ions derived from polycarboxylic acids, 
even at acidic pH in a variety of solvent mixtures. Derivatisation of the presumed carboxylates to 
methyl esters was intended to enable purification or ease characterisation by NMR and mass 
spectrometry. However, conversion to the methyl ester via Fischer esterification was unsuccessful and 
only afforded a more complex NMR spectrum, possibly due to incomplete reaction or eventual 
oxidation of anthracene. 
A notable observation during the NMR analysis of this unknown product was that the carbon signal 
for the anthracenyl CH could not be found. Such a signal had been very consistently observed (at ~105 





characteristic signal was not observed during characterisation of the deprotection product. It was also 
found that despite varying the reaction times from 30 minutes to 16 hours, the product obtained was 
very consistent which implied that this unexpected reaction was very fast. 
This information would suggest that an acid promoted loss or destruction of the anthracene core was 
taking place. Three potential acid promoted side reactions were hypothesised. Firstly, α-elimination of 
water from the carboxylic acid can give an acylium ion (see Hayashi rearrangement and Schmidt 
reaction).55,56 This was then followed by a 5-exo-dig cyclisation and loss of a proton to restore 
aromaticity which gives a cyclic ketone (Scheme 16). An alternate pathway would be protonation of 
the carboxyl carbonyl followed by a 5-exo-trig cyclisation to form a geminal diol, this intermediate can 
then lose water to form a cyclic ketone (Scheme 17). Both of these reaction pathways would be 
promoted by the electron donating alkoxy groups on the anthracene facilitating the cyclisation step. It 
was unknown how many cyclisations could occur per anthracene but this outcome could lead to 
asymmetrical products – resulting in complicated product NMR spectra. An additional possible side 
reaction was the acid promoted heterolytic cleavage of the urea at the benzylic position (Scheme 18). 
This would yield a benzylic cation, which would be stabilised through resonance of electrons in the 
electron rich anthracene. Loss of a proton can then facilitate formation of a bis-alkene. Loss of 
aromaticity is compensated by delocalisation of electrons into the anthracene ring system, from the 
alkoxy substituents. Such a reactive intermediate as the bis-alkene could then react further, leading to 














Scheme 16 Hypothesised mechanism for the 5-exo-dig cyclisation of anthracene and the pendant solubilising 










Scheme 17 Hypothesised mechanism for the 5-exo-trig cyclisation of anthracene and the protonated carboxylic 




















Scheme 18 Hypothesised mechanism for the acid promoted heterolytic cleavage of the benzylic ureas (A), 
generating a resonance stabilised benzylic cation (B). Loss of a proton generates a bis-alkene which is stabilised 
through resonance of the alkoxy groups. 
To elucidate which undesired reaction was taking place, as well as probe the instability of the 
macrocycle to acidic conditions, two model substrates were synthesised. One of these was designed 
to represent the urea spacers 63 and the other to represent the anthracene surface 64 of the 
macrocycle (Scheme 19). Model bis-urea 63 was synthesised and then exposed to TFA (50% v/v) in 
dichloromethane, with NMR of the crude reaction mixture showing no change after 2 days. Acetylation 
of diamine 41 afforded 64 which was then stirred in TFA (50% v/v) and dichloromethane for 16 hours. 
NMR analysis of the product after neutralisation to pH 7 revealed a mixture of products had been 
obtained. Some signals corresponded to those seen in the attempted deprotection of macrocycle 37, 
but the spectra obtained were still highly complex so full characterisation was not possible. These 
results would initially suggest that the anthracene unit was the source of the problem – possibly due 
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to the intramolecular cyclisations proposed in Scheme 16 and Scheme 17. The stability of 63 to acid 
infers that the heterolytic cleavage of the ureas (Scheme 18) was less likely. However, there was no 
reason to suggest such a reaction was not occurring for 64, since the anthracene units stabilise the 









Scheme 19 (i) benzyl isocyanate, CH2Cl2, reflux, 16h, 90%; (ii) Acetyl chloride, DIPEA, CH2Cl2, rt, 16h, 84%. 
In attempts to confirm which side reaction was occurring to macrocycle 37 and test substrate 64, 
further test reactions were performed on intermediate 44 (Table 2). Tetra ester 44 was subjected to a 
range of TFA concentrations for a set reaction time (16 hours), then neutralised to pH 7 and filtered, 
with the yield recorded and purity of product observed by 1H NMR. It was found that varying the 
concentration of TFA had no effect on the purity of the product obtained, with all test reactions yielding 
pure tetra carboxylate 65 (by 1H NMR analysis in D2O). Varying the concentration of TFA did have a 
dramatic effect on the yield of reaction however, with full conversion of 44 to 65 only observed when 
>30% (v/v) of TFA was used. It was speculated that lower concentrations of TFA reduce the rate of 
reaction, resulting in incomplete deprotection of 44. Such partially deprotected intermediates would 
not be soluble in water at pH 7, and are thus likely filtered out during the neutralisation process. This 
would explain the lower yields but pure products obtained for the lower concentrations of TFA. Most 
curiously however, was the complete lack of degradation of the anthracene when exposing 44 to high 
concentrations of TFA. This lends to the theory that no intramolecular cyclisations are taking place 
during deprotection of macrocycle 37 (Scheme 16 and Scheme 17) and that the decomposition 
observed was largely due to the cleavage of the ureas (Scheme 18) via a benzylic cation (stabilised by 




Table 2 TFA concentrations screened for test substrate 44; (i) TFA, Et3SiH, CH2Cl2, 16h, rt (ii) NaOH (aq), H2O. 
 
Entry TFA (% of total volume) Yield (%) Comments 
1 1 10 Pure after neutralisation 
2 5 21 Pure after neutralisation 
3 10 32 Pure after neutralisation 
4 20 67 Pure after neutralisation 
5 30 96 Pure after neutralisation 
6 50 Quantitative Pure after neutralisation. 
 
Despite this relationship of concentration of acid and yield of tetra carboxylate 65, it was decided to 
attempt the deprotection of macrocycle 37 with much lower concentrations of TFA (i.e. <10% v/v). It 
was speculated that a potential balance could be reached, where the concentration of TFA would be 
enough to drive the reaction to completion without decomposing the product. Macrocycle 37 was 
then exposed to several concentrations of TFA (1%, 2% and 5% v/v) for 6 hours, and the crude product 
analysed by 1H NMR (in CD3OD) before neutralisation to pH 7. Signals characteristic of the tert-butyl 
groups were clearly visible in the 1H NMR and confirmed by observation of the C(CH3)3 quaternary sp3 
carbon using 1H-13C HMBC. No degradation was observed which was deemed promising. However the 
reaction was now very slow to proceed, due to the decreased amount of TFA. Disappointingly, 
increasing the concentration of TFA to 10% (v/v) and above appeared to cause degradation of 
macrocycle 37, while still not removing all the tert-butyl groups. This would suggest the proposed urea 
cleavage occurs at a similar or faster rate than the deprotection, meaning the current deprotection 
strategy and conditions are not workable. No purification was deemed possible at this stage, so even 
if fully deprotected macrocycle 36 had formed there would be no way of accessing it. Later work 
revealed that the deprotected macrocycles could be purified by reverse phase HPLC (see Chapter 4, 












Scheme 20 (i) TFA (1-5%), Et3SiH, CH2Cl2, rt 6h; (ii) NaOH (aq), H2O. 
Macrocycle 67 (Scheme 21) was now proposed as a model substrate to investigate how sensitive the 
deprotection conditions were to changes in the linker functionality – with 67 employing a bis-amide 
spacer unit akin to more classical receptors such as anthracene receptor 25. This would demonstrate 
whether the electronics of the anthracene unit stabilising the benzylic cation are the source of the 
issues, and not the bis-urea linker functionality. If 67 did successfully deprotect to give a clean product, 
this would still yield a novel receptor and interesting comparison to 25.35 The effects of removing the 
dendrimer groups on binding properties has not been investigated before and this new anthracene 
surface may yet yield new interesting activities towards guest molecules. Synthesis of 67 proceeded 
smoothly. Reaction of diamine 41 with bis-pentafluorophenyl ester 66 gave 67 in 26% yield after 
purification by reverse phase HPLC. However, as seen before for 37, macrocycle 67 also displayed rapid 
oxidation of the anthracene surfaces in organic solvents (see Scheme 13). Oxidation would routinely 
occur during NMR characterisation – especially during the experiments with longer acquisition times 
(i.e. 1D 13C spectra, Figure 26). Attempts to remove oxygen from NMR solvents and use of amberised 
glass NMR tubes appeared to have little improvement. It is possible that the macrocycle resides in a 
conformation that promotes this oxidation, even more so than for 37. Use of protic NMR solvents (such 
as CD3OD) to suppress oxidation were not viable due to insolubility of 67 and so full 13C characterisation 
of 67 was not achieved. Despite incomplete NMR characterisation, 67 was exposed to similar acidic 
deprotection conditions as for 37. Neutralisation to pH 7 and subsequent 1H NMR analysis (in D2O) 
yielded a similarly complex spectrum as seen when attempting to deprotect 37. While the spectrum 
was not entirely consistent with the deprotection products seen for 37, differences were rationalised 
to be due to the different spacer units used for 67. It was very evident however that a single 
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symmetrical product had not been obtained. This result was deemed to corroborate with previous 
hypotheses: that the tetra carboxyl anthracene unit was the source of the issues by promoting 





















Figure 26 Partial 1H NMR (500 MHz, CDCl3, 298 K) of isolated receptor 67 (top) and partially oxidised receptor 








After 3 hours 
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Formic and acetic acid were then screened to see if weaker acids would reduce the amount of 
decomposition of 37. However, very little to no deprotection was observed when using weaker acids 
– even at high concentrations (>50% v/v of acid used). Varying the solvent was also investigated, with 
the use of more polar solvents lowering the acidity of TFA and in turn prevent the hypothesised 
cleavage of the benzylic ureas. However, as seen for the weaker acids, no reaction was observed when 
using TFA in alcohols. A reaction system of TFA in methanol was attempted to deprotect the tert-butyl 
esters and then convert them to the equivalent methyl esters, which could then be hydrolysed under 
mild conditions with aqueous base. Again, no deprotection of the tert-butyl groups was evident. 
There is literature precedent for base mediated hydrolysis of tert-butyl esters to the carboxylate but 
under forcing conditions with long reactions times.57 Despite this, various basic conditions were 
screened for the deprotection of 37 (Table 3). Unfortunately, none of the desired macrocycle 36 was 
observed by 1H NMR (in D2O) after neutralisation to pH 7 with acidic ion exchange resin. The NMR 
spectra obtained after using these conditions were arguably more convoluted than those seen for the 
acidic deprotections – a possible indicator for multiple species. The concentration of sodium 
hydroxide, as well as reaction time, were screened (entries 1-3, Table 3) to probe whether the ‘milder 
conditions’ (i.e. entry 1) were not enough to enable the reaction to reach completion. However, all 
produced complex mixtures. 
Entries 4 and 5 were derived from procedures for the hydrolysis of tert-butyl esters at room 
temperature using a 1:1 ratio of THF and methanol. However, the reaction at room temperature (entry 
4) appeared to be very slow as the NMR showed several tert-butyl ester species, presumably due to 
incomplete reaction. Refluxing this procedure (entry 5) instead appeared to cause a loss of urea linker 
signals, as did entry 6 when using tBuOK. Previous studies demonstrate that the hydrolysis of 
substituted ureas is possible under strongly basic conditions, which might explain the complex spectra 
obtained using these procedures. However, when model bis-urea 63 was refluxed in strongly basic 
conditions for 3 days (same as entry 3) there were no signs of hydrolysis. It could be speculated that 
macrocycle 37 is more sensitive to urea hydrolysis, particularly if the system resides in a higher energy 
strained conformation - as cleavage of the ureas would favourably relieve this strain. The long reaction 
times and forcing conditions could promote oxidation of the anthracene as well, even though all efforts 
were maintained to eliminate oxygen from the system.  
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Table 3 Bases, solvents and conditions screened for the base mediated hydrolysis of 37.  
 
Entry Base Solvent Conditions 
1 aq. NaOH (3M) THF reflux, 1 day 
2 aq. NaOH (4M) THF reflux, 1 day 
3 aq. NaOH (6M) THF reflux, 2 days 
4 aq. NaOH (6M) THF:MeOH (1:1) rt, 1 day 
5 aq. NaOH (6M) THF:MeOH (1:1) reflux, 2 days 
6 tBuOK THF rt, 1 day 
 
Evidently, the tert-butyl ester was not a suitable protecting group for macrocycle 37 given the observed 
sensitivity to acid. Therefore other routes to the carboxylate were considered. The simplest 
modification was to replacewitch the tert-butyl esters for methyl esters, which were expected to be 
sufficiently susceptible to hydrolysis under mild basic conditions. It was envisaged that the synthetic 
route would remain largely the same. Indeed, synthesis of tetra methyl ester 68 proceeded smoothly 
from tetra-ol 45 using methyl bromoacetate (Scheme 22). Conversion to the bromide 69 was found to 
be not possible however. Following work up and extraction, analysis of the crude material by 1H NMR 
gave a complex mixture featuring multiple methyl ester species. Signals relating to the anthracene 
were severely reduced, as was mass recovery of the product which was no longer fluorescent. Larger 
atoms such as bromides and iodides are known to quench fluorescence through collisional quenching 
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mechanisms which could explain this observation.58 The aqueous extraction phase was observed to be 
highly fluorescent however and it was initially postulated that the basic aqueous work up could be the 
source of the problem through potential hydrolysis of the methyl esters. However, analysis of the crude 
reaction mixture before work up also gave a complex mixture, with no major product discernible, 
suggesting the aqueous work up was not degrading the product. It was then hypothesised that the 
radical reaction was somehow interfering with the methyl ester side chains, although by what 
mechanism this could occur is unknown at this time. Considering the equivalent reaction with tert-
butyl esters occurs in quantitative yield, it would seem rational to suggest the newly substituted methyl 








Scheme 22 (i) methyl bromoacetate, K2CO3, THF, reflux, 24h, 65%; (ii) NBS, ABCN, CH2Cl2, reflux, 1h, bromide 69 
not observed. 
Other protecting groups strategies were considered after this, such as silicon containing esters that 
could be deprotected under very mild conditions with fluoride.59 However, after the numerous issues 
encountered with using highly substituted electron rich anthracene units (including acid instability and 
increased risk of oxidation), it was eventually decided to focus on a different receptor design that 
















Scheme 23 Successful methodology (Scheme 12 and Scheme 14) developed to access tetraurea macrocycle 37 
from diamine 38 and bis-isocyanate 39. Deprotection to water soluble macrocycle 36 was not achieved. 
Synthetic methodology towards incorporation of bis-urea spacer units into macrocycles was achieved, 
with the successful synthesis of tetraurea 37 after optimisation of the synthetic route (Scheme 23). 
Subsequent attempts to access the water soluble macrocycle 36 were not successful however (Scheme 
23). The deprotection of the tert-butyl groups was probed using reaction condition screening, in depth 
NMR studies and synthesis of test substrates. This work revealed that the electron rich anthracene 
units were potentially facilitating cleavage of the benzylic ureas via a benzylic cation intermediate, 
when exposed to acidic conditions. The electron rich anthracenes were also extremely susceptible to 
oxidation, making the macrocycles and intermediates difficult handle. No solution to obtaining 36 was 
able to be determined at the time of this work however, and it was concluded that heavily substituted 
electron rich anthracene units are not viable substrates to work with due to their instability to acid and 
sensitivity to oxidation. Future efforts would be directed towards other receptor designs that would 
not suffer from these problems. 
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Chapter 3 – Development of a Diamino Spacer Unit 
3.1 Design Rationale and Potential for Future Receptor Designs 
Following on from the successful synthesis of anthracene macrocycle 37 (and problems faced regarding 
instability of the macrocycle), efforts were directed towards installing a solubilising group on the urea 
spacer unit. To do so would require synthesis of an appropriate 1,2-diaminobenzene ‘linker’ with the 
solubilising group pre-installed. Development of this linker unit would enable the use of a much 
simpler anthracene core, when compared to the electron rich anthracene used for 37 (Scheme 24). 






Scheme 24 Proposed receptor design, featuring a new diamino linker unit and simple anthracene. 
Several potential designs could be envisaged, with maintaining symmetry of the macrocycle being a 
key consideration (Figure 27). Other desirable attributes would be a rigid ring structure to assist in 
maintaining a cage conformation of the macrocycle, as well as electron withdrawing groups to amplify 
the hydrogen bonding character of the ureas in the target receptor. Once a route towards this diamino 
linker had been established, it was to be incorporated into an anthracene based receptor (Scheme 24) 




Figure 27 Some examples of possible linker targets, where R = dendritic solubilising group.
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Proceeding this, now that the solubilising group was part of the spacer unit, various anthracene 
derivatives that alter the optical and electronic properties towards binding were to be investigated. 
Modularity would also exist with regards to the solubilising group, which could be tuned to optimise 
solubility, functionality at various pH ranges or even facilitate attachment to a solid state support or 
surface. This new linker could even be incorporated into different aromatic surfaces, thus generating 
a new library of receptors. The Davis group and others have developed methodology towards various 
aromatic amines previously (Figure 28).33,35,38,39,60 Conversion of these amines to the corresponding 
isocyanate and reaction with this new linker would yield the equivalent urea receptors – comparisons 








Figure 28 Examples of aromatic amines previously synthesised by the Davis group that have been incorporated 
into carbohydrate receptors.33,35,38,39,60 
3.2 Synthesis of Diamino Phthalimide Spacer 
The initial diamino spacer target to be pursued was diamino phthalimide 71, as this featured all the 
desired properties of symmetry, rigidity, and electron deficiency, as well as being synthetically 
accessible. The route towards 71 had already been partly undertaken in previous literature, which 
made the synthesis all the more theoretically feasible.61 Retrosynthetic analysis revealed that 71 could 
be accessed in 5 steps from commercially available 2-nitro-4,5-dimethyl aniline 78 (Scheme 25). The 












Scheme 25 Retrosynthetic analysis of the proposed diamino phthalimide 71, where R = solubilising group. 
The inherent protection of one of the amines as a nitro group 74 provides potential for two routes to 
the desired macrocycle (Scheme 26). Reduction to the diamine 71 and then reaction with diisocyanato 
anthracene 60 leads to the amino urea half receptor 80 (red box, Scheme 26). This intermediate can 
then react with another equivalent of isocyanate to yield the tetraurea macrocycle 81 in a similar 
fashion to 37 seen before (see Chapter 2). However, reaction of the unreduced nitro aniline 74 would 
afford the nitro urea half receptor 79 (blue box, Scheme 19). This could be a potentially cleaner 
reaction when compared to reaction with diamine 71, as there would be no potential for further 
reaction of the half receptor with more isocyanate. Reduction to the amine and subsequent cyclisation 
would then give the target macrocycle 81. Both routes were to be investigated for viability during the 
synthesis and were predicted to be largely reliant on how facile the reduction of the nitro groups of 



















Scheme 26 Two possible routes to the target macrocycle 81 via two different half receptor intermediates, where 




Scheme 27 (i) Acetic anhydride, Acetic Acid, reflux, 2h, 98%; (ii) KMnO4, H2O, reflux, 3 days, 67%. 
Commercially available 2-nitro-4,5-dimethyl aniline 78 was acetylated with acetic anhydride in 
refluxing acetic acid to afford 77 in near quantitative yield (Scheme 27). Acetylated amine 77 had been 
oxidised to the bis-acid 76 previously in the literature using potassium permanganate, although no 
reaction temperature or time was given in the procedure.61 It was found that oxidation with potassium 
permanganate in refluxing water for 3 days gave 76 in good yield, with no purification necessary after 
work up. It was also found that the oxidative conditions unexpectedly resulted in deprotection of the 
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acetyl group as well, effectively removing the step from the route. Acetylation of 78 was found to be 
critical to oxidation, as attempted oxidation of 78 using the same conditions, resulted in near 
quantitative recovery of starting material. Esterification with methanol and catalytic H2SO4 allowed 
purification and subsequent characterisation of the reaction products. It was found that the main 
product was the desired bis-acid 76 and the minor products were two mono carboxylic acid isomers. 
Therefore, future procedures featured additional equivalents of potassium permanganate being added 
part way through the reaction. This resulted in a reduction of yield of the mono carboxylic acid isomers, 




Scheme 28 (i) Acetic anhydride, THF, reflux, 16h; (ii) benzylamine, acetic acid, reflux, 3h, 87%. 
Dehydration of 76 to the anhydride 75 was achieved by addition of acetic anhydride and then refluxing 
in THF (Scheme 28). Conversion to 75 was inferred by TLC and 1H NMR of the crude reaction mixture, 
with 75 being used immediately without purification in the next step to form the phthalimide. To test 
phthalimide formation, benzylamine was added to 75 and then refluxed in acetic acid to promote ring 














With model phthalimide 82 successfully synthesised, the procedure was repeated with the 2nd 
generation amine solubilising group (G2MM, Scheme 29) 83, which was prepared according to 
previous literature.36 However, none of the desired product was observed in the crude reaction 
mixture by mass spectrometry or after attempted purification. It was thought that the tert-butyl esters 
of 74 might be partially deprotected in the acidic solvent, and that the high temperatures help force 
this deprotection even in relatively weak acid (compared to TFA). The reaction solvent was then 
changed to toluene and the test reaction repeated to form model benzyl phthalimide 82, which was 
again synthesised in excellent yield (84%). To test this new procedure, the more synthetically accessible 
1st generation amine solubilising group (G1M) 85 was used, which was prepared according to previous 
literature.36 Upon purification however, none of 86 was isolated. It was in fact discovered that the 
majority of 85 had cyclised to lactam 87 (Scheme 30). This unwanted reaction has been previously 
reported to occur in polar solvents at high temperatures but was not known to occur in more apolar 
















Scheme 31 (i) R-NH2 83, toluene, 60 °C, 30 min, then ZnBr2, HMDS, 60 °C, 16h, 64%. 
54 
 
This procedure was then repeated with G2MM amine 83, which cannot cyclise to form a lactam unlike 
G1M 85. None of Phthalimide 84 was isolated initially, although some consumption of starting 
materials did occur – an indication that amine 83 had reacted with the anhydride but would not cyclise 
to form the imide. It was only when zinc bromide and HMDS were added after 30 minutes of initial 
reaction that the reaction appeared to proceed further, with the zinc bromide acting as a Lewis acid 
to facilitate formation of the silicon ester intermediate which can then promote the final ring closure 
step to afford the imide (Scheme 32).63 Phthalimide 84 was then isolated in a good yield after column 
chromatography. It was rationalised that the reaction was not as high yielding as for 82 due to the 
bulky nature of 83 reducing the rate of attack at the anhydride or rate of cyclisation. This may allow 
more time for the anhydride or silicon esters to hydrolyse, evidence for this was that some amine 







Scheme 32 Proposed mechanism for the formation of the phthalimide 84 via a silicon ester intermediate. 
Phthalimides 82 and 84 were then tested for reaction with anthracene diisocyanate 60 to form half 
receptor 79 (Scheme 33). However, it was found that no reaction was observed upon stirring either 82 
or 84 with 60 in dichloromethane at room temperature or reflux. It was thought that both the electron 
withdrawing nitro and imide groups render the amine a very poor nucleophile. Addition of organic 
bases such as Et3N and DIPEA appeared to have no effect. Addition of relatively strong organic base 
DBU to a solution of 84 and 60 in dichloromethane induced a distinct colour change from yellow to 
red/orange – believed to be due to deprotonation of the amine. A very fast reaction was then observed 
when monitoring with TLC, with the isocyanate rapidly consumed (<1 hour). However, none of 79 was 
isolated after purification with column chromatography. Upon this result, it was then discovered that 
DBU has been previously reported to undergo adduct formation with isocyanates to form thermally 
stable heterocyclic structures for use as polymerisation initiators.64 With this information in hand, the 
reaction was repeated but with a slow addition of isocyanate 60 to a solution of 84 and DBU. It was 
speculated that this method would minimise interaction of free basic DBU and isocyanate. The 
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[M+2Na]+ adduct of the product was observed using ESI mass spectrometry of the crude reaction 
mixture, but no product was isolated upon purification. This may be due to 84 more easily forming 
charged adducts under mass spectrometry conditions compared to the other reaction components 
and that only very small amounts of 84 are forming in the reaction. Cooling the reaction to 0 °C did 








Scheme 33 (i) DBU, CH2Cl2, rt, 1h, 88 not isolated. 
Reduction of the nitro group of 84 would afford the diamino phthalimide, increasing the nucleophilicity 
of the amines towards isocyanate 60. Diamino phthalimide 88 was synthesised in excellent yield after 
reduction of 84 using Pd/C and 1 bar pressure of hydrogen (Scheme 34). Attempts to form half receptor 
80 from phthalimide 88 and diisocyanate 60 were unsuccessful however. No reaction was observed at 
room temperature or when refluxed in dichloromethane (Scheme 34). As seen for nitro phthalimide 
84, addition of organic bases also appeared to have very little positive effect. Synthesis of previous half 
receptor 59 (Chapter 2) used vast excesses of diamine to drive the reaction (up to 20 equivalents) – 
something not possible here to due to limited quantities of 88. It is possible that the amines may still 
be deactivated via the electron withdrawing effects of the imide, or the bulky solubilising group 
hinders approach to the isocyanate. Initially, further investigations into this lack of reactivity were 











Scheme 34 (i) H2, Pd/C, MeOH, rt, 3h, 90%; (ii) CH2Cl2, reflux, 48h, 80 not observed. R = G2MM solubilising group 
Future work covered in Chapter 5 found that addition of acylation catalysts such as pyridine and DMAP 
greatly increased reactivity of electron deficient anilines towards isocyanates. This was then applied in 
a limited capacity to some intermediates discussed earlier in this chapter. Nitro bis-acid 76 was 
converted to bis-methyl ester 89 via Fischer esterification in methanol and then reduced to diamine 
90 with hydrogen and Pd/C in excellent yield (Scheme 35). Reaction of this diamine 90 with anthracene 
isocyanate 60, in the presence of DMAP, afforded half receptor 91 in good yield. Half receptor 91 
proved relatively insoluble in most organic solvents, but this allowed straightforward purification by 
filtration. Limited NMR characterisation was carried out for 91, but the product was confirmed by high 
resolution ESI mass spectrometry – where the [M+2H]2+ ion was observed. While this methodology 
could be applied to the earlier phthalimide systems (Scheme 34), there was not sufficient time or 
material to attempt this, although it is expected that addition of DMAP would allow access to half 
receptor 80. Intermediate 91 is arguably more versatile however, as functional group conversion of the 
methyl esters could afford several derivatives including phthalimides and bis-amides featuring large 
solubilising groups (such as G2MM). Future work will therefore focus on development of 90 as a linker 
unit, to generate methyl ester receptors (such as 92, Scheme 35) which can then undergo late stage 

















Scheme 35 (i) H2SO4, MeOH, reflux, 3h, 80%; (ii) H2, Pd/C, MeOH, 1h, 93%; (ii) 60, DMAP, CH2Cl2, reflux, 16h, 76%. 
3.3 Synthesis of Diamino Amide Spacer 
With the previously synthesised phthalimides initially proving unreactive towards isocyanates, other 
linker units were targeted such as bis-amide 94. The route to such compounds had been previously 
outlined in the literature, and initially appeared particularly suitable as previously synthesised bis-acid 
76 could be used.65,66 Conversion of 76 to the bis-acyl chloride 93 was achieved using catalytic DMF in 
SOCl2. Formation of 93 was inferred by TLC and 1H NMR of the crude reaction mixture. Acyl chloride 
93 was then used without further purification (Scheme 36). Reaction of 93 with G1M amine 85 
however did not yield the desired bis-amide 94. A small amount of phthalimide 86 was isolated upon 
purification however, suggesting that a cyclisation takes place upon addition of one amine to the acyl 
chloride to give the imide. Additional equivalents of G1M amine 85 were used to suppress the 
cyclisation, but this appeared unsuccessful as 94 was not isolated upon purification. It could be 
speculated that addition of a second amine is comparatively slow due to the bulky nature of the 
dendrimer, and that the rates of cyclisation and hydrolysis outcompete this. It was then decided that 











Scheme 36 (i) DMF, SOCl2, (ii) G1M amine 85, DMAP, Et3N, CH2Cl2, rt, 16 h. 
A simpler linker unit was then proposed: mono-amide 95 was postulated to be sufficiently reactive at 
the amines to form ureas upon addition to an isocyanate (such as 60). Being unsymmetrical however 
would mean that one of the amines would require functional group protection before half receptor 
formation to avoid isomers when forming the macrocycle (Scheme 37). Fortunately, recent literature 
precedent was set where 3,4-diaminobenzoic acid 99 was mono-Fmoc protected 100 and then able to 
undergo successful amide coupling to a solid phase peptide resin 101 (Scheme 38) using HBTU.67 
Following this route would leave the less reactive amine (para conjugated with the amide) exposed to 
react to form the half receptor. Deprotection then reveals the ‘more reactive’ amine for the more 










Scheme 37 Proposed synthetic route with protected diamino linker unit 95. Where P = suitable protecting group, 






Scheme 38 Literature precedent for Fmoc-protection of one amine of 3,4-diaminobenzoic acid 99 and then 
subsequent amide coupling. R = solid phase peptide resin. 
Fmoc protection of 3,4-diaminobenzoic acid 99 proceeded smoothly to give protected substrate 100 
in excellent yield (Scheme 39). Initial attempts to replicate the amide coupling using G1M amine 85 as 
a test amine were unsuccessful. None of desired amide 102 was observed. Not all starting materials 
were consumed but the major product appeared to be dimerised product 103, where apparent Fmoc 
deprotection of a percentage of starting material had caused the more reactive amine to be revealed 
and then participate in the coupling reaction to give a dimer. Other coupling reagents such as HATU 
and DCC were screened but gave either similar results or little evidence of reaction. The reaction was 
repeated using benzylamine as a test amine which afforded the benzyl amide in excellent yield. The 
reaction was then closely monitored by TLC and it was found that the undesired dimer 103 only formed 
upon addition of G1M amine 85. This would suggest either the G1M amine 85 or an unknown impurity 







Scheme 39 (i) Fmoc-OSu, MeCN, NaHCO3 (0.1 M), 16h, 90% (ii) G1M amine 85, HBTU, HOBt, DIPEA, 16h, DMF. 
Attempts to access the amide via the acyl chloride were also unsuccessful (Scheme 40). TLC analysis 
inferred that carboxylic acid 99 had been converted to the acyl chloride 104 with catalytic DMF in 
SOCl2. Acyl chloride 104 was used in the next step without further purification. Addition of G1M amine 
85 to 104 resulted in a complex mixture upon analysis by 1H NMR of the crude reaction mixture, with 
none of the desired product isolated upon purification. Subjecting the acyl chloride 104 to the reaction 
conditions (no 85 present) and monitoring by TLC showed a second compound appearing over time, 
which could be a potential dimer as there is a free amine in the starting material. This would compete 







Scheme 40 (i) DMF, SOCl2, (ii) G1M amine 64, DMAP, Et3N, CH2Cl2, rt, 16h. 
With the direct coupling of G1M amine 85 to Fmoc-acid 100 proving to be an issue, a new route was 
attempted where the macrocycle or advanced intermediates were formed prior to attachment of the 
solubilising group. Addition of Fmoc protected acid 100 to isocyanate 60 was attempted and 
consumption of starting materials was observed by TLC, with a very fluorescent compound appearing 
on the baseline (Scheme 41). Purification on silica proved impractical due to poor solubility and polar 
functionality of molecules formed. Analysis by 1H NMR of the crude reaction mixture suggested 
product formation (or at least reaction) had occurred with clear shifts of characteristic signals for both 







Scheme 41 (i) CH2Cl2, reflux, 3 days. 105 not isolated. 
It was then investigated whether protection of the carboxylic acid groups would increase solubility and 
reduce the polarity of the molecule, thereby allowing purification by chromatography. The proposed 
route was then modified to use methyl 3,4-diaminobenzoate 106 instead of 100, with the intention 
that the methyl ester would make the products more soluble and thus more manageable. Protection 
of methyl 3,4-diaminobenzoate 106 with Fmoc-OSu afforded the protected amino ester 107 in 







Scheme 42 (i) Fmoc-OSu, MeCN, NaHCO3 (0.1M), 98%. 
Subsequent reaction of 107 with isocyanate 60 afforded half receptor 108 in moderate yield (Scheme 
43), although the product proved to be insoluble in most organic solvents (such as dichloromethane, 
methanol and ethyl acetate). Purification proved difficult due to insolubility in most eluents used for 
flash chromatography on silica and often caused the product to precipitate and adsorb to the silica 
stationary phase, and so 108 was used in the next step without further purification. Deprotection of 
half receptor 108 proved facile using piperidine in DMF (Scheme 43) and afforded amino half receptor 










Scheme 43 (i) CH2Cl2, reflux, 3 days, 52%; (ii) piperidine, DMF, 1h, rt, 90%. 
The macrocyclisation of half receptor 109 with isocyanate 60 was then attempted, using similar 
conditions that were successful for earlier system 37 (Scheme 44, Chapter 2). Consumption of 
isocyanate and half receptor was observed by TLC with new highly fluorescent compounds visible. 
However, any attempted purification proved very difficult due to very poor solubility of the crude 
reaction mixture. This also made analysis of the crude products difficult by 1H NMR and reverse phase 
HPLC. Nevertheless, macrocycle 80 was observed by ESI mass spectrometry ([M+2Na]2+ and [M+3Na]3+ 








Scheme 44 (i) pyridine, CH2Cl2, rt, 4 days. 110 not isolated. 
Attempts were then made to introduce the solubilising group at the half receptor stage, with the 
intention that this would aid purification of the macrocycle in the next step. Hydrolysis of the methyl 
ester to the carboxylic acid would be required to perform the amide coupling. Unfortunately, the very 
poor solubility of 109 proved sufficient enough to prevent the hydrolysis from proceeding, even when 
refluxed in a variety of solvent mixtures (THF and methanol), with >95% of starting material being 





Scheme 45 (i) 2M NaOH (aq), MeOH, THF, reflux, 2 days. 111 not isolated. 
Direct coupling of the solubilising group to the linker unit was then revisited, with Fmoc protected acid 
100 converted to the pentafluorophenyl ester 112 using DCC and pentaflurophenol in good yield 
(Scheme 46). Ester 112 however proved remarkably unreactive, showing no reaction with G2MM 
amine 83 even after 2 weeks at reflux. The only observed change was a small amount of Fmoc 
deprotection to diamine 114. This apparent lack of reactivity compared to previous pentafluorophenyl 
ester systems is most likely due to the more electron rich aromatic centre, as the free amine can 
delocalise its lone pair into the para located ester group. This would make the ester less electrophilic 
and thus potentially unreactive to the G2MM amine 83, which may already be slow to react due to its 













Scheme 46 (i) C6F5OH, DCC, THF, 84%, (ii) G2MM amine 83, DIPEA, THF, reflux, 2 weeks, 113 not observed, 114 
5%, 112 >90%. R = G2MM solubilising group. 
The direct amide coupling reaction with G2MM amine 83 and Fmoc acid 100 was then reconsidered, 
since it was becoming increasingly apparent during other studies in the Davis group that the G1M 
amine 85 was proving unreactive in known methodology. This methodology was very reproducible 
with several (including much larger) dendritic amines. Future work performed by Masters Student 
Kristian Jones would also demonstrate this unexpected lack of reactivity for G1M amine 85. Several 
reaction conditions and coupling reagents were screened but the equivalent amide 102 was never 
isolated using G1M 85. Remarkably, switching to the slightly larger “1st generation large” (G1L) amine 
115 allowed access to the equivalent amide 116 on the first attempt in good yield. This would suggest 
that there is a fundamental problem with the nucleophilicity of G1M 85; it could exist in solution in a 
self-associated conformation that masks the amino group and the dendrimer chain is the perfect size 
to facilitate this. This low reactivity of 85 could be the reason why most of the methodology described 
in this chapter was unsuccessful, as G1M 85 was used as a test compound given its more accessible 
synthesis compared to G2MM 83. There was not time to repeat the aforementioned reactions with 















Scheme 47 Amide coupling reactions performed by Masters Student Kristian Jones, which revealed the 
fundamental lack of reactivity of G1M 85 towards forming aromatic amides. Similar dendrimer G1L 115 showed 
no indication of any such issues. 
The amide coupling was then repeated using G2MM amine 83 and the conditions outlined in Scheme 
39, with amide 113 isolated in good yield (76%) after purification by flash column chromatography. 
The reaction was further optimised by using THF in place of DMF as solvent, with a longer reaction 
time of 16 hours to achieve an improved yield of 86%. A precipitate was noticed during removal of the 
reaction solvent and addition of dichloromethane. Isolation and analysis of this precipitate identified 
it as benzotriazole ester 117. It was then discovered that subjecting 100 to the reaction conditions 
without G2MM amine 83 formed this intermediate 117 exclusively, which could then be isolated by 
precipitation in a diethyl ether/water mixture and filtration. Ester 117 proved to be stable in the solid 
state to air and subsequent reaction with G2MM amine 83 afforded amide 113. Test reactions 
indicated that 117 does undergo rapid hydrolysis when subjected to non-anhydrous reaction 
conditions however. There was no distinct advantage obtained in yield or purity of 113 by prior 








Scheme 48 (i) G2MM amine 83, HBTU, HOBt, DIPEA, THF, rt, 16h, 86%. R = G2MM solubilising group. 
3.4 Conclusions 
A synthetic route was successfully established towards diamino phthalimide 89, which features large 
dendritic solubilising group G2MM. Initial attempts to react 89 with anthracene isocyanate 60 were 
unsuccessful and this synthetic route to the macrocycle was abandoned. Future work (Chapter 5) 
inspired a revisit to this reaction procedure however and it was found that addition of DMAP allowed 
the reaction of diamine 90 and isocyanate 60 to give half receptor 91 (Scheme 49). Unfortunately, 
there was not time to continue the synthetic route, but synthesis of macrocycle 92 seems entirely 
plausible given the successful synthesis of other anthracene macrocycles (Chapters 2 and 4). It is then 
envisaged that derivatisation of 92 will yield a library of receptors – including the originally targeted 












Scheme 49 Diamine 90 was synthesised successfully reacted with isocyanate 60, in the presence of DMAP 
(inspired by future work, Chapter 5). There was not sufficient time to proceed this synthesis further however, 
but future of synthesis of macrocycle 92 is expected to be possible. 
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Efforts were then directed to simpler Fmoc protected linker 113, in which the solubilising group was 
attached via a single amide. All test reactions of various methodology using G1M amine 85 were 
unsuccessful. It was eventually discovered that 85 appeared to have inherent issues with reactivity in 
amide coupling reactions with substrate 100 – as other dendritic and model amine substrates gave the 
equivalent amides in good yields. Fmoc-acid 100 was then converted to amide 113 upon reaction with 











Scheme 50 All attempts to synthesise Fmoc-protected linker with G1M 85 were unsuccessful. Reaction occurred 
smoothly with G2MM 83 solubilising group however, suggesting an inherent issue with the reactivity of G1M 85.  
With target substrate 113 now in hand, the next step would be to form the half receptor 118 upon 
reaction with isocyanate 60 (Scheme 51). Fmoc deprotection then gives 119 followed by 
macrocyclisation to afford macrocycle 120. The results obtained in carrying this out are covered in the 
next chapter (Chapter 4). The newly synthesised linker 113 has the potential to be incorporated into 
other receptors with different aromatic surfaces, other than anthracene. These receptors might 
possess novel and interesting activities towards certain guests. Indeed, such a receptor was 


















Chapter 4 – Anthracene tetraurea receptor 

















Scheme 52 Retrosynthetic analysis of anthracene tetraurea 1 leads to two key components, both of which were 
previously synthesised (chapters 2 and 3): isocyanate 60 and linker 113. Formation of half receptor 119 and 
subsequent macrocyclisation yield protected macrocycle 120. Global deprotection of the solubilising groups and 
neutralisation to pH 7 gives the water soluble receptor 1. R = tert-butyl protected G2MM solubilising group. R’ = 
water soluble G2MM solubilising group. 
With a viable synthetic route established towards linker unit 113, synthesis towards anthracene 
tetraurea 1 could proceed (Scheme 52). Formation of protected half receptor 118 followed by 
deprotection of the Fmoc groups affords amino half receptor 119. Macrocyclisation by reaction of 119 
with isocyanate 60 yields protected macrocycle 120. Exposure of 120 to acidic conditions, followed by 
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neutralisation to pH 7, affords the desired polycarboxylate macrocycle 1. It was hypothesised that use 
of a unsubstituted anthracene would circumvent the numerous instability issues encountered for 
previously synthesised anthracene macrocycles (Chapter 2) – most notably improved stability towards 
acid and oxidation by singlet oxygen in solution. Receptor 1 was designed towards binding linear 
cellodextrin oligosaccharides (reasons for which are covered in Chapter 2), and binding affinities for 
these substrates were to be determined using NMR spectroscopy titrations but also with fluorescence 
spectroscopy based methods, given the inherent fluorescent nature of anthracene.  








Scheme 53 (i) CH2Cl2, reflux, 2 days, 118 67%, 121 ~20%; (ii) pyridine, CH2Cl2, reflux, 16h, 118 86%, 121 not 
isolated. R = G2MM solubilising group. 
Synthesis of protected half receptor 118 was attempted by refluxing isocyanate 60 and linker 113 in 
dichloromethane. The reaction seemed slow, taking 2 days to appear to reach completion (Scheme 
53). Separation of reaction products using silica as a stationary phase proved difficult, but separation 
was achieved using reverse phase HPLC with an acetone/water eluent, giving bis-urea 118 in good 
yield. Also isolated however was mono-urea 121 and linker 113 which appeared to be an indication of 
incomplete reaction. It was unclear whether 121 existed as the mono-isocyanate before purification 
by HPLC, as the water eluent could promote hydrolysis, or whether hydrolysis to the amine had already 
occurred during the reaction. The long reaction times suggested low reactivity for both intermediates 
though. Future work (chapter 5) discovered that addition of pyridine promoted a much faster and 
cleaner reaction when forming Fmoc protected half receptors from 113 and isocyanates. Application 
of this methodology to this system enabled an excellent yield of 118 with greatly increased rate of 
reaction, with no discernible amount of 121 produced either. Fmoc-protected half receptor 118 
exhibited severe broadening of 1H NMR signals during characterisation (in CDCl3), most notably for 
signals relating to anthracene and linker aromatic protons. Signals related to the aromatic groups of 
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the Fmoc appeared relatively well resolved however. This broadening was observed in a variety of 
solvents, including more polar ones such as acetone and methanol, with dilution appearing to have no 
effect. It was therefore hypothesised that slow interconversion between conformations (relative to the 
NMR timescale) was occurring, potentially caused by slow rotation due to the bulky Fmoc groups. This 
severe broadening meant that full characterisation of 118 was not possible (especially 13C 





Scheme 54 (i) DBU, CH2Cl2, 0 °C, 1h, 95%. R = G2MM solubilising group.  
Deprotection of the Fmoc groups proved trivial using DBU in dichloromethane (Scheme 54), affording 
amino half receptor 119 in near quantitative yield after purification by column chromatography on 
silica. Half receptor 119 displayed severe broadening by 1H NMR in CDCl3, presumably due to 
intramolecular hydrogen bonding between ureas or intermolecular aggregation. Dissolution in CD3OD 







Scheme 55 (i) CH2Cl2, reflux, 4 days, 23%; (ii) DMAP, CH2Cl2, reflux, 16h, 38%. 
Reaction of amino half receptor 119 with anthracene isocyanate 60 was intended to afford the 
protected macrocycle 120, however initial reactions in dichloromethane at room temperature were 
very slow. These were performed at relatively high dilution (<0.5 mM reaction concentration) to favour 
the intramolecular cyclisation, with a slow addition of isocyanate 60 to half receptor 119. No reaction 
was observed after two days by TLC and HPLC however. Heating the reaction to reflux did appear to 
promote consumption of both starting materials however, and it was found that after 4 days all half 
receptor was consumed. Monitoring of the reaction by TLC was difficult due to the fluorescent nature 
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of anthracene, and so the reaction was monitored by reverse phase analytical HPLC. The presence of 
the target macrocycle in the crude reaction mixture was confirmed by mass spectrometry, which was 
deemed promising. Isolation of the macrocycle proved non-trivial initially however, with no separation 
achieved using flash chromatography on silica. Some separation was achieved using reverse phase 
preparative HPLC with an acetone/water eluent, but was hampered by consistent co-elution of 
unknown by-products. It was eventually found that initial purification by HPLC with an acetone/water 
eluent and then re-purification with a methanol/water eluent gave a very pure product (Figure 29). 
The closely co-eluting by-products were found to be oxidised forms of the receptor, where singlet 
oxygen had irreversibly reacted with the anthracene surfaces (see chapter 2 for a more detailed 











Figure 29 Reverse phase HPLC chromatograms for purification of macrocycle 120. Separation of the product peak 
(denoted by •) and other impurities shown in acetone/water (top) and then methanol/water (bottom). Detection 
wavelength used λ = 394 nm. Stationary phase: preparative scale C18, flow rate: 16 mL/min, eluents: 
acetone/water (top) and methanol/water (bottom). 
Future work (chapter 5) found that macrocyclisation rates were greatly enhanced by the addition of 
DMAP, and indeed the addition of DMAP appeared to have a very positive effect towards the formation 
of macrocycle 120. Reaction times were vastly reduced to 16 hours, with an increased yield of ~40%. 
Purification was also markedly easier, with purification by reverse phase HPLC using only an 
acetone/water eluent to yield a very pure product. Macrocycle 120 was then fully characterised by 1H 







adducts were observed. The effect that the asymmetry of the spacer unit has on the macrocycles 
symmetry was very apparent in the 1H and 13C NMR, showing two different signals relating to the 









Figure 30 Partial 1H NMR (500 MHz, CD3OD, 298K) of macrocycle 120, showing the aromatic region. The 
asymmetry of the spacer unit is apparent here, showing two different environments for anthracene protons at 
position 1. 
As for previously discussed anthracene macrocycle 37 (chapter 2), tetraurea 120 showed susceptibility 
to oxidation with singlet oxygen in both solution and in the solid state. Solution stability was increased 
with the use of protic solvents such as CD3OD, however storage of 120 under nitrogen in the solid state 
was necessary – as oxidation in the solid state in air was observed over a period of weeks, rendering 
the material impure and difficult to re-purify. It was therefore imperative to deprotect the solubilising 
groups to form the water soluble macrocycle 1, where the aqueous solvent was expected to greatly 
suppress this oxidation.  
Past anthracene receptors (with amide spacer units) that incorporated the G2MM solubilising groups 
used a minimum of 50% TFA (v/v) in dichloromethane for 16 hours to achieve complete conversion of 
the tert-butyl esters to the corresponding carboxylic acids. However, given the previous instability of 
urea anthracene macrocycles (discussed in chapter 2) to acid, such high concentrations of TFA were 





















Scheme 56 (i) TFA (20% v/v), CH2Cl2, rt, 16h; (ii) NaOH (aq). 1 not observed. 
Unfortunately, exposure of macrocycle 120 to 20% TFA (v/v) in dichloromethane for 16 hours did not 
yield the corresponding polycarboxylic acid macrocycle. Removal of the TFA and solvent under vacuum 
afforded a crude solid that gave a suspension when water was added. This was to be expected as the 
polycarboxylic acid form of the receptor was predicted to be insoluble in water at low pH (i.e. pH <5), 
and was expected to become soluble upon neutralisation to pH 7 where to polycarboxylate form of 
the receptor 1 predominates. However, neutralisation of the crude mixture to pH 7 still yielded a 
suspension. Filtration of this suspension and analysis of the aqueous filtrate by 1H NMR gave a 
spectrum that did not feature any signals relating to the anthracene surfaces (Figure 31). The only 
peaks observed were those characteristic of the spacer aromatic protons and the G2MM dendrimer 
solubilising group. Washing of the filtered solid with acetone and methanol yielded a fluorescent 
solution, analysis of which by 1H NMR gave a spectrum consisting of two broad signals in the aromatic 
region. No signals pertaining to the spacer unit or dendrimer solubilising groups were observed, which 
















Figure 31 1H NMR (400 MHz, D2O, pH 7, 298 K) spectrum of the water soluble fraction from the deprotection of 
macrocycle 120 with conditions outlined in Scheme 56. No signals relating to anthracene are observed, with only 
the characteristic signals for the spacer aromatic and dendrimer solubilising groups present. This would suggest 
that cleavage of the anthracene surfaces from the spacer units during the acidic deprotection was occurring. 
These results would corroborate with the hypothesis discussed in chapter 2 about anthracene 
tetraurea macrocycle stability to acid, and suggest that an acid promoted heterolytic cleavage of the 
benzylic ureas was occurring – resulting in cleavage of the anthracene surfaces from the spacer units 
via a benzylic cation intermediate (Scheme 57). It had been speculated that use of the simpler 
anthracene (compared to the more electron rich derivatives described in chapter 2) would not favour 
this reaction pathway via the benzylic cation, but the initial evidence suggested this was not the case. 
However, it was presumed that the simpler anthracene might at least promote a slower decomposition 
of the macrocycle, with the loss of electron donating groups on the anthracene disfavouring formation 
of the benzylic cation. With this hypothesis in mind, various deprotection conditions were screened 
(mostly varying TFA concentration and reaction time), with the intention of discovering conditions that 























Scheme 57 Hypothesised mechanism for the acid promoted heterolytic cleavage of the benzylic ureas (A), 
generating a resonance stabilised benzylic cation (B). Loss of a proton generates a bis-alkene. 
After screening a small range of conditions it was found that a minimum TFA concentration of 10% 
(v/v) was required to promote loss of the tert-butyls, with 5% TFA (v/v) showing no decrease in tert-
butyl signals by 1H NMR after 1 hour. Reaction of macrocycle 120 with 10% TFA (v/v) for 1 hour showed 
a 60% reduction in the tert-butyl signals by 1H NMR (in CD3OD) and no obvious signs of decomposition, 
which was deemed promising. However, increasing the reaction time to 3 hours still did not fully 
deprotect the solubilising groups. More concerning though was the appearance of several new signals 
in the aromatic and urea methylene regions of the spectrum, with peak shapes not resembling those 
related to the symmetrical macrocycle. Increasing the reaction time to 6 hours appeared to completely 
remove all tert-butyls from the solubilising groups, but also increased the intensity of the unknown 













Figure 32 Partial 1H NMR spectra (400 MHz, D2O, pH 7, 298 K) of the crude reaction mixtures after reaction of 
protected macrocycle 120 with differing reaction conditions (listed right). Loss of the tert-butyl signal was 
observed over time but an increase of signals in the aromatic region also accompanied this (spectra shown left) 
suggesting some decomposition occurs before deprotection can reach completion. 
Upon removal of the TFA and solvent, and neutralisation of the crude product to pH 7 with aqueous 
sodium hydroxide, a very fine suspension was observed – similar to the one seen when using the 
conditions described in Scheme 56. After filtration, analysis of the aqueous filtrate by 1H NMR (in D2O 
at pH 7) revealed a mixture of products had been obtained, potentially in similar ratios as no 
predominant signals for the symmetrical macrocycle were distinctly evident. Despite this, there were 
signals indicative of the symmetrical macrocycle, but there was no immediate procedure to separate 
the target macrocycle from these by-products at this time. What was apparent however, were 
potential signals relating to the hypothesised alkene by-products 122 at δ ~5.3 ppm in the 1H NMR, 
which result from cleavage of the benzylic ureas to give a benzylic cation. Analysis of these suspected 
alkene signals using 1H-13C HSQC NMR revealed a 13C signal of δ ~129 ppm, which is somewhat 
comparable to literature data for alkene compound 123 (Figure 33).68 These data would compound the 
notion that acid promoted cleavage of the ureas was occurring. 
Attempts to lower the acidity of TFA by changing the reaction solvent were also unsuccessful, with no 
reaction observed when using methanol as a solvent. Previous literature often uses >50% TFA (v/v) in 
methanol to convert tert-butyl esters to carboxylic acids, and this would explain the lack of reactivity 
observed. Use of weaker acids such as formic and acetic acid also showed no reaction, even at higher 
A 5% TFA (v/v) for 1 hour. 
No reaction observed. 
 
 
B 10% TFA (v/v) for 1 hour. 
~40% tert-butyls remain. 
 
 
C 10% TFA (v/v) for 3 hours. 
<5% tert-butyls remain. 
New signals appearing in aromatic region 
 
D 10% TFA (v/v) for 6 hours. 
No tert-butyls remain. 







concentrations of acid (>30% v/v). This would suggest that a stronger acid such as TFA was necessary 
to deprotect the tert-butyl esters, but seeing as this also resulted in decomposition of the protected 
macrocycle, it might not be possible to obtain conditions sufficient for both deprotection and 
macrocycle stability. It was therefore concluded from this study that even at these much milder 
deprotection conditions, rate of decomposition of the macrocycle was comparable to the rate of 
deprotection of the solubilising groups under acidic conditions, and that a clean outcome of this 
reaction was not possible. Given that no methods for purification of polycarboxylic acid compounds 








Figure 33 Hypothesised bis-alkene by-product 122 (left) and the observed chemical shifts (in D2O) for the 
suspected alkene, which compares somewhat to a known literature compound 123 (right, chemical shifts quoted 
as for in CDCl3).68 This would suggest that the decomposition of macrocycle 120 under acidic conditions was 








Scheme 58 (i) TFA, CH2Cl2, rt, 24h, (ii) 5% HCl (v/v), trimethyl orthoformate/MeOH (1:1), 24h, 99% over two steps. 
  
1H δ: 5.32 ppm 
13C δ: 129 ppm 
1H δ: 5.55 ppm 
13C δ: 118 ppm 
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After the investigation into the sensitivity of tert-butyl protected macrocycle 120 to acidic conditions, 
it was concluded that different carboxyl protecting groups be explored. Fortunately, previous work in 
the Davis group had developed methodology to convert linker 124 into the equivalent methyl ester 
version 125 in quantitative yield (Scheme 58).39 This linker, once attached to a macrocycle, was then 
deprotected using very mild conditions: 0.5 M aqueous sodium hydroxide at room temperature. 
Published literature suggests that substituted ureas undergo hydrolysis very slowly unless subjected 
to very forcing conditions, and so it was deemed that the methyl ester protected macrocycle 126 would 
be a suitable synthetic target (Figure 34).69 The conversion to the methyl ester proceeds via 
deprotection to the carboxylic acid using TFA and then esterification in acidic methanol with trimethyl 
orthoformate. This methodology was then applied to Fmoc protected linker 113 (Scheme 59), which 
was successfully converted to methyl ester linker 127 in excellent yield. The poorer yield when 
compared to 125 was attributed to potential reaction of the free amine in 127 reacting with methyl 







Figure 34 Structure of tetraurea anthracene macrocycle 126, featuring methyl ester protected solubilising groups 











Reaction of methyl ester linker 127 with isocyanate 60 proceeded as for previous half receptor 118 
(Scheme 53), providing half receptor 128 in excellent yield (Scheme 60). An added benefit of the 
methyl ester protected dendrimers was that 128 proved easier to purify than equivalent tert-butyl half 
receptor 118 and separated well from excess linker 127 during purification by flash column 
chromatography on silica. This was presumably due to the increased polarity of 128 versus 118. 
Deprotection of the Fmoc group to the diamino half receptor proved trivial again using DBU in 









Scheme 60 (i) pyridine, CH2Cl2, reflux, 16h, 89%; (ii) DBU, CH2Cl2, 0 °C, 1h, 93%. Rm = methyl protected G2MM 
solubilising group. 
The macrocyclisation of half receptor 129 and isocyanate 60 was then attempted, using the same 
conditions as for previous macrocycle 120 (Scheme 55, conditions ii). Upon completion, the reaction 
mixture was purified using reverse phase preparative HPLC with an acetone/water eluent. As for half 
receptors 128 and 129, the methyl ester protected macrocycle 126 proved easier to purify than the 
equivalent tert-butyl protected macrocycle 120, with better separation of peaks during HPLC 
purification. However, the yield was largely the same as for previous macrocycles, occurring in ~40% 
yield (Scheme 61). The main difference between tert-butyl 120 and methyl ester protected macrocycle 
126 was solubility, where 126 appeared to only be soluble in DMSO. The 1H and 13C NMR (in (CD3)2SO) 
for 126 was very similar to that of 120, and featured the same doubling of anthracene signals due to 









Scheme 61 (i) DMAP, CH2Cl2, reflux, 16h, 38%. Rm = methyl protected G2MM solubilising group. 
With methyl ester protected macrocycle 126 now in hand, deprotection of the solubilising groups with 
aqueous base was intended to yield the water-soluble macrocycle 1. However, the very poor solubility 
of 126 proved a great hindrance when attempting hydrolysis of the methyl esters with aqueous sodium 
hydroxide, with no apparent conversion to the carboxylate when analysing the reaction mixture by 1H 
NMR (in (CD3)3SO). Addition of polar organic solvents such as methanol or THF appeared to give 
improved solubility but the reaction still was unable to reach completion. Extensive analysis by 
analytical reverse phase HPLC was then undertaken to see whether separation of the full deprotected 
carboxylate could be achieved. Previous attempts in the group to purify polycarboxylic acid receptors 
with reverse phase HPLC were unsuccessful, and this was presumed to be due to the extreme polarity 
of the substrates giving no retention with the C18 stationary phase. However, it was found that 
acidifying the eluents with 0.1% TFA appeared to give retention. A gradient of 100% water to 100% 
organic solvent (usually methanol or acetonitrile) allowed separation and analysis of deprotection 
products. This method was then used to analyse the basic deprotection (in methanol and THF) of 126, 
where it was very evident that the reaction had not reached completion – most likely due to the poor 
solubility of 126. More than 14 distinct products were visible by HPLC, presumably due to varying 
degrees of methyl ester hydrolysis (Figure 35). The predominant products appeared to be the least 









Figure 35 HPLC chromatogram of the reaction mixture after attempted hydrolysis of the methyl esters of 
macrocycle 126 with 0.5 M NaOH (aq) in methanol. A large distribution of products was evident, presumably due 
to varying degrees of methyl ester hydrolysis caused by poor solubility in the reaction medium. Detection 














Figure 36 HPLC chromatograms of the reaction mixture after attempted hydrolysis of the methyl esters of 
macrocycle 126 with 0.5 M NaOH (aq) in DMSO. The predominant product (denoted with •) does not show UV 
absorption at 394 nm (the wavelength used to monitor for the presence of anthracene), which would imply this 
product does not feature anthracene. Analysis of this product by NMR confirmed this, as only signals relating to 
the spacer aromatic were observed, implying that hydrolysis of the ureas had occurred. A complex mixture of 
anthracene products was also observed (bottom). Stationary phase: preparative scale C18, flow rate: 16 mL/min, 
eluents: methanol/water (+0.1% TFA). 
• 





Given that improved solubility of macrocycle 126 was observed in more polar solvents such as DMSO 
and DMF, hydrolysis with 0.5 M sodium hydroxide in these solvents was attempted. While the 
improved solubility did appear to promote faster hydrolysis of the methyl esters, also apparently 
evident upon analysis of the reaction mixture by HPLC was hydrolysis of the ureas as well. The major 
product isolated from the HPLC did not shown UV absorption at 360-400 nm, which was the 
wavelength typically used to monitor for the presence of fluorescent compounds such as anthracene. 
Analysis of this product by 1H NMR (in DMSO) inferred the product to be the spacer unit, with fully 
deprotected solubilising group, now no longer attached to anthracene – an indication full hydrolysis of 
all the ureas had occurred. Attempts to lower the concentration of sodium hydroxide used had little 
positive effect, either rendering no reaction or giving partial hydrolysis of the ureas to give a complex 
mixture of products by HPLC (Figure 36). Ultimately, very little control over the hydrolysis was 
achieved. This was unexpected given that published research suggested the rates of urea hydrolysis 
are very slow.69 It was theorised that the rate of urea hydrolysis for 126 might be greater than for 











Scheme 62 (i) 0.5M NaOH (aq), DMSO, 2h; (ii) Amberlyst 15 acidic ion exchange resin, H2O, to pH 6 then NaOH 
(aq) to pH 7.4. Receptor 1 not isolated. 
Conversely, more reaction control was exhibited when attempting the deprotection of the tert-butyl 
protected macrocycle 120 with TFA (Figure 32). However, there was no viable method for separation 
of the deprotected macrocycle at that time. Therefore, with methodology now developed that enables 
purification of polycarboxylic acid macromolecules by HPLC, the acidic deprotection of anthracene 
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macrocycle 120 was revisited with the intention of purifying the deprotected macrocycle after closely 
monitoring the progress of the reaction by analytical HPLC. Exposure of tert-butyl protected 
macrocycle 120 to 10% TFA (v/v) in dichloromethane for 2 hours, and then analysis of the crude 
reaction by analytical HPLC revealed 4 well separated major products. Isolation of these products by 
preparative reverse phase HPLC and analysis by 1H NMR (CD3OD) revealed most products still featured 
signals relating to the tert-butyl esters, implying the reaction had not reached completion. Increasing 
the reaction time to 4 hours appeared to generate one predominant product, eluting at ~28 minutes 
(Figure 37). Analysis of the earlier eluting products (~26 and 27 minutes) suggested this was a 
decomposition by-product, whereas later eluting products still featured tert-butyl esters and are likely 
partially deprotected macrocycles. The predominant product featured no NMR signals relating to 
decomposition or tert-butyl esters, and so was theorised to be the target polycarboxylic acid 






















Figure 37 Reverse phase HPLC chromatograms for the purification of 120 using conditions outlined in Scheme 
63, using a methanol/water (0.1% TFA) eluent. The major product at ~28 minutes (denoted with •) was desired 
deprotected macrocycle 1, with earlier products resulting from acid promoted decomposition. Later eluting 
compounds are partially deprotected macrocycles. Receptor 1 isolated in 80% yield. Detection wavelengths used 
are 210 nm (top) and 394 nm (bottom). Stationary phase: preparative scale C18, flow rate: 16 mL/min, eluents: 
methanol/water (+0.1% TFA). 
Neutralisation of the polycarboxylic acid macrocycle to pH 7.4 with aqueous sodium hydroxide was 
expected to yield the water soluble macrocycle 1. Indeed, at pH 5 in water a suspension was observed, 
which became a colourless solution upon approaching pH 7. Freeze drying this solution and 
reconstitution in D2O allowed analysis of tetraurea 1 by 1H NMR. However, analysis of 1 in D2O 
indicated that signals relating to the anthracene and urea methylenes had significantly broadened, 
almost to the point where they were no longer discernible (Figure 38). Only signals relating to two of 
the spacer aromatic protons and the dendrimer solubilising groups were well resolved. A dilution study 
was performed to ascertain whether this broadening was due to intermolecular aggregation, but 
spectra over the concentration regime 2-0.1 mM were consistent implying that this was not the case. 
It was then postulated that the broadening could be a result of slow rotation about bonds or 
interconversion between conformations. A variable temperature study by 1H NMR was then 
performed, and indeed reaching 45 °C and above showed a dramatic sharpening of all 1H NMR signals 
relating to the core macrocyclic structure (Figure 39). This would corroborate with the hypothesis that 
receptor 1 undergoes slow interconversion between conformations at room temperature, and the 
elevated temperatures increase this rate of interconversion to give more resolved spectra.  
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Figure 38 Partial 1H NMR spectrum (500 MHz, D2O, pH 7.4, 298 K) of receptor 1 (0.5 mM) in. Majority of signals 
relating to core macrocyclic structure are significantly broadened at 298 K, with protons 8 and 10 (and NH) being 
the only well resolved signals. Dilution of the receptor appeared to have no effect, which implied the broadening 












Figure 39 Partial 1H NMR spectra showing receptor 1 at various temperatures in D2O. Receptor signals sharpen 
upon heating – most notably for signals relating to anthracene and urea methylenes.  
The origins of this slow interconversion between conformations could be due to intramolecular 
hydrogen bonding from the ureas on each spacer unit, as well as hydrophobic CH-π interactions 













25 °C after 75 °C 
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conformation proposed in Scheme 64). Evidence for this can be seen in the 1H NMR, where one of the 
anthracene protons at position 1 (δ ~6.8 ppm) was much more shielded and thus upfield than the 
others – due to the protons interacting with the anthracene π-cloud. The fact that four distinct protons 
environments for the protons at position 1 are not seen, suggest that the receptor is interconverting 
between conformations faster than the NMR timescale and what was observed is the time averaged 
NMR spectrum. Although the severe broadness of peaks might suggest that interconversion rate is 
similar to the NMR timescale (fast-intermediate exchange rate), and increasing the temperature 






Scheme 64 Proposed conformations of receptor 1 in water at 298 K, with the conformation on the right 
predominating. Bond rotation enables preference for the right-hand conformation through intramolecular 
hydrogen bonding between ureas and CH-π interactions between the anthracene surfaces. 
This ‘self-associated’ conformation (Scheme 64) was also observed through molecular modelling of 
the ground state conformation of receptor 1 using MCMM calculations (Figure 40). Where it was 
predicted that the ground state conformation featured intramolecular hydrogen bonding between 
ureas and rotation of one anthracene surface to facilitate a CH-π interaction with the protons at 
position 1. Further work is currently underway to fully characterise the conformation of the free 
receptor 1 in aqueous media through in-depth NMR studies such as TOCSY and NOESY in a 9:1 H2O/D2O 
solvent composition, which would allow characterisation of interactions with the urea NH protons. 
NOE interactions between the urea NHs and spacer aromatics would infer that rotation of the ureas is 
occurring as described in Scheme 64. Differentiation of each anthracene surface would also allow any 
observed interactions to be absolutely characterised and allow construction of a more confident 
hypothesis regarding conformation. This could be achieved through TOCSY NMR to ascertain which 
NMR signals correspond to each anthracene surface, NOE interactions could then be assigned to each 




Figure 40 Ground state conformation of receptor 1 from Monto Carlo molecular mechanics conformational 
searches. Observed are intramolecular hydrogen bonds between ureas (dashed lines) and rotation of one 
anthracene surface to facilitate CH-π interactions. This corroborates with information from NMR that the 
predominant conformation of receptor 1 is that as described in Scheme 64. Force field used: OPLS2005 with 
aqueous GB/SA solvation. 
4.3 Binding Studies 
Despite indications during characterisation that receptor 1 potentially featured a collapsed cavity due 
to intramolecular interactions between ureas and anthracene surfaces, binding studies with several 
carbohydrate substrates were undertaken using a range of analytical techniques. If binding of a 
particular guest molecule is more favourable than the predicted intramolecular interactions, then 
binding events would be observable and thus association constants determinable. Initial studies were 
directed towards smaller substrates such as monosaccharide D-glucose 4. This was to determine what 
differences in binding affinity the urea spacer unit enabled over previous anthracene receptor 25, 
which utilised an isophthalamide spacer to give an association constant of Ka ~60 M-1 for D-glucose 4.35  
An NMR titration in D2O was therefore undertaken, where both stock solutions of receptor 1 and 
substrate (here D-glucose 4) were confirmed to be at pH 7.4 to avoid changes in pH giving misleading 
changes in the NMR spectrum upon addition of D-glucose 4. The solution of D-glucose 4 was allowed 
to reach equilibrium of both α and β anomers by dissolution in the titration medium (here D2O) 24 
hours beforehand, with the equilibrated anomeric ratio verified by 1H NMR. A solution of D-glucose 4 
(1 M), with added receptor 1 (0.5 mM) to keep the concentration of receptor constant throughout the 




K a = 5.22 ± 0.19 M-1 (3.58%)


























Figure 41 Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 K) (A) and binding analysis curve (B) for receptor 1 
(0.5 mM) titrated with a combined solution of D-glucose 4 (1 M) and receptor 1 (0.5 mM). Spectra imply binding 
with fast exchange on NMR timescale. Changes in chemical shift of peak δ 7.55 ppm (Δδ, denoted with •) were 
plotted against D-glucose concentration (mM). The calculated values for Δδ are overlaid with the observed 
values, giving Ka = 5.2 ± 0.2 M-1 (3.6%). 
Upon addition of D-glucose 4 to receptor 1, a change in chemical shift was observed for the two most 
resolved signals (relating to the spacer aromatic protons) in the 1H NMR spectra. This would imply that 
binding was occurring with ‘fast exchange’ kinetics relative to the NMR timescale, which results in a 
time averaged spectrum of both the free host and host guest complex. This change in chemical shift 
(Δδ) was plotting against D-glucose concentration, and the curve fitted to a 1:1 binding model to yield 
an association constant (Ka), which afforded a Ka ~5 M-1 for receptor 1 and D-glucose 4. This is 
approximately 12 times weaker than that observed for previous anthracene receptor 25, and was 
rationalised to be due to the partially collapsed cavity of receptor 1. Required disruption of the 
intramolecular interactions for binding of substrates to receptor 1 would lower the Gibb’s free energy 
of binding (ΔG) and thus association constant (Ka), especially if said intramolecular interactions are 
particularly favourable. These interactions may not even be disrupted, with the D-glucose only partially 
encapsulated by the anthracenes and the two remaining ureas providing hydrogen bonding 








anthracene surfaces prevent intramolecular hydrogen bonding of the amides and thus collapse of the 
cavity for previous anthracene receptor 25, and this was believed to be the reason for the higher 
affinity observed for D-glucose for this receptor. The smaller cavity size for receptor 25 did disfavour 
larger substrates such as disaccharide D-cellobiose 31 however, which featured a Ka of ~28 M-1.35 NMR 
titration of receptor 1 with D-cellobiose 31 however showed an increased association constant of Ka ~ 
50 M-1, which was believed to be due to the larger cavity size of 1. It is possible that receptor 1 is able 
to take advantage of the larger substrate size of D-cellobiose 31 (compared to D-glucose 4), with an 
increased number of intermolecular interactions to give the observed increased affinity when 














Figure 42 Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 K) (A) and binding analysis curve (B) for receptor 1 
(0.2 mM) titrated with a combined solution of D-cellotriose 2 (30 mM) and receptor 1 (0.2 mM). Spectra imply 
binding with fast exchange on NMR timescale. Changes in chemical shift of peak δ 7.55 ppm (Δδ, denoted with 
•) were plotted against concentration of 2 (mM). The calculated values for Δδ are overlaid with the observed 
values, giving Ka = 951 ± 3 M-1 (0.3%). 
 
 
K a = 951.32 ± 2.92 M-1 (0.31%)






















This trend of larger substrates giving stronger affinities was observed for the longer cellodextrins, 
where NMR titration of D-cellotriose 2 with receptor 1 gave a much-increased binding affinity of Ka ~ 
950 M-1 – 19 times stronger than for D-cellobiose 31. It was theorised that the dramatically increased 
affinity is due to the full length of the cavity becoming involved in binding, with the substrate threading 
through until optimal interactions are achieved between receptor and substrate. Some limited 
evidence for this was that during the NMR titration of D-cellotriose 2 (and other substrates) with 
receptor 1, the broad signal for the terminal anthracene protons showed a Δδ of ~0.5 ppm – moving 
from δ ~6.7 to 7.2 ppm. This was potentially an indication that the receptor cavity opens upon binding, 
disrupting the CH-π interactions between anthracenes, allowing larger substrates (such as D-
cellotriose 2) to thread through, and thus resulting in the more downfield shift for the terminal 













Figure 43 Partial 1H spectra (600 MHz, D2O, pH 7.4, 298 K) during NMR titration of receptor 1 and D-cellotriose 
2, showing the large change in chemical shift (Δδ ~ 0.5 ppm) for the terminal anthracene protons (A). This was 
theorised to occur due to opening of the anthracene cavity upon binding of the substrate, disrupting the CH-π 
interactions between anthracene surfaces and resulting in a more downfield chemical shift (B). 
Attempts to ascertain a binding affinity for the larger cellodextrins: D-cellotetraose 33, D-





receptor signals were observed by NMR upon addition of each substrate during the titration – an 
indication that the binding kinetics were operating within an ‘intermediate exchange’ regime, meaning 
there was no way to extract any tangible data to fit to a binding model and thus calculate the 
association constant. The slower kinetics observed for these substrates could originate from the 
increased size of the substrates increasing the time taken to associate or dissociate from the receptor 
due to steric effects. However, this can also result from increased binding affinities increasing the time 
taken for the substrate to decomplex from the receptor, which would agree with the trend of 
increasing affinities with increasing cellodextrin length. Receptor 1 did appear to saturate at roughly a 
similar rate with these substrates as for D-cellotriose 2 however, which would qualitatively imply 














Figure 44 Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 K) for NMR titration of D-cellotetraose 33 (left) and 
D-cellopentaose 130 (right) with receptor 1. Spectra imply binding with intermediate exchange, whereby 
broadening of receptor signals were observed upon addition of substrate. Therefore, no Ka was determinable 
from these data. Some small peak movements were observed, but due to ambiguous chemical shift values, fitting 





In order to determine the binding affinity for the longer cellodextrins, as well as corroborate the results 
already obtained, an alternate method was sought other than NMR titration. Therefore, binding 
affinities were investigated using isothermal titration calorimetry (ITC) experiments.70 This technique 
titrates a guest solution into a solution of host and measures the heat changes upon each addition. 
This is done by the instrument maintaining the temperature of the sample cell (where the host solution 
resides) relative to a reference cell of pure water. The power applied by the instrument, to offset these 
changes in heat between the two cells, is then used to determine the exotherm upon addition of guest 
to host. Integration of the exotherm peak upon each addition gives the change in enthalpy (ΔH) for 
that point in the titration. Collation of this data and plotting the change in enthalpy versus 
concentration gives a curve – this can be fitted to a binding model (as for NMR titrations) to yield a 
binding constant (Ka). It is instructive to consider the enthalpy of dilution upon addition of guest to 
host solutions (i.e. enthalpy of dilution of sugars in water). Therefore, each ITC experiment consists of 
a ‘blank’ run where substrate is added to pure water (no receptor) and the enthalpy of dilution is 
obtained. Subtraction of this ‘blank’ from the titration of substrate into receptor effectively removes 
the heat of dilution from the titration – any enthalpy changes that remain must be a result of 
interaction of substrate with receptor (i.e. binding events). 
Titration of D-cellobiose 31 (200 mM) into receptor 1 (0.2 mM) using ITC gave an association constant 
of Ka ~40 M-1, comparable to the NMR titration results. ITC titration of D-cellotriose 2 (15 mM) into 
receptor 1 (0.2 mM) gave much a larger exotherm upon addition of substrate, and fitting this data to 
a 1:1 binding model yielded the expected higher affinity of Ka ~ 950 M-1 – essentially the same as for 
NMR titration. A distinct advantage of using ITC to determine binding affinities (compared to NMR for 
example) is that the thermodynamic properties of binding can be extracted from the ITC data. The 
enthalpy of binding (ΔH) is equivalent to the heat change per mol of host-guest complex formed. The 
binding affinity (Ka) can be used to determine the Gibbs free energy of binding (ΔG) using the equation: 
ΔG = RTlnKa. This then allows determination of the entropy of binding (ΔS) using the equation: ΔG = 
ΔH – TΔS. Applying this to the ITC results obtained for D-cellotriose 2 and 1 shows that the main 
contribution of binding appears to be enthalpically based, with a much smaller contribution from the 
entropy of binding. This is most likely due to the strong intermolecular interactions formed between 2 
and the receptor 1 being the main driving force for complexation – such as multiple CH-π interactions 
between the oligosaccharide CHs and the anthracene.. Large increases in entropy upon binding are 
usually indicative of many water molecules being displaced from the binding site or an increase in 
receptor/substrate flexibility upon binding.71,72 Neither would appear likely in the case of 1, given its 




Ka = 955.53± 11.17 M-1 (1.17%)
r = 0.999934
ΔG =-17.01± -0.2 kJ.mol-1
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Figure 45 ITC binding results for receptor 1 (0.2 mM) titrated with D-cellotriose 2 (15 mM) in water (pH 7.4) at 
298 K, in which: A) shows the blank run (addition of substrate into water); B) shows the titration (substrate into 
receptor); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the fit calculated using an Excel 
spreadsheet (Ka = 955 ± 11 M-1). 
Unfortunately, the affinities for the longer cellodextrins such as 33, 130, and 131 could not be 
determined using this technique (ITC) at the time of writing due to prolonged instrument failure. 
Therefore, further NMR studies were undertaken in the meantime to ascertain the selectivity of 
receptor 1 for linear oligosaccharides and whether threading of these substrates through the receptor 
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cavity was indeed occurring. NMR titrations were therefore performed with maltodextrins, which are 
α-1,4 linked oligosaccharides comprised of glucose monomers. These substrates are not linear, 
compared to the β-1,4 cellodextrins already tested, and are therefore unlikely to thread through the 
receptor cavity upon binding. If this was the case, then reduced affinities for these maltodextrins to 
receptor 85 (compared to the cellodextrins) are therefore expected. Indeed, such a result was 
obtained, where NMR titration of D- maltose 132 with receptor 1 yielded an association constant of Ka 
~15 M-1 – approximately 3 times weaker than for D-cellobiose 31. An even more supportive result was 
obtained from the NMR titration of D-maltotriose 133 with receptor 1 however, which afforded a 
binding affinity of Ka ~ 20 M-1 – only marginally higher than for D-maltose 132. The affinity for non-
linear trisaccharide 133 is approximately 48 times weaker than for linear D-cellotriose 2, which would 
imply very different modes of binding to receptor 1. This would strengthen the hypothesis that the 
linear cellodextrins are indeed threading through the receptor cavity, unlike the non-linear 
maltodextrins. Given the very similar association constants for D-maltose 132 and D-maltotriose 133 
it could be reasonably speculated that only a small portion of the substrate (such as part of the 
terminal sugar) takes part in binding to receptor 1, and that the steric effects of the α-linked glycosidic 
bonds make greater encapsulation by the receptor impossible. 
Current work is underway to confirm the threading of the cellodextrin substrates through more in-
depth NMR methods such as NOESY studies of the receptor-guest complexes. Given the intermediate 
exchange rate of binding for longer substrates (such as D-cellopentaose 130), acquisition of these 
spectra at reduced or elevated temperatures is predicted to give more resolved signals pertaining to 
the receptor-guest complex by increasing or reducing the rate of exchange, and thus provide more 
accurate data. Critical signals that would indicate threading would be through space interactions 




















Figure 46 Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 K) for titration of D-maltose 132 (A) and D-
maltotriose 133 (B) with receptor 1 (0.2 mM). Spectra imply binding with fast exchange on NMR timescale. 
Changes in chemical shift of peak δ 7.55 ppm (Δδ, denoted with •) were plotted against concentration of 132 or 
133 (mM). The calculated values for Δδ are overlaid with the observed values, giving Ka = 15 ± 2 M-1 (11.8%) for 
132 (C) and Ka = 20 ± 0.8 M-1 (3.3%) for 133 (D). 
Given the inherent fluorescent nature of anthracene, studies were performed to see whether there 
was a measurable fluorescence response upon binding of a substrate to receptor 1, and thus whether 
a binding affinity could be obtained through fluorescence titrations. An excitation wavelength of 395 
nm was used, which produced an emission maximum at 423 nm. This was plotted against guest 
concentration to yield the binding curves. Fitting this data to a 1:1 binding model yielded the 
association constants in a similar manner as for previously described methods (NMR and ITC). 
Fluorescence titrations of receptor 1 with D-cellobiose 31 showed an increase in fluorescence intensity 
K a = 15.04 ± 1.78 M-1 (11.84%)














K a = 20.33 ± 0.67 M-1 (3.31%)




















K a = 49.77 ± 2.62 M-1 (5.26%)


















upon binding, with an overall 20% increase in emission intensity upon reaching saturation with guest. 
Plotting the change in emission intensity against concentration of 31 yielded a binding curve. Fitting 
this data to a 1:1 binding model yielded a Ka of ~50 M-1 – essentially the same as for NMR and ITC 
titrations. Fluorescence binding studies with D-glucose 4 gave an affinity of Ka ~ 5 M-1, whereas methyl 
β-D-glucoside 14 gave a similar association constant of Ka ~6 M-1 with this method. The fact that 14 
also features a very low affinity for receptor 1, despite its increased hydrophobic nature due to 
methylation at the anomeric hydroxyl, would suggest that they bind in a similar manner. It would also 
suggest that only larger linear carbohydrates bind to receptor 1 with any appreciable affinity, as they 
are able to maximise interactions with the receptor cavity due to their increased length – presumably 
















Figure 47 Fluorescence titration results for D-cellobiose 31 (150 mM) and receptor 1 (10 µM) in water (pH 7.4) 
at 298 K. Excitation wavelength of 395 nm used, while monitoring emission intensity at 423 nm. Changes in 
emission intensity at 423 nm were plotted against concentration of D-cellobiose 31. The calculated values for 




An increase in fluorescence emission upon binding was also observed for previous anthracene receptor 
25, whereby close contact of the anthracene surfaces in the free receptor resulted in self-quenching 
of the fluorescence emission.35 Binding of a guest to this receptor separated the anthracene surfaces 
and removed this quenching pathway, thereby increasing overall fluorescence emission intensity upon 
binding. Given that a similar result was observed for tetraurea anthracene 1, and that previous NMR 
data suggests close contact between the anthracene surfaces in the free receptor, it would seem 
reasonable to assume a similar mechanism is the source of increased emission intensity for 1 upon 
binding as well.  
Quantification of binding affinities for the longer cellodextrins (i.e. D-cellopentaose 130) was not 
possible by fluorescence titration due the relatively large volume of the sample cell (3 mL), compared 
to NMR titration (0.5 mL). This results in needing a much larger quantity of guest needing to be added 
to drive the equilibrium of binding towards complexation, as guest titrant solutions are significantly 
diluted upon addition to the sample cell. This was not possible given the small quantities of 
oligosaccharides possessed. Future work is currently pursuing potentially the use smaller sample cells 
for fluorescence, as well as other techniques such as induced circular dichroism (ICD) to determine 
binding affinity for these longer cellodextrins, as this method was successfully deployed in determining 
binding constants for another receptor system (see chapter 5).73 ICD also uses similar sample cell 
volumes to NMR titrations and would therefore be more applicable to investigating the binding 
properties of these longer cellodextrin substrates.  
This measurable fluorescence output upon binding is desirable, as it creates the potential for receptor 
1 to function as sensor. Given its affinity and apparent selectivity for linear cellodextrins, it could be 
applied towards the detection of β-glucans (such as 134, Figure 48) which are a natural component of 
the cells walls of bacteria and fungi.74,75 Receptor 1 could then be applied to a detection assay for 
invasive bacterial and fungal infections in biological samples, as detection of these characteristic 
oligosaccharides by 1 would be indicative of their presence, leading to a faster diagnosis.76,77 Future 










Figure 48 Example structure of a typical β-glucan 134, which features a linear oligomeric structure of D-glucose 
monomers linked with β-glycosidic bonds. 
The binding results obtained for tetraurea anthracene 1 and all substrates tested using various 
techniques (NMR, ITC and fluorescence) are compiled in Table 4 below. When listed in this format, 
receptor 1 clearly shows a preference for binding linear glucose derived saccharides (i.e. cellodextrins), 
as very poor binding was observed for non-linear substrates of similar monomer lengths (i.e. 
maltodextrins). The weak affinities to smaller substrates suggest that they do not take full advantage 
of the receptor cavity, unlike longer substrates such as D-cellotriose 2 which showed almost a 50 times 
increased affinity over D-cellobiose 31. Future work is currently underway to ascertain the binding 
affinities for the longer cellodextrins, as well as corroborate the other binding results with secondary 
methods. The binding interactions of receptor 1 with cellodextrins is also being investigated with 
exploratory NMR techniques such as NOESY, to ascertain whether the oligosaccharides are threading 
through the receptor cavity as predicted.  
Table 4 Summary of binding results for receptor 1 with various substrates and their associated errors for each 
technique used (NMR, ITC or fluorescence). All binding studies conducted in H2O (or D2O for NMR), at pH 7.4 
and at 298 K unless otherwise stated. a n.d. = not determinable due to intermediate exchange binding kinetics. 
 
Substrate  
Binding constant Ka (M-1) determined by: 
 NMR ITC Fluorescence 
D-Glucose  5 ± 1.0% - 5 ± 6.2% 
D-Cellobiose 46 ± 0.9% 38 ± 6.5% 49 ± 5.3% 
D-Cellotriose 950 ± 0.3% 960 ± 1.2% - 
D-Cellotetraose n.d.a - - 
D-Cellopentaose n.d.a - - 
D-Cellohexaose n.d.a - - 
Methyl β-D-glucoside - - 6 ± 3.5% 
D-Maltose 15 ± 11.8% - - 




While the magnitude of affinities obtained for 1 and oligosaccharide guests far exceed those of 
previous anthracene receptor 25, they do not fully compare to previously reported pyrene receptor 
32 – which featured an affinity 5 times as strong for D-cellotriose 2 of Ka ~ 5000 M-1.39 This was 
speculated to be due to the more rigid macrocyclic structure preventing collapse of the cavity, unlike 
32 which can form intramolecular hydrogen bonds between ureas and CH-π interactions between the 
anthracene surfaces. However, pyrene receptor 32 was much more difficult to synthesise and so 
anthracene receptor 1 represents a much more accessible system that still features substrate affinities 
and selectivities comparable to natural carbohydrate binding proteins (such as lectins). Another 
advantage of 1 over 32 was that a fluorescence response was observed upon binding of guests to 1, 
postulated to be due to conformational changes upon binding. No such fluorescence activity was 
observed for 32, and this was attributed to the previously mentioned rigid structure. Pyrene receptor 
32 also featured diminishing binding constants with increased cellodextrin length, where D-
cellotetraose 33 gave the highest observed affinity but D-cellopentaose 130 and D-cellohexaose 131 
then gave a reported 30% reduction in affinity compared to 33. This was speculated to be due to the 
tripodal arrangement of the spacer units, where longer substrates (such as 130 and 131) would then 
feature steric clash with one of the large solubilising groups. This would not be predicted for 
anthracene system 1, as the solubilising groups are perpendicular to the anthracene surfaces and thus 
cannot interfere with the substrate once bound to the receptor. It would therefore be predicted that 
binding affinity to 1 would increase with substrate length, although if the oligosaccharide became long 
enough two receptors binding to one substrate could be possible. This would emulate the ultimate 
function of the receptor threading onto cellulose and thus assisting in solubilising the polymeric 







Figure 49 Previously synthesised pyrene based receptor 32 reported an association constant of Ka ~ 5000 M-1 for 
D-cellotriose 2. While this affinity is markedly higher than for anthracene receptor 1, 32 is much more difficult 
to synthesise than 1 and does not output a fluorescence response upon binding. R = G2MM solubilising group. 
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Scheme 65 Schematic outlining the prediction that terminal substitution of the anthracenes would disfavour the 
collapsed cavity predicted for receptor 1, due to unfavourable steric interactions. It was speculated that 
promotion of the open cavity conformation of the receptor would increase binding affinities. R = sterically bulky 
group. 
With the hypothesis that free receptor 1 adopts a conformation resulting in a partially collapsed cavity 
in water, and that this potentially diminishes binding affinities, receptor derivatives with extended 
anthracene surfaces were proposed. The increased length of the anthracene surfaces would be 
designed to promote a more open receptor conformation, through unfavourable steric interactions 
between anthracene surfaces forcing the anthracene surfaces to lie parallel to each other (Scheme 
65). Therefore, receptor design 135 was proposed, which featured four methoxy groups at the terminal 
positions of the anthracene. These methoxy groups would increase the length of the anthracene 
surfaces but also increase the electron density of the anthracene ring system, which would strengthen 








Figure 50 Proposed receptor design for protected anthracene macrocycle 135, which substitutes the terminal 
positions of the anthracene with methoxy groups. These increase the length of the anthracene surface which 
disfavour collapse of the cavity (Scheme 65) through steric interactions. They also increase the electron density 
of the anthracene surfaces which are predicted to strengthen any CH-π interactions between the anthracenes 
and carbohydrate substrates. 
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Synthesis towards macrocycle 135 commenced through construction of the anthracene scaffold, which 
began with previously synthesised tetra-methoxy anthracene 46 (Scheme 66). A radical bromination 
with NBS and radical initiator ABCN afforded dibromide 136 in good yield, followed by conversion to 
the diazido anthracene 137 in good yield via substitution with sodium azide. A Staudinger reduction 
using triphenylphosphine afforded diamine 138 in good yield, which was then converted to the 
diisocyanate 139 in moderate yield using triphosgene. Presence of the isocyanate functional group 
was confirmed via IR spectroscopy where the characteristic NCO stretch was observed at 2255 cm-1. 











Scheme 66 (i) NBS, ABCN, CH2Cl2, reflux, 4h, 71%; (ii) NaN3, MeCN, reflux, 16h, 70%; (iii) PPh3, THF, H2O, 60 °C, 
16h, 76%; (iv) triphosgene, toluene, reflux, 2h, 54%. 
Formation of Fmoc protected half receptor 140 proceeded as before, whereby reaction of linker 113 
with diisocyanate 139 in the presence of pyridine afforded 140 in good yield (Scheme 67). As for Fmoc 
protected half receptor 118, 140 showed extreme broadening during characterisation by NMR but was 
confirmed by high resolution ESI mass spectrometry. Deprotection of the Fmoc groups with DBU 













Scheme 67 (i) pyridine, CH2Cl2, reflux, 16h, 65%; (ii) DBU, CH2Cl2, 0 °C, 1h, 92%. R = G2MM solubilising group. 
The methodology developed for forming protected anthracene macrocycles 120 and 126 proved 
completely transferable to this methoxy-anthracene system thus far. Indeed, formation of the octa-
methoxy macrocycle 135 also proved comparable to previous systems when employing the optimised 
macrocyclisation conditions (Scheme 55, conditions ii). Reaction of amino half receptor 141 with 
diisocyanate 139, in the presence of DMAP at a reaction concentration of 0.5mM in refluxed 
dichloromethane, afforded the target macrocycle 135 in a moderate yield of 32% (Scheme 68). 
Purification of the macrocycle was largely the same by reverse phase HPLC as for tert-butyl protected 
macrocycle 120, eluting in acetone/water.  
As for protected anthracene macrocycle 120, the two different anthracene surfaces were visible (made 
inequivalent due to the asymmetric spacer unit) during characterisation with 1H and 13C NMR in 
CD3OD. However, one notable difference was that signals pertaining to the anthracene surfaces were 
noticeably broader for 135 when compared to previous anthracene macrocycles 120 and 126. This was 
theorised to be due to the increased sterics of the methoxy groups hindering rotation of the 
anthracene surfaces, resulting in slower conformational exchange and thus broader NMR signals. This 
was deemed promising, as the increased length of the anthracene units were already having some 
effect on potential conformation. However, whether this effect would persist in aqueous media was 
yet to be seen. Macrocycle 135 did show incredible susceptibility to oxidation with singlet oxygen 
however, presumably due to the more electron rich nature of the anthracene surface – akin to the 
oxygen sensitivity of tetra-alkoxy anthracene macrocycle 37 (chapter 2). Macrocycle 135 was observed 
to undergo rapid oxidation in organic solvents during NMR characterisation in a matter of days. 
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Scheme 68 (i) DMAP, CH2Cl2, reflux, 16h, 32%. R = G2MM solubilising group. 
Unfortunately, exposure of protected macrocycle 135 to previously optimised deprotection conditions 
with 10% TFA (v/v) did not afford deprotected macrocycle 142 (Scheme 70). Upon addition of TFA to 
tetraurea 135 a bright pink solution was observed. It was theorised that this was due to formation of 
a benzylic cation intermediate (described in chapter 2 and earlier in this chapter) through acid 
promoted heterolytic cleavage of the ureas. The extreme colour change was postulated to be due to 
conjugation of the mesomeric methoxy groups, stabilising the benzylic cation by delocalisation into 
the anthracene ring system (Scheme 69). The reaction was therefore stopped earlier than previous 
systems and attempted purification by reverse phase HPLC was undertaken. Most evident, however, 
was the presence of the spacer unit cleaved from the anthracene – as the major product visible by 
HPLC showed UV absorption at 210 and 254 nm but not 370 nm, which was typically used to monitor 
for the presence of anthracene. A very complex mixture of products was observed when monitoring 



















Scheme 70 (i) TFA (10% v/v), CH2Cl2, rt, 2h; (ii) NaOH (aq) to pH 7.4, macrocycle 142 not observed. R = tert-butyl 
protected G2MM solubilising group. R’ = nonacarboxylate G2MM solubilising group.  
Given how notoriously sensitive the previous anthracene systems were to deprotection with acid, and 
that this octa-methoxy anthracene appeared even more unstable, it was decided to not pursue the 
acquisition of 142 any further at the time of writing. Future work could investigate the synthesis of 
anthracene surfaces that are much less electron rich such as tetra-carboxyl 143 or imide 144, as these 
provide the desired increased surface length but also possess increased stability towards acid and 
oxidation. Alternatively, a long polyaromatic surface not derived from anthracene could be 
investigated, such as tetraoxa-pentacene 145, which would be impervious to oxidation. The stability 
to acidic conditions of a tetraurea macrocycle incorporating 145 is not certain at this time however, 
but it would be predicted to be much more stable than 135 at the very least. The synthetic routes 
towards these three aromatic surfaces and their respective benzylic diamines is already known from 
previous work in the Davis group. Therefore synthesis of the corresponding macrocycles, using the 
optimised methodology discussed earlier in this chapter, would be predicted to be relatively 
straightforward. If acquisition of the water-soluble macrocycles can then be achieved, comparison of 
their activities to anthracene receptor 1 for cellodextrin substrates would be most interesting – 












Figure 51 Potential aromatic surfaces that could incorporated into a tetraurea receptor. These all feature 
elongated aromatic surfaces compared to unsubstituted anthracene, and could provide increased binding 
affinities by promoting an open cavity conformation. The reduced electron density for each surface is also 
believed to be beneficial, by increasing stability to acid and oxidation. The synthetic route to each diamine is 
already known and thus their incorporation into the corresponding macrocycles is predicted to be feasible. 
4.5 Conclusions 
The urea spacer was successfully implemented into anthracene receptor 1, which was synthesised 
from diisocyanate 60 and linker 113 in 4 steps, in 25% yield. Key optimisation was achieved in the 
deprotection of the tert-butyl protected solubilising groups with TFA, with new methodology enabling 
purification of the deprotected receptor 1 with reverse phase HPLC. Receptor 1 exhibited indications 
of intramolecular association between the ureas and anthracenes for the free receptor in water, with 
current work further characterising the conformation of the free receptor with NMR studies such as 
NOESY. 
Receptor 1 showed good affinities for linear cellodextrins, such as D-cellotriose 2, in water with 
affinities of Ka ~1000 M-1 – much increased over previous anthracene receptor 25 which was predicted 
to have too small a cavity to bind larger substrates such as cellodextrins.35 The affinity shown by 1 is 
also very comparable to natural lectins.19,78 The increased affinities here are attributed to the urea 
spacer units enlarging the cavity and providing an increased number of hydrogen bonding interactions. 
Selectivity over other oligosaccharides was good where tested, with linear cellodextrins binding ~50 
times stronger than non-linear maltodextrins of the same monomer length. Work is currently 
underway to fully ascertain the binding affinities of longer cellodextrins (such as D-cellopentaose 130), 
as well as confirming the selectivities over the weaker binding substrates. Full characterisation of the 
binding interactions between 1 and cellodextrin substrates with NMR is also underway and will confirm 
the hypothesis that the oligosaccharides are threading through the cavity. Once threading of receptor 
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1 onto oligosaccharides is confirmed, studies with larger fragments of D-cellulose 8 will be performed 
to ascertain whether threading is still taking place. Attempts can then be undertaken to see whether 








Figure 52 Anthracene tetraurea 1 was successfully synthesised and showed a distinct preference for the binding 
of linear cellodextrins, such as D-cellotriose 2, which were bound selectively over monosaccharides and non-
linear oligosaccharides (i.e. maltodextrins). Receptor 1 also produced a measurable fluorescent output upon 
binding, which could enable 1 to be employed as a sensor for the detection of β-glucans. 
While receptor 1 did not match the binding performance of previous pyrene receptor 32, it is far more 
synthetically accessible.39 Tetraurea 1 also produces a measurable fluorescence response upon binding 
substrates. This, coupled with its affinity and selectivity for cellodextrins, make it a potential candidate 
as a sensor for the detection of β-glucans, which are characteristic biomarkers for invasive bacterial 
and fungal infections – these employ linear cellodextrins as components of the cell walls and are 
expected to be detectable by receptor 1. Future study will be needed to confirm this through binding 
studies to β-glucans however. 
With the modular synthetic approach towards receptor 1, and seemingly robust synthetic 
methodology established, future synthetic work surrounding derivatives of 1 is predicted to be rich. 
The first point of derivatisation would be variation of the anthracene surfaces. Elongation of the 
surfaces could prevent cavity collapse and thus increase binding affinities. Altering of the electronic 
properties through electron donating or withdrawing groups could alter affinities, increase receptor 
stability and tune the fluorescence output.  
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Chapter 5 – Triethyl Benzene Hexaurea Receptor 









Figure 53 Common carbohydrate D-glucose 4 can be considered as featuring two distinct regions to exploit for 
binding interactions with a synthetic receptor: an apolar region on top and bottom comprised of CHs and a polar 
circumference of hydroxyls. Synthetic lectins 25 and 34 take advantage of these regions to afford affinities in 
water of Ka ~60 M-1 and 250 M-1 respectively.35,40 
The carbohydrate D-glucose 4 is one of the most common organic molecules found in nature, and 
functions as a source of energy for most living organisms.79 The most common isomer in aqueous 
solution is the pyranose (6-membered ring) form, which exists simultaneously as both α and β anomers 
(approximately 36:64, α:β ratio). Synthetic receptors looking to target D-glucose as a substrate will 
then focus on forming interactions with the pyranose form as it is the most abundant form in aqueous 
solution (>99%). Carbohydrate binding proteins (such as the lectin concanavalin A) traditionally target 
the α-anomer, as they can exploit the axial orientation of the anomeric hydroxyl groups with 
complementary binding motifs.11 However, other proteins, such as hexokinases, can target the β-
anomer exclusively.80 It would be difficult to design a synthetic receptor that could bind both anomers 
with equal affinity, so traditional approaches to binding D-glucose target a single anomer. The β-
anomer of D-glucose in particular features two distinct apolar and polar regions which can be 
exploited: axial CHs and an all equatorial arrangement of hydroxyls (Figure 53).81 Previously reported 
synthetic lectins 25 and 34 displayed unprecedented (albeit modest compared to natural systems) 
affinities for D-glucose in water, through non-covalent apolar CH-π and polar hydrogen bonding 
interactions, with a preference for the β-anomer.35,40  
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D-glucose is of particular interest as a substrate for synthetic receptors as it plays a pivotal role in the 
disease Diabetes Mellitus (commonly referred to as just diabetes). Problems resulting in regulation of 
blood glucose levels give rise to diabetes, which causes very high blood glucose concentrations 
(hyperglycaemia). Long term symptoms of diabetes include kidney failure, blindness, brain damage 
and even death.82 Diagnosis of diabetes is ever increasing in developed countries, with one in three 
people currently diagnosed with pre-diabetes (high risk of developing diabetes) in the United Kingdom. 
In all forms of diabetes, the body either does not produce the hormone insulin, or it no longer 
functions correctly, thus allowing blood glucose levels to remain unregulated. People suffering from 
diabetes must therefore manually monitor their blood glucose levels by drawing blood from their body 
(usually from a finger) and analysing the concentration of glucose in their blood. If the levels of glucose 
are too high, they must then manually administer insulin by injection to reduce their blood glucose 
levels. These readings are painful, not particularly accurate and must be performed several times a day 
– a significant practical and social hurdle to daily management of diabetes. 
Future advanced treatments for diabetes are focused on developing continuous glucose monitors 
(smart sensors) – devices which would supply continual accurate blood glucose level measurements 
without the need to draw blood.15,83 Also being developed in conjunction with these smart sensors are 
glucose responsive insulins (or smart insulins), which would independently recognise the presence of 
glucose in the blood and automatically release insulin only when it is needed, such as after a meal.84 
These treatments would effectively mimic the functions of the pancreas – leading to creation of an 
‘artificial pancreas’ for diabetics, which would monitor and regulate their blood glucose levels 
autonomously.85  
However, development of these idealistic treatments has been hindered by access to a suitable 
receptor that can selectively recognise D-glucose in a biological context (i.e. the blood). Most work has 
focussed on using natural proteins, such as the lectin concanavalin A and glucose oxidase, or boronic 
acid based receptors.84,86,87 Both of these approaches suffer from numerous drawbacks including poor 
selectivity for D-glucose, pH sensitivity, lack of stability and toxicity.88,89 Therefore, design and synthesis 
of a synthetic receptor that could selectively target D-glucose would be of significant interest, and 
could potentially revolutionise future diabetes treatments. 
5.2 Receptor design and retrosynthetic analysis 
Upon the synthesis of linker unit 113 (Chapter 3) and its successful incorporation into anthracene 
tetraurea receptor 1 (Chapter 4), efforts were directed towards implementation of 113 with other 
receptor designs. Previous synthetic lectin research in the Davis group has mainly focused on variation 
of the aromatic surfaces to generate new receptors. This required the synthesis of a variety of aromatic 
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surfaces with pendant amines (Figure 54).33,35,38,39,60 Conversion of these amines to the isocyanate 
would allow reaction with linker 113 to yield the corresponding urea linked receptor derivatives. This 
would allow direct comparisons to be made with previously published receptors and better 








Figure 54 Aromatic amines previously synthesised in the Davis group that have been incorporated into various 
carbohydrate receptors. Conversion of these amines to isocyanates and reaction with linker 113 yields the 






Figure 55 Incorporation of 1,3,5-substituted triethyl benzenes (blue box) into anion receptor 146 and cation 
binder 147, as reported by Anslyn and co-workers.90,91 
However, recent interest has turned towards utilising the popular supramolecular scaffold: 1,3,5-
substituted triethyl benzene (TEB). This scaffold was initially pioneered by Anslyn et al., where it was 
successfully incorporated into a variety of cation and anion receptors (Figure 55).90,91 This scaffold has 
already seen some application towards carbohydrate recognition in organic solvents, with reports of 
macrocyclic receptor 16 by Roelens and colleagues.23 Extensive investigation of carbohydrate 
recognition in organic media with derivatives of this scaffold has also been reported by Mazik et al., 
with both acyclic 17 and monocyclic variants 18 showing appreciable activity towards their respective 
guests.24,25 The TEB scaffold features steric preorganisation, in the case of acyclic architectures 147 and 
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17, where the ethyl and nitrogen functionalised groups (in these examples) tend to occupy the 
opposite face of the central aromatic ring.92 Such preorganisation would be less integral in the case of 
closed cage structures like 16 and 18 but may assist in the favouring the conformation of previous 
intermediates required to form the macrocycle. Such steric effects may even lend to increasing the 







Figure 56 Examples of previous supramolecular architectures derived from triethyl benzene (TEB) scaffold that 
target carbohydrates in organic media. Pyrrole based macrocycle 16 reported by Roelens et al, and acyclic and 






Figure 57 Unpublished results from the Davis group report synthesis of macrocyclic receptor 148, which features 
the two TEB surfaces and three isophthalamide spacer units. Unfortunately, no binding to either D-glucose 4 or 
D-xylose 149 was observed by NMR binding studies, and this was believed to be due to the cavity being too small 
to accommodate the substrates. This hypothesis was corroborated by molecular modelling studies of receptor 
148 and both guests inside the cavity. R= water solubilising group.93 
The TEB scaffold has never been successfully incorporated into a receptor targeting carbohydrates in 
water however. Unpublished results from the Davis group outline the synthesis of hexa-amide 148, 
which makes use of the previously discussed isophthalamide spacer units. Unfortunately, no evidence 
of binding to D-glucose 4 was observed by NMR spectroscopy binding studies. Subsequent molecular 
modelling then suggested that the cavity was too small, with the spacer units providing insufficient 
space between the aromatic surfaces for the substrate to fit. No binding was also witnessed with the 
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smaller sugar D-xylose 149, which corroborates with the hypothesis that the cavity is indeed too 
small.93 At the time of this work, no viable synthetic route to a larger spacer was known. However, with 
the successful synthesis of linker unit 113 (Chapter 3) and incorporation into anthracene tetraurea 
receptor 1 (Chapter 4), application of this linker unit 113 to the TEB scaffold could yield a receptor 
cavity of sufficient size to accommodate a desired carbohydrate guest. Thus, the design of receptor 3 
was proposed, which would feature three bis-urea linkages (one more than anthracene receptor 1, 
Chapter 4). The optimised design employs six ureas and thus up to twelve hydrogen bond donors 
directed towards the central cavity. Water solubility would be enabled by three pendant solubilising 
groups – each composed of G2MM dendritic nonacarboxylates, same as for anthracene receptor 1. 
Given that anthracene receptor 1 was fully soluble with two solubilising groups and featured larger 
hydrophobic surfaces, it was predicted that the three G2MM dendrimers will provide ample water 











Figure 58 Proposed design for receptor 3, which features six ureas to provide twelve hydrogen bond donors 
directed towards the central cavity. Initial attempts will make use of the G2MM solubilising group, as used for 
anthracene receptor 1 (Chapter 4). 
The cavity of 3 would be smaller in size when compared to previous anthracene systems, but was 
predicted to be very complementary and thus selective towards all equatorial monosaccharides such 
as β-D-glucose 4. Indeed, such predictions were corroborated by computational studies and molecular 
modelling of both the free receptor and receptor bound with various guests. MCMM conformational 
searches yielded a ground state conformation where 3 featured an open cavity that had not collapsed 
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or distorted. No intramolecular hydrogen bonding was observed between urea spacer units, in fact all 
ureas were predicted to be directed inwards towards the central cavity. Introduction of β-D-glucose 
into the cavity and modelling of host-guest interactions predicted that five out of six ureas participate 
in intermolecular hydrogen bonding. Only one urea of 3 and the hydroxyl at position 1 in β-D-glucose 
are not involved (Figure 60). Modelling of other carbohydrate guests such as methyl α-D-glucoside, D-
mannose and D-galactose predicted that the relatively small cavity might disfavour such guests due to 
steric interactions, as well reduced numbers of and weaker (i.e. increased intermolecular distance 
between) hydrogen bonding interactions. These results already suggested some degree of selectivity 








Figure 59 Ground state structure from MCMM of hexaurea 3. All ureas are predicted to point inwards towards 
the cavity, with the distance between aromatic surfaces predicted at 8.4 Å. Force field used: OPLS2005 with 













Figure 60 Ground state structure from MCMM of hexaurea 3 complexed with β-D-glucose 4. Ten intermolecular 
hydrogen bonds are predicted (shown as yellow broken lines), with lengths of 1.95 – 2.48 Å. Only one urea and 
the hydroxyl at the 1 position on glucose do not take part in hydrogen bonding. Force field used: OPLS2005 with 
aqueous GB/SA solvation. 
The increased stability of the TEB scaffold when compared with anthracene was also desirable. There 
was predicted to be a much lower risk of oxidation upon reaction with singlet oxygen, which was 
expected to enable long term stability in the solid state and even in solution – something of paramount 
importance for potential practical application of carbohydrate sensing. It was also hypothesised that 
the single benzene ring of 3 would be less prone to the same acid instability that afflicted the 
anthracene class of urea receptors (Chapters 2 and 4). The loss of adjacent conjugated aromatic rings 
was predicted to make cleavage of the urea via a benzylic cation much less favourable, and so was 
hypothesised to be less of an issue for 3.  
Retrosynthetic analysis predicts a similar route as for anthracene receptor 1 (chapter 4), and ultimately 
leads to two major components: previously synthesised linker 113 and tris-isocyanate 151 (Scheme 
71). Isocyanate 151 can be synthesised from triamine 154, and then macrocyclisation via the half 
receptors 153 and 152 will enable access to protected macrocycle 150, with subsequent deprotection 























Scheme 71 Retrosynthetic analysis of hexaurea 3, leads to two key components: previously synthesised linker 
113 and tris-isocyanate 151, which was predicted to be synthesised from the equivalent triamine 154. R = tert-
butyl protected G2MM solubilising group. R’ = water soluble G2MM solubilising group. 
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Scheme 72 (i) NaN3, MeCN, reflux, 16h, 92%, (ii) PMe3, H2O, THF, rt, 16h 90%, (iii) triphosgene, NaHCO3 (0.1 M 
aqueous), CH2Cl2, rt, 1h 78%. 
Synthesis of the tris-isocyanate 151 began with commercially available tris-bromide 155, which was 
converted to the tris-azide 156 in excellent yield using sodium azide in DMF (Scheme 72). Reduction 
of 154 to tris-amine 154 was achieved also in excellent yield using trimethylphosphine and water in 
THF. Conversion of 154 to the corresponding isocyanate 151 was achieved using triphosgene in a 
biphasic mixture of dichloromethane and aqueous sodium hydrogen carbonate, this afforded 151 in 
good yield. A slight excess of triphosgene was needed to obtain the pure isocyanate with exact 
stoichiometry resulting in formation of urea by-products – although these by-products could be 
removed by precipitation and filtration in cold toluene or dichloromethane. The isocyanate group was 
confirmed by infra-red spectroscopy, where a very intense band attributed to the NCO stretch was 








Scheme 73 (i) THF, reflux, 4 days, 56%. R = G2MM solubilising group. 
Reaction of linker 113 and isocyanate 151 under reflux in THF afforded protected half receptor 153 in 
a moderate yield. The reaction proceeded very slowly, taking more than 3 days to consume all 
isocyanate 151. This could potentially be due to increased steric bulk near the isocyanate once two 
linker units had already reacted, making addition of the third bulky amine much slower. Purification 
on silica using flash column chromatography proved difficult, but separation was achieved using 
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reverse phase preparative HPLC. The protected half receptor also displayed broadening in the 1H NMR 
spectrum as seen for anthracene Fmoc-protected half receptors 118 and 128 (see chapter 4). It was 
speculated that this is due to the same reasons as well: where slow rotating conformers interconvert 







Scheme 74 (i) DBU, CH2Cl2, 0 °C, 2h, 92%. R = G2MM solubilising group. 
Deprotection of Fmoc half receptor 153 to 152 was achieved in excellent yield using DBU in 
dichloromethane. Severe line broadening was also observed in the 1H NMR spectrum when using 
aprotic solvents (such as CDCl3 or CD2Cl2), believed to be sign of possible self-association between the 
urea and aniline groups or intermolecular aggregation. Using CD3OD as solvent appearing to disrupt 
this to provide well resolved spectra, suggesting that CD3OD suppresses the intramolecular 
interactions observed in the aprotic media. Interestingly, tris-amino half receptor 152 was fluorescent 
when exposed to 365 nm UV light, emitting blue/purple light in solution. This is speculated to be a 
result of the ‘push-pull’ conjugation of the amine and carbonyls on the urea spacer units. This emission 
may have been masked by the inherent fluorescence of anthracene in previously synthesised half 








Scheme 75 (i) CH2Cl2 (2 mM), reflux, 4 days, 8%. R = G2MM solubilising group. 
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With both the amino half receptor 152 and tris-isocyanate 151 in hand, the macrocyclisation to 
generate hexaurea 150 was attempted (Scheme 75). Rate of reaction initially appeared very slow upon 
monitoring of the reaction by TLC and analytical HPLC. Additional equivalents of isocyanate were 
added throughout to promote consumption of half receptor, although whether this consumption 
indicated cage formation or simply oligomerisation was initially uncertain. Once complete 
consumption of 150 was observed, purification by reverse phase HPLC was attempted. However, 
neither the product nor any distinct intermediates were discernible within the chromatogram, as all 
eluting peaks were very broad with minimal separation (Figure 61). Isolation of these peaks and 
analysis by 1H NMR suggested all products were very similar, featuring broad resonances with very 












Figure 61 Comparison of HPLC traces for initial macrocyclisation attempts, eluting with acetone/water. The top 
chromatogram was an early attempt showing the typical broad and poor resolved peaks observed, no macrocycle 
was isolated. Later optimisation yielded the bottom chromatogram, the peak relating to macrocycle 150 is 
denoted with •. Isolated yield of 150 was 8%. Detection wavelength of 210 nm was used for both 
chromatograms. Stationary phase: preparative scale C18, flow rate: 16 mL/min, eluents: acetone/water. 
Several reaction conditions were screened in an effort to optimise the macrocyclisation, with desired 
outcomes including faster reaction rates and cleaner reactions to aid in purification by HPLC. Reaction 
concentrations were increased from 0.1 mM to 1 mM and then 5 mM to increase reaction rate. 




pyridine/dichloromethane gave very convoluted chromatograms. It was also speculated at this time 
that the tris-isocyanate 151 was unstable after isolation and decomposed in the solid state after a few 
days. In order to circumvent the apparent issues with storing isocyanate 151, this reagent was 
subsequently prepared immediately prior to use, as decomposition of 151 to amines or ureas would 
greatly increase the number of potential products generated. It was eventually found that refluxing in 
dichloromethane (2 mM reaction concentration) for 4 days, using fresh isocyanate, gave a relatively 
clean chromatogram with somewhat resolved peaks (Figure 61). Isolation of the peaks and analysis by 
1H NMR was non-trivial. Several of the isolated products displayed very broad spectra but a few 
displayed more defined signals. These were potentially indicative of macrocyclic species. Analysis of 
these selected fractions by MALDI mass spectrometry revealed that one of them was indeed the 










Scheme 76 Conversion of amino half receptor 152 to tris-isocyanate 157 by residual triphosgene. Intramolecular 
cyclisation then affords tris-cyclic urea 158. R = G2MM solubilising group. 
Unfortunately, it was found that synthesis of macrocycle 150 could not be replicated. The predominant 
product isolated was tris-cyclic urea 158 (>20% isolated yield, Scheme 76), which featured a 1H NMR 
spectrum of well resolved peaks with characteristically different chemical shifts for the spacer aromatic 
protons when compared to macrocycle 150. The product was ultimately confirmed as 158 by high 
resolution ESI mass spectrometry, where the [M+3Na]3+ was observed as 1731.6936 (calculated value: 
1731.6922). This m/z value is also the same as for tris-isocyanate 157, but it was expected that such a 
reactive species would not persist in the high energy conditions of mass spectrometry. It was 
confirmed to not be 157, as IR spectroscopy showed no characteristic stretch for the NCO group. The 
13C NMR also revealed two different urea environments. It was theorised that 158 does arise from the 
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formation of tris-isocyanate 157 however, and that 157 was formed by reaction with residual 
triphosgene left over from synthesis of TEB isocyanate 151. It was noted during synthesis of TEB 
isocyanate 151 that the triamine 152 was not completely soluble in dichloromethane, which may lead 
to incomplete reaction of the amine with triphosgene. This coupled with the slight excess of 
triphosgene used to drive the reaction may enable some triphosgene to be carried through into the 
next step. This discovery could also relate to the complex mixture of products observed during 
purification by HPLC, as partial conversion of half receptor 152 to a mono or bis-isocyanate would 
increase the number of potential side products formed. Upon reviewing this, it was decided to revisit 





Scheme 77 (i) Triphosgene, EtOAc, NaHCO3 (0.1 M, aqueous), 0 °C, 1h, 32%; (ii) triphosgene, toluene, reflux, 3h, 
91%. 
The original procedure for the synthesis of 151 was revisited. The solvent was changed from 
dichloromethane to ethyl acetate, as it was noted that triamine 152 was much more soluble in ethyl 
acetate (Scheme 77). A stoichiometric amount of triphosgene was also used (one equivalent of 
triphosgene per triamine 152). Extraction of the reaction mixture after 1 hour with ethyl acetate 
afforded very pure 151, although the yield had been reduced considerably to 32%. The procedure was 
very consistent, with no isolated yield ever exceeding 32%. It was speculated that the improved 
solubility of triamine 152 enables it to react with the isocyanates as they are being formed, leading to 
an increase in urea by-products.  
A new procedure was then developed in collaboration with Ziylo Ltd. researchers Mike Orchard and 
Johnathan Matlock. Triamine 152 was added to an excess of triphosgene in toluene, which was then 
refluxed for 3 hours (Scheme 77). Removal of the solvent and extraction with cold toluene or 
dichloromethane then afforded very pure tris-isocyanate 151 in excellent yield. All of 151 used 
henceforth was made using this method. Isocyanate 151 also now appeared much more stable in the 
solid state than when previously synthesised, which would suggest that unknown impurities from the 
previous biphasic procedure were responsible for the previously observed instability. The reaction is 
believed to proceed by initial addition of triamine 152 to triphosgene to give the carbamoyl chloride 
intermediate, with the excess triphosgene preventing intermolecular reaction between free amines 
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and these intermediates. Upon refluxing, thermal decomposition of the carbamoyl chloride to the 
isocyanate occurs yielding the product 151.95 Excess triphosgene is decomposed to phosgene, which 
is then evaporated by the high temperatures of the reaction but also by exposure of 151 to high 
vacuum. Test studies of refluxing triphosgene in toluene revealed that no triphosgene or phosgene 
remained after 3 hours – suggesting that no phosgene type reagents remained after isolation of 151 





Scheme 78 (i) Carbonyldiimidazole, THF, 45 °C, 2h, 159 not isolated. 
In search of a more optimal procedure, conversion of 152 to tris-imidazole urea 159 using 
carbonyldiimidazole (CDI) was also attempted (Scheme 78) to avoid issues related to residual 
triphosgene. However, shortly after addition of CDI to the reaction a white precipitate was observed – 
initially thought to be an indication of imidazolium formation. TLC of the reaction mixture implied more 
than one product had formed. Filtration of the reaction and analysis of the solid by 1H NMR revealed 
the precipitate to be a mixture of mono and bis-imidazole ureas, as well as imidazole. The filtrate was 
found to contain predominantly imidazole, although mass recovery was low for the filtrate. It was then 
hypothesised that the mono and bis-urea intermediates are insoluble in the reaction mixture and 
cannot progress fully to the product 159. No further investigations were attempted as the procedure 










Scheme 79 (i) pyridine, CH2Cl2, reflux, 16h, 84%. R = G2MM solubilising group. 
With TEB isocyanate 151 synthesised using the new procedure, previous reactions to synthesise Fmoc 
protected half receptor 153 were no longer reproducible. No reaction was observed when refluxing 
linker 113 and 151 in both THF and dichloromethane. It was deduced from this that trace impurities 
from the previously used isocyanate synthesis (e.g. inorganic bases such as carbonate) were potentially 
catalysing the reaction, and this impurity was now absent using the new isocyanate procedure. Several 
additives were then screened to replicate this previous activity. It was found that no product was 
formed upon addition of organic bases such as DIPEA, although consumption of isocyanate was 
observed – this was most likely due to hydrolysis to the amine and then urea formation. Addition of 
the nucleophilic catalyst DMAP appeared to promote a relatively rapid reaction, with new products 
clearly appearing by TLC. However, also evident was Fmoc deprotection of both products and starting 
materials. This yielded a complex mixture of products by TLC, with attempted purification by column 
chromatography on silica proving non-trivial. Fortunately, pyridine was found to both accelerate the 
rate of reaction and keep the Fmoc protecting groups intact. This afforded a very clean reaction that 
gave protected half receptor 153 in excellent yield after column chromatography on silica. It was found 
that an eluent of 1:1 EtOAc/dichloromethane allowed elution of excess linker 113 and flushing of the 
column with 5% methanol in dichloromethane eluted pure 153. Excellent separation was also achieved 
by reverse phase flash chromatography using a Biotage Isolera One, with a C18 stationery phase and 
eluting with acetone/water. Deprotection of the Fmoc groups using DBU to give amine half receptor 
















Scheme 80 Attempted conversion of linker 113 to an electrophile and reaction with triamine 152 did not yield 
half receptor 153. Only hydrolysis of the imidazole urea 160 was observed. Whereas isocyanate 1161 yielded 
dimerised product 163 and cyclic urea 162. 
In conjunction with screening additives to promote reaction to the half receptor 153 (Scheme 79), the 
reverse approach was also attempted – where linker 113 would be converted to an electrophile and 
subsequent reaction with triamine 152 would yield half receptor 153. Imidazole urea 160 was prepared 
in situ from 113 using CDI, with formation inferred by TLC. Upon addition of amine 152 however, no 
product was observed by TLC analysis, with mainly starting material recovered upon purification. 
Hydrolysis of the imidazole urea must have occurred, with the triamine 152 introducing water to 
reaction as it would be predicted to be hygroscopic. A very different outcome was observed for 
reaction of isocyanate 161, which was converted from 113 using triphosgene. Analysis by TLC and IR 
spectroscopy indicated conversion to the isocyanate. After addition of triamine 152 to 161, two new 
products were clearly visible within a matter of hours. Isolation of these products and analysis by NMR 
and mass spectrometry, suggested the structures of cyclic urea 162 and dimerised product 163. 
Hydrolysis of the isocyanate to the aniline and then reaction with another isocyanate would yield 
dimerised urea 163. Intramolecular cyclisation of the Fmoc-carbamate onto the isocyanate would yield 
a cyclic urea (see Scheme 5, Chapter 2 for a similar example). It is postulated that the Fmoc group 
becomes more labile in this intermediate and is then lost, potentially by deprotection from triamine 
152, as no characteristic indications of the Fmoc group were visible in the product by NMR. No further 
investigation of this route was then attempted, as synthesis of 153 by another route had been 










Scheme 81 (i) octyl β-D-glucoside 12, DMAP, CH2Cl2 (0.6 mM reaction concentration), reflux, 2 days, 48%. 
Reaction yield was greatly improved upon addition of octyl β-D-glucoside 12, which templates formation of 
macrocycle 150. R = G2MM solubilising group. 
TEB isocyanate 151 synthesised using the new procedure also proved unreactive when attempting to 
form macrocycle 150 from 151 and 152. With lessons learned from the synthesis of 153 and the critical 
discovery of using pyridine to promote reaction, several additives were screened for the 
macrocyclisation to give 150. As for Fmoc half receptor 153, organic bases such as DIPEA and even 
DBU showed no reaction – TLC and analytical HPLC showed only half receptor 152, with no products 
formed. Addition of nucleophilic catalysts such as DMAP and pyridine however rapidly increased the 
rate of reaction, with DMAP providing the greatest increase of rate. No reaction control was evident 
however, with very complex chromatograms being produced (Figure 62). 
When octyl β-D-glucoside 12 was added (with DMAP present) a dramatic improvement in reaction 
control was observed, with a much cleaner reaction observed by TLC and analytical HPLC. A peak of 
large intensity at the correct retention time of 150 was observed. Indeed, isolation of this fraction by 
reverse phase HPLC (acetone/water eluent) revealed it to be macrocycle 150 in much improved yield 
(~30%). Furthermore, this result proved highly reproducible with isolated yields typically in the range 
of 30-40%. These results suggested that octyl glucoside is templating the formation of the macrocycle 
150. Fortuitously, the octyl glucoside 12 did not appear to interfere with HPLC purification either, 
eluting very early along with the solvent front and DMAP, and was found to not be complexed to the 
receptor upon isolation. No evidence that DMAP facilitated reaction of octyl β-D-glucoside 12 and TEB 
isocyanate 151 to give a carbamate was found either through isolated products or control studies with 
NMR spectroscopy. 
NMR binding studies between half receptor 152 and octyl glucoside 12 gave a Ka of ~300 M-1 in CD2Cl2 
(1:1 binding model). This association constant is relatively weak when compared to similar receptor 
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architectures reported by the groups of Roelens and Mazik – these typically feature association 
constants in the range of 103-105 M-1 in CDCl3.23,25 The spectra of 152 were much broader in CD2Cl2 
compared with CD3OD, which may imply some degree of intramolecular interaction between the urea 
groups and the anilines. Dilution of 152 appeared to have no effect on the spectra which disfavours 
the theory that the broad spectra are due to intermolecular aggregation. It is speculated that the lower 
binding to octyl glucoside 12 is due to the fact that binding of 12 would require disruption of these 
intramolecular hydrogen bonds. This would lower the net thermodynamic gain (i.e. ΔG of binding) 
upon binding of octyl glucoside 12, thus lowering the association constant. Indeed, such a hypothesis 
was further reinforced upon synthesis of acyclic receptors 165 and 166 by visiting student Eléa Wallisky 
(Scheme 82). These receptors exhibited even lower binding constants (than 152) to octyl glucoside 12 
in CDCl3, and it was rationalised that conversion of the aniline groups to ureas strengthened the 








Scheme 82 Synthesis of acyclic hexaurea receptors 165 and 166 from 152 and 164, which was carried out by 
visiting student Eléa Wallisky. Both receptors show very weak binding to octyl β-D-glucoside 12 in CDCl3 (Ka <100 
M-1). R = G2MM solubilising group. 
An NMR binding study of macrocycle 150 and octyl β-D-glucoside 12, in CD2Cl2, however implied a 
much higher association constant. The receptor appeared to saturate around roughly one equivalent 
of glucoside and gave a very convoluted NMR spectrum, presumably due to the asymmetry of the 
glucoside and receptor complex. No binding constant was able to be determined due to the complex 
spectra and rate of saturation, but it is speculated to be much higher than that of half receptor 152 
although this will need to be quantified in future work. This information lends to the theory that the 
association constant of octyl glucoside 12 to reaction intermediates increases as formation of the 
macrocycle proceeds, with each urea linkage formed strengthening the interactions between the 
intermediate and the glucoside. Once one urea linkage has been formed between half receptor 152 
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and isocyanate 151, the octyl glucoside 12 binds to the new intermediate and then preorganises the 
conformation towards macrocycle formation. The low binding affinity of octyl glucoside to half 
receptor 151 might allow unwanted partial oligomerisation to occur however, as there may be no 
preorganisation before binding of the glucoside to the macrocyclic intermediates. Some evidence of 












Figure 62 HPLC chromatograms showing the effect of templating the reaction with octyl β-D-glucoside 12 
(detection wavelength used is 210 nm). The top chromatogram is a typical trace from initial screening of the 
macrocyclisation using pyridine or DMAP to accelerate reaction rate but without control of the products formed. 
None of macrocycle 150 was isolated and very complex mixture of products is observed. The bottom 
chromatogram is typical of the optimised reaction when octyl β-D-glucoside 12 is present and shows two main 
products: receptor 150 (A) and a dimerised product 167 (B, see Figure 63 below). Isolated yield of 150 is 48%. 
Stationary phase: preparative scale C18, flow rate: 16 mL/min, eluents: acetone/water. 
  
Without octyl glucoside 












Figure 63 Hypothesised dimerised product 167 (B, Figure 62) isolated during purification of macrocycle 103. It 
consists of 2 equivalents of half receptor 152 and 1 equivalent of isocyanate 151. Species with similar exact mass 
observed in mass spectrometry. 
The macrocyclisation was then further improved by decrease of reaction concentration to 0.5-0.6 mM 
and a slow addition of TEB isocyanate 151 via syringe pump. It was also found that co-evaporation of 
half receptor 152, DMAP and octyl β-D-glucoside with dry toluene prior to reaction provided an even 
cleaner reaction – possibly due to the removal of water from the more hygroscopic components (such 
as octyl β-D-glucoside). These modifications gave a final improved yield of ~50%, which again was very 
reproducible, even on larger scales (>0.5 g).  
With macrocycle 150 now routinely accessible, full characterisation of the macrocycle was possible. 
The 1H and 13C NMR spectra featured similarities when compared with anthracene macrocycle 120 
(chapter 4). Chemical shifts and general arrangement of the signals related to the spacer aromatics 
were largely consistent between the two macrocycles. Also clearly evident by NMR were the two TEB 
surfaces, which displayed distinct signals in both 1H and 13C NMR (Figure 64). The macrocycle was also 





















Figure 64 Partial 1H (top) and 13C (middle and bottom) NMR spectra (500 MHz, CD3OD, 298 K)  of macrocycle 150, 
demonstrating the inequivalence of the TEB surfaces due to the asymmetric spacer unit. 
Deprotection of the tert-butyl esters on the solubilising groups with acid was required to afford water-
soluble macrocycle 3. Given the immense amount of work investigating the stability of previous 
anthracene urea receptors to acid (see chapters 2 and 4), a more cautious approach was taken initially 
to the acidic deprotection of 150. However, the first attempt at finding suitable deprotection 
conditions, which consisted of 20% TFA (v/v) in dichloromethane for 16 hours, did not appear to 
decompose the macrocycle (Scheme 83). Removal of the TFA and solvent, and then analysis by 1H NMR 
in CD3OD revealed that the tert-butyls had all been removed but the macrocyclic structure appeared 
to still be intact, as the spectra displayed a similar composition of chemical shifts and peaks as 



















meant to afford polycarboxylate macrocycle 3 and thus water solubility. Indeed, during neutralisation 
of the reaction product, an insoluble suspension of the polycarboxylic acid (pH ~4) became a solution 
of polycarboxylate 3 at pH 7. Removal of the solvent and analysis by 1H NMR in D2O afforded a 











Scheme 83 (i) TFA (20% v/v), CH2Cl2, rt, 16h, 89%. R = tert-butyl protected G2MM solubilising group. R’ = 
polycarboxylate G2MM solubilising group. 
It was noted however, that small broad peaks not associated with macrocycle 3 were present in the 1H 
NMR – most notably in the aromatic and urea methylene regions (Figure 65). It was theorised that 
these impurities may arise from a small amount of decomposition of protected macrocycle 150 during 
the acidic deprotection, given that the equivalent anthracene macrocycles would completely 
decompose under the same conditions. Analysis of the product (at pH 4) by reverse phase HPLC using 
a methanol/water (buffered with 0.1% TFA) eluent, did reveal a major product (i.e. receptor 3) but also 
a small quantity of impurity (<10% by integration of the chromatogram). Purification of the receptor 
using preparative reverse phase HPLC with this same eluent did afford pure receptor 3 (Figure 65), and 
thus this purification was routinely carried out upon the crude deprotected macrocycle before 
neutralisation to pH 7. Occasionally, minor esterification of the solubilising chains to the methyl ester 
would occur in the methanol/water (buffered with 0.1% TFA) eluent. Use of methanol as an eluent 
was necessary, as poor solubility in acetonitrile was observed and no retention was achieved using 
acetone. It was determined by integration in the 1H NMR that approximately <30% of the receptors 
featured one methyl ester. Fortunately, stirring 3 in aqueous base (0.5 M NaOH) removed all traces of 
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methyl esters. Test studies by NMR also revealed receptor 3 to be stable to 0.5M NaOH (aq) for at least 
1 day. The purity of the receptor was then determined by 1H NMR in D2O, whereby a known 
concentration of receptor was compared to 1 equivalent of DMF which was added as an internal 
standard. A long relaxation delay (>45 seconds) was used during acquisition and comparison of the 
integrals for both receptor and DMF gave a ratio of the two species, and thus an indication of purity 
(often >80% pure). The impurities not visible by 1H NMR are assumed to be various salts (e.g. sodium 
trifluoroacetate) that persist through the neutralisation procedure. Accurate determination of purity 
and thus receptor concentration is critical when attempting binding studies, as the wrong 














Figure 65 Comparison of 1H NMR spectra (500 MHz, D2O, pH 7.4, 298 K) of receptor 3 before (top) and after 





















Figure 66 Numbering system used for the discussion of the conformational and binding properties of receptor 3. 
Triethylbenzene proton designations (blue) are prefixed with “t” (i.e. t1, t1’ etc.), spacer CH protons (red) are 
prefixed with “s” and protons from the dendritic solubilising groups (green) are prefixed with “d”. The urea and 
amide protons are also denoted accordingly. 
Now that receptor 3 could be reproducibly synthesised and purified, full characterisation was achieved 
using NMR. The numbering system used for discussing characterisation and conformational 
experiments for receptor 3 is outlined in Figure 66. The 1H NMR was obtained in both D2O and 9:1 
H2O/D2O - so that the urea and amide NHs would be visible and reduce exchange with deuterium from 
the D2O solvent (Figure 67). The asymmetry of the spacer units and the effect this has on the TEB 
surfaces could be most clearly seen for the CH2 (t2) and CH3 (t1) protons, with both featuring a small 
broader peak adjacent to the main peak (denoted as t1’ and t2’). These major and minor peaks were 
further characterised by 2D NMR 1H-13C HSQC, where they correlated to carbon atoms with very similar 
chemical shifts (Figure 69). The 1D 13C spectrum corroborated this with all carbons relating to the TEB 
surfaces featuring two carbon signals of similar chemical shift (Figure 68) – as seen for protected 
macrocycle 150. Furthermore, 1H-1H COSY spectra also revealed that the t1-CH3 correlated to t2-CH3, 
and that t1’-CH3 correlated to t2’-CH2, which would infer that the major and minor peaks are indeed 















Figure 67 Comparison of partial 1H NMR spectra (600 MHz, pH 7.4, 298 K)  of receptor 3 in D2O (top) and 9:1 
H2O/D2O (bottom), where the added water reduces deuterium exchange and allows visualisation of the NH 











Figure 68 Partial 13C NMR spectra (600 MHz, D2O, pH 7.4, 298 K)  of receptor 3. The non-equivalence of the 































Figure 69 Partial COSY (1H-1H correlation, left) of receptor 3 (600 MHz, D2O, pH 7.4, 298 K), showing the 
correlations between major (t1-t2) and minor (t1’-t2’) ethyl signals. Partial HSQC (1H-13C correlation, one bond, 
right) of 3 in D2O displays that both major and minor ethyl peaks (i.e. t1 and t1’) correlate to very similar carbon 
signals. These data would suggest that the major peaks (i.e. t1 and t2) are from the same TEB surface, and that 
t1’ and t2’ originate from the other TEB surface. 
Receptor conformation was then probed using 2D NOESY (1H-1H correlation, through space) spectra in 
9:1 H2O/D2O – so that correlations between the NH protons and other parts of the molecule could be 
observed. Molecular modelling of the free receptor (Figure 59) predicted a conformation where the 
urea NH protons were directed inwards towards the centre of the cavity. Analysis of the NOESY spectra 
appeared to confirm that this conformation was indeed the predominant form of receptor 3. If rotation 
of the urea bonds were to occur, then aromatic ureas NHB/B’ would be directed towards spacer protons 
s3 and s1 (Figure 70). However, no such correlation was observed in the NOESY spectrum. The only 
visible correlations to the aromatic ureas NHB/B’ were to the ethyl protons (t1/t1’ and t2/t2’), the urea 
methylenes (t3/t3’), and to the adjacent urea NHA/A’. This may suggest that steric interactions between 
the urea protons and the ethyl groups may prevent rotation and force the ureas to face inwards 

















Figure 70 Theoretical conformations of receptor 3 in water. The pink boxes represent possible NOE interactions 
between protons. The NOESY data infers the conformation on the left, where the ureas are pointing inwards, as 
through space interactions are observed for the urea and ethyl protons. Evidence for the conformation on the 
right was not observed, as no interaction was seen for urea NHB/B’ and spacer proton s1. 
The NOESY spectra also confirmed the aforementioned characterisation of the two distinct TEB ethyl 
groups, where correlations were only seen between t1 and t2, and between t1’ and t2’ for example. 
Determination of where each TEB surface (i.e. surface with protons t1 or t1’) is located relative to the 
asymmetric spacer unit was also achieved – with protons t1’ and t2’ only showing correlations to 
spacer protons s1. The broad peaks associated with protons t1’ and t2’ could therefore be due to the 
increased steric bulk on the side of the spacer unit where the dendrimer is attached via the amide, as 
impeded rotation could broaden NMR signals. Conversely, surface protons t1 and t2 only appeared to 
interact with spacer protons s2 and s3, which would imply t1 and t2 are on the same side as protons 
s2 and s3. The reduced steric bulk at this part of molecule corroborates with the sharper peaks 
observed for ethyl group (t1 and t2). These observations are consistent with the structure and 















Figure 71 Partial NOESY (1H-1H correlation, through space) spectra for receptor 3 (600 MHz, pH 7.4, 298 K) in 9:1 
H2O/D2O. The top two spectra confirm the assignment of the receptor (bottom right), showing that each TEB 
surface only interacts with one side of the spacer unit. The bottom left spectra confirm that the ureas are pointed 
inwards towards the cavity, as no correlation between urea protons NHB/B’ and spacer protons are seen. 
Studies by NMR were then performed on receptor 3 to probe any aggregation or self-association 
effects, as changes in NMR spectra due to these phenomena are important to characterise, this is so 
they are not misinterpreted as binding events during later studies.96 Variable temperature 1H NMR 
studies were then undertaken. Several resonances sharpened as the temperature increased (Figure 
72). The most significant changes were observed for protons t1/t1’, t2/2’, s1 and s3. This might suggest 
that these protons are involved in sterically hindering rotation and the higher temperatures provide 
enough energy to exceed this barrier to rotation. Such steric effects may be the reason for the rigid 
conformation where the ureas are directed inwards towards the cavity. A dilution study of receptor 3 
was also performed using 1H NMR, and it was found that there was no change in the spectra over the 
concentration regime 1-0.05 mM. This would imply that the receptor is monomeric and does not 














Figure 72 Partial 1H NMR spectra (500 MHz, D2O, pH 7.4) showing receptor 3 at various temperatures. Receptor 
signals sharpen upon heating – most notably for t1/t1’, t2/t2’, s1 and s3. Chemical shifts (δ, ppm) relative to t1 
(1.18 ppm). Signal for t3/t3’ omitted for clarity due to overlap with residual solvent peak that varied in chemical 
shift upon heating. 
The thermal stability of the receptor was also tested, initially by heating 3 (in D2O) in a sealed vessel. 
No changes were observed by NMR spectroscopy until 100 °C, whereupon decomposition was 
observed (Figure 73). The new peaks were much more resolved than that of the receptor at room 
temperature and it was found the spectra remained unchanged upon cooling to 25 °C. It became 
apparent that hydrolysis of the some ureas had occurred to give an acyclic molecule, as signals for the 
TEB surface were still visible. However, heating 3 to 150 °C in the solid state appeared to have no effect, 
with no evidence for decomposition. Such stability is desirable for sterilisation purposes, if the receptor 
were incorporated into a medical device.97 Receptor 3 was also tested for cytotoxicity towards HeLa 
cells, studies of which were performed by Hongyu Li. It was found that incubation of the HeLa cells for 
18 hours, with the receptor present at a range of concentrations (0.01 mM – 1 mM), gave no indication 
of any toxic effects. Low or non-toxicity is critical towards medical applications, and these initial studies 
bode well for the potential implementation of 3 into medical devices that interface with the body. It is 
speculated that receptor 3 is not cell permeable, due to its polycarboxylate solubilising groups, and 
















Figure 73 Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 K) of 3 at 25 °C (top), and after heating at 150 
°C for 1 hour in the solid state (middle), showing no signs of decomposition. Heating to 134 °C in D2O however 
showed complete decomposition of the receptor (bottom). 
5.4 Binding studies 
Given that receptor 3 was designed with β-D-glucose 4 as a target substrate, initial binding studies with 
3 and D-glucose 4 were performed by 1H NMR in D2O. Both stock solutions of receptor 3 and D-glucose 
4 were confirmed to be at pH 7.4 (with 10 mM phosphate buffer solution) to avoid variations in pH 
giving misleading changes in the NMR spectrum. The solution of D-glucose was allowed to reach 
equilibrium of both α and β anomers by dissolution in the titration medium (here D2O) 24 hours 
beforehand, with the equilibrated anomeric ratio verified by 1H NMR. A solution of D-glucose (~100 
mM), with added receptor 3 (~0.3 mM), was titrated into a solution of 3 (~0.3 mM). This is so that the 
concentration of receptor 3 remains constant, as guest concentration increases, throughout the 
titration and makes extraction of the binding constant from the data much simpler. A modest Ka of 
~1000 M-1 was estimated initially for the complexation of D-glucose with 3, and the planned titration 
would have given a good number of data points if this were the case. However, it became rapidly 
apparent that the binding constant was much higher. The symmetrical NMR spectrum of free receptor 
3 became very convoluted (especially in the aromatic region) upon the initial addition of D-glucose, 
25 °C 
25 °C after 150 °C in solid state 
25 °C after 134 °C in D2O 
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which gave a final glucose concentration of 2 mM (or roughly 5-6 equivalents). Further additions of D-
glucose appeared to have no effect on the spectrum, implying the receptor was most likely fully bound 
with guest after the first addition of D-glucose. No determination of the binding constant was possible 
at this point, although rough calculations based on concentrations of host and guest at this period in 
the titration estimated the Ka to be ~104 M-1.  
The NMR titration was then repeated where the amount of glucose titrated into receptor was much 
reduced (Figure 74). The NMR titration spectra indicated that the binding of glucose to 3 was occurring 
with slow exchange relative to the NMR timescale (see Figure 4, Chapter 1). Integration of part of the 
aromatic region that relates to host guest complex (IntHG) relative to the whole aromatic region (IntH + 
IntHG) can be used to calculate the total concentration of host guest complex ([HG]) at each point in 
the titration. This can then be used to calculate concentrations of free host ([H]) and guest ([G]) and 
thus determine the binding affinity. Applying this to each point in the titration of glucose with 3 and 
fitting the collated data to a 1:1 binding model (one guest per one host) gave a binding constant of Ka 
~ 18,000 M-1. This affinity for D-glucose by a synthetic lectin using non-covalent interactions in water 
is unprecedented, with the previous record being two orders of magnitude lower – receptor 34 with 
























Figure 74 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated with 
a combined solution of D-glucose 4 (9.6 mM) and receptor 3 (0.25 mM), in D2O with 10 mM phosphate buffer 
(pH 7.4) at 298 K. Spectra imply binding with slow exchange on NMR timescale.  Integrations of the peak at 8.19 
ppm (denoted with •) versus the region 8.35-7.39 ppm were plotted against D-glucose concentration (mM). The 
calculated values for the integrals are overlaid with the observed values, giving Ka = 18,026 ± 208 M-1 (1.04%). 
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The binding affinity for D-glucose to 3 was then corroborated using isothermal titration calorimetry 
(ITC) experiments (see Chapter 4 for a more in-depth explanation of this technique). Titration of D-
glucose (7.5 mM) into receptor 3 (0.13 mM) using ITC gave a very large exotherm upon addition of 
glucose (Figure 75). Subtraction of the heat of dilution from the titration gave the change in enthalpy 
for binding, which was plotted against concentration to give a curve. Fitting this curve to a 1:1 binding 
model yielded a binding affinity for D-glucose and 3 of Ka ~ 18,000 M-1 – essentially the same as 
determined by NMR titrations. The thermodynamic results obtained for D-glucose and 3 shows that 
the main contribution of binding appears to be enthalpically based, with a smaller contribution from 
the entropy of binding. This is most likely due to the strong hydrogen bonding interactions formed 
between glucose and the receptor being the main driving force for complexation. Large increases in 
entropy upon binding are usually indicative of many water molecules being displaced from the binding 
site or an increase in receptor/substrate flexibility upon binding. Neither would appear likely in the 
case of 3, given its very rigid structure and small cavity size, and this was reflected in the 
thermodynamic results. The large enthalpic contribution towards binding is too large to be solely a 
result of CH-π interactions between the receptor 3 and substrate – the enthalpy gain for binding 
interactions between one carbohydrate and one aromatic is typically ~8 kJ mol-1.98 Therefore, it can be 
speculated that a large part of the driving force of the binding affinity is hydrogen bonding between 

























Figure 75 ITC binding results for receptor 3 (0.2 mM) titrated with D-glucose 4 (7.5 mM) in 10 mM phosphate 
buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows the titration 
(sugar into receptor 2); C) shows the plotted change in enthalpy vs molar ratio and D) shows the fit calculated 
using a 1:1 binding model (Ka = 18,000 ± 372 M-1). 
 
 
Ka = 18048.12± 372.31 M-1 (2.06%)
r = 0.999587
ΔG =-24.3± -0.5 kJ.mol-1
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An NMR titration for receptor 3 and D-glucose 4 was also attempted in a 9:1 H2O/D2O solvent medium, 
to provide information regarding the interactions between the urea NH protons and D-glucose. 
However, it was found that large broad artefacts were observed during the titration both downfield 
and upfield from the signal for the bulk water protons (which were suppressed using NMR solvent 
suppression techniques). These artefacts would appear to change in size and broadness between 
additions during the titration and would require recalibration of the water suppression between each 
addition – this proved unpractical given the number of data points required for a NMR titration 
experiment. The artefacts are speculated to arise from exchange of water in the cavity with the bulk 
solvent water, as water bound to the receptor would possess a different chemical shift to that of free 
bulk water. This process can be considered comparable to the effect MRI contrasting agents have upon 
water, whereby water bound to the contrasting agent is perturbed enough to exhibit a distinct signal 
compared to the bulk water.99 Given that this phenomenon would be unavoidable, it was deemed not 












Figure 76 Partial 1H NMR spectrum (600 MHz, pH 7.4, 298 K)  of 3 saturated with D-glucose in 9:1 H2O/D2O (top), 
where the complex was preformed. The bottom spectrum is part of an attempted NMR titration of D-glucose 
into 3 in 9:1 H2O/D2O, where large broad artefacts are observed δ ~3.6-5.8 ppm. These artefacts are speculated 
to arise from slow exchange of bound water molecules in the receptor binding site with bulk solvent water 
molecules. 
Receptor-glucose complex in 9:1 H2O/D2O 
Attempted Titration in 9:1 H2O/D2O 
Urea NHA/A’ protons 
Exchange of bound water 
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However, preformation of the saturated receptor and glucose complex in 9:1 H2O/D2O was predicted 
to feature very limited (if any) exchange of water in and out of the cavity, and therefore these bound 
water artefacts would not be present. Indeed, such a result was observed, with no broad artefacts 
present adjacent to the bulk water signal. The NMR spectrum of the complex was now more 
convoluted than when obtained in pure D2O, as all NH protons will be visible. Part of this complexity is 
presumably due to the fact that all urea NH protons (12H) are now inequivalent when bound to an 
unsymmetrical guest (i.e. D-glucose). Given the asymmetry of the receptor itself with regards to the 
‘horizontal axis’, there are two main possible binding orientations of glucose with the receptor. This 
further complicates the number of individual urea NH protons in the NMR spectrum for the complex 
– potentially generating 24 unique urea NH environments. This can be seen to some effect for the 
benzylic urea NH protons, which appear to occupy a chemical shift range of > 1 ppm in the 1H NMR 







Figure 77 Schematic of two different possible orientations of D-glucose inside the receptor cavity. Each complex 
would lead to a potential of 12 different urea NH environments, giving 24 different urea NH environments for 
both complexes combined. Potential evidence for this can be seen in Figure 76. 
One of the advantages of a host guest system exhibiting slow exchange kinetics upon binding, as seen 
for 3 and D-glucose, is that a large amount of structural information of the complex can be garnered 
using 2D NMR experiments. Analysis of the receptor and glucose complex was then performed using 
2D TOCSY, NOESY and ROESY 1H NMR experiments. These spectra further exemplified the asymmetry 
of the receptor-glucose complex, with many different protons environments visible. Signals relating to 
bound glucose were obscured by receptor protons (most notably the dendrimer solubilising groups) 
in the 1D 1H NMR, but could be observed using these 2D NMR methods. A ROESY spectrum in D2O very 
clearly indicated chemical exchange peaks between free and bound glucose, with signals for the bound 
form shifted upfield approximately 1.5 ppm (Figure 78). These signals are shifted upfield due to the 
receptor shielding the bound substrate from the magnetic field, and are most notable for positions 3-
CH, 4-CH, and 5-CH of β-D-glucose – suggesting these regions of the substrate are located most deeply 
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within the cavity. Upfield movements of the 6-CH2 were relatively small however, which would imply 
that the CH2OH extends outwards from the cavity – an observation that is consistent with molecular 
modelling of 3 and glucose. Also prevalent were two species of bound glucose, with two distinct signals 
observed for the bound substrate (most notably for 4-CH). This was consistent with the prediction of 
two major orientations of glucose within the receptor cavity (Figure 77). No signals corresponding to 
the α-anomer of glucose were observed under these conditions (mixing time of 100 ms). However, use 
of longer mixing times (>500 ms) did reveal signals for the bound α-anomer. No quantitative 
deductions of selectivity between the α and β anomer could be concluded from these data, as the 
exchange peaks observed are dependent on exchange rates of glucose in and out of the receptor cavity 
and not from actual populations of bound and unbound species. Determination of selectivity between 
the anomers was determined using 1H-13C HSQC however, with signals for only β-D-glucose bound to 
3 visible. The intensity of signals for bound β-D-glucose relative to baseline noise was measured to be 
6:1 (signal:noise). If the signals for bound α-D-glucose are at most the same intensity of the baseline 
noise, then it can be presumed that the selectivity of 3 for β and α-D-glucose is at least 6:1 (β:α). The 
selectivity could potentially be higher however, but would require a much more concentrated sample 




















Figure 78 Partial ROESY (1H-1H correlation, through space, top spectrum) NMR spectrum (600 MHz, D2O, pH 7.4, 
298 K) of receptor 3 (2 mM) with D-glucose 4 (5 mM, 2.5 equivalents). Chemical exchange peaks are observed 
between the D-glucose bound to the receptor (whose signals appear more upfield) and free D-glucose. Only 
signals relating to bound β-D-glucose are labelled, as exchange peaks are observed for only the β anomer under 
these conditions (mixing time of 100 ms). Exchange peaks for the α anomer were observed at much longer mixing 
times (>500 ms). Partial HSQC (1H-13C correlation, one bond, bottom spectrum) NMR spectrum of the same 
sample. The signals for “free” and “bound” states of D-glucose are shown in black for CH protons and red for 
CH2 protons, and are labelled as for the ROESY spectrum. NMR signals corresponding to bound D-glucose are 
observed for the β anomer only, indicating an expected preference for binding the β anomer. The ratio of 
intensity of signals for bound β-D-glucose and baseline noise is measured as 6:1 (signal:noise). Assuming the 
bound signals for the α anomer are at most the same intensity as the baseline noise, then it can be assumed the 






The receptor-glucose complex was also investigated using 2D NOESY NMR, using 9:1 H2O/D2O as 
solvent to enable visualisation of the NH protons (Figure 79). This was to allow observation of 
interactions between the urea NH protons and bound glucose. Indeed, such interactions were 
observed but the sheer complexity of the spectra obtained meant that characterisation of individual 
interactions was non-trivial. Interactions could be grouped by similarity however, and each of the urea 
(NHA/A’ and NHB/B’) protons showed distinct interactions with D-glucose. The inequivalence of the urea 
protons in the complex was now very apparent, with NHA/A’ in particular displaying signals over a 
chemical shift range of δ >1.5 ppm. Also evident were interactions between the ethyl groups (protons 
t1/1’ and t2/2’) and glucose. This may suggest some hydrophobic interactions are occurring between 
the ethyl groups on the receptor surfaces and the axial CH protons of glucose – this may effectively 













Figure 79 Partial NOESY (1H-1H correlation, through space, 500 ms mixing time) NMR spectrum (600 MHz, pH 
7.4, 298 K) of 3 and D-glucose in 9:1 H2O/D2O. Correlations between urea NH and glucose protons highlighted 













Given that receptor 3 displays a clear preference for binding β-D-glucose over α-D-glucose, it was 
deemed imperative to determine whether 3 influences the equilibration between anomers. The 
previous association constants (Ka) determined for 3 and glucose are ‘apparent association constants’, 
as D-glucose is effectively composed of two different substrates (i.e. α and β anomers) with largely 
differing affinities to 3 based on previous binding data (Figure 78). These obtained binding constants 
are calculated under the assumption that the anomeric ratio is unperturbed by binding of β-D-glucose 
to the receptor. However, the anomeric ratio could be affected by this through the sequestering of β-
D-glucose in the receptor causing the amount of free β-D-glucose in solution to be lowered. As a 
consequence of this, some α-D-glucose then is converted to β-D-glucose to compensate for this 
‘removal’ of β-D-glucose from the equilibrium. This newly generated β-D-glucose is then bound by 
receptor 3, and this process repeated until almost all α-D-glucose is converted to the β-anomer and 
thus bound by 3. This scenario would effectively result in the amount of binding guest (i.e. β-D-glucose) 
to steadily increase between additions during the titration, making the concentration of binding guest 
unknown at each point – this would produce inaccurate calculated binding constants, as the value of 
binding affinity is directly proportional to guest concentration. This scenario would be true if 





Figure 80 Partial 1H NMR spectrum (600 MHz, D2O, pH 7.4, 298 K) of D-glucose. The peaks corresponding to the 
protons at position CH-1 for α-D-glucose and CH-2 for β-D-glucose are labelled accordingly. These protons were 
selected to determine (using integration) the α:β anomeric ratio during NMR studies into whether receptor 3 
affects the anomeric equilibrium.  
To determine whether receptor 3 does indeed influence the anomeric equilibrium, a series of 1H NMR 
experiments were undertaken. The titration spectra for D-glucose into receptor 3 were reviewed, with 
protons at position CH-1 for α-D-glucose and CH-2 for β-D-glucose used to quantify the ratio of 
anomers using integration (Figure 80). The ratio of unbound anomers was determined at each point in 
the titration using this method, whereupon it was found that the anomeric ratio remained constant at 
64:36 (β:α) past halfway through the titration– the same as for free glucose in water. Integrations of 
the anomeric ratio earlier on in the titration (i.e. <1 equivalent of D-glucose) were deemed inaccurate 





This finding would appear to corroborate with previous literature outlining that if a substrate is 
composed of two isomers/anomers (i.e. D-glucose), then the ratio of these anomers complexed to a 
receptor will be constant provided the ratio of free anomers in solution is also constant.34 This will be 
true if both anomers in are in sufficient excess relative to the receptor. If this is the case, then the 
titration will proceed as if only one guest were present, yielding a ‘composite’ or apparent binding 
constant. This hypothesis would be consistent with the results observed for receptor 3 binding to D-
glucose, which is in approximately 5 fold excess towards saturation of 3 – with NMR studies showing a 
constant anomeric ratio when possible to determine. Attempts to plot the titration data assuming only 
β-D-glucose binds (so effectively only 64% of the total concentration of D-glucose used) results in data 
that does not fit to a binding model, with no association constant determinable. This would suggest 
that the apparent binding constant must be resulting from binding of both anomers to receptor 3, 
albeit with a preference for the β-anomer. 
To further investigate this, and see if receptor 3 could accelerate equilibration between anomers of D-
glucose (effectively acting as an enzyme – an ‘anomerase’), another NMR experiment was undertaken. 
Pure α-D-glucose was dissolved in D2O and 1D 1H NMR spectra recorded over time until equilibrium 
was reached, with the ratio of anomers deduced using integration as described earlier (Figure 80). This 
was then repeated in the presence of receptor 3, with the ratio of anomers again calculated at certain 
intervals over time. It was found, however, that the receptor appeared to have no effect on the rate of 
equilibration of α-D-glucose to β-glucose. Plotting the ratio of α and β anomers against time gave very 
similar linear curves, with rate of equilibration appearing constant with or without receptor present. 
In light of these results, it was therefore concluded that receptor 3 does not influence the equilibration 
between α and β-anomers of D-glucose, and that the binding constants obtained earlier are indeed 
accurate. 
While high affinities for substrates can be difficult to obtain (especially for carbohydrates in water), the 
ultimate challenge is selectivity for a target substrate over all others – especially substrates with similar 
structural properties. This is particularly difficult for a molecule trying to distinguish between 
carbohydrates, as inversion of the stereochemistry of a single hydroxyl can result in an entirely 
different monosaccharide – often with unique and important biological properties. A receptor that is 
unable to distinguish between two carbohydrates would not be useful in a medical context as such off-
target binding would give false results if incorporated into a biological sensor; or even outright 
dangerous if the binding disrupted biological pathways of key carbohydrate substrates. Given the 
excellent affinity of hexaurea 3 for D-glucose 4, quantification of its selectivity for D-glucose 4 over 
other substrates was critical if 3 was to ever function in a medicinal context. The selectivity of receptor 
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K a = 7522.19 ± 414.32 M-1 (5.51%)

























0 µM MBG (0 eq) 
20 µM MBG (0.3 eq) 
40 µM MBG (0.6 eq) 
60 µM MBG (0.9 eq) 
80 µM MBG (1.1 eq) 
100 µM MBG (1.4 eq) 
120 µM MBG (1.7 eq) 
140 µM MBG (2.0 eq) 
160 µM MBG (2.3 eq) 
180 µM MBG (2.6 eq) 
200 µM MBG (2.9 eq) 
234 µM MBG (3.4 eq) 
291 µM MBG (4.2 eq) 
347 µM MBG (5.0 eq) 
440 µM MBG (6.3 eq) 
620 µM MBG (8.9 eq) 
3 was then surveyed by performing binding studies with other substrates, including similar 




















Figure 81 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.07 mM) titrated with a 
combined solution of methyl β-D-glucoside 14 (10 mM) and receptor 3 (0.07 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K. Spectra imply binding with slow exchange on NMR timescale. Integrations of peak at 
8.31 ppm (denoted with •) versus region 8.36-7.36 ppm were plotted against guest concentration (mM).  The 
calculated values for the integrals are overlaid with the observed values, giving Ka = 7522 ± 414 M-1 (5.51%) 
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The first substrate to be tested was methyl β-D-glucoside 14, as this is an all equatorial carbohydrate 
(like D-glucose) but only exists as the β-anomer due to methylation of the anomeric OH – this prevents 
ring opening and thus possible formation of two isomers upon re-cyclisation (as for reducing sugars 
such as D-glucose). In past receptors from the Davis group, 14 has exhibited increased affinities over 
D-glucose due to the increased hydrophobic nature of the methyl group vs the free hydroxyl in D-
glucose. For 3, however, the opposite trend was observed – whereby the affinity of 14 and 3 is lower 
than that of 3 and D-glucose 4. NMR titrations for 14 and receptor 3 suggested slow exchange binding 
kinetics (as for D-glucose), although signals relating to the sugar-receptor complex were more defined 
for 3 than for D-glucose 4 – potentially due to there being only one anomer of 14 unlike D-glucose 4. 
Integration of the spectra and fitting the data to a 1:1 binding model gave an association constant of 
Ka ~7500 M-1, almost 2.5 times weaker than for D-glucose 4 (Figure 81). This binding affinity was also 
confirmed by ITC. The observed reduction in affinity is presumed to be due to the increased steric 
effects of methyl β-glucoside 14 compared to D-glucose, with the anomeric methyl group making the 
substrate larger and a poorer fit for the cavity.  
A similar result was also obtained for D-glucuronic acid 168, which displayed a binding affinity of Ka 
~5400 M-1 using ITC. No binding constant for 168 was able to be determined by NMR titration as the 
binding of receptor and substrate appeared to operate under ‘intermediate exchange’ kinetics (Figure 
82). This resulted in severe broadening of receptor signals as 168 was added, meaning there was no 
way to extract any tangible data (through integration or change in chemical shift) to be fitted to a 
binding model. As for methyl β-D-glucoside 115, the increased sterics of D-glucuronic acid 168 are 
small when compared to D-glucose but appear to have a significant negative effect on the binding 
affinity. This would suggest that receptor 3 is very sensitive to the size of guest substrates – most likely 
due to its relatively small cavity size. 
NMR titrations of receptor 3 with D-xylose 149 and 2-deoxy-D-glucose 169 also implied binding with 
intermediate rates of exchange – as for D-glucuronic acid 168. Again, this meant that no binding 
constant was determinable using the NMR data. Binding affinities were measurable using ITC however, 
with D-xylose 149 having an association constant of Ka ~5800 M-1. Most surprising however was that 
2-deoxy-D-glucose 169 displayed a binding constant of Ka ~725 M-1, which is approximately 25 times 
weaker than D-glucose (Figure 83). These reduced affinities are most interesting as both substrates 
feature reduced sterics over D-glucose 4 (with removal of certain hydroxyls compared to D-glucose 4) 
and yet remarkably depressed binding affinities. It could therefore be inferred from these results that 
the hydrogen bonding interactions between the receptor and sugar hydroxyls are thus critical to the 
strength of binding affinities. The 2-OH hydroxyl is clearly critical to the binding affinity, given the 
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Figure 82 Binding results for receptor 3 and D-glucuronic acid 168. Attempted NMR titration (600 MHz, D2O, pH 
7.4, 298 K) (A) showed extreme broadening of receptor peaks upon addition of 168, which imply binding with 
intermediate rate of exchange – no binding constant was thus determined from these data. Binding constant was 
determined using ITC (B), which gave a Ka of ~5400 M-1 when the data was fit to a 1:1 binding model (C). 
Ka = 5348.08± 189.39 M-1 (3.54%)
r = 0.999179
ΔG =-21.28± -0.75 kJ.mol-1

























ITC data fit, 






Inversion of a single hydroxyl (relative to D-glucose) also appeared to significantly weaken binding. This 
was demonstrated with NMR and ITC titrations for D-galactose 5 and D-mannose 6, both of which were 
determined to have binding affinities to 3 of Ka <200 M-1 – two orders of magnitude lower than for D-
glucose 4 (Figure 83). This is equal to receptor 3 having a D-glucose vs D-galactose/D-mannose 
selectivity of >100:1, far exceeding previous synthetic receptors which managed a selectivity of up to 
10:1. Differentiation between these monosaccharides is considered very difficult, with even natural 
proteins struggling to differentiate between the different sugars – the lectin concanavalin A binds both 
















Figure 83 Binding affinities for various carbohydrates and receptor 3 in water (at pH 7.4, 298 K), showing the 
selectivity for D-glucose over other similar carbohydrates. n.d. – not determined, due to intermediate rate of 




D-Glucose 8 18,000 19,000
Methyl β-D-Glucoside 9 7,500 7,800
D-Glucuronic Acid 10 n.d. 5,300
D-Xylose 11 n.d. 5,800
2-Deoxy-D-Glucose12 n.d. 730
D-Galactose 13 130 180
D-Mannose 14 140 140
D-Ribose 15 270 220
D-Fructose 16 50 60
D-Cellobiose 17 30 30
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The reduced affinities for D-galactose 5 and D-mannose 6 are presumably due to the axial hydroxyls 
making both guests less ideal for the receptor cavity for two potential reasons: increased steric 
interactions make both guests poor fits for the shape of the relatively small cavity, but also that 
inversion of an equatorial hydroxyl to the axial position severely disrupts the hydrogen bonding 
interactions from the ureas (see reduced affinity of 2-deoxy-D-glucose 169). These reductions in 
binding affinity due to axial hydroxyls are also apparent for D-fructose 20, which can feature up to 3 
axial hydroxyls in the α-pyranose form. This is reflected by the further reduced association constant of 
Ka ~50 M-1 (Figure 83). The fact that D-fructose 20 in solution is also composed of ~30% as the furanose 
form may also have an effect, as this structural isomer may bind even weaker or not at all. 
Differentiation between D-glucose 4 and D-fructose 20 has been historically difficult for carbohydrate 
receptors derived from boronic acids, as arrangements of diols in both substrates are complementary 
for boronate formation.31 The selectivity of hexaurea 3 and D-glucose 4 over D-fructose 20 however 
appears extraordinary, with D-glucose binding more than 350 times more strongly. Substrates 5, 6, 20 
and 170 all bound to 3 with a fast rate of exchange relative to the NMR timescale. It could be 
speculated that these fast binding kinetics may be due weaker intermolecular interactions and thus 
lower affinities observed for these substrates, but the increased steric factors may also disfavour full 
encapsulation inside the cavity and thus enable fast exchange between free and bound guests. 
A slightly increased affinity (relative to 5, 6 and 20) was observed for D-ribose 170 however, which also 
features an axial hydroxyl (3-position). An association constant of ~240 M-1 for D-ribose 170 with 
receptor 3 was determined by NMR and ITC titrations (Figure 83). This increased affinity compared to 
other sugars with axial hydroxyls may be due to a lack of substitution at the 6-position – alleviating 
some of the increased sterics of the axial hydroxyl. The affinity of 170 relative to D-glucose 4 however 
is still very low meaning selectivity of 3 for D-glucose 4 is still excellent. The lowest association constant 
to be measured for a carbohydrate was for D-cellobiose 31, which had a measured affinity of Ka ~ 30 
M-1, and this was rationalised to be due to the substantially larger size of the substrate (Figure 83). 
Interestingly, D-cellobiose 31 appears to bind to 3 with slow exchange kinetics on the NMR timescale 
despite its low affinity. This might imply that while the large size makes the substrate unfavoured for 
binding to the cavity, the size of the substrate also makes the kinetics of decomplexation slow due to 














Figure 84 Compounds where binding to 3 was undetectable by ITC titrations, with some also investigated by 
NMR - although no evidence of binding was observed by this methods as well. 
However, many substrates tested for binding affinity by ITC, showed no affinity towards receptor 3 
(Figure 84). Given that the affinity of D-cellobiose 31 (Ka ~ 30 M-1) was detectable using ITC, and 
previous examples in the literature have measured very low association constants using ITC, it is 
plausible that such low association constants could have been acquired using this technique.100 
Furthermore, distinct differences between the heat of dilution and binding titrations are clearly visible 
for D-cellobiose 31 but not for these non-binding substrates – where both blank and titration runs are 
essentially identical (Figure 85). On this basis, there is confidence that these non-binding substrates 
can indeed be classed as non-binding or have undetectable association constants (i.e. Ka <10 M-1), and 
therefore selectivity of receptor 3 for D-glucose 4 over these substrates is equivalent to >1800:1. 
These non-binding substrates include carbohydrates such as methyl α-glucoside 171, although this is 
less surprising given the selectivity observed for β-D-glucose over α-D-glucose for receptor 3. This 
coupled with the apparent sensitivity of 3 to sterics (see methyl β-glucoside 14, Figure 81) can 
rationalise the lack of affinity seen here for 171. Carbohydrates L-fucose 172 and D-maltose 132 also 
exhibit no evidence of binding to receptor 3, and this can also be rationally explained through 
unfavourable steric effects as well. Most surprising, however, was the apparent lack of affinity N-
acetylglucosamine 7 has towards receptor 3, as it is a carbohydrate with an all equatorial substitution 
of hydroxyls with one acetamide at the 2-position. Analysing the structure of 7 reveals that the 
acetamide (position 2) and the CH2OH (position 6) are ‘trans’ to each other, and reside at opposite 
154 
 
positions of the pyranose ring. This symmetry is not compatible with the C3-symmetry of receptor 3, 
as one of these groups (CH2OH or acetamide) would always be directed towards one of the urea spacer 
units and cause unfavourable steric interactions. This incompatible symmetry may mean that 7 simply 
cannot fit inside the cavity, and would result in very low or no binding affinity. NMR titrations were 
attempted for these carbohydrate substrates, but no evidence of binding to 3 was observed. 
Broadening and slight movement of some signals was observed at very high concentrations of guest 
(>500 equivalents of guest to host), but gave linear straight lines when fit to a 1:1 binding model which 
















Figure 85 ITC traces for D-cellobiose 31 (top), which show heat of dilution (A), titration run (B) and plotted 
enthalpy change (ΔH) vs guest concentration (C). The same is displayed for the ITC experiment with methyl α-
glucoside 171 (bottom). Distinct difference in ΔH (y-axis) for titration of cellobiose (B) compared to heat of 
dilution (A). This was not seen for 171, and thus no typical binding curve seen when plotted (C). These data 
suggest no binding of 171 to 3, and is typical for all non-binding substrates. 
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Linear polyols D-Mannitol 173 and D-Gluconic acid 174 (D-gluconate at pH 7.4) also displayed no 
evidence of binding to 3, which infers that the cyclic pyranose structure of D-glucose is essential for 
binding. No binding was also confirmed by NMR titration. Previous carbohydrate receptors derived 
from boronic acids tend to complex polyols in general, and have historically had difficulties 
distinguishing between them and their target carbohydrates. No such issues were evident for receptor 
3 however.  
Substrates bearing aromatic core structures or pendant aromatic groups, all of which tested are key 
substrates in human biology, also displayed no evidence of binding to receptor 3. Nucleobases cytosine 
175 and uracil 176 showed no affinity for 3 by ITC, and the same negative result was obtained for uric 
acid 177 – a major constituent of human blood. Nucleobases guanine and adenine were unable to be 
tested due to complete insolubility in water. However, improved solubility was observed for these 
nucleobases affixed to ribose, as for adenosine 178, and this allowed testing for binding affinity to 
receptor 3 – even then no binding affinity for 178 was seen. This is interesting as D-ribose 170 shows 
some minor affinity towards 3, but substitution with nucleobases removes all activity. This is perhaps 
because of increased steric effects due to the presence of the pendant nucleobases but also could be 
due to the ribose now adopting predominantly the furanose (5-membered ring) structure, which is 









Figure 86 Previously reported synthetic lectins 24 and 25 by the Davis group, which show affinities for target 
substrate D-glucose 4 of Ka ~ 60 M-1. However, aromatic substrates were found to bind much more strongly than 
D-glucose 4 to both receptors. Biphenyl receptor 24 bound adenosine 178 with Ka ~1500 M-1, whereas 




The lack of affinity of 3 towards these biologically relevant substrates is important for potential 
medicinal applications but also because previous carbohydrate receptors based on non-covalent 
interactions suffered from off-target binding to such substrates, often binding them much more 
strongly than their intended carbohydrate guests. For example, biphenyl receptor 24 bound adenosine 
178 with Ka ~1500 M-1 (>25 times greater than D-glucose), whereas anthracene receptor 25 bound uric 
acid 177 with Ka ~200,000 M-1 (>3500 times greater than D-glucose) and other small aromatic 
substrates with even higher affinities (Figure 86).101 Therefore, the apparent lack of binding between 
3 and such substrates can be considered a great advancement over previous receptor designs. This 
advantageous lack of affinity is believed to arise from the increased distance between the aromatic 
surfaces, when comparing 3 to 25 for example. The urea spacers seen for 3 hold the surfaces further 
apart than the previous isophthalamide spacers used for 25, and this increased distance for 3 is 
believed to be too large for π-π stacking interactions between receptor and substrate, thus giving vastly 
reduced affinities towards aromatic substrates. The same rationale can also be applied to amino acids 
L-tryptophan 179 and L-phenylalanine 180, which both feature aromatic substituents and display no 
observable binding to receptor 3 by ITC. 
Two substrates of note are acetaminophen (paracetamol) 181 and ascorbic acid (vitamin C) 182. 
Neither show any binding affinity towards receptor 3, which is not surprising given similar substrates 
mentioned earlier (i.e. polyols and aromatics) also do not bind. The lack of affinity of 3 towards these 
substrates is very significant as they are very biologically relevant compounds, and are commonly 
consumed for medicinal purposes. Current commercial glucose sensing methodology based on 
boronic acids or proteins (such as glucose oxidase) struggles to distinguish between D-glucose 4 and 
these substrates (181 and 182) – this leads to false positives and can lead to inaccurate measurements 
of blood glucose concentration, something which can be detrimental to health or even fatal.102 Given 
that receptor 3 does not appear bind either substrate, it possesses a potential advantage over existing 








Scheme 84 Inositols (hexahydroxy cyclohexanes) are cyclic polyols and can exist as 9 possible stereoisomers, with 
myo-inositol 183 being the most prevalent in nature. Scyllo-inositol 184 is the all equatorial form, and is predicted 
to bind to hexaurea 3 strongly given its complementary symmetry and resemblance to D-glucose 4. 
Inositols are cyclic polyols, being a derivative of cyclohexane substituted with six hydroxyl groups 
(Scheme 84). The most abundant in nature is myo-inositol 183, which features only one axial hydroxyl 
with the other five being equatorial, and functions as a secondary messenger for intracellular signal 
transduction pathways for several biological processes.103,104 The all-equatorial form: scyllo-inositol 
184 is very rarely found in nature, occurring in small quantities in some tropical plants and species of 
shark.105 These cyclic polyols are interesting substrates as they strongly resemble D-glucose 4, they are 
in fact derived from D-glucose 4 in biology but feature more hydroxyl groups with a higher degree of 
symmetry.106 Scyllo-inositol 184 in particular features the same C3-symmetry as receptor 3 and is 
therefore predicted to have a high affinity, as it can potentially take advantage of all urea groups 



















Figure 87 Binding results for myo-inositol 183 and receptor 3. Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 
K) (A) show the NMR titration, which implies binding with slow exchange on NMR timescale. Integrations of peak 
at δ 7.98 ppm (denoted with •) versus region δ 8.39-7.32 ppm were plotted against guest concentration, fitting 
this curve to a 1:1 binding model yielded a Ka of ~7300 M-1. Binding constant was also determined using ITC (B), 
which gave a Ka of ~7500 M-1 when the data was fit to a 1:1 binding model (C). 
NMR binding studies of receptor 3 with myo-inositol 183 implied that binding was occurring with slow 
exchange kinetics, with signals relating to the complex evolving upon each addition of substrate. 
Signals related to the complex were very well defined compared to previous slow exchange spectra, 
and this was rationalised to be due to the substrate being one isomer (unlike D-glucose in solution) 
and the binding kinetics being the slowest observed thus far – with equilibrium being reached 
approximately 5 minutes after each addition of 183 to 3. Integration of the spectra and fitting the data 
to a 1:1 binding model afforded a binding constant of Ka ~ 7300 M-1 (Figure 87). The same affinity was 
confirmed by ITC as well, with the slower kinetics of binding visualised with increased peak widths due 
to a slower evolution of heat upon binding. This binding affinity is relatively high considering the axial 
hydroxyl featured in the structure of 183. Previously tested sugars with axial hydroxyls, such as D-
Ka = 7562.58± 313.59 M-1 (4.15%)
r = 0.999781
ΔG =-22.14± -0.92 kJ.mol-1
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galactose 5, displayed very low affinities (Ka <200 M-1) in comparison. It is postulated that the increased 
affinity for myo-inositol 183 is due to presence of 2 more hydroxyl groups directly attached to the 
cyclohexane skeleton (when compared to D-galactose 5). These must create more hydrogen bonding 
interactions for 183 compared to 5, and thus result in the higher affinity observed – despite the axial 
hydroxyl. These increased number of intermolecular interactions as well as the increased size of the 
substrate (relative to most tested sugars) are likely the cause of the slower binding kinetics as well.  
NMR binding studies were then performed with scyllo-inositol 184 and receptor 3. Studies were 
initially performed using a similar concentration regime as for D-glucose 4. However it soon became 
apparent, when the receptor appeared to saturate very rapidly, that the binding affinity was much 
higher than for D-glucose 4. The concentration of scyllo-inositol 184 added was lowered accordingly 
and a successful titration carried out (Figure 88). As for myo-inositol 183, scyllo-inositol also appeared 
to bind with slow exchange kinetics on the NMR timescale, albeit with even slower kinetics than for 
183 – taking approximately 20 minutes to reach equilibrium after each addition of 184 to 3. 
Nevertheless, the receptor appeared to saturate around approximately one equivalent of 3, which 
already indicated very strong binding. Signals relating to the host-guest complex also appeared highly 
symmetrical and very well resolved, undoubtedly due to the apparent high affinity and matching 
symmetry of host and guest. Integration of the titration spectra and fitting the data to a 1:1 binding 
model gave a large binding constant of Ka ~480,000 M-1, more than 26 times stronger than D-glucose 
4. Such a high affinity is to be expected, as scyllo-inositol 184 can be considered ‘the ideal substrate’ 
























Figure 88 Binding results for scyllo-inositol 184 and receptor 3. Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 
298 K) (A) show the NMR titration, which implies binding with slow exchange on NMR timescale. Signals relating 
to the complex (B) are very resolved and show a high degree of symmetry, presumably due to the matching 
symmetry of 184 and 3. Integrations of any peak relating to the complex versus region δ 8.10-7.20 ppm were 
plotted against guest concentration, fitting this curve to a 1:1 binding model yielded a Ka of ~480,000 M-1.  
K a = 481959.33 ± 23365.21 M-1 (4.85%)
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However, measuring such a high binding constant by NMR titration can be difficult due to the relatively 
high concentrations of host and guest required to get reliable signal intensity during the titration – 
especially for slow exchange binding events where signal intensity can become severely reduced if the 
host-guest complex is spread over a large chemical shift range. Minor errors in measured 
concentrations can result in very large errors for calculated binding constants, as high affinities are 
very sensitive to concentration of both host and guest, and these errors become more impactful with 
increased concentrations of host and guest used for NMR titrations. Indeed, this was observed for the 
titration of scyllo-inositol 184 with receptor 3, where adjustment of host (or guest) concentration by 
5-10% resulted in a deviation of binding constant of ~200,000 M-1 – with the binding curves still 
producing good fits with errors below 10%. Despite this, all indications suggested a binding constant 
of at least 105 M-1 for scyllo-inositol 184 and receptor 3. However, such uncertainty in the binding 
affinity is not acceptable and so other methods were explored to determine accurate binding affinity, 
such as ITC where the use of lower concentrations of host and guest is routinely feasible. 
Extraction of a binding constant from titration of 184 into 3 using ITC proved non-trivial however, due 
to the slow binding kinetics originally seen during the NMR titration. Applying the same ITC method 
used for earlier substrates resulted in one very broad evolution of heat upon addition of 184. It wasn’t 
until a delay of 20 minutes between additions was applied to the method that separate exotherm 
peaks were observed for each addition of 184, even then the peaks were very broad and thus of low 
intensity – with heat being slowly evolved for over 10 minutes after addition of substrate. Not only 
this, but the acquisition times became highly impractical with the required 40 additions of substrate 
taking >13 hours to reach completion. Furthermore, the broadness of the exotherm peaks were a 
major issue during processing of the titration data. The software used to extract the enthalpies of each 
addition automatically integrates each exotherm peak to get the change in enthalpy (ΔH) at that point 
in the titration, but also performs a baseline correction to make integration more accurate. However, 
the broadness of the peaks obtained for 184 meant that the software automatically eliminated most 
of the heat produced upon each addition of 184 by misinterpreting this as baseline distortion, and 
thus smoothing out the peaks during baseline correction. This gave very inaccurate and reduced 
enthalpies for each addition and thus no binding constant was determinable from these data initially. 
However, removal of the baseline correction and manual integration of each peak did give a more 
consistent plot of ΔH versus concentration of 184 – albeit with a presumed large error as the limits of 
integration were determined visually.  
This plotted data yields an ‘S-curve’ which is typical for binding constants greater than 104 M-1 - all 
previous ITC data does not exhibit an S-curve when plotted for this very reason. This S-curve arises 
from all substrate titrated in during the earlier additions becoming immediately complexed with the 
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receptor, with no free substrate remaining in solution due to the high binding constant.100 Therefore, 
the same change in enthalpy (ΔH) is observed for each of these additions until a higher proportion of 
the receptor is bound (here until ~60% of receptor is bound) and some substrate does not participate 
in binding. At this point, the ΔH per addition begins to decrease to give the rest of the curve, yielding 
overall an S-curve. Fitting this curve to a 1:1 binding model did yield a high affinity of 3 for Scyllo-
inositol 184 however, with a measured binding constant of Ka ~ 230,000 M-1. While this measured 
binding affinity is approximately 50% of that when deduced by NMR titration, it was found (as 
mentioned earlier) that the binding constant derived from NMR was very sensitive to concentration – 
reducing host or guest concentration by <10% gave a binding constant similar to that obtained by ITC. 
It is also instructive to consider that the binding constant derived from ITC must contain some error 
due to the slow complexation kinetics and manual integration of the broad exotherm peaks. Therefore, 
these data obtained from both NMR and ITC titration would suggest that the association constant for 























Figure 89 ITC binding results of scyllo-inositol 184 (2.5 mM) with receptor 3 (0.2 mM). Very large difference in 
exotherm observed when comparing heat of dilution (A) with titration run (B). Exotherm peaks (C) exhibit slow 
evolution of heat (>10 mins), which are evidence of slow complexation kinetics. Plotting this data as change in 
enthalpy (ΔH) versus concentration (D) and fitting to 1:1 binding model gives association constant of Ka ~230,000 
M-1. 
When determination of a large binding constant is impractical due to minor errors in concentration of 
host or guest, alternative methods to accurately determine the binding constant must be considered. 
The easiest solution would be to lower both host and guest concentrations used, in order to minimise 
deviations in concentration upon creation of titration solutions. However, as described before, this can 
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prove impractical when concentration is directly responsible for signal intensity for methods such as 
NMR. An alternative approach would be to perform a competitive titration, in this case by NMR.16 This 
procedure involves pre-saturation of the host receptor with a guest of a known (usually lower) binding 
affinity, with the higher affinity guest then titrated into this already saturated system. The presence of 
the weaker binding guest effectively lowers the binding constant of the stronger binding guest in this 
system, due to the equilibrium now also being governed by decomplexation of the weaker binding 
guest – lowering the Gibb’s free energy of binding (ΔG) and thus association constant (Ka). This 
competitive titration system is governed in part by the following equilibria (where A is the weaker 
binding guest and B is the stronger binding guest, i.e. scyllo-inositol): 
 
     (Eqn. 16)         (Eqn. 17) 
 
Equations that govern complexation in these equilibria are as follows: 
𝐾𝐻𝐴 = 
 𝐻𝐴 
 𝐻  𝐴 
    (Eqn. 18)                𝐾𝐻𝐵 = 
 𝐻𝐵 
 𝐻  𝐵 
    (Eqn. 19) 
Therefore, in the proposed competitive titration, the complexation of the stronger binding guest can 
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    (Eqn. 20) 
Fortunately, if both guests (A and B) exhibit binding kinetics that are slow on the NMR timescale, most 
of these parameters can be calculated from the integration of a single spectrum. The ratio of [HB]/[HA] 
can be determined directly from integration of signals relating to both complexes, assuming an 
appropriate ratio of each complex had been reached upon equilibrium (i.e. 1:1 [HA]:[HB]). Values for 
[A] and [B] are simply calculated from the following: 
 𝐴 =   𝐴 𝑡𝑜𝑡𝑎𝑙 −  𝐻𝐴     (Eqn. 21)           𝐵 =   𝐵 𝑡𝑜𝑡𝑎𝑙 −  𝐻𝐵     (Eqn. 22) 
The association constant of guest A (KHA) is calculated from previous titration data, and is thus known. 
Despite the opportunity to calculate KHB from a single slow exchange spectrum, it was initially decided 
to perform a titration to maximise the amount of calculated binding constants from each titration 
spectra, to obtain the most accurate value for KHB.  
The weaker binding guest was initially chosen to be myo-inositol 183, as it bound to receptor 3 in slow 
exchange on the NMR timescale with a weaker binding constant (~2 orders of magnitude lower, Ka ~ 
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7500 M-1), but also because both complexes of receptor with 183 or 184 featured distinct NMR signals 
that did not overlap – allowing more accurate determination of [HB]/[HA]. Initially a ratio of 20:1 
(183:184) was used, but this was then repeated with a larger ratio of 100:1 (183:184) to allow a more 
gradual titration and thus determine a more accurate value for KHB. However, it was discovered upon 
processing of the titration data that an anomalous increase in the ratio of [HB]/[HA] had occurred part 
way through the titration (Figure 90) – even though a constant amount of scyllo-inositol 184 was being 
added before and after this anomalous result. The other points in the titration appeared very 
consistent, with a linear increase in the ratio of [HB]/[HA] after addition of scyllo-inositol 184. The only 
variable was equilibration time, where the anomalous was result was left for a much longer time (90 
minutes vs 20 minutes for the other additions) before acquisition of the spectra. This would imply that 
equilibration between the myo 183 and scyllo-inositol 184 complexes was very slow after addition of 
scyllo-inositol 184, and the 20 minutes equilibration period was insufficient. Indeed, following test 
studies aimed at generating a rough 1:1 ratio of myo 183 and scyllo-inositol 184 complexes showed 
that equilibrium had not been reached after 1 day. It was then hypothesised that myo-inositol 183 may 
be unsuitable as a competitor, as it is the substrate with the second slowest binding kinetics tested. 
Given that the slowest binding kinetics are observed for scyllo-inositol 184 itself, these slow binding 
kinetics may compound one another and result in an incredibly slow equilibrium, especially if the rate 
of decomplexation of myo-inositol 183 or the rate of binding of scyllo-inositol 184 are rate limiting 
A new competitor was needed and it was decided that methyl β-D-glucoside 14 would be suitable for 
several reasons: it exhibits faster binding kinetics than myo-inositol 184 while still operating with slow 
exchange kinetics relative to the NMR timescale (so the previous methodology used to calculate Ka can 
still be used); both receptor and guest complexes (for 14 and 184) do not have overlapping NMR signals 
and so can be accurately integrated; and it has essentially the same binding constant as for 183 so 
previous competitive titration data can be used to predict experimental parameters for this new 
competitive study. A slightly different experiment was proposed than the previous competitive 
titrations however, with two simultaneous studies planned. One experiment would feature addition of 
scyllo-inositol 184 to receptor 3 saturated with methyl β-D-glucoside 14 (equivalents ratio of 2:1:400, 
184:3:14). At the same time, the opposite addition would be performed where 14 would be added to 
3 saturated with 184 (same equivalents ratio). NMR spectra would then be recorded until equilibrium 
had been reached – this would now be obvious as the measured ratio of both complexes (i.e. 























Figure 90 Partial 1H NMR of titration spectra (600 MHz, D2O, pH 7.4, 298 K) from addition of scyllo-inositol 184 (8.5 
mM) to receptor 3 (0.2 mM) saturated with myo-inositol 183 (40 mM). Ratio of complexes ([HB]/[HA]) determined by 
integration of peak at ~8 ppm (denoted with •) versus region 7.3-8.4 ppm. Earlier additions during titration (A and B) 
featured an equilibration time of 20 minutes before acquisition and a consistent evolution of scyllo-inositol 184 and 
receptor 3 complex was observed. Subsequent addition (same volume of guest added, spectrum C) was equilibrated 
for 90 minutes and a large increase in scyllo-inositol complex was observed (see difference in integrations and graph 
D). Additions after this point were then equilibrated for 20 minutes prior to acquisition and linear trend continues 
(graph D). These data imply that very slow conversion to the scyllo-inositol complex is taking place, and therefore that 
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However, it became apparent that the rate of equilibration was still incredibly slow, with the amount 
of scyllo-inositol 184 and receptor 3 complex still increasing after 18 hours. Both samples were then 
left for approximately 2 weeks, with the intention that both would have certainly reached equilibrium 
by then. Indeed, integration of both samples after this period indicated that approximately 30% 
consisted of scyllo-inositol 184 and receptor 3 complex, with the other 70% of receptor 3 bound to the 
competitor methyl β-D-glucoside 14. Analysis of the integrals over time and extrapolation of this data 
suggested an equilibration time of 4-5 days, which is incredibly slow when compared to equilibration 
times seen for free receptor and other guests. It was noted that the predicted equilibration time was 
1.5 times slower for scyllo-inositol 184 displacing methyl β-D-glucoside 14 from complexation with 
receptor 3 – this would imply that either decomplexation of 14 or complexation of 184 is rate limiting. 
Given that 184 exhibits the slowest complexation kinetics with free receptor, it is then presumed that 
the binding of 184 to the receptor is rate limiting – possibly due to its larger size when compared to 
14. For the reverse system, where 14 is added to 184 complexed to 3, the slow kinetics are presumed 
to be due to the high binding affinity of 183 reducing the rate of dissociation.  
Applying the integrated ratio of complexes to the previously outlined methods for calculating binding 
constants for a competitive binding system afforded an association constant of Ka ~800,000 M-1 for 
scyllo-inositol 184 and receptor 3 (~45 times stronger than D-glucose). This value is towards the upper 
end of error for the previously determined binding constants, but those methods (1:1 NMR and ITC 
titrations) potentially carried a lot of error due to the issues outlined earlier. Future work could employ 
different competitors and acquire a larger sample size of data to derive the binding constant from – 
something that would reduce the error in this value. A study at increased temperatures would result 
in faster kinetics and thus equilibrations times, allowing faster acquisition of data. However, a study of 
such scale was not feasible due to insufficient time. It is worth mentioning that such a high binding 
constant for a neutral polar molecule (or “carbohydrate -like” molecule) in water with non-covalent 
interactions is largely unprecedented, and represents a significant advancement in the area of 

















Figure 91 Competitive binding studies of scyllo-inositol 184 and methyl β-D-glucoside 14 with receptor 13 
(equivalents ratio of 2:400:1, 184:14:3). Integration of NMR spectrum (600 MHz, D2O, pH 7.4, 298 K) (A) once 
system reaches equilibrium gives ratio of complexes (i.e. [HB]/[HA]). Applying this ratio to competitive binding 
equations (B) allows calculation of binding constant (C) for scyllo-inositol 184 to receptor 3. Calculated binding 
affinity is Ka ~811,000 M-1 using this method. 
Despite this very high binding affinity of scyllo-inositol 184 for receptor 3, scyllo-inositol 184 is not 
commonly found in nature.105 Thus, D-glucose 4 remains the strongest binding molecule that could be 
considered ‘biologically relevant’, with still excellent selectivity over other biologically relevant 
substrates. To further ascertain how robust the binding and selectivity of D-glucose can be in a more 
representative biological environment, binding of D-glucose in complex mixtures of organic molecules, 
salts and variations in pH was investigated. Binding studies to D-glucose by ITC were then undertaken 
in standard phosphate buffered saline (PBS, for composition see experimental) at pH 6 ,7 and 8. A large 
exotherm was observed for each titration and fitting the data to a 1:1 binding model gave Ka ~ 17,300-
18,300 M-1, essentially the same affinity as in water. PBS contains significant quantities of sodium and 
potassium chloride, and it would appear that such salts do not have an effect on binding affinity.  
  
Raw Integration from NMR 6.56
[HA]/[HB] 2.19


















 𝐴 =   𝐴 𝑡𝑜𝑡𝑎𝑙 −  𝐻𝐴             𝐵 =   𝐵 𝑡𝑜𝑡𝑎𝑙 − [𝐻𝐵] 
 𝐴 =   𝐴 𝑡𝑜𝑡𝑎𝑙 −  𝐻𝐴             𝐵 =   𝐵 𝑡𝑜𝑡𝑎𝑙 − [𝐻𝐵] 
 𝐻𝐵 =  
𝐼𝑛𝑡(𝐻𝐵)
𝐼𝑛𝑡(𝐻𝐴 + 𝐻𝐵)
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Figure 92 Control NMR studies (600 MHz, D2O, pH 7.4, 298 K) investigating the effects of calcium and magnesium 
cations on binding of D-glucose 4 to receptor 3. Free receptor 3 (A) at 0.25 mM is saturated with 0.54 mM of D-
glucose 4 (B). Addition of CaCl2 (1.8 mM) or MgSO4 (0.8 mM) appears to suppress binding (C and D), with the 
same amount of D-glucose 4 (0.54 mM) not saturating receptor 3.  
Binding of 3 to D-glucose 4 in two types of cell culture media was then tested. Dulbecco's Modified 
Eagle Medium (DMEM) and Leibovitz’s L-15 (L-15) culture media were chosen as neither contained 
any D-glucose 4 but both contained significant quantities of amino acids, vitamins, sugars and inorganic 
salts (for formulations see Chapter 7, Table 8 and Table 9) – a very demanding environment for the 
receptor to still function in.107,108 ITC binding studies with D-glucose 4 in both media did show that 
receptor 3 still bound D-glucose, albeit with a lowered affinity of Ka ~5200-5600 M-1. Given that 
receptor 3 showed no binding to several amino acids, vitamins and very weak binding to sugars in 
isolated studies, it was rationalised that the reduced affinity might be due to the high concentrations 
of inorganic salts present in both media. A control medium was then created which was comprised of 
only inorganic salts at the same concentrations found in the DMEM cell culture medium (for 
formulation see Chapter 7, Table 7). ITC titrations of D-glucose 4 and 3 in this medium gave effectively 
the same results as for the DMEM medium, with a measured binding constant of Ka ~5200 M-1. This 
would confirm that the salts (or one specific salt) is the cause of the lower binding constant. Further 
control experiments concluded that the reduced binding was due to calcium chloride and magnesium 
sulfate salts. These are present at millimolar concentrations in the culture media, and partial binding 
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Receptor 3 (0.25 mM) saturated 
with D-glucose (0.54 mM) 
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studies indicated that higher concentrations of D-glucose were needed to saturate receptor 3 in their 
presence (relative to in just pure water). It is as of yet not fully known by what mechanism these cations 
suppress the binding affinity, as control experiments and previous literature suggest the metal cations 
do not perturb D-glucose itself.109 A minor change in chemical shift for NMR signals relating to the 
dendritic solubilising groups was observed and it is well known that these divalent cations (Ca2+ and 
Mg2+) can associate with up to two carboxylates (i.e. Mg+(RCOO-)2).110 Given that the solubilising groups 
are comprised of carboxylates (with receptor 3 featuring 27 carboxylates in total), it is theorised that 
these metal cations could effectively ‘cross-link’ the solubilising group network and hinder entry to the 
cavity. They could even bind to the linker carbonyls and distort the shape of the receptor, which would 
undoubtedly affect the binding affinity to D-glucose.  
Although these cations (Ca2+ and Mg2+) do appear to diminish the binding affinity for D-glucose, they 
do not occur in such high concentrations in the human body or blood, and would have a reduced effect 
if applied to a system more representative of these environments. As such, the binding affinity of D-
glucose in human serum was investigated. Human serum is comprised of all components of whole 
blood minus blood cells and clotting factors – so consists of proteins, antibodies, hormones, salts and 
many small molecules, and is commonly used in both healthcare and research environments as a 
model system for studying blood.111 For the purposes of investigating the binding of 3 to D-glucose 4 
in this medium, the first step is to remove the large amount endogenous D-glucose. Concentrations of 
D-glucose in human serum were measured using a YSI 2300 STAT Plus D-glucose and L-lactate analyser, 
with the initial concentration in human serum measured as 6.2 mM.112 The D-glucose was removed 
from the serum using enzymes glucose oxidase and catalase, which firstly oxidise the D-glucose to D-
glucono-δ-lactone 185 (Scheme 85) which then hydrolyses in the medium to D-gluconic acid 174, 
which is known not to bind to receptor 3 through previous binding studies (Figure 84).113 Analysis of 
the medium after oxidation (using the YSI 2300) suggested oxidation was successful, with the 




Scheme 85 Oxidation of D-glucose 4 to D-glucono-δ-lactone 185 with glucose oxidase. Hydrolysis of 185 at 
biological pH (7.4) yields acyclic polyol gluconic acid 174, which is known to not bind to receptor 3 through 
previous binding studies. 
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Removal of high molecular weight components (such as antibodies, and large proteins) is necessary as 
ITC is very sensitive to anything that produces heat, such as precipitation and secondary binding events 
like aggregation, and phenomena like these can either be misinterpreted as or mask binding events 
and thus the influence results obtained.114 Filtration of the serum post oxidation of D-glucose through 
a membrane (10,000 MWCO) to remove the enzymes and high molecular weight components gave a 
solution which retains all the small proteins/peptides, molecules and salts that might bind to receptor 













Figure 93 Partial 1H NMR spectra (600 MHz, D2O, pH 7.4, 298 K) of human serum after oxidation of D-glucose, 
with glucose oxidase and catalase, which shows a significant quantity of glycerol 186 present (A, denoted with 
•). Filtration of enzymes and analysis of filtrate shows only glycerol (B), suggesting glycerol originates from 
enzymes used for oxidation of D-glucose. Dialysis of enzymes in pure water and repeating oxidation procedure 
shows vastly reduced amounts of glycerol 186 in human serum, with the signals for D-gluconic acid 174 (denoted 
with •) now much increased in intensity (relative to those in spectrum A). 
Initial ITC binding studies of D-glucose 4 to 3 in human serum, gave an association constant of Ka ~2500 
M-1, even lower than observed for D-glucose in cell culture media. It was difficult to rationalise how 
the binding constant could be even lower than the cell culture media given the limited data provided 
by ITC, so several control experiments were performed. The controls were initially to ascertain whether 
the enzymes used to ‘remove’ D-glucose from the human serum (glucose oxidase and catalase) were 
Human serum, after oxidation 
with enzymes (not dialysed) 
Filtrate from washing enzymes 
Human serum, after oxidation 


















the cause of the lower affinity, either by impurities carried through, or by incomplete oxidation of all 
D-glucose and then failure by the YSI 2300 to detect any residual D-glucose. A control sample of 6 mM 
D-glucose in water was prepared and exposed to the same enzymes (glucose oxidase and catalase) as 
the human serum. Filtration of this medium through a membrane (10,000 MWCO) removed the 
enzymes and an ITC titration with D-glucose in this medium gave a similarly reduced affinity as for the 
human serum – association constant for 3 and D-glucose 4 of Ka ~4000 M-1. Analysis by 1H NMR of this 
control medium after filtration revealed that all of the D-glucose had indeed been converted to D-
gluconic acid 174, so the reduced binding affinity cannot be due to residual D-glucose. What was 
observed however, was a significant amount of glycerol 186 – which was present in amounts many 
times greater than the D-gluconic acid 174. Freeze drying the human serum used for the ITC titration 
(after removal of D-glucose and enzymes) and reconstitution in D2O allowed analysis of the human 
serum by NMR, which also revealed that significant quantities of glycerol 186 were present. Based on 
evidence from the ‘control medium’, and the fact that D-gluconic acid 174 shows no evidence of 
binding affinity by NMR or ITC titrations in isolated studies, the reduced binding must be caused by 
the presence of large quantities of glycerol 186. It is rationalised that if 186 were present in such 
significant quantities, it could effectively alter the solvent composition of the medium which would 
undoubtedly affect binding to the receptor – as solvent effects are arguably one of the biggest factors 
that influence how favourable binding interactions can be.115 Future studies would need to be 









Figure 94 ITC binding results for D-glucose 4 and receptor 3 in human serum. ITC titration without dialysing 
enzymes, and thus presence of large amounts of glycerol 186, results in weaker binding and lower heat output 
(A). Removal of glycerol 186 from enzymes by dialysis, results in larger heat output upon addition of D-glucose 4 
to 3 (B, note y-axis values) and thus stronger binding affinity (C) – measured Ka ~11,300 M-1. 
Ka = 11300± 270.33 M-1 (2.39%)
r = 0.999496
ΔG =-23.14± -0.55 kJ.mol-1
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Analysis of the human serum by 1H NMR, before use of the enzymes to oxidise D-glucose, revealed 
clear signals for D-glucose but no signals relating to glycerol 186. It was therefore assumed that the 
glycerol 186 must be introduced via the enzymes. Filtration (10,000 MWCO membrane) and washing 
of the enzymes with water confirmed this, as the filtrate contained predominantly glycerol 186 when 
analysed by 1H NMR. Present literature indicates that glycerol 186 is added to enzymes before they are 
lyophilised, to preserve the protein structure upon freezing before sublimation.116 Unfortunately, the 
presence of this glycerol 186 was not indicated by the manufacturer. The procedure to remove the D-
glucose from the human serum was thus modified, with the glucose oxidase and catalase being 
dialysed (10,000 MWCO) in pure water to remove the glycerol 186 from the enzymes. Repeating the 
oxidation of D-glucose in the human serum with these dialysed enzymes, and filtration through a 
membrane (10,000 MWCO), gave a clear solution. Analysis of this medium by 1H NMR revealed the 
presence of D-gluconic acid 174 and a very complex mixture of other molecules – but most importantly 
the amount of glycerol 184 was now severely reduced (presumably now at standard biological 
concentration). Gratifyingly, an ITC titration in this medium (with vastly reduced glycerol 186) gave a 
good affinity for D-glucose 4 and 3, with a measured Ka ~11,300 M-1 – roughly a 30% reduction in 
activity compared to pure water. The reduced affinity when compared to in pure water is presumably 
due to many weakly binding molecules needing to be displaced by D-glucose from the receptor 3, or 
presence of magnesium/calcium cations as discussed earlier. However, the relatively high affinity 
would indeed suggest that the receptor is still proving to be very selective towards D-glucose, even in 
such a complex mixture of molecules and salts as human serum. Such affinity and excellent selectivity 
would make receptor 3 a promising candidate towards recognition of D-glucose in a biological context. 
Despite sufficient binding data being acquired from NMR and ITC titrations, other methods were also 
pursued to quantify binding affinity. Spectroscopic techniques like fluorescence are of particular 
interest, as if a quantifiable change in fluorescence emission upon binding can be measured, this would 
be an early proof of principle in the application of receptor 3 as a D-glucose sensor.15 A fluorescence 
excitation spectrum of receptor 3 revealed an absorption maximum at ~270 nm, which if then used as 
an excitation wavelength for 3 produced an emission maximum at 370 nm – a large stokes shift of ~100 
nm. It was this excitation wavelength of 270 nm that was used during the fluorescence titration of D-
glucose 4 and 3, while monitoring intensity at emission wavelength of 370 nm. However, it was found 
that only a very small increase in emission intensity was observed upon addition of D-glucose to 3. 
Such a small increase in intensity introduced large errors when attempting to plot the data and fit the 
curve to a 1:1 binding model, and so no binding constant was determinable from the fluorescence 
titration data. Previous synthetic lectin systems such as anthracene receptors 25 and 1 (Chapter 4), 
provided a large increase in fluorescence emission upon binding carbohydrates.35 This was rationalised 
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to be due to a change in conformation upon binding, which reduced the fluorescence quenching of 
the anthracene surfaces. Other synthetic lectin systems that were more rigid in conformation, such as 
32 (Chapter 1, Figure 18), displayed very little to no change in fluorescence upon binding – presumably 
due to this lack of conformational change upon binding.39 It is therefore hypothesised that something 
similar is occurring for receptor 3 as well, where the free receptor is sufficiently rigid in conformation 










Figure 95 Fluorescence titration results from addition of D-glucose 4 to receptor 3 in water, excitation wavelength 
of 270 nm and monitoring at wavelength of 370 nm. Very small increase in fluorescence emission upon increasing 
concentration of D-glucose 4. This introduced a large degree of error when fitting data to binding model and thus 




With no determination of binding constant from fluorescence titration, other spectroscopic methods 
were considered, such as circular dichroism (CD). This technique has been applied to studying the 
complexation of molecules before, where the complexation of achiral (with a chromophore) and chiral 
(no chromophore) binding partners produced a CD absorption band. Such a phenomenon is known as 
induced circular dichroism (ICD), an example of which is the complexation of β-cyclodextrin (chiral, no 
chromophore) with cyclohexanone (achiral, chromophore) – which afforded an ICD band due to the 
n→π* transition of the carbonyl group of the cyclohexanone.73,117 This induction of a CD signal occurs 
due to the chiral partner distorting the conformation of the achiral UV-active partner upon 
complexation, this destruction of symmetry results in a UV-active chiral complex that produces a CD 
absorption band. This process was predicted to translate well to the binding of receptor 3 (achiral, 
chromophore) and D-glucose 4 (chiral, no chromophore), with an expected ICD upon complexation. 
Indeed, such a result was obtained, whereby titration of D-glucose 4 to receptor 3 in water resulted in 
a CD absorption of negative intensity (Figure 96). Fitting this data to a 1:1 binding model yielded a Ka 
of ~17,200 M-1, essentially the same as for other methods (NMR, ITC). Titration of L-glucose (opposite 
enantiomer to naturally occurring D-glucose) into receptor 3 gave essentially the mirror image of the 
CD spectrum for D-glucose, with a CD absorption of positive intensity. Processing of this data also 
afforded the same binding constant of Ka ~17,200 M-1, which is expected due to the achiral nature of 
receptor 3. Distinguishing these enantiomeric complexes by NMR and ITC would not have been 
possible. The binding affinity was also confirmed using CD titration for carbohydrate substrates which 
exhibited intermediate exchange kinetics relative to the NMR timescale, which meant no binding 
constant was determined by NMR titration. Affinities determined using CD for D -xylose 149 (Ka ~ 5000 
M-1), D-glucuronic acid 168 (Ka ~ 4400 M-1) and 2-deoxy-D-glucose 169 (Ka ~ 680 M-1) were all very 

























Figure 96 ICD binding results for D-glucose (A) and L-glucose (B) with receptor 102. Both chiral guests induce a 
CD signal upon addition to 3, with each enantiomer giving the opposite absorption intensity. Fitting this data to 
a 1:1 binding curve gave an association constant similar to other methods (C), Ka ~17,200 M-1. The binding curve 





































K a = 17177.02 ± 453.21 M-1 (2.64%)












































A novel experiment was then proposed, where receptor 3 was pre-saturated with L-glucose of known 
concentration (here 2.4 mM of L-glucose) in water. A mixture of D-glucose, with 3 and L-glucose (2.4 
mM) added to keep their concentrations constant, was to be titrated into this medium and it was 
predicted that the CD signal would equal zero when an equal racemic mixture of complexes had been 
reached (i.e. 1:1, L-glucose:D-glucose complexes). Most pleasingly, such a result was obtained, where 
the CD signal intensity reached zero upon the addition of D-glucose that resulted in an equal 
concentration of D and L-glucose in solution – and thus an equal concentration D and L-glucose 







Figure 97 ICD results from titration of D-glucose into receptor 3 pre-saturated with L-glucose (2.4 mM). 3 and L-
glucose (2.4 mM) were added to titrant to keep their concentrations constant. Spectra decrease in intensity upon 
increased additions of D-glucose (A). CD signal reaches zero intensity when concentrations of D and L-glucose 
are equal (B), and thus concentrations of D and L-glucose complexes are also equal. 
One application of this ability to manipulate the CD signal depending on the ratio of D and L-glucose 
bound to receptor 3, is quantification of D-glucose in various media such as human serum. As titration 
of L-glucose into human serum (with receptor 3 present) would give zero CD signal when the ratio of 
D and L-glucose complexes is equal – the concentration of L-glucose added at his point would therefore 
be equal to the concentration of D-glucose in the human serum. However, before attempting this, 
analysis of the human serum medium itself by CD was undertaken to further probe how effective 
removal of the D-glucose (Scheme 85) by the glucose oxidase and catalase was. 
Analysis of unfiltered human serum by CD resulted in observation of large absorption artefacts (Figure 
98), presumably due to the presence of high molecular weight biological structures (proteins and 
antibodies etc.) or scattering of light by insoluble particles. Filtration of the human serum through a 
membrane (10,000 MWCO) removed these artefacts, with no observed CD absorption. It presumed 
that any specific UV-active chiral molecules (e.g. amino acids such as L-tryptophan) are present at low 
enough concentration to not produce an observable CD absorption at the wavelengths monitored 
[D-Glc] mM CD [mdeg] [DGlc]:[LGlc] 
1.86 2.78 0.77 
2.08 1.68 0.86 
2.29 0.71 0.96 
2.40 -0.02 1.00 
2.93 -2.23 1.22 
3.44 -4.07 1.44 





(225-325 nm). Addition of receptor 3 to this medium resulted in a distinct CD absorption, due to the 
binding of 3 to D-glucose already present in the human serum. Removal of D-glucose from the human 
serum using glucose oxidase and catalase, and filtering through a membrane (10,000 MWCO), again 
showed no CD absorption – even upon addition of receptor 3. This would indeed imply that removal 
of D-glucose using the enzymes is effective, as earlier titrations in water by CD indicate D-glucose 
concentrations as low as 0.07 mM give a very noticeable CD absorption. A titration of D-glucose into 
receptor 3, in human serum (with D-glucose removed), was then performed and gave a binding 





















Figure 98 CD absorption spectra from analysis of human serum. The raw unfiltered serum produced very large 
absorption artefacts, presumably due to high molecular weight components (proteins, antibodies etc.) or light 
scattering from insoluble particles. Filtration through a membrane (10,000 MWCO) and analysis of this medium 
gave no observed CD absorption (A). Addition of receptor 3 to this medium did induce a CD signal, due to the 
binding of 3 to D-glucose. Removal of D-glucose from the human serum (using glucose oxidase and catalase) 
showed no CD signal upon addition of receptor however (B), which would imply that all D-glucose has been 

































[O] serum (with and without TEB)
[O] serum (50%)
serum (50%) + TEB





With the knowledge that receptor 3 still provides a measurable output upon binding in human serum 
using CD, attempts were undertaken to ascertain whether this method could be used to quantify the 
concentration of D-glucose in human serum – a proof of principle of receptor 3 functioning as a D-
glucose sensor in physiological media. Initially, a medium was prepared that consisted of human serum 
(still containing D-glucose) and receptor 3. A solution of L-glucose, with added receptor 3 in human 
serum, was then titrated into this medium. As seen before for the similar experiment in water, when 
the CD absorption intensity is equal to zero, the ratio of D and L-glucose complexes will be equal. 
Therefore, the concentration of L-glucose added at this point will be equal to the concentration of D-
glucose in the human serum. Such an experiment was performed successfully, with zero CD signal 
observed upon reaching an L-glucose concentration of 5.7-5.9 mM – thus the concentration of D-
glucose in the human serum must be 5.7-5.9 mM also. 
To further exemplify this concept, a system was developed that could measure any concentration of 
D-glucose in this sample of human serum – replicating a practical procedure of measuring D-glucose 
in a blood sample. A calibration study was therefore performed, where the intensity of the CD 
absorption in human serum was measured at many different concentrations of D-glucose. This was 
achieved by pre-saturation of receptor 3 with L-glucose (at two different concentrations, 2mM and 8 
mM) in human serum. Two systems with differing concentrations of L-glucose were tested to ascertain 
which concentration of L-glucose would give the most accurate results. Titration of D-glucose, with 
added L-glucose (at either 2mM or 8 mM) and 3, into this medium gave the predicted decrease in CD 




























Figure 99 CD results for quantification of D-glucose in human serum. Titration of D-glucose into receptor 3 pre-
saturated with L-glucose (here 2 mM), in human serum (D-glucose removed), showed decrease in CD absorption 
intensity (A). Plotting of CD intensity versus D-glucose concentration gave a calibration curve for D-glucose 
concentration in this system (B). Measurement of CD signal intensity of receptor 3, with added L-glucose (2 mM), 
in human serum (D-glucose still present), allowed quantification of D-glucose in the human serum by inputting 
this CD signal intensity into the calibration curve equation (C). This gave a measured D-glucose concentration of 















































Observed CD [mdeg] [D-glucose] / mM
Run 1 -3.50 5.78
Run 2 -3.17 5.58
Run 3 -3.37 5.70
Average -3.35 5.69





Plotting CD signal intensity against D-glucose concentration for each system (2mM or 8mM L-glucose) 
gave a curve, and applying a non-linear least squares curve-fitting programme (as for the calculated 
binding constants) gave the ‘calibration curve’ and thus equation for the curve. Measurement of CD 
absorption intensity for receptor 3 in human serum (still containing D-glucose) with added L-glucose 
(either 2mM or 8mM to replicate each calibration system) was performed 3 times and then averaged. 
Inputting of this CD intensity to the calibration curve equations afforded D-glucose concentrations of 
5.7 mM (2 mM L-glucose system) and 5.8 mM (8 mM L-glucose system) – within the range of measured 
D-glucose concentration for the human serum (5.7-5.9 mM, discussed earlier). This result would 
suggest that receptor 3 could be employed to accurately determine D-glucose concentration in 
physiological systems such as blood – a proof of concept for real world application. 
The binding results obtained for 3 and all substrates tested using various techniques (NMR, ITC and 
CD) are compiled in  
Table 5 below. When listed in this format, the incredible selectivity of 3 for D-glucose 4 is apparent, 
with most other substrates tested showing no evidence of binding. Those that do exhibit binding 
affinity do so with affinities 1-3 orders of magnitude weaker, including similar carbohydrates. The only 
exception is scyllo-inositol 184, essentially the ideal substrate for receptor 3, and appears to 
approximately bind an order of magnitude stronger than D-glucose 4. Fortunately, scyllo-inositol 184 
is not commonly found in nature, and so selectivity for D-glucose 4 versus biologically relevant 
substrates remains excellent. 
Table 5  Summary of binding results for receptor 3 with various substrates and their associated errors for each 
technique used (NMR, ITC or CD). All binding studies conducted in H2O (or D2O for NMR), at pH 7.4 (with 10 mM 
phosphate buffer) and at 298 K unless otherwise stated. a n.d. = not determinable due to intermediate exchange 
binding kinetics. b No errors given for scyllo-inositol due to the inherently large errors obtained during measuring 







Binding constant Ka (M-1) determined by: 
 NMR ITC CD 
D-Glucose  18,000 ± 1.0% 18,400 ± 2.2% 17,200 ± 9.8% 
L-Glucose - - 17,200 ± 2.6% 
D-Glucose pH 6 (PBS) - 17,800 ± 3.8% - 
D-Glucose pH 7 (PBS) - 17,300 ± 5.5% - 
D-Glucose pH 8 (PBS) - 18,300 ± 1.8% - 
D-Glucose (human serum) - 11,300 ± 2.4% 10,300 ± 5.9% 
D-Glucose (DMEM cell culture) - 5640 ± 2.1% - 
D-Glucose (DMEM salt control) - 5160 ± 5.9% - 
D-Glucose (Leibovitz’s L-15) - 5210 ± 8.6% - 
Methyl β-D-Glucoside 7520 ± 5.5% 7890 ± 16% - 
D-Glucuronic Acid n.d.a 5340 ± 3.5% 4400 ± 4.3% 
D-Xylose n.d.a 5800 ± 3.0% 5000 ± 8.8% 
2-Deoxy-D-Glucose n.d.a 725 ± 5.7% 680 ± 5.7% 
D-Galactose 132 ± 10% 182 ± 2.3% - 
D-Mannose 140 ± 1.3% 143 ± 1.1% - 
D-Ribose 267 ± 3.8% 216 ± 1.9% - 
D-Fructose 51 ± 5.5% 60 ± 2.7% - 
D-Cellobiose 31 ± 9.0% 30 ± 16% - 
Mannitol - 0 - 
D-Gluconic acid 0 0 - 
Methyl α-D-Glucoside 0 0 - 
N-Acetyl-D-glucosamine 0 0 - 
D-Maltose - 0 - 
L-Fucose - 0 - 
Ascorbic Acid  - 0 - 
Uracil (PBS) - 0 - 
Uric Acid (PBS) - 0 - 
Cytosine - 0 - 
Adenosine - 0 - 
L-Phenylalanine - 0 - 
L-Tryptophan - 0 - 
Paracetamol  - 0 - 
Myo-inositol 7300 ± 7.4% 7600 ± 4.2% - 











Scheme 86 Synthesis of hexaurea macrocycle 3 from components tris-isocyanate 151 and linker 113. The key 
step was macrocyclisation, where octyl β-D-glucoside 12 appeared to template the formation of the target 
macrocycle in ~50% yield. Global deprotection of the solubilising groups and neutralisation to pH 7.4 yielded the 
water soluble macrocycle 3. R = G2MM solubilising group. 
The potential of the urea spacer unit was fully realised when incorporated into triethylbenzene 
hexaurea 3. Synthesis of 3 was achieved from components 151 and 113 in 4 steps, in 36% yield (Scheme 
86). The key synthetic step was the macrocyclisation, which was templated in the presence of octyl β-
D-glucoside 12, providing the protected macrocycle in ~50% yield. Deprotection of the G2MM 







Figure 100 Hexaurea 3 shows unprecedented binding affinity for D-glucose 4, and extraordinary selectivity for D-
glucose 4 against other small biologically relevant molecules (including other similar carbohydrates). Receptor 3 
even continues to selectively recognise D-glucose 4 in human blood serum, which allowed quantification of D-




Hexaurea 3 showed unprecedented affinity for D-glucose 4, with an association constant of Ka ~18,000 
M-1 – the previous record for a synthetic lectin system based on non-covalent interactions being Ka 
~250 M-1 (Figure 100). More impressive however, is the extraordinary selectivity that receptor 3 
demonstrates for D-glucose 4 over many other biologically relevant molecules. These include very 
similar carbohydrates D-galactose 5 and D-mannose 6, which are bound >100 times weaker. Many 
other substrates tested, including other carbohydrates, vitamins, amino acids, medically important 
substrates (such as paracetamol 181 and vitamin C 182), small aromatics and other biologically 
relevant molecules showed no evidence of binding to 3 when tested. This exceptional selectivity of 3 
for D-glucose 4 allowed it to continue to function as a receptor in biologically relevant media – such as 
human serum derived from whole blood. This allowed quantification of D-glucose 4 in the human 
serum using optical methods (CD), a proof of concept of receptor 3 functioning as a D-glucose sensor 
for potentially medicinal purposes.  
The affinity and selectivity receptor 3 demonstrates for D-glucose 4 are unparalleled by any current 
synthetic system, and are more closely related to biomolecules such as proteins – even then receptor 
3 outperforms many naturally occurring carbohydrate binding molecules found in nature by affinity 
but most importantly by also demonstrating vastly superior selectivity. Based on this, receptor 3 can 
be confidently described as ‘biomimetic’ for its target substrate: D-glucose 4. In terms of practical 
application, receptor 3 is easy to synthesise, stable and shows no toxicity when tested. Given its 
synthetic nature, it should be readily adaptable and derivatisable for purposes towards treatments for 
Diabetes: continuous glucose monitoring and glucose-responsive insulins. 
Future work surrounding receptor 3 is predicted to be very rich, with many derivatives of the structure 
possible due to the modular synthetic approach. Variations of the surfaces and urea spacer units would 
lead to a library of receptors with the potential to tune the affinities and selectivities for certain 
substrates accordingly. It could be possible that other substrates could be targeted through these 
synthetic modifications, for example variation of one of the urea spacers may increase cavity size and 
allow targeting of larger substrates such a N-acetyl-D-glucosamine 7. Incorporation of fluorescent 
components may allow a fluorescence output upon substrate binding, increasing potential of 
receptors like 3 to be applied towards medicinal sensing applications (i.e. continuous glucose 
monitoring). Given that the protected receptor 3 is soluble in apolar media, it could also be applied to 
the replication of glucose transporter proteins, by shuttling D-glucose 4 across membranes – 
something largely unprecedented by a synthetic receptor. 
186 
 
Chapter 6 – Conclusions 
The main body of work discussed within this thesis is the design, synthesis and analysis of carbohydrate 
receptors that incorporate ureas into the spacer units. This approach is distinct from previous receptor 
designs which employed a bis-amide spacer unit. By progressing to a bis-urea spacer, it was predicted 
that improved selectivities and affinities would be achieved for target carbohydrate guests – through 
increased contributions from hydrogen bonding towards affinities and increased cavity sizes 





Figure 101 Evolution of bis-amide spacer unit to bis-urea spacer unit (left). The bis-urea features double the 
number of hydrogen bond donors as well as increased distance between the aromatic surfaces. Hypothesised 
hydrogen bonding array provided by the bis-urea spacer towards a diol motif commonly found in carbohydrates 
(right). 
The first receptor design to be pursued was anthracene tetraurea 36 (Chapter 2), which was designed 
to target linear polysaccharides derived from D-cellulose 8 and D-chitin 9. The anthracene surfaces 
were designed to run parallel to polysaccharide chain to provide CH-π interactions with the axial CHs 
from the sugar, but also to provide a fluorescence response upon binding. The bis-urea spacer was also 
predicted to form hydrogen bonding interactions with the hydroxyls of the sugar by MCMM modelling 
studies. The design of anthracene tetraurea 36 features water solubilising groups attached to the 
anthracene. This was to facilitate development of synthetic methodology of the bis-urea linkage within 
the macrocycle. Synthesis of protected macrocycle 37 was achieved in two steps from phenylene 1,2-
diamine and anthracene isocyanate 39. The alkoxy carboxyl groups on the anthracenes proved to be a 
great hindrance however, as they made the anthracene surfaces very electron rich and thus very 
susceptible to irreversible oxidation. The electron rich anthracenes also facilitated fragmentation of 
the macrocycle upon acidic deprotection of the solubilising groups, meaning no route to the water 















Figure 102 Successful methodology (Scheme 12 and Scheme 14) developed to access tetraurea macrocycle 37 
from diamine 38 and bis-isocyanate 39. Deprotection to water soluble macrocycle 36 was not achieved. 
An alternate anthracene tetraurea design was then proposed: one which featured a much simpler 
anthracene core and solubilising groups attached to the urea spacer units. It was predicted that this 
approach would circumvent the issues observed for previous macrocycle 37. This was preceded by 
successful development of linker unit 113 (Chapter 3), which featured a large solubilising group 
(G2MM). Incorporation of this linker unit into an anthracene macrocycle afforded protected 
macrocycle 120 (Chapter 4). However, tetraurea 120 still suffered from similar stability problems as for 
37 but ultimately proved much more controllable. This allowed controlled deprotection of the 
solubilising groups and access to water soluble anthracene receptor 1. Receptor 1 showed good 
affinities and selectivities for its target substrates of linear cellodextrins, such as D-cellotriose 2, in 
binding studies by NMR , ITC and fluorescence. The affinities demonstrated by 1 are comparable to 
natural lectins but do not match previous pyrene receptor 32. Nevertheless, tetraurea 1 is much more 
synthetically accessible than 32 and could improve its binding affinity through synthetic modification, 
with the modular synthesis enabling several points for derivatisation. Receptor 1 also demonstrated a 
fluorescence response upon binding, and this could lead to application of 1 in the detection of β-











Figure 103 Anthracene tetraurea 1 was successfully synthesised and showed a distinct preference for the binding 
of linear cellodextrins, such as D-cellotriose 2, which were bound selectively over monosaccharides and non-
linear oligosaccharides (i.e. maltodextrins). Receptor 1 also produced a measurable fluorescent output upon 
binding, which could enable 1 to be employed as a sensor for the detection of β-glucans. 
The potential of the urea spacer unit was fully realised when incorporated into triethylbenzene 
hexaurea 3, which featured none of the instability issues possessed by tetraurea anthracene 
macrocycles 37 and 1, as well as being much easier to synthesise. Hexaurea 3 showed unprecedented 
affinity for D-glucose 4, with a >70 times increased affinity over the previous record, which is attributed 
to urea spacer providing a much denser and more complementary arrangement of hydrogen bond 
donors. More impressive however, is the extraordinary selectivity that receptor 3 demonstrates for D-
glucose 4 over many other biologically relevant molecules. These include similar carbohydrates that 
are bound ~100 times weaker. Most other substrates tested, including other carbohydrates, vitamins, 
amino acids, small aromatics, drugs and other biologically relevant compounds showed no evidence 
of binding to receptor 3. This exceptional selectivity for D-glucose 4 allowed 3 to continue to function 
in complex biological media (such as human blood serum), allowing accurate quantification of D-
glucose 4 in the human serum using optical methods – a proof of concept of 3 functioning as a D-
glucose 4 sensor. The performance of hexaurea 3 far exceeds any previous synthetic system and even 
outcompetes most carbohydrate binding proteins (such as lectins), therefore making hexaurea 3 the 











Figure 104 Hexaurea 3 shows unprecedented binding affinity for D-glucose 4, and extraordinary selectivity for D-
glucose 4 against other small biologically relevant molecules (including other similar carbohydrates). Receptor 3 
even continues to selectively recognise D-glucose 4 in human blood serum, which allowed quantification of D-
glucose 4 concentrations in the human serum using optical methods 
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Chapter 7 – Experimental 
7.1 General Experimental, materials and methods 
Commercial reagents were purchased from Sigma-Aldrich, Alfa-Aesar, Fisher Scientific, VWR, Frontier 
Scientific, Fluorochem, Carbosynth, Megazyme, Santa Cruz Biotech, TCI chemicals or Acros Organics 
and were used without further purification unless otherwise specified. Cell culture media were 
obtained from ThermoFisher Scientific. Human Serum and enzymes were obtained from Sigma Aldrich.  
All air and moisture sensitive manipulations were carried out using standard vacuum line and Schlenk 
techniques.  Solvents for air and moisture sensitive manipulations were obtained from an Anhydrous 
Engineering Solvent Purification System, distilled and dried over activated molecular sieves, or 
purchased from Acros Organics. 
Flash column chromatography was performed using silica gel 60 Å (Sigma Aldrich, particle size 35-70 
micron) and a suitable eluent.  Reverse phase flash chromatography was performed on a Biotage 
Isolera One with Biotage SNAP Ultra C18 25 µm columns, typically with acetone/water eluents.  TLC 
was performed using aluminium backed TLC plates (Merck-Keiselgel 60 F254) and visualised using UV 
fluorescence (254 or 365 nm) and/or developed using ninhydrin, potassium permanganate, 
EtOH/H2SO4, vanillin, Pd(OAc)2/H2O or iodine. 
HPLC chromatography was performed using a Waters 600 Controller with a Waters 2998 Photodiode 
Array Detector.  For analytical runs a XSELECT CSH C18 5 µm (4.6 × 150 mm) column was used and for 
preparative runs a XSELECT CSH Prep C18 5 µm OBD (19 × 250 mm) column was used, normally with 
an acetone/water or methanol/0.1% trifluoracetic acid (aqueous) solvent mixtures. 
1H and 13C NMR spectra were recorded on Varian VNMR 400 MHz, Bruker 400 MHz, Varian VNMRS 500 
MHz, Bruker Advance III HD Cryo 500 MHz and Varian VNMRS (equipped with a 1H observe 
cryogenically cooled probe) 600 MHz spectrometers.  All spectra were obtained at ambient 
temperature unless stated otherwise.  All 1H and 13C NMR chemical shifts are reported relative to the 
1H (residual) and 13C chemical shifts of the solvent as standard.   
IR spectra were recorded on a Perkin-Elmer Spectrum One FT-IR spectrometer with an ATR accessory 
and frequencies reported in wavenumbers (cm-1).  ESI-HRMS (electrospray ionisation high resolution 
mass spectrometry) was performed on a Bruker Daltonics micrOTOF II. 
UV/vis spectra were recorded on a Thermo Helios Gamma or an Agilent Cary 300 spectrometer. 
Fluorescence spectra were recorded on a PerkinElmer LS45. All optical measurements were conducted 
in Ultrapure water using a Hellma QS-101 or QS-111 four-sided quartz cuvette. Any in-cuvette stirring 
was conducted using Fisherbrand PTFE encased 5mm x 2mm micro magnetic stir bars. Isothermal 
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Titration Calorimetry (ITC) titrations were conducted using a Malvern Microcal iTC200. Circular 
Dichroism was performed on a Jasco J-815 Circular Dichroism Spectropolarimeter using Hellma QS-
101 quartz absorption cells (1 mm path length). 
7.2 General procedures for binding studies 
1H NMR titrations.  1H-NMR titrations were performed on a Varian VNMRS 600 MHz spectrometer 
equipped with a 1H observe cryogenically cooled probe.  Solutions of saccharides in D2O (99.9%) with 
10 mM phosphate buffer (pH 7.4), containing receptor at a known concentration to be used in the 
experiment, were prepared and allowed to equilibrate overnight before use if necessary. Aliquots were 
then added to an NMR tube containing a known concentration of receptor solution (typically 50 µM – 
250 µM). The receptor concentration was therefore held constant while the carbohydrate 
concentration was increased.  The NMR tube was shaken after each addition, manually centrifuged 
and the 1H-NMR spectra acquired at 298 K. 
Isothermal Titration Microcalorimetry (ITC) titrations.  Isothermal Titration MicroCalorimetry (ITC) 
experiments were performed on a MicroCal iTC200 microcalorimeter.  ITC experiments were carried 
out at 298 K.  Saccharide solutions were prepared in HPLC-grade water with 10 mM phosphate buffer 
solution (pH 7.4) and allowed to equilibrate overnight if necessary.  The sample cell was charged with 
a known concentration of receptor solution in HPLC-grade water with 10 mM phosphate buffer 
solution at pH 7.4 (typically 50 µM – 200 µM).  Then, aliquots (typically 1.0 μL) of carbohydrate solution 
were added and the evolution of heat was followed as a function of time.  Heats of dilution were 
measured by injecting the same carbohydrate solution into HPLC-grade water with 10 mM phosphate 
buffer solution at pH 7.4, using identical conditions.  For every addition, the heat of dilution was 
subtracted from the heat of binding using a MicroCal software programme implemented in ORIGIN 
7.0.  This gave an XY matrix of heat vs. total guest concentration.  This matrix was then imported into 
a specially written Excel programme to fit the data to a 1:1 binding model to give a Ka. 
Preparation of biological media.  Cell culture media were obtained from ThermoFisher Scientific and 
human serum from Sigma-Aldrich, and were aliquoted into 10 mL batches in a specially designed 
sterile fume hood.  The cell culture media and human serum were passed through a membrane (10k 
MWCO) and then with 10 mM phosphate buffer (pH 7.4).  These batches were then used immediately 
for ITC binding studies to avoid contamination.  The two varieties of cell culture media used were: 
Dulbecco's Modified Eagle Medium (DMEM, no glucose, cat. no. 11966025) and Leibovitz’s L-15 
Medium (no glucose, cat. no. 11415049). The Human Serum used originates from male AB clotted 
whole blood (cat. no. H6914).  Formulations for both cell culture media, phosphate buffered saline 




Removal of D-glucose from human serum.  The concentration of initial D-glucose present in the 
human serum was measured to be 6.2 mM using a YSI 2300 STAT Plus Glucose and L-Lactate analyser.  
The D-glucose was oxidised to the D-glucono-δ-lactone (which then hydrolysed to gluconic acid in 
solution at pH 7.4) using a combination of enzymes: glucose oxidase and catalase.  After oxidation, the 
concentration of D-glucose in the human serum was measured to be 0-0.005 mM (using the YSI 2300 
STAT Plus).  The procedure for the oxidation of D-glucose in the serum is as follows: A solution of 
enzymes (20 mL) consisting of glucose oxidase (10,000 U) and catalase (300,000 U) was prepared and 
then dialysed (500 MWCO) to remove low MW contaminants (notably glycerol).  0.2 mL of this enzyme 
solution was added to human serum (10 mL) at 25-30 °C.  The mixture was stirred at 25-30 °C while air 
was bubbled through the suspension for 2 hours.  The mixture was then cooled to room temperature 
and passed through a membrane (10k MWCO) to give a colourless solution, which was used 
immediately for the corresponding binding studies. 
Table 6 Formulation for phosphate buffered saline (PBS). 
Component Concentration (mM) 
Sodium Chloride (NaCl) 140 
Potassium Chloride (KCl) 2.7 
Disodium phosphate (Na2HPO4) 10 
Monopotassium phosphate (KH2PO4) 1.8 
 2.5  
Table 7 Formulation for DMEM salt control 
Component Concentration (mM) 
Calcium Chloride (CaCl2) (anhyd.) 1.8 
Ferric Nitrate (Fe(NO3)3.9H2O) 2.50×10-4 
Magnesium Sulfate (MgSO4) (anhyd.) 0.81 
Potassium Chloride (KCl) 5.3 
Sodium Bicarbonate (NaHCO3) 44 
Sodium Chloride (NaCl) 110 




Table 8 Formulation for DMEM cell culture medium used, as described by the manufacturer.  
Component Concentration (mM) 
Glycine 0.4 
L-Arginine hydrochloride 0.4 
L-Cystine 2HCl 0.2 
L-Glutamine 4.0 
L-Histidine hydrochloride-H2O 0.2 
L-Isoleucine 0.8 
L-Leucine 0.8 






L-Tyrosine disodium salt dihydrate 0.4 
L-Valine 0.8 
Choline chloride 0.029 
D-Calcium pantothenate 0.0084 
Folic Acid 0.0091 
Niacinamide 0.033 
Pyridoxine hydrochloride 0.019 
Riboflavin 0.0011 
Thiamine hydrochloride 0.012 
i-Inositol 0.04 
Calcium Chloride (CaCl2) (anhyd.) 1.8 
Ferric Nitrate (Fe(NO3)3.9H2O) 2.50×10-4 
Magnesium Sulfate (MgSO4) (anhyd.) 0.81 
Potassium Chloride (KCl) 5.3 
Sodium Bicarbonate (NaHCO3) 44 
Sodium Chloride (NaCl) 110 
Sodium Phosphate monobasic (NaH2PO4-H2O) 0.91 




Table 9 Formulation for Leibovitz’s L-15 cell culture medium used, as described by the manufacturer.  


















Choline chloride 0.0071 
D-Calcium pantothenate 0.0021 
Folic Acid 0.0023 
Niacinamide 0.0082 
Pyridoxine hydrochloride 0.0049 
Riboflavin 5'-phosphate Na 2.0 × 10-4 
Thiamine monophosphate 0.0022 
i-Inositol 0.011 
Calcium Chloride (CaCl2) (anhyd.) 1.3 
Magnesium Chloride (anhydrous) 0.99 
Magnesium Sulfate (MgSO4) (anhyd.) 0.81 
Potassium Chloride (KCl) 5.3 
Potassium Phosphate monobasic (KH2PO4) 0.44 
Sodium Chloride (NaCl) 140 
Sodium Phosphate dibasic (Na2HPO4) anhydrous 1.3 
D-Galactose 5.0 
Phenol Red 0.027 
Sodium Pyruvate 5.0 
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7.3 Synthetic procedures and characterisation 
2,3,6,7-tetramethoxy-9,10-dimethylanthracene (46)118 
 
A solution of concentrated H2SO4 (24 mL, 95% aqueous) was cooled to -10 °C. A mixture of 1,2-
dimethoxybenzene 47 (5.4 mL, 42.4 mmol), acetaldehyde 48 (2.4 mL, 42.4 mmol) and acetonitrile (6 
mL) was added via syringe pump over 2 hours, ensuring the temperature did not exceed 5 °C. The 
reaction mixture was then stirred under N2 at -10 °C for 30 mins and then warmed to room 
temperature, after which the mixture was stirred for 1 hour. The reaction mixture was then poured 
onto ice and water (160 mL) added. The precipitate was then filtered, washed with water and air-dried. 
The crude solid was then purified by flash column chromatography (100% CH2Cl2) to yield 46 (3.8 g, 
11.6 mmol, 55%) as an off white solid. 1H NMR: (400 MHz, (CDCl3): δ 2.95 (s, 6H, 2 × C(6)H3),  4.08 (s, 
12H, 4 × OC(1)H3), 7.41 (s, 4H, 4 × C(3)H), [lit.118 (400 MHz, CDCl3) δ 2.95, 4.08, 7.40]; 13C NMR: (100 
MHz, (CDCl3): δ 15.1 (C(6)H3), 56.0 (OC(1)H3), 102.6 (C(3)H), 124.2 (C(5)), 126.0 (C(6)), 148.9 (C(6)). 
νmax  3019, 2996, 2963, 2833, 1495, 1164, cm-1; HRMS: (ESI+) Calculated for C20H22O4Na: 349.1410, 
found [M+Na]+: 349.1405. 
9,10-dimethylanthracene-2,3,6,7-tetraol (45)119 
 
Under an inert N2 atmosphere, 46 (3.8 g, 11.6 mmol) was suspended in anhydrous CH2Cl2 (600 mL) and 
BBr3 (6.4 mL, 1M in CH2Cl2) was added dropwise over 5 mins. The reaction mixture was then stirred 
under reflux for 16 hours, after which it was cooled to room temperature and poured into a solution 
of HCl (400 mL, 1M) cooled to 0 °C and stirred for 30 mins. The precipitate was then extracted with 
EtOAc (4 × 350 mL), washed with water (200 mL, brine (200 mL) and dried (MgSO4). The solvent was 
removed under vacuum and the crude solid purified by flash column chromatography (5% 
MeOH:CH2Cl2 → 10% MeOH:CH2Cl2) to yield 45 (2.5 g, 9.16 mmol, 79%) as a deep red solid. 1H NMR: 
(400 MHz, ((CD3)2CO): δ 2.78 (s, 6H, 2 × C(6)H3),  7.50 (s, 4H, 4 × C(3)H), 8.34 (s, 4H, OH), [lit.119 (400 
MHz, (CD3)2SO) δ 2.71, 7.40, 9.45]; 13C NMR: (100 MHz, ((CD3)2CO): δ 13.6 (C(6)H3), 105.5 (C(3)H), 122.2 
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(C(5)), 126.1 (C(4)), 145.4 (C(2)). νmax  3210, 3020, 2961, 2837, 1501, 1168 cm-1; HRMS: (ESI+) 
Calculated for C16H14O4Na: 293.0784, found [M+Na]+: 293.0792. 
tetra-tert-butyl-2,2',2'',2'''-((9,10-dimethylanthracene-2,3,6,7-tetrayl)tetrakis(oxy))tetraacetate (44) 
 
Under an inert N2 atmosphere, 45 (2.35 g, 8.7 mmol) was dissolved in anhydrous THF (500 mL). K2CO3 
(4.9 g, 35.2 mmol) and tert-butyl bromoacetate (7 mL, 47.4 mmol) were added and the reaction 
mixture stirred under reflux for 16 hours. The mixture was cooled to room temperature and the solvent 
removed under vacuum. The crude residue was then dissolved in CH2Cl2 (500mL) and washed with 
water (150 mL), brine (200 mL) and dried (MgSO4). The solvent was removed under vacuum and the 
crude residue purified by flash column chromatography (1% MeOH:CH2Cl2) to yield 46 (3.8 g, 5.2 mmol, 
60%) as a yellow solid. 1H NMR: (400 MHz, (CDCl3): δ 1.49 (s, 36H, 3 × C(1)H3), 2.85 (s, 6H, 2 × C(9)H3), 
4.76 (s, 8H, C(4)H2), 7.38 (s, 4H, 4 × C(6)H); 13C NMR: (100 MHz, (CDCl3): δ 14.6 (C(9)H3), 28.1 (C(1)H3), 
66.6 (C(4)H2), 82.3 (C(2)(CH3)3), 105.7 (C(6)H), 124.3 (C8), 126.2 (C7), 147.2 (C5), 167.8 (C(3)O); νmax  
2987, 2901, 1750, 1453, 1369, 1145, 1066 cm-1; HRMS: (ESI+) Calculated for C40H54O12Na: 749.3507, 




Under an inert N2 atmosphere, 44 (3 g, 4.1 mmol) was dissolved in anhydrous CH2Cl2 (500 mL). NBS 
(1.84 g, 10.3 mmol) and ABCN (50 mg, 5 mol%) were added, and the mixture stirred under reflux for 
1.5 hours. The reaction mixture was then cooled to room temperature and diluted with CH2Cl2 (300 
mL). The solution was washed with NaOH (300 mL, 1M), water (300 mL) and the solvent removed 
under vacuum to yield 43 (3.5 g, 4.0 mmol, 98%) as an orange solid. 1H NMR: (400 MHz, (CDCl3): δ 1.52 
(s, 36H, 3 × C(1)H3), 4.81 (s, 8H, C(4)H2), 5.22 (s, 4H, 2 × C(9)H2), 7.38 (s, 4H, 4 × C(6)H); 13C NMR: (100 
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MHz, (CDCl3): δ 28.1 (C(1)H3), 29.7 (C(9)H3), 66.4 (C(4)H2), 82.6 (C(2)(CH3)3), 104.2 (C(6)H), 126.2 (C8), 
126.4 (C7), 148.7 (C5), 167.4 (C(3)O); νmax  2987, 2933, 1706, 1488, 1362, 1228, 1183, 1066 cm-1; 




Under an inert N2 atmosphere, 43 (3.5 g, 4.0 mmol) was dissolved in anhydrous MeCN (300 mL). NaN3 
(1 g, 15.9 mmol) was added and the reaction stirred under reflux for 3 hours. The reaction mixture was 
cooled to room temperature and the solvent removed under vacuum. The crude product was dissolved 
in CH2Cl2 (400 mL), washed with water (3 × 100 mL) and the solvent removed under vacuum to yield 
42 (3.2 g, 3.9 mmol, 98%) as an orange solid. 1H NMR: (400 MHz, (CDCl3): δ 1.52 (s, 36H, 3 × C(1)H3), 
4.78 (s, 8H, C(4)H2), 5.08 (s, 4H, 2 × C(9)H2), 7.40 (s, 4H, 4 × C(6)H) [lit.44 (CDCl3, 400 MHz): δ 7.41 (4H, 
s), 5.08 (4H, s), 4.78 (8H, s), 1.52 (36H, s)]; 13C NMR: (100 MHz, (CDCl3): δ 28.1 (C(1)H3), 46.9 (C(9)H3), 
66.4 (C(4)H2), 82.6 (C(2)(CH3)3), 104.6 (C(6)H), 124.2 (C8), 126.8 (C7), 148.7 (C5), 167.5 (C(3)O); νmax  
2988, 2931, 2091, 1736, 1498, 1364, 1227, 1186, 1062cm-1; HRMS: (ESI+) Calculated for 




Under an inert N2 atmosphere, 42 (100 mg, 0.12 mmol) was dissolved in anhydrous degassed THF (8 
mL). PMe3 was added (2.5 mL, 2.5 mmol, 1M in THF) and the mixture stirred at room temperature for 
3 hours. Degassed water (2 mL) was added and the reaction mixture stirred for 1 hour. The solvent was 
then evaporated under a flow of nitrogen and the crude residue dissolved in THF/H2O (5:1, 3 mL). The 
solvent was then removed by freeze-drying to yield 41 (90 mg, 0.12 mmol, 96%) as a pale brown solid. 
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1H NMR: (400 MHz, (CDCl3): δ 1.50 (s, 36H, 3 × C(1)H3), 4.58 (s, 4H, 2 × C(9)H2), 4.77 (s, 8H, C(4)H2), 
7.49 (s, 4H, 4 × C(6)H) [lit.44 (CDCl3, 400 MHz): δ 7.47 (4H, s),4.73 (8H, s), 4.64 (4H, s), 1.47 (36H, s);]; 
13C NMR: (100 MHz, (CDCl3): δ 28.1 (C(1)H3), 38.9 (C(9)H2), 66.5 (C(4)H2), 82.4 (C(2)(CH3)3), 105.0 
(C(6)H), 125.8 (C8), 126.2 (C7), 148.0 (C5), 167.6 (C(3)O); ); νmax 2982, 2926, 1729, 1497, 1358, 1222, 




Under an inert N2 atmosphere, a flask was charged with 41 (30 mg, 0.04 mmol). CH2Cl2 (1 mL) and 
NaHCO3 (aq. 0.1 M, 1 mL) were added, the mixture cooled to 0 °C and rapidly stirred. Triphosgene (9.4 
mg, 0.016 mmol) was added and the reaction mixture stirred at room temperature for 30 minutes. The 
reaction mixture was diluted with CH2Cl2 (10 mL) and the organic layer separated, dried (MgSO4) and 
the solvent removed under vacuum to afford 39 (29 mg, 0.036 mmol, 91%) as an orange solid. 1H NMR: 
(400 MHz, (CDCl3): δ 1.51 (s, 36H, 3 × C(1)H3), ), 4.78 (s, 8H, C(4)H2), 5.07 (s, 4H, 2 × C(9)H2), 7.35 (s, 
4H, 4 × C(6)H); 13C NMR: (100 MHz, (CDCl3): δ 28.0 (C(1)H3), 39.83 (C(9)H2), 66.6 (C(4)H2), 82.7 
(C(2)(CH3)3), 104.4 (C(6)H), 125.5 (C8), 126.0 (C7), 148.7 (C5), 167.3 (C(3)O); νmax  2979, 2934, 2251, 






Under an inert N2 atmosphere, a flask was charged with anthracene-9,10-diyldimethanamine (20 mg, 
0.085 mmol). CH2Cl2 (1 mL) and NaHCO3 (aq. 0.1M, 1 mL) were added, the mixture cooled to 0 °C and 
rapidly stirred. Triphosgene (20 mg, 0.068 mmol) was added and the reaction mixture stirred at room 
temperature for 30 minutes. The reaction mixture was diluted with CH2Cl2 (10 mL) and the organic 
layer separated, dried (MgSO4) and the solvent removed under vacuum to afford 60 (22 mg, 0.076 
mmol, 91%) as a yellow solid. 1H NMR: (400 MHz, (CDCl3): δ 5.38 (s, 4H, C(5)H2), 7.66 (dd, J = 6.9, 3.2 
Hz, 4H, C(1)H), 8.35 (dd, J = 6.9, 3.2 Hz, 4H, C(2)H); 13C NMR: (100 MHz, (CDCl3): δ 39.0 (C5), 124.1 (C2), 
124.2 (C6), 126.8 (C1), 129.5 (C3), 129.8 (C4); νmax  2921, 2234, 1491, 1448, 1324, 1185, 858, 751 cm-
1; HRMS: (ESI+) Calculated for C18H12N2O2Na: 311.0791, found [M+Na]+: 311.0785. 
1,1'-(anthracene-9,10-diylbis(methylene))bis(3-phenylurea) (61)120 
 
Under an inert N2 atmosphere, aniline (15 µL, 0.14 mmol) was added to a solution of 60 (20 mg, 0.069 
mmol) in dry CH2Cl2 (50 mL) and stirred at room temperature for 16 hours. The resultant precipitate 
was filtered and washed with CH2Cl2 to afford 61 (25 mg, 0.053 mmol, 85%) as an off white solid. 1H 
NMR: (400 MHz, ((CD3)2SO): δ 5.31 (d, J = 4.8 Hz, 4H, C(5)H2), 6.88 (m, 4H, N(12)H and C(10)H)), 7.21 
(d, J = 7.4 Hz, 4H,  C(8)H), 6.66-6.70 (m, 2H, C(15)H), 6.77 (t, J = 7.6 Hz, 2H, C(14)H), 7.38 (d, J = 8.9 Hz, 
4H, C(2)H), 7.64 (m, 4H, C(9)H), 8.53 (m 4H, C(1)H), 8.62 (s, 2H, N(11)H), ), [lit.120 (400 MHz, (CD3)2SO) 
δ 5.32, 6.88, 7.20, 7.39, 7.63, 8.53, 8.61]; 13C NMR: (100 MHz, ((CD3)2SO): δ 36.3 (C(5)H2), 118.4 (C(8)H), 
121.8, 125.9, 126.8, 129.4, 130.5 (Aryl-C), 132.2 (C3), 141.3 (C7), 155.8 (C6), [lit.120 (100 MHz, (CD3)2SO) 
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δ 36.2, 118.4, 121.8, 125.9, 126.8, 129.4, 130.5, 132.2, 141.3, 155.8]; LRMS: (ESI+) Calculated for 
C30H26N4O2Na: 497.2, found [M+Na]+: 497.2. 
tert-butyl protected bis-phenylurea anthracene (62) 
 
Under an inert N2 atmosphere, aniline (21 µL, 0.24 mmol) was added to a solution of 39 (20 mg, 0.024 
mmol) in dry CH2Cl2 (50 mL) and stirred at room temperature for 16 hours. The solvent was removed 
under vacuum and the crude residue redissolved in EtOAc (30 mL). The organic layer was washed with 
1M Acetic acid (20 mL), water (20 mL), brine (20 ml), dried (MgSO4) and the solvent removed under 
vacuum. The crude solid was purified by flash column chromatography (5% MeOH:CH2Cl2 → 10% 
MeOH:CH2Cl2) to afford 62 (20 mg, 0.02 mmol, 82%) as an orange/brown solid. 1H NMR: (400 MHz, 
((CD3)2SO): δ 1.45 (s, 36H, C(1)H3), 4.87 (s, 8H, C(4)H2), 5.10 (d, J = 5.1 Hz, 4H, C(9)H2), 6.43 (m, 2H, 
N(16)H), 6.88 (t, J = 7.3 Hz, 2H, C(14)H)), 7.20 (t, J = 7.8 Hz, 4H,  C(13)H), 7.41 (d, J = 8.6 Hz, 4H, C(12)H), 
7.65 (s, 4H, C(6)H), 8.30 (s, 4H, N(15)H); 13C NMR: (100 MHz, ((CD3)2SO): δ 28.1 (C(1)H3), 39.7 (C(9)H2), 
66.8 (C(4)H2), 82.5 (C(2)(CH3)3), 105.7 (C(6)H), 121.6 (C12), 126.1 (C8), 126.4 (C7), 128.1 (C14), 128.9 
(C13), 139.4 (C11), 148.4 (C5), 154.3 (C10), 167.2 (C(3)O); LRMS: (ESI+) Calculated for C54H66N4O14Na: 
1017.4, found [M+Na]+: 1017.4. 
201 
 
tert-butyl protected half receptor (59) 
 
Under an inert N2 atmosphere, 1,2-phenylene diamine 38 (0.3 g, 2.70 mmol) was dissolved in dry 
degassed CH2Cl2 (120 mL). A solution of 39 (55mg, 0.068 mmol) in dry degassed CH2Cl2 (50 mL) was 
added dropwise over 10 minutes and then stirred at room temperature for 30 minutes. The solvent 
was removed under vacuum and the crude solid purified by flash column chromatography (80:20 
EtOAc:hexane → 5:95 MeOH:CH2Cl2 → 10:90 MeOH:CH2Cl2) to yield 59 (53 mg, 0.052 mmol, 77%) as 
an orange brown solid. 1H NMR: (400 MHz, ((CD3)2SO): δ 1.47 (s, 36H, 3 × C(1)H3), ), 4.59 (s, 4H, 
N(19)H2), 4.87 (s, 8H, C(4)H2), 5.12 (s, 4H, 2 × C(9)H2), 6.50-6.57 (m, 4H, C(13)H and N(18)H), 6.66-6.70 
(m, 2H, C(15)H), 6.77 (t, J = 7.6 Hz, 2H, C(14)H), 7.42-7.48 (m, 4H, C(12)H and N(18)H),  7.66 (s, 4H, 4 × 
C(6)H); 13C NMR: (100 MHz, ((CD3)2SO): δ 28.2 (C(1)H3), 36.7(C(9)H2), 66.8 (C(4)H2), 82.9 (C(2)(CH3)3), 
105.2 (C(6)H), 114.5 (C15), 118.9 (C13), 122.8 (C11), 125.2, 125.5 (C12 and C14), 125.8 (C8), 126.2 (C7), 
148.3 (C5), 149.5 (C16), 154.2 (C10), 167.5 (C(3)O); νmax  3315, 2973, 2901, 1733, 1622, 1494, 1393, 




tert-butyl protected tetra-urea macrocycle (37) 
 
Under an inert N2 atmosphere, 39 (40 mg, 0.049 mmol) was dissolved in dry degassed CH2Cl2 (600 mL). 
To this was added a solution of 59 (50 mg, 0.049 mmol) in dry degassed pyridine (60 mL) dropwise 
over 20 minutes. The reaction was stirred at room temperature for 16 hours and then the solvent 
removed under reduced pressure. The crude residue was suspended in HPLC grade water and freeze-
dryed to afford a fine crude solid. The product was then purified by reverse phase HPLC 
(acetone/water) and freeze dried to afford 37 (50 mg, 0.027 mmol, 56%) as an off white solid. 1H NMR: 
(400 MHz, (CD3)2CO): δ 1.49 (s, 72H, 3 × C(1)H3), ), 4.78 (m, 16H, C(4)H2), 5.12 (m, 8H, C(9)H2), 6.95 (s, 
4H, C(13)H), 7.65 (s, 8H, C(6)H), 8.07 (s, 4H, C(12)H); 13C NMR: (100 MHz, (CD3)2CO): δ 27.3 (C(1)H3), 
36.0 (C(9)H2), 66.0 (C(4)H2), 81.6 (C(2)(CH3)3), 105.3 (C(6)H), 126.3 (C8), 126.9 (C7), 127.4 (C12), 132.2 
(C13), 135.6 (C11), 147.8 (C5), 155.5 (C10), 167.9 (C(3)O); HRMS: (ESI+) Calculated for C96H120N8O28Na: 
1856.8138, found [M+Na]+: 1856.8145; Calculated for C96H120N8O28Na2: 939.9015, found [M+2Na]2+: 
939.9019. Retention time: (C18, 70:30 water/acetone → 100% acetone over 70 mins, 16 mL/min flow 
rate) 60 mins (analytical), 59 mins (preparative). 
1,1'-(1,2-phenylene)bis(3-benzylurea) (63)121 
 
Under an inert N2 atmosphere, benzyl isocyanate (0.5 g, 3.76 mmol) was added to a solution of 
phenylene-1,2-diamine 38 (81 mg, 0.75 mmol) in dry CH2Cl2 (30 mL) and stirred at reflux for 16 hours. 
The resultant precipitate was filtered and purified by flash column chromatography (100% CH2Cl2) to 
afford 63 (0.25 g, 0.68 mmol, 90%) as a white solid. 1H NMR: (400 MHz, (CD3)2SO): δ 4.26 (d, J = 5.8 
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Hz, 4H, C(5)H2), 6.92-6.99 (m, 4H, N(11)H and C(1)H)), 7.16-7.31 (m, 10H, Aryl-H), 7.49 (dd, J = 6, 3.6 
Hz, 2H, C(15)H), 7.87 (s, 2H, N(10)H), [lit.121 (400 MHz, (CD3)2SO) δ 4.28, 7.30, 6.96, 7.55, 7.90]; 13C 
NMR: (100 MHz, (CD3)2SO): δ 43.42 (C(5)H2), 123.8 (C(1)H), 124.0 (C(2)H), 127.1, 127.7, 128.7 (Aryl-
CH), 132.0 (C3), 140.7 (Aryl-C6), 156.4 (C5), [lit.121 (100 MHz, (CD3)2SO) δ 42.9, 123.2, 123.4, 126.6, 




Under an inert N2 atmosphere, 41 (30 mg, 0.04 mmol) was dissolved in anhydrous degassed CH2Cl2 (10 
mL). DIPEA was added (0.02 mL, 0.12 mmol) and then acetyl chloride (0.04 mL, 0.48 mmol) at 0 °C and 
then the mixture stirred at room temperature for 16 hours. MeOH (2 mL) was added and the solvent 
removed under vacuum. The crude product was dissolved in CH2Cl2 (30 mL), washed with water (30 
mL), 5% NaHCO3 (30 mL), dried (MgSO4) and the solvent removed under vacuum. The crude product 
was then purified by flash column chromatography (2% MeOH:CH2Cl2) to yield 64 (28 mg, 0.033 mmol, 
84%) as a pale brown solid. 1H NMR: (400 MHz, (CDCl3): δ 1.49 (s, 36H, 3 × C(1)H3), 1.85 (s, 6H, C(11)H3), 
4.79 (s, 8H, C(4)H2), 5.07 (s, 4H, 2 × C(9)H2),  7.48 (s, 4H, 4 × C(6)H); 13C NMR: (100 MHz, (CDCl3): δ 23.3 
(C(11)H3), 28.2 (C(1)H3), 36.4 (C(9)H2), 66.7 (C(4)H2), 82.1 (C(2)(CH3)3), 105.2 (C(6)H), 125.8 (C8), 126.1 




tert-butyl protected tetra-amide macrocycle (67)  
 
Under an inert N2 atmosphere, 42 (65 mg, 0.086 mmol) was dissolved in dry degassed 
dichloromethane (600 mL) and DIPEA (1 mL) was added. Pentaflurophenyl ester 66 (43 mg, 0.086 
mmol) in dry degassed dichloromethane (45 mL) was added via syringe pump (1 mL/hour) and the 
reaction stirred at room temperature for 3 days. The solvent was removed under vacuum and the 
crude product purified by reverse phase HPLC (acetone/water) and then freeze dried to afford 67 (36 
mg, 0.021 mmol, 24%) as a white solid. 1H NMR: (400 MHz, (CDCl3): δ 1.46 (s, 72H, C(1)H3), 4.77 (s, 
16H, C(4)H2), 5.46 (d, J = 5.1 Hz, 8H, C(9)H2), 7.48 (t, J = 7.9 Hz, 2H, C(12)H), 7.58 (s, 8H, C(6)H), 8.01 (d, 
J = 8.1 Hz, 2H, C(11)H, 8.13 (d, J = 7.6 Hz, 2H, C(15)H), 8.30 (s, 2H, C(14)H); HRMS: (ESI+) Calculated for 
C96H116N4O28Na: 1796.7702, found [M+Na]+: 1796.7711. Retention time: (40:60 water/acetone → 
100% acetone over 40 mins, 16 mL/min flow rate) 13 mins (analytical), 12 mins (preparative). 
No 13C data was obtained due to instability of compound 67 during prolonged characterisation. 
tetramethyl 2,2',2'',2'''-((9,10-dimethylanthracene-2,3,6,7-tetrayl)tetrakis(oxy))tetraacetate (68) 
 
Under an inert N2 atmosphere, 45 (0.5 g, 1.85 mmol) was dissolved in dry THF (100 mL). K2CO3 (1.15 
g, 8.32 mmol) and methyl bromoacetate (1.1 mL, 11.1 mmol) were added and the reaction mixture 
stirred at reflux for 24 hours. The mixture was cooled to room temperature and the solvent removed 
under vacuum. The crude solid was then dissolved in CH2Cl2 (100 mL), washed with water (40 mL), 
brine (40 mL) and dried (MgSO4). The solvent was removed under vacuum and the crude residue 
purified by flash column chromatography (1% MeOH:CH2Cl2) to yield 68 (400 mg, 0.72 mmol, 39%) as 
an orange brown solid. 1H NMR: (400 MHz, (CDCl3): δ 2.79 (s, 6H, C(8)H3), 3.84 (s, 12H, C(1)H3), 4.87 
(s, 8H, C(3)H2), 7.36 (s, 4H, C(5)H); 13C NMR: (100 MHz, (CDCl3): δ 14.6 (C8), 52.3 (C1), 66.3 (C3), 106.2 
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(C5), 124.8 (C7), 126.3 (C6), 147.1 (C4), 169.2 (C2); vmax 2955, 1754, 1495, 1435, 1380, 1214, 1188, 
1068 cm-1; HRMS: (ESI+) Calculated for C28H30O12Na: 581.1629, found [M+Na]+: 581.1623. 
N-(4,5-dimethyl-2-nitrophenyl)acetamide (77)61 
 
4,5-dimethyl-2-nitroaniline 78 (2 g, 12 mmol) was suspended in glacial acetic acid (24 mL) and heated 
to 90 °C. Acetic anhydride (1.2 mL, 13 mmol) was added and the mixture stirred at reflux for 2 hours. 
The reaction mixture was cooled to room temperature and poured into water (300 mL). The yellow 
precipitate was filtered, washed with water and recrystallized from ethanol to yield 77 (2.4 g, 11.6 
mmol, 97%) as a yellow crystalline solid. m.p. (ethanol) 105-107 °C [lit.122 (ethanol) 101-104 °C]; 1H 
NMR: (400 MHz, (CDCl3): δ 2.25 (s, 6H, C(9, 10)H3), 2.32 (s, 3H, C(1)H3), 7.93(s, 1H, C(8)H), 8.51 (s, 1H, 
C(5)H), 10.26 (br s, 1H, NH), [lit.61 (400 MHz, CDCl3) δ 2.27, 2.28, 2.35, 7.98, 8.54, 10.30]; 13C NMR: 
(100 MHz, (CDCl3): δ 19.1 (C10), 20.5 (C9), 25.6 (C1), 122.6 (C8), 125.9 (C5), 132.3 (C7), 132.7 (C6), 
134.1 (C3), 146.8 (C4), 168.9 (C(2)O); νmax  3341, 2987, 2901, 1708, 1695, 1576, 1323, 1151, 759 cm-
1; HRMS: (ESI+) Calculated for C10H12N2O3Na: 231.0740, found [M+Na]+: 231.0745. 
4-amino-5-nitrophthalic acid (76)61 
 
Under an inert N2 atmosphere, 77 (2 g, 9.6 mmol) and KMnO4 (6 g, 37.9 mmol)) was suspended in 
water (50 mL) and stirred at reflux for 3 days. Additional KMnO4 (3g, 19 mmol) was added halfway 
through the reaction time. The resultant brown precipitate was filtered hot and washed with water. 
The yellow filtrate was acidified to pH 3 with 1M HCl, extracted with EtOAc (3 × 100 mL), washed with 
brine (100 mL) and dried (MgSO4). The solvent was removed under vacuum to yield 76 (0.77 g, 2.88 
mmol, 60%) as a yellow orange crystalline solid. m.p. (H2O) 232-236 °C [lit.123 (H2O) 238 °C); 1H NMR: 
(400 MHz, (CDCl3): δ 7.25 (s, 1H, C(6)H), 7.63 (br s, 2H, NH2), 8.70 (s, 1H, C(3)H), 11.50 (br s, 2H, C(7, 
8)O2H) [lit.61 (400 MHz, (CD3)2SO) δ 7.91, 8.26, 13.0]; 13C NMR: (100 MHz, (CDCl3): δ 117.7 (C4), 118.7 
(C6), 129.3 (C3), 132.6 (C5), 141.5 (C2), 146.9 (C1), 167.8 (C7), 169.0 (C8); νmax  3486, 3364, 2972, 
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Under an inert N2 atmosphere, 76 (40 mg, 0.15 mmol) was dissolved in anhydrous THF (8 mL) and 
acetic anhydride (0.4 mL, 2.5 mmol) added. The reaction mixture was stirred at reflux for 4 hours and 
then cooled to room temperature. The solvent was removed under vacuum and the crude residue co-
evaporated with toluene (3 × 20 mL) to afford a yellow solid 75 which was used without further 
purification. This crude product was then dissolved in anhydrous toluene (5 mL) under an N2 
atmosphere and benzylamine (19 µL, 0.16 mmol) was added. The reaction mixture was stirred a reflux 
for 16 hours, after which the solvent was removed under vacuum and the crude solid purified by flash 
column chromatography (1% MeOH:CH2Cl2) to afford 82 (37 mg, 0.13 mmol, 84%) as a yellow solid. 1H 
NMR: (400 MHz, (CDCl3): 4.81 (s, 2H, C(9)H2), 7.21-7.39 (m, 5H, Aryl-H), 7.57 (s, 1H, C(6)H), 7.99 (br s, 
2H, NH2), 8.46 (s, 1H, C(3)H); 13C NMR: (100 MHz, (CDCl3): δ 41.3 (C9), 114.4 (C6), 117.2 (C4), 122.2 
(C3), 122.3, 127.9, 128.4 (Aryl-CH), 133.6 (C5), 136.8 (Aryl-C) 137.3 (C2), 150.2 (C1), 165.9 (C7), 165.9 
(C8); νmax  3466, 3353, 3051, 2971, 1766, 1697, 1642, 1598, 1530, 1260, 1070, 743 cm-1; LRMS: (EI) 
Calculated for C15H11N3O4: 297.1, found [M]+: 297.1. 
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G2MM 2-nitro-4,5-phthalimido aniline (84) 
 
Under an inert N2 atmosphere, 76 (40 mg, 0.15 mmol) was dissolved in anhydrous THF (5 mL) and 
acetic anhydride (0.4 mL, 2.5 mmol) added. The reaction mixture was stirred at reflux for 4 hours and 
then cooled to room temperature. The solvent was removed under vacuum and the crude residue co-
evaporated with toluene (3 × 20 mL) to afford a yellow solid 75 which was used without further 
purification. This crude product was then dissolved in anhydrous toluene (5 mL) under an N2 
atmosphere and G2MM amine 83 (140 mg, 0.1 mmol) was added. The reaction mixture was stirred a 
reflux for 16 hours, after which the solvent was removed under vacuum and the crude solid purified 
by flash column chromatography (1% MeOH:CH2Cl2) to afford 84 (104 mg, 0.064 mmol, 64%) as a 
yellow solid. 1H NMR: (400 MHz, (CDCl3): 1.42 (s, 81H, C(19)H3), 1.86-.195 (m, 24H, C(10, 15)H2), 2.12-
2.22 (m, 24, C(11, 16)H), 6.81  (br s, 3H, N(13)H), 6.81 (s, 1H, C(6)H), 8.74 (s, 1H, C(3)H); 13C NMR: (100 
MHz, (CDCl3): δ 28.2  (C19), 29.7, 29.9 (C16/15), 31.3, 31.5 (C10/11), 55.1 (C14), 57.7 (C9), 80.8 (C18), 
117.3 (C4), 118.2 (C6), 129.8 (C5), 130.5 (C3), 145.4 (C2), 147.9 (C1), 166.6 (C7), 172.8 (C12), 173.0 
(C17); ν max  3464, 3348, 2987, 2901, 1725, 1681, 1628, 1542, 1393, 1250, 1056 cm-1; LRMS: (ESI) 
Calculated for C84H136N6O25Na: 1629.0. found [M+Na]+: 1629.0. 
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G2MM 1,2-diamino-4,5-phthalimide (88) 
 
Under an inert N2 atmosphere, a solution of 84 (200 mg, 0.12 mmol) in MeOH (10 mL) was added to 
Pd/C (10 mg). The reaction vessel was then purged with hydrogen (1 atm) and the reaction mixture 
stirred at room temperature for 3 hours. After which, the reaction mixture was filtered through celite 
and washed with CH2Cl2, and the filtrate concentrated under vacuum. The crude product was then 
purified by flash column chromatography (4% MeOH:CH2Cl2) to afford 88 (179 mg, 0.11 mmol, 90%) 
as light brown solid. 1H NMR: (400 MHz, (CDCl3): δ 1.41 (s, 81H, C(14)H3), 1.95 (m, 18H, C(11)H2), 2.12 
(m, 6H, C(6)H2), 2.19 (m, 18H, C(10)H2), 2.27 (m, 6H, C(7)H2), 7.07 (s, 2H, C(2)H); 13C NMR: (100 MHz, 
(CDCl3): δ 28.1 (C14), 29.9 (C10), 30.0 (C11), 31.9 (C7), 32.3 (C6), 53.5 (C5), 57.5 (C9), 80.7 (C13) 110.6 




Dimethyl 4-amino-5-nitrophthalate (89) 
 
76 (0.8 g, 3.5 mmol) was dissolved in MeOH (30 mL) and concentrated H2SO4 (0.5 mL) added. The 
reaction mixture was stirred at reflux for 3 hours and then the solvent was removed under vacuum. 
The residue was dissolved in EtOAc (60 mL), washed with 5% NaHCO3 (60 mL), brine (60 mL) and dried 
(MgSO4). The solvent was removed under vacuum and the crude solid purified by flash column 
chromatography (100% CH2Cl2) to yield 89 (0.72g, 2.8 mmol, 80%) as an orange solid. 1H NMR: (400 
MHz, (CDCl3): δ 3.88 (s, 3H, C(10)H3), 3.92 (s, 3H, C(9)H3),  6.91 (s, 1H, C(6)H), 7.26 (br s, 2H, NH2), 8.74 
(s, 1H, C(3)H); 13C NMR: (100 MHz, (CDCl3): δ 52.5 (C9), 53.1 (C10), 116.9 (C4), 118.3 (C6), 129.7 (C3), 
131.2 (C5), 140.7 (C2), 146.6 (C1), 164.7 (C7), 168.0 (C8); νmax  3486, 3342, 2987, 2901, 1736, 1697, 
1621, 1502, 1435, 1339, 1250, 1027, 762 cm-1; LRMS: (ESI+) Calculated for C10H10N2O6Na: 277.0, found 
[M+Na]+: 277.1. 
Dimethyl 4,5-diamino-phthalate (90)124 
 
Under an inert N2 atmosphere, a solution of 89 (100 mg, 0.39 mmol) in MeOH (10 mL) was added to 
Pd/C (10 mg). The reaction vessel was then purged with hydrogen (1 atm) and the reaction mixture 
stirred at room temperature for 1 hour. After which, the reaction mixture was filtered through celite 
and washed with CH2Cl2, and the filtrate concentrated under vacuum. The crude product was then 
purified by flash column chromatography (5% MeOH:CH2Cl2) to afford 90 (81 mg, 0.36 mmol, 93%) as 
light brown solid. 1H NMR: (400 MHz, (CDCl3): δ 3.84 (s, 6H, C(5)H3), 7.02 (s, 2H, C(2)H), [lit.124 (500 
MHz, CDCl3) δ 3.83, 6.99]; 13C NMR: (100 MHz, (CDCl3): δ 52.4 (C5), 116.6 (C2), 124.1 (C3), 1136.6 (C1), 
168.4 (C4), [lit.124 (125 MHz, CDCl3) δ 52.3, 116.5, 123.9, 136.7, 168.4]; νmax 3363, 2997, 2950, 1694, 
1624, 1574, 1522, 1434, 1323, 1262, 1209, 1128, 1050 cm-1; HRMS: (ESI+) Calculated for C10H12N2O4Na: 
247.0689, found [M+Na]+: 247.0685. 
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3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-aminobenzoic acid (100)67 
 
To a suspension of 3,4-diaminobenzoic acid 99 (1 g, 6.60 mmol), in MeCN/0.1M aqueous NaHCO3 (1:1, 
40 mL), was added Fmoc-Su (2.20 g, 6.60  mmol) over 30 minutes. The mixture was rapidly stirred at 
room temperature for 24 hours and then acidified to pH 1 with 1M HCl. The pink precipitate was then 
filtered and washed with cold Et2O (20 mL), hexane (20 mL) and methanol (20 mL) before being air 
dried to afford 99 (2.14 g, 5.94 mmol, 90%) as a light pink solid. 1H NMR: (400 MHz, ((CD3)2SO): δ 4.25-
4.34 (m, 1H, C(10)H), 4.35-4.45 (m, 2H, C(9)H2), 5.68 (s, 2H, NH2), 6.71 (d, J = 8.4 Hz, 1H, C(4)H), 7.30-
7.38 (m, 2H, C(13)H), 7.40-7.46 (m, 2H, C(14)H), 7.50 (d, J = 7.8 Hz, 1H, C(3)H), 7.69-7.78 (m, 2H, 
C(15)H), 7.79 (s, 1H, C(7)H), 7.91 (d, J = 7.5 Hz, 2H, C(12)H), 8.77 (s, 1H, C(O)NH), 12.10 (s, 1H, CO2H), 
[lit.67 (400 MHz, (CD3)2SO) δ 4.29-4.40, 6.72, 7.33-7.36, 7.43, 7.51, 7.74-7.80, 7.90, 8.78]; 13C NMR: 
(100 MHz, ((CD3)2SO): δ 41.8 (C10), 66.4 (C9), 114.7 (C4), 118.0 (C5), 120.6 (C15), 122.2 (C6), 125.8 
(C13), 127.6 (C12), 128.3 (C3, 7), 128.2 (C14), 141.2 (C16), 144.2 (C11), 155.0 (C8), 167.7 (C1), [lit.67 
(100 MHz, (CD3)2SO) δ 46.6, 114.1, 117.4, 120.0, 125.2, 127.0, 127.6, 140.6, 143.7, 154.4, 167.1]; νmax  
3409, 3336, 3218, 3066, 2932, 1682, 1605, 1576, 1415, 1341, 1297, 1221, 1034, 736 cm-1; HRMS: (ESI+) 
Calculated for C22H19N2O4: 375.1339, found [M+H]+: 375.1359, Calculated for C22H18N2O4Na: 397.1159, 
found [M+Na]+: 397.1168. 
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methyl 3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-aminobenzoate (107) 
 
To a suspension of methyl 3,4-diaminobenzoate 106 (1 g, 6.0 mmol), in MeCN/0.1M aqueous NaHCO3 
(1:1, 30 mL), was added Fmoc-Su (2 g, 6.0 mmol) over 30 minutes. The mixture was rapidly stirred at 
room temperature for 24 hours. The light orange precipitate was then filtered and washed with cold 
hexane (20 mL) before being air dried to afford 107 (2.38 g, 5.99 mmol, 99%) as a pale orange solid. 1H 
NMR: (400 MHz, (CDCl3): δ 3.85 (s, 3H, C(17)H3), 4.12-4.28 (m, 3H, C(9, 10)H),  6.35 (br s, 2H, NH2), 
6.72 (d, J = 8.4 Hz, 1H, C(4)H), 7.29-7.35 (m, 2H, C(13)H), 7.40 (t, J = 7.8 Hz, 2H, C(14)H), 7.49-7.64 (m, 
2H, C(12)H), 7.76 (d, J = 7.7 Hz, 3H, C(3, 15)H), 7.83 (d, J = 1.9 Hz, 1H, C(7)H); 13C NMR: (100 MHz, 
(CDCl3): δ 47.2 (C10), 51.8 (C17), 67.1 (C9), 115.9 (C4), 120.0 (C15), 121.5 (C6), 125.0 (C13), 127.1 (C12), 
127.8 (C7), 128.2 (C14), 129.5 (C3) 141.4 (C16), 143.6 (C11), 155.2 (C8), 166.7 (C1); νmax 3346, 3068, 
2936, 1688, 1612, 1582, 1425, 1347, 1294, 1230, 1044, 745 HRMS: (ESI+) Calculated for C23H21N2O4: 
389.1496, found [M+H]+: 389.1489, calculated for C23H20N2O4Na: 411.1315, found [M+Na]+: 411.1311. 
Diamino methyl ester anthracene half receptor (109) 
 
Under an inert N2, 107 (754 mg, 1.94 mmol) was dissolved in anhydrous dichloromethane (50 mL) and 
60 (280 mg, 0.97 mmol) was added. The reaction was heated to reflux for 16 hours and the solvent 
removed under vacuum. The crude residue was suspended in cold methanol and filtered to afford 108 
(312 mg, 50.4 mmol, 52%) as a crude yellow solid. Under an inert N2 atmosphere, 108 was dissolved 
in piperidine (20% in DMF, 20 mL) and stirred at room temperature for 4 hours. The piperidine was co-
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evaproated with toluene and the crude residue triturated in dichloromethane. The precipitate was 
filtered and air dried to afford 109 (90 mg, 0.15 mmol, 90%) as a pale yellow solid. 1H NMR: (400 MHz, 
((CD3)2SO): δ 3.76 (s, 6H, C(14)H3), 5.11 (s, 4H, NH2), 5.34 (d, J = 5.3 Hz, 4H, C(5)H2), 7.18 (dd, J = 2.0 
and 8.4 Hz, 2H, C(9)H), 7.27 (d, J = 2.1 Hz, 1H, C(11)H), 7.44 (t, J = 5.4 Hz, 2H, NH), 7.63 (dd, J = 3.3 and 
6.9 Hz, 4H, C(1)H), 7.96 (d, J = 8.5 Hz, 1H, C(8)H), 8.53 (dd, J = 3.3 and 6.9 Hz, 4H, C(2)H), 8.58 (s, 2H, 
NH); 13C NMR: (100 MHz, ((CD3)2CO): δ 35.9 (C5), 52.0 (C14), 116.1 (C9), 118.7 (C11), 119.3 (C8), 125.6 
(C2), 126.4 (C10), 126.5 (C1), 127.4 (C3), 129.4 (C4), 131.4 (C12), 138.1 (C7), 155.4 (C6), 166.4 (C13); 
HRMS: (ESI+) Calculated for C34H32N6O6Na: 643.2276, found [M+Na]+: 643.2256.  
Fmoc protected pentafluorophenyl ester (112) 
 
Under an inert N2 atmosphere, 100 (200 mg, 0.53 mmol) was suspended in anhydrous THF (20 ml). A 
solution of pentafluorophenol (140mg) and DCC (160 mg) in anhydrous THF (10 mL) was added, and 
the reaction heated to 55 °C upon which the precipitate disappeared. The reaction was stirred for 16 
hours, cooled to room temperature and concentrated under vacuum. The crude residue was 
suspended in dichloromethane and filtered, and the filtrate concentrated under vacuum. The crude 
product was then purified by flash column chromatography (1:1, 40/60 → 1:4, 40/60 petroleum 
ether:EtOAc) to afford 112 (240 mg, 0.45 mmol, 84%) as a white solid. 1H NMR: (400 MHz, (CDCl3): δ 
4.24 (s, 1H, C(10)H), 4.59 (s, 2H, C(9)H2),  6.22 (br s, 2H, NH2), 6.79 (d, J = 8.6 Hz, 1H, C(4)H), 7.31 (s, 
2H, C(13)H), 7.41 (t, J = 7.5 Hz, 2H, C(14)H), 7.58 (br s, 2H, C(12c)H), 7.77 (d, J = 7.5 Hz, 2H, C(15)H), 
7.91 (d, J = 8.6 Hz, 1H, C(4)H), 7.95 (s, 1H, C(7)H); 13C NMR: (100 MHz, (CDCl3): δ 47.2 (C10), 67.2 (C9), 
116.0 (C3), 121.6 (C6), 127.0 (C7), 127.1 (C12), 129.5 (C3), 131.0 (C4), 143.5 (C11), 155.2 (C8), 161.9 
(C1); 19F NMR: (377 MHz, (CDCl3)): δ -162,68 (t, J = 21.1 Hz, 2F, C(15)F), -158.57 (t, J = 21.1 Hz, 1F, 
C(16)F), -152.57 (m, 2F, C(14)F), HRMS: (ESI+) Calculated for C28H17F5N2O4Na: 563.1001, found [M+Na]+: 
563.0981. 
The 13C signals for fluorinated carbons 13, 14, 15 and 16 were of too weak intensity to be observed. 
213 
 









Under an inert N2 atmosphere, 100 (100 mg, 0.267 mmol), HBTU (100 mg, 0.267 mmol) and HOBt (36 
mg, 0.267 mmol) were suspended in anhydrous THF (10 mL). DIPEA (0.15 mL, 0.534 mmol) was added 
and the reaction stirred at room temperature for 10 minutes. G2MM amine 83 (192 mg, 0.133 mmol) 
was then added and the reaction stirred for 24 hours. The solvent was then removed under vacuum 
and the crude residue purified by flash column chromatography (5% MeOH:CH2Cl2) to afford 84 (229 
mg, 0.127 mmol, 96%) as an off white solid. 1H NMR: (400 MHz, (CDCl3): δ 1.41 (s, 81H, C(26)H3), 1.95 
(m, 18H, C(23)H2), 2.11 (t, J = 7.2 Hz, 6H, C(18)H2), 2.18 (m, 18H, C(22)H2), 2.26  (t, J = 7.2 Hz, 6H, 
C(19)H2), 4.14-4.34 (br m, 3H, C(7)H and NH2), 4.46 (d, J = 7.4 Hz, 2H, C(8)H2), 6.11 (s, 3H, NH), 6.77 (d, 
J = 8.4 Hz, 1H, C(13)H), 7.26-7.31 (m, 2H, C(4)H), 7.39 (t, J = 7.4 Hz, 2H, C(3)H), 7.57-7.69 (m, 2H, C(5)H), 
7.72 (d, J = 8.7 Hz, 1H, C(2)H), 7.76 (d, J = 7.6 Hz, 3H, C(2)H), 7.78 (d, J = 2.1 Hz, 1H, C(15)H), 8.59 (s, 
1H, NH); 13C NMR: (100 MHz, (CDCl3): δ 28.0 (C26), 29.8 (C22), 29.9 (C23), 31.8 (C19), 32.2 (C18), 47.2 
(C7), 53.4 (C17), 57.4 (C21), 67.3 (C8), 80.6 (C25) 116.6 (C12), 119.9 (C2), 122.6 (C10), 124.6 (C14), 
125.3 (C4), 126.0 (C15), 126.8 (C13), 127.0 (C5), 127.6 (C3), 141.3 (C1), 143.8 (C6), 145.3 (C11), 154.9 
(C9), 166.6 (C16), 172.7 (C24), 173.1 (C20); νmax  2977, 2963, 1752, 1723, 1689, 1637, 1535, 1367, 
1242, 1151, 1098, 844 cm-1; HRMS: (ESI+) Calculated for C98H150N6O24Na2: 921.0260, found [M+2Na]2+: 
921.0252. Retention time: (C18, 20:80 water/acetone → 100% acetone over 30 mins, 16 mL/min flow 
rate) 13 mins (analytical), 13 mins (preparative). 
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Diamino tert-butyl protected G2MM anthracene half receptor (119) 
Under an inert N2 atmosphere, 113 (500 mg, 0.288 mmol) and 60 (37 mg, 0.130 mmol) were dissolved 
in anhydrous dichloromethane (8 mL). Pyridine (60 µL, 0.74 mmol) was added and the reaction heated 
to reflux for 16 hours. The reaction was cooled to room temperature and the solvent removed under 
vacuum. The crude residue was purified by flash column chromatography (4% MeOH:CH2Cl2) to afford 
the Fmoc protected product 118 (464 mg, 0.12 mmol, 92%) as a white solid. Conversion to 118 was 
confirmed by limited NMR studies* and high resolution mass spectrometry (ESI+): Calculated for 
C214H312N14O50Na2: 1963.1077, found [M+2Na]2+: 1963.1067. Under an inert N2 atmosphere, 118 (260 
mg, 0.066 mmol) was dissolved in anhydrous dichloromethane (10 mL) and cooled to 0 °C. DBU (45 
µL, 0.28 mmol) was added and the reaction mixture warmed to room temperature and stirred for 2 
hours. The solvent was removed under vacuum and the crude product purified by flash column 
chromatography (5% MeOH:CH2Cl2) to afford 119 (215 mg, 0.063 mmol, 95%) as an off white solid. 1H 
NMR: (400 MHz, (CD3OD): δ 1.43 (s, 162H, C(23)H3), 1.93 (m, 36H, C(20)H2), 2.08 (m, 12H, C(15)H2), 
2.18 (m, 48H, C(19, 16)H2), 5.36 (s, 4H, C(5)H2), 7.18 (dd, J = 2.1, 8.3 Hz, 2H, C(9)H), 7.26 (d, J = 2.1 Hz, 
2H, C(11)H), 7.41 (d, J = 8.3 Hz, 2H, C(8)H), 7.41 (s, 6H, NH), 7.60 (dd, J = 3.3, 6.9 Hz, 4H, C(1)H), 7.89 
(s, 2H, NH), 8.47 (dd, J = 3.3, 6.9 Hz, 4H, C(2)H); 13C NMR: (100 MHz, (CDCl3): δ 27.1 (C23), 29.1 (C20), 
29.3 (C21), 31.0 (C15), 31.1 (C16), 57.4 (C18), 58.0 (C14), 80.2 (C22), 115.9 (C11), 117.4 (C9) 123.1 (C8), 
124.6 (C2), 125.9 (C1), 128.5 (C10), 130.1 (C4), 130.5 (C3), 131.4 (C7), 140.0 (C12), 156.7 (C6), 168.6 
(C13), 173.0 (C21), 174.1 (C17); νmax 3321, 2976, 2938, 1725, 1653, 1534, 1455, 1391, 1308, 1249, 
1148, 1101, 954, 844 cm-1; HRMS: (ESI+) Calculated for C184H293N14O46Na: 1730.5524, found 
[M+H+Na]2+: 1730.5507. 
* Limited NMR studies were only possible due to believed slow conformational exchange of 118 resulting in very 
broad signals of low intensity. 
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tert-butyl protected G2MM anthracene tetra urea macrocycle (120) 
 
Under an inert N2 atmosphere, 119 (63 mg, 0.029 mmol) and DMAP (7 mg, 0.058 mmol) were dissolved 
in anhydrous degassed dichloromethane (60 mL) and heated to reflux. 60 (8.4 mg, 0.029 mmol) in 
anhydrous degassed dichloromethane (5 mL) was added and the reaction stirred at reflux for 2 days. 
The solvent was then removed under vacuum and the crude product purified by reverse phase HPLC 
(acetone/water) and then freeze dried to afford 120 (41 mg, 0.011 mmol, 38%) as a white solid. 1H 
NMR: (400 MHz, (CD3OD): δ 1.45 (s, 162H, C(23)H3), 1.99 (m, 36H, C(20)H2), 2.17 (m, 12H, C(15)H2), 
2.24 (m, 48H, C(19)H2), 2.31 (m, 12H, C(16)H2), 5.39 (s, 8H, C(5)H2), 7.31, 7.44 (br s, 4H, C(1)H), 7.49 (s, 
6H, NH), 7.70 (dd, J = 2.1, 8.5 Hz, 2H, C(9)H), 7.89 (d, J = 8.5 Hz, 2H, C(8)H), 7.98 (s, 2H, C(11)H), 8.39 
(br s, 8H, C(2)H); 13C NMR: (100 MHz, (CDCl3): δ 27.0 (C23), 29.1 (C20), 29.3 (C21), 30.8 (C15), 31.1 
(C16), 57.3 (C18), 58.1 (C14), 80.3 (C22), 121.6 (C9), 121.77 (C12) 124.4 (C2), 124.7 (C11), 125.8, 125.9 
(C1), 130.0 (C10), 130.4 (C3), 130.6 (C3), 131.4 (C7, 12), 156.0, 156.8 (C6), 168.1 (C13), 173.1 (C21), 
174.1, 174.2 (C17); HRMS: (ESI+) Calculated for C202H304N16O48Na3: 1264.3861, found [M+3Na]3+: 
1264.3835, Calculated for C202H304N16O48Na4: 954.0369, found [M+4Na]4+: 954.0378. Retention time: 
(C18, 20:80 water/acetone → 100% acetone over 30 mins, 16 mL/min flow rate) 23 mins (analytical), 
21 mins (preparative). 
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Fmoc protected methyl ester G2MM linker (127) 
 
113 (215 mg, 0.12 mmol) was dissolved in dichloromethane (5 mL) and TFA (5 mL) added dropwise. 
The solution was stirred at room temperature for 16 hours and the TFA and solvent evaporated under 
a flow of N2. The residue was redissolved in methanol (5 mL) and trimethyl orthoformate (5 mL). HCl 
(5% v/v, 0.5 mL) was added and the mixture stirred for 24 hours. The solvent was then removed under 
vacuum and the crude product purified by flash column chromatography (5% MeOH:CH2Cl2) to afford 
127 (147 mg, 0.10 mmol, 87%). 1H NMR: (400 MHz, (CDCl3): δ 1.99 (m, 18H, C(23)H2), 2.108(m, 6H, 
C(18)H2), 2.25 (m, 24H, C(22, 19)H2), 3.60 (s, 27H, C(25)H3), 4.23 (m, 1H, C(7)H), 4.48 (m, 2H, C(8)H2), 
6.31 (s, 3H, NH), 6.72 (d, J = 8.4 Hz, 1H, C(13)H), 7.26 (m, 3H, C(4, 12)H), 7.38 (t, J = 7.4 Hz, 2H, C(3)H), 
7.63 (m, 2H, C(5)H), 7.75 (d, J = 7.9 Hz, 3H, C(2, 15)H), 8.12 (s, 1H, NH); 13C NMR: (100 MHz, (CDCl3): 
28.3 (C22), 29.6 (C23), 31.8 (C19), 32.2 (C18), 47.2 (C7), 51.8 (C25), 57.3 (C21), 58.2 (C17), 67.1 (C8), 
116.4 (C12), 120.0 (C2), 122.6 (C10), 124.4 (C14), 125.1 (C4), 125.2 (C15), 126.6 (C13), 127.7 (C5), 127.8 
(C3), 141.3 (C1), 143.6 (C11), 143.8 (C6), 155.0 (C9), 166.6 (C16), 173.3 (C20), 173.8 (C24); νmax  3330, 
2976, 2961, 1727, 1658, 1531, 1452, 1367, 1249, 1150, 846 cm-1; HRMS: (ESI+) Calculated for 








Diamino methyl ester protected G2MM anthracene half receptor (129) 
 
Under an inert N2 atmosphere, 127 (500 mg, 0.353 mmol) and 60 (42 mg, 0.147 mmol) were dissolved 
in anhydrous dichloromethane (5 mL). Pyridine (50 µL, 0.62 mmol) was added and the reaction heated 
to reflux for 16 hours. The reaction was cooled to room temperature and the solvent removed under 
vacuum. The crude residue was purified by flash column chromatography (4% → 6% MeOH:CH2Cl2) to 
afford the Fmoc protected product 128 (410 mg, 0.131 mmol, 89%) as a white solid. Conversion to 
128 was confirmed by limited NMR studies* and high resolution mass spectrometry (ESI+): m/z 
calculated for C180H204N14O50Na2: 1584.1834, found [M+2Na]2+: 1584.1849. Under an inert N2 
atmosphere, 128 (450 mg, 0.144) was dissolved in anhydrous dichloromethane (10 mL) and cooled to 
0 °C. DBU (85 µL, 0.58 mmol) was added and the reaction mixture warmed to room temperature and 
stirred for 4 hours. The solvent was removed under vacuum and the crude product purified by flash 
column chromatography (5% MeOH:CH2Cl2) to afford 129 (335 mg, 0.125 mmol, 87%) as an off white 
solid. 1H NMR: (400 MHz, (CD3OD): δ 1.94 (m, 36H, C(20)H2), 2.07 (m, 12H, C(15)H2), 2.24 (m, 48H, 
C(19, 16)H2), 3.60 (s, 54H, C(22)H3), 4.94 (s, 4H, C(5)H2), 7.05 (d, J = 8.3 Hz, 2H, C(9)H), 7.15 (m, 4H, 
C(11, 8)H), 7.37 (s, 6H, NH), 7.48 (dd, J = 3.3, 6.9 Hz, 4H, C(1)H), 7.85 (s, 2H, NH), 8.21 (dd, J = 3.3, 6.9 
Hz, 4H, C(2)H); 13C NMR: (100 MHz, (CDCl3): δ  28.5 (C20), 29.3 (C21), 31.0 (C15), 31.1 (C16), 51.8 (C22), 
57.3 (C18), 58.1 (C14), 116.1(C11), 117.5 (C9) 123.0 (C8), 124.4 (C2), 125.8 (C1), 128.6 (C10), 130.0 
(C4), 130.5 (C3), 131.4 (C7), 140.1 (C12), 155.5 (C6), 166.7 (C13), 173.3 (C17), 173.9 (C21); HRMS: (ESI+) 
Calculated for C130H184N14O46Na3: 915.7400, found [M+3Na]3+: 915.7415. Retention time: (C18, 
water/acetone, 50:50 → 100% acetone over 30 mins, 16 mL/min flow rate) 19 mins (analytical), 19 
mins (preparative). 
* Limited NMR studies were only possible due to believed slow conformational exchange of 128 resulting in very 
broad signals of low intensity. 
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Methyl ester protected G2MM anthracene tetra urea macrocycle (126) 
 
Under an inert N2 atmosphere, 129 (100 mg, 0.037 mmol) and DMAP (9 mg, 0.074) were dissolved in 
anhydrous degassed dichloromethane (32 mL) and heated to reflux. 60 (10.7 mg, 0.037 mmol) in 
anhydrous degassed dichloromethane (5 mL) was added and stirred at reflux for 2 days. The solvent 
was then removed under vacuum and the crude product purified by reverse phase HPLC 
(acetone/water) and then freeze dried to afford 126 (37 mg, 0.013 mmol, 34%) as a pale yellow solid. 
1H NMR: (400 MHz, (CD3)2SO): δ 1.89 (m, 36H, C(20)H2), 1.95 (m, 12H, C(15)H2), ), 2.12 (m, 12H, 
C(16)H2), 2.22 (m, 36H, C(19)H2), 5.25 (s, 8H, C(5)H2), 7.32 (s, 6H, NH), 7.42 (br s, 4H, C(1)H), 7.52 (m, 
6H, C(1, 9)H), 7.74 (s, 2H, NH), 7.87 (d, J = 8.5 Hz, 2H, C(8)H), 8.07 (s, 2H, C(11)H), 8.37 (br s, 8H, C(2)H); 
13C NMR: (100 MHz, (CD3)2SO): δ 28.3 (C20), 29.2 (C19), 29.5, 29.8 (C15), 30.7, 31.0 (C16), 35.7 (C5), 
51.8 (C22), 56.8 (C18), 57.9 (C14), 120.0 (C8), 122.8 (C9), 123.3 (C11), 125.4 (C2), 125.7 (C12), 126.4, 
126.5 (C1), 129.0, 129.5 (C3), 129.9 (C4), 135.6 (C7) 155.1, 155.7 (C6), 166.0 (C13), 172.9 (C17), 173.7 
(C21); HRMS: (ESI+) Calculated for C148H196N16O48Na2: 1506.1603, found [M+2Na]2+: 1506.1621, 
Calculated for C148H196N16O48Na3: 1011.7699, found [M+3Na]3+: 1011.7687. Retention time: (C18, 




Deprotected G2MM anthracene tetra urea macrocycle (1) 
 
Protected receptor 120 (30 mg, 0.008 mmol) was dissolved in dichloromethane (HPLC grade, 2.7 ml) 
and cooled to 0 °C. Trifluoroacetic acid (TFA) (0.3 mL) was added dropwise and the reaction warmed 
to room temperature and stirred for 4 hours.  The solvent was then removed under a flow of nitrogen, 
then the residue was co-evaporated with toluene (3 x 10 mL) to remove residual TFA, suspended in 
water and freeze dried.  The product was then purified by preparative HPLC eluting with 100% Water 
(buffered with 0.1 % TFA) → 100% methanol over 40 minutes. The solvent was removed under 
vacuum, the residue co-evaporated with toluene (3 × 10 mL), the product suspended in water and 
freeze dried.  The solid was then suspended in water, neutralised to pH 7.4 with NaOH (aq), filtered 
and then freeze dried to afford 1 as a white solid (21 mg, 0.0068 mmol, 85%). 1H NMR: (400 MHz, 75 
°C, D2O): δ 2.40-2.50 (m, 36H, C(19)H2), 2.58-2.71 (m, 48H, C(20)H2, C(15)H2), 2.80-2.90 (m, 12H, 
C(16)H2), 5.63, 5.81 (br s, 4H, C(5)H2), 7.43-7.50, 7.98-8.06 (br m, 4H, C(1)H),8.25 (br s, 2H, C(11)H), 
8.27 (d, 2H, C(9)H), 8.39 (d, 2H, C(8)H), 7.63 (d, J = 8.3 Hz, 3H, C(10)H), 8.58-8.65, 8.82-8.89 (br m, 4H, 
C(2)H). 13C NMR: (100 MHz, 75 °C, (D2O): δ 30.4 (C19), 30.6 (C15), 30.9 (C16), 31.2 (C20), 37.7, 37.9 
(C5), 57.4 (C18), 58.3 (C14), 124.6, 124.8 (C2), 124.9 (C11, C9), 125.7, 125.9 (C1), 128.3 (C12), 129.8 
(C4), 130.1 (C10), 130.5, 130.7 (C3), 135.6 (C7), 156.4, 157.2 (C6), 168.4 (C13), 174.8 (C17), 182.0 (C21). 
Retention time: (C18, 100% Water (buffered with 0.1 % TFA) → 100% methanol over 40 minutes, 16 





Under an inert N2 atmosphere, 91 (2 g, 6.1 mmol), NBS (4 g, 22.6 mmol) and ABCN (73 mg, 0.3 mmol) 
were dissolved in anhydrous dichloromethane (150 mL), and the mixture stirred at reflux for 4 hours. 
The mixture was then cooled to 0 °C and filtered. The solid was then dried under high vacuum to afford 
136 (2.1 g, 4.3 mmol, 71%) as a bright yellow solid. 1H NMR (400 MHz, CDCl3) δ 4.11 (s, 12H, C(1)H), 
5.35 (s, 4H, C(6)H), 7.40 (s, 4H, C(3)H), 13C NMR (100 MHz, CDCl3) 28.7 (C6), 56.0 (C1), 101.8 (C3), 125.7 
(C5), 125.9 (C4), 150.1 (C2); νmax 3002, 2942, 2829, 1633, 1535, 1498, 1458, 1430, 1371, 1247, 1201, 
1160, 1147, 1030, 830 cm-1; HRMS (ESI)+ Calculated for C20H20Br2O4Na: 506.9600, 504.9621, found 




Under an inert N2 atmosphere, 136 (2.7 g, 5.58 mmol) and NaN3 were suspended in anhydrous MeCN 
(70 mL). The mixture was stirred at reflux for 16 hours and then cooled to room temperature and the 
solvent was evaporated in vacuo. The remaining residue was then suspended in water (200 mL) and 
filtered. The solid was washed with ethanol (3 × 100 mL) and dried under high vacuum to afford 137 
(1.6 g, 3.9 mmol, 70%) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 4.10 (s, 12H, C(1)H), 5.19 (s, 4H, 
C(6)H), 7.42 (s, 4H, C(3)H), 13C NMR (100 MHz, CDCl3) 47.7 (C6), 56.1 (C1), 101.8 (C3), 123.8 (C5), 126.9 
(C4), 150.2 (C2); vmax 2997, 2968, 2936, 2831, 2105, 1632, 1535, 1497, 1455, 1432, 1371, 1244, 1200, 






Under an inert N2 atmosphere, 137 (1.6 g, 3.90 mmol) and PPh3 (8 g, 31.4 mmol) were suspended in 
degassed THF (80 mL). Degassed water (4 mL) was added and the reaction heated to 60 °C for 16 
hours. The reaction was cooled to room temperature and the solvent removed under vacuum. The 
crude residue was suspended in toluene (200 mL), filtered, washed with toluene (2 × 100 mL) and 
dried under high vacuum to afford 138 (1.05 g, 2.96 mmol, 76%) as a pale brown solid. 1H NMR (400 
MHz, CDCl3) δ 4.08 (s, 12H, C(1)H), 4.69 (s, 4H, C(6)H), 7.49 (s, 4H, C(3)H), 13C NMR (100 MHz, CDCl3) δ 
39.5 (C6), 56.0 (C1), 101.9 (C3), 125.3 (C5), 125.5 (C4), 149.7 (C2); νmax 3361, 2998, 2910, 2828, 1633, 
1535, 1494, 1455, 1433, 1241, 1205, 1168, 1042, 1029, 842 cm-1; HRMS: (ESI+) Calculated for 





Under an inert N2 atmosphere, a flask was charged with triphosgene (324 mg, 1.1 mmol) and 
anhydrous toluene (15 mL) was added. A suspension of 138 (200 mg, 0.55 mmol) in anhydrous toluene 
(5 mL) was added dropwise and the reaction mixture stirred at reflux for 2 hours. The reaction mixture 
was cooled and the solvent removed under high vacuum. The crude solid was resuspended in 
dichloromethane (50 mL) and filtered. The filtrate was collected and the solvent removed under 
vacuum to afford 139 (121 mg, 0.30 mmol, 54%) as a brown solid. 1H NMR (400 MHz, CDCl3) δ 4.11 (s, 
12H, C(1)H), 5.21 (s, 4H, C(6)H), 7.37 (s, 4H, C(3)H); 13C NMR (100 MHz, CDCl3) δ 40.1 (C6), 56.0 (C1), 
101.3 (C3), 124.5 (C7), 125.4 (C5), 125.7 (C4), 150.2 (C2); νmax  2934, 2832, 2255, 1498, 1435, 1245, 














Under an inert N2 atmosphere, 113 (507 mg, 0.283 mmol) and 139 (50 mg, 0.13 mmol) were dissolved 
in anhydrous dichloromethane (8 mL). Pyridine (60 µL, 0.74 mmol) was added and the reaction heated 
to reflux for 16 hours. The reaction was cooled to room temperature and the solvent removed under 
vacuum. The crude residue was purified by reverse phase HPLC (acetone/water) to afford 140 (336 
mg, 0.84 mmol, 65%) as a white solid. Conversion to 140 was confirmed by limited NMR studies* and 
high resolution mass spectrometry (ESI+): m/z calculated for C218H320N14O54Na2: 2023.1288, found 
2023.1299. Under an inert N2 atmosphere, 140 (100 mg, 0.028 mmol) was dissolved in anhydrous 
dichloromethane (10 mL) and cooled to 0 °C. DBU (50 µL, 0.31 mmol) was added and the reaction 
mixture warmed to room temperature and stirred for 1 hour. The solvent was removed under vacuum 
and the crude product purified by flash column chromatography (6% MeOH:CH2Cl2) to afford 141 (91 
mg, 0.026 mmol, 92%) as an off white solid. 1H NMR: (400 MHz, (CD3OD): δ 1.42 (s, 162H, C(23)H3), 
1.84-2.0 (m, 36H, C(20)H2), 2.02-2.14 (m, 12H, C(15)H2), 2.13-2.31 (m, 48H, C(19, 16)H2), 3.95 (br s, 
12H, C(24)H3), 4.58 (br s, 4H, C(5)H2), 7.13 (d, J = 8.3 Hz, 2H, C(9)H), 7.23 (s,2H, C(11)H), 7.31 (d, J = 8.3 
Hz, 2H, C(8)H), 7.38 (br s, 4H, C(2)H), 7.41 (s, 6H, NH), 7.89 (s, 2H, NH); 13C NMR: (100 MHz, (CDCl3): δ 
27.1 (C23), 29.1 (C20), 29.3 (C21), 30.8 (C15), 31.1 (C16), 54.9 (C24), 57.4 (C18), 58.1 (C14), 80.3 (C22), 
101.9 (C2), 115.8 (C11), 117.3 (C9) 123.3 (C8), 126.1 (C4), 126.1 (C3), 128.2 (C10), 131.6 (C7), 140.3 
(C12), 149.5 (C1), 157.0 (C6), 168.5 (C13), 173.0 (C21), 174.1 (C17); HRMS: (ESI+) Calculated for 
C188H300N14O50Na3: 1208.3702, found [M+3Na]2+:1208.3682. Retention time: (C18, 20:80 
water/acetone → 100% acetone over 30 mins, 16 mL/min flow rate) 22 mins (analytical), 20 mins 
(preparative).* Limited NMR studies were only possible due to believed slow conformational exchange of 140 
resulting in very broad signals of low intensity.
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tert-butyl protected octa-methoxy anthracene tetra urea macrocycle (97) 
 
Under an inert N2 atmosphere, 96 (25 mg, 0.007 mmol) and DMAP (1.7 mg, 0.014 mmol) were 
dissolved in anhydrous degassed dichloromethane (12 mL) and heated to reflux. 94 (2.7 mg, 0.007 
mmol) in anhydrous degassed dichloromethane (2 mL) was added and the reaction stirred at reflux 
for 2 days. The solvent was then removed under vacuum and the crude product purified by reverse 
phase HPLC (acetone/water) and then freeze dried to afford 89 (Xmg, X mmol, X%) as a white solid. 
1H NMR: (400 MHz, 75 °C, D2O): δ 2.40-2.50 (m, 36H, C(19)H2), 2.58-2.71 (m, 48H, C(20)H2, C(15)H2), 
2.80-2.90 (m, 12H, C(16)H2), 5.63, 5.81 (br s, 4H, C(5)H2), 7.43-7.50, 7.98-8.06 (br m, 4H, C(1)H),8.25 
(br s, 2H, C(11)H), 8.27 (d, 2H, C(9)H), 8.39 (d, 2H, C(8)H), 7.63 (d, J = 8.3 Hz, 3H, C(10)H), 8.58-8.65, 
8.82-8.89 (br m, 4H, C(2)H). 13C NMR: (100 MHz, (D2O): δ 30.4 (C19), 30.6 (C21), 30.9 (C16), 31.2 (C17), 
36.1, 36.4 (C6), 54.8, 54.9 (C1), 57.3, (C15), 58.2 (C19), 80.2 (C23), 101.5, 101.9 (C3), 121.1 (C9), 124.3, 
(C10, C12), 124.9 (C11, C9), 125.7 (C5), 125.9 (C4), 128.1 (C13), 129.6 (C11), 135.7 (C8), 149.4, 149.5 
(C2), 156.0, 157.0 (C7), 168.0 (C14), 173.0 (C18), 174.2 (C22); HRMS: (ESI+) Found 
[M+3Na]3+:1339.7453. Retention time: (C18, 20:80 water/acetone → 100% acetone over 30 mins, 16 
mL/min flow rate) 21 mins (analytical), 19 mins (preparative). 
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1,3,5-triethyl-2,4,6-tris(aminomethyl)benzene (154)125  
 
Under an inert N2 atmosphere, 1,3,5-tris(bromomethyl)-2,4,6-triethylbenzene 155 (324 mg, 0.74 
mmol) was dissolved in anhydrous DMF (4.5 mL) and NaN3 (157 mg, 2.42 mmol) added. The reaction 
was heated to 60 °C for 16 hours. The reaction mixture as then diluted with ethyl acetate (20 mL) and 
washed with water (3 × 20 mL), dried (MgSO4) and filtered. DMF (4 mL) was added to the filtrate and 
the solvent removed under vacuum to a volume of ~4 mL. Conversion to tris-azide 156 was confirmed 
by 1H NMR (220 mg, 0.68 mmol, 92%). The resultant DMF solution was transferred to a degassed 
anhydrous solution of THF (22 mL) and PMe3 (1M in THF, 4.1 mL) under an inert N2 atmosphere. The 
reaction mixture was stirred at room temperature for 1 hour and degassed H2O (5 mL) added, with the 
reaction mixture stirred for a further 16 hours. The solvent and excess PMe3 was then evaporated by 
bubbling N2 through the solution, and the crude residue suspended in H2O (~10 mL). The suspension 
was then freeze dried to afford 154 (148 mg, 0.61 mmol, 90%) as a white solid. 1H NMR: (400 MHz, 
(CDCl3): 1.24 (t, J = 7.5 Hz, 9H, C(1)H), 2.83 (q, J = 7.5 Hz, 6H, C(2)H), 3.88 (s, 6H, C(5)H2), [lit.125 (400 
MHz,CDCl3) δ 1.23, 2.82 , 3.87 ]; 13C NMR: (100 MHz, (CDCl3): δ 16.8 (C(1)H2), 22.6 (C(2)H), 39.7 (C(5)H), 





Under an inert N2 atmosphere, a flask was charged with triphosgene (180 mg, 0.61 mmol) and 
anhydrous toluene (6 mL).  A solution of triamine 154 (50 mg, 0.20 mmol) in anhydrous toluene (6 mL) 
was added dropwise and the reaction mixture was heated to reflux then stirred for 2 hours.  The 
mixture was cooled and the solvent removed under vacuum. The crude solid was triturated with cold 
toluene, filtered and dried under high vacuum to afford tris-isocyanate 151 (63 mg, 0.20 mmol, 91%) 
as a colourless oil that crystallised over time.1H NMR: (400 MHz, (CDCl3): 1.26 (t, J = 7.6 Hz, 9H, C(1)H), 
2.84 (q, J = 7.6 Hz, 6H, C(2)H), 4.50 (s, 6H, C(5)H2); 13C NMR: (100 MHz, (CDCl3): δ 16.1 (C(1)H2), 22.8 
(C(2)H), 40.4 (C(5)H), 123.1 (C6), 132.4 (C3), 143.1 (C4); νmax  2973, 2933, 2875, 2243, 1495, 1453, 











Under an inert N2 atmosphere, 113 (556 mg, 0.31 mmol) was added to a solution of 151 (28 mg, 0.086 
mmol) in anhydrous dichloromethane (5 mL).  Anhydrous pyridine (40 µL) was added and the reaction 
heated to 34 °C for 16 hours, after which it was cooled to room temperature and the solvent removed 
under vacuum.  The residue was purified by reverse phase flash chromatography (Biotage SNAP Ultra 
C18 25 µm) eluting with acetone/water (10:90 → 90:10 over 10 column volumes then 100% acetone 
over 4 column volumes) to afford 153 (400 mg, 0.072 mmol, 84%) as a white solid.  Conversion to 153 
was confirmed by limited NMR* and high resolution mass spectrometry (ESI+): m/z calculated for 
C312H471N21O75Na3: 1928.1155, found [M+3Na]3+: 1928.1160; calculated for C312H471N21O75Na4: 
1451.8339, found [M+4Na]4+: 1451.8320.  Under an inert N2 atmosphere, 153 (300 mg, 0.052 mmol) 
was dissolved in anhydrous dichloromethane (8 mL) and cooled to 0 °C.  DBU (50 µL, 0.30 mmol) was 
added dropwise and the reaction mixture stirred at 0 °C for 1 hour.  The solvent was removed under 
vacuum and the crude product purified by flash column chromatography (4% MeOH:CH2Cl2) to afford 
152 as a white solid (238 mg, 0.047 mmol, 91%).  1H NMR: (400 MHz, (CD3OD): δ 1.26 (t, J = 7.6 Hz, 
C(1)H3), 1.43 (s, 243H, C(23)H3), 1.94 (m, 54H, C(20)H2), 2.09 (m, 18H, C(15)H2), 2.19 (m, 54H, C(19)H2), 
2.24 (m, 18H, C(16)H2), 2.82-2.95 (m, 6H, C(2)H2), 4.52 (s, 6H, C(5)H2), 6.17 (br s, 3H, C(5)H2NH), 7.21 
(dd, J = 2.1, 8.4 Hz, 3H, C(9)H), 7.30 (d, J = 2.1 Hz, 3H, C(11)H), 7.40 (d, J = 8.4 Hz, 3H, C(8)H), 7.42 (s, 
9H, C(18)NH), 7.93 (s, 3H, OC(13)NH); 13C NMR: (100 MHz, (CDCl3): δ 17.0 (C1), 22.5 (C2), 28.5 (C23), 
30.5 (C19), 30.7 (C20), 32.3 (C15), 32.6 (C16), 37.9 (C5), 58.9 (C18), 59.4 (C14), 81.6 (C22), 117.4 (C11), 
118.9 (C9) 124.5 (C8), 130.0 (C10), 132.9 (C3), 133.8 (C7), 141.4 (C12), 145.1 (C4), 157.9 (C6), 170.1 
(C13), 174.4 (C21), 175.6 (C17); HRMS: (ESI+) calculated for C267H441N21O69Na3: 1706.0472, found 
[M+3Na]3+: 1706.0490. Retention time: (C18, acetone/water, 70:30 → 96:4 over 30 mins, then 96:4 
isocratic over 10 mins, then 100:0 over 5 mins, 16 mL/min flow rate) 31 mins (analytical), 29 mins 
(preparative). 
* Limited NMR studies were only possible due to believed slow conformational exchange of 152 resulting in very 
broad signals of low intensity.
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Under an inert N2 atmosphere, 152 (500 mg, 0.1 mmol), octyl β-D-glucoside 12 (59 mg, 0.2 mmol) and 
DMAP (37 mg, 0.3 mmol) were dissolved in anhydrous dichloromethane (180 mL).  A solution of 151 
(33 mg, 0.1 mmol) in anhydrous dichloromethane (20 mL) was added at a rate of 1 mL/hr and the 
reaction stirred at 34 °C for 2 days.  The reaction mixture was cooled to room temperature and the 
solvent removed under vacuum.  The residue was purified by preparative HPLC eluting with 
acetone/water (70:30 → 96:4 over 30 mins, then 96:4 isocratic over 10 mins, then 100:0 over 5 mins).  
The solvent was removed under vacuum and the product suspended in water and freeze dried to 
afford 150 as a white solid (257 mg, 0.048 mmol, 48%).  1H NMR: (400 MHz, (CD3OD): δ 1.21 (m, 18H 
C(1)H3), 1.43 (s, 243H, C(23)H3), 1.95 (m, 54H, C(20)H2), 2.13 (m, 18H, C(15)H2), 2.20 (m, 54H, C(19)H2), 
2.25 (m, 18H, C(16)H2), 2.72, 2.83 (br m, 6H, C(2)H2), 4.40, 4.49 (br s, 6H, C(5)H2), 7.43 (s, 9H, NH), 7.63 
(d, J = 8.7 Hz, 3H, C(10)H), 8.04 (d, J = 8.7 Hz, 3H, C(11)H), 8.06 (s, 3H, C(8)H); 13C NMR: (100 MHz, 
(CDCl3): δ 15.5, 15.6 (C1), 22.3, 22.5 (C2), 27.1 (C23), 29.1 (C19), 29.3 (C20), 30.8 (C15), 31.0 (C16), 
37.5 (C5), 57.3 (C18), 58.1 (C14), 80.2 (C22), 120.3 (C11), 123.5 (C8), 124.1 (C10), 127.6 (C7), 129.4 
(C9), 132.0, 132.6 (C3), 135.0 (C12), 143.0, 143.2 (C4), 155.8, 156.6 (C6), 168.2 (C13), 173.0 (C21), 
174.1 (C17); HRMS: (ESI+) calculated for C285H462N24O72Na3: 1816.1084, found [M+3Na]3+: 1816.1093. 
Retention time: (C18, acetone/water, 70:30 → 96:4 over 30 mins, then 96:4 isocratic over 10 mins, 
then 100:0 over 5 mins, 16 mL/min flow rate) 33 mins (analytical), 31 mins (preparative). 
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150 (50 mg, 9.3 µmol) was dissolved in dichloromethane (HPLC grade, 2 ml) and cooled to 0 °C.  
Trifluoroacetic acid (TFA) (0.5 mL) was added dropwise and the reaction warmed to room temperature 
and stirred for 16 hours.  The solvent was then removed under a flow of nitrogen, then the residue 
was co-evaporated with toluene (3 x 10 mL) to remove residual TFA, suspended in water and freeze 
dried.  The product was then purified by preparative HPLC eluting with 100% Water (buffered with 0.1 
% TFA) → 100% methanol over 40 minutes.  The solvent was removed under vacuum, the residue co-
evaporated with toluene (3 × 10 mL), the product suspended in water and freeze dried.  The solid was 
then suspended in water, neutralised to pH 7.4 with NaOH (aq), filtered and then freeze dried to afford 
3 as a white solid (36.9 mg, 8.3 µmol, 89%).  1H NMR: (400 MHz, (D2O): δ 0.93-1.12,1.11-1.25 (br m, 
18H, C(1)H3), 1.89-1.98 (m, 54H, C(20)H2), 2.08-2.15 (m, 18H, C(15)H2), 2.13- 2.20 (m, 54H, C(19)H2), 
2.27-2.35  (m, 18H, C(16)H2), 2.67-2.85 (br m, 12 jH, C(2)H2), 4.46 (br s, 6H, C(5)H2), 7.63 (d, J = 8.3 Hz, 
3H, C(10)H), 7.78 (br s, 3H, C(8)H),7.80-7.85 (br m, 3H, C(11)H); 13C NMR: (100 MHz, (CDCl3): δ 15.4, 
15.5 (C1), 22.4, 22.6 (C2), 30.3 (C19), 30.5 (C15), 30.8 (C16), 31.1 (C20), 37.5, 37.7 (C5), 58.2 (C18), 
58.6 (C14),122.4 (C11), 124.9 (C8, C10), 128.4 (C7), 130.0 (C9), 132.0, 132.4 (C3), 135.6 (C12), 144.0, 
144.2 (C4), 157.0, 157.7 (C6), 169.6 (C13), 175.2 (C17), 182.1 (C21). Retention time: (C18, 100% Water 
(buffered with 0.1 % TFA) → 100% methanol over 40 minutes, 16 mL/min flow rate) 33 mins 
(analytical), 32 mins (preparative). 
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Chapter9 – Appendix 
9.1 Anthracene Receptor (1) 





































































Figure 108 Fluorescence emission spectrum of receptor 1 (10 µM) in water (pH 7.4) at 298 K, using excitation 
wavelength of 395 nm. 
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K a = 5.18 ± 0.19 M-1 (3.58%)
r  = 0.99899
0.0
0.2
































Figure 109 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for 1 (1 mM) titrated with a 
combined solution of D-glucose 4 (1 M) and 1 (1 mM), in D2O with at pH 7.4 and 298 K. Change in chemical shifts 
(Δδ, ppm) denoted with • were plotted against D-glucose 4 concentration (mM). The calculated values for Δδ 
are overlaid with the observed values, giving Ka = 5.1 ± 0.2 M-1 (3.6%). 
0 mM D-glucose 
9.9 mM D-glucose 
19.6 mM D-glucose 
29.1 mM D-glucose 
47.6 mM D-glucose 
65.4 mM D-glucose 
99.0 mM D-glucose 
130 mM D-glucose 
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K a = 46.14 ± 0.41 M-1 (0.89%)


































Figure 110 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for 1 (0.25 mM) titrated with a 
combined solution of D-cellobiose 31 (250 mM) and 1 (0.25 mM), in D2O with at pH 7.4 and 298 K. Change in 
chemical shifts (Δδ, ppm) denoted with • were plotted against D-cellobiose concentration (mM). The calculated 
values for Δδ are overlaid with the observed values, giving Ka = 46 ± 0.4 M-1 (0.89%). 
  
0 mM D-cellobiose 
4.9 mM D-cellobiose 
9.6 mM D-cellobiose 
14.2 mM D-cellobiose 
18.5 mM D-cellobiose 
22.7 mM D-cellobiose 
34.5 mM D-cellobiose 
45.1 mM D-cellobiose 
60.6 mM D-cellobiose 
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K a = 949.08 ± 2.88 M-1 (0.3%)




































Figure 111 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for 1 (0.2 mM) titrated with a 
combined solution of D-cellotriose 2 (15 mM) and 1 (0.2 mM), in D2O with at pH 7.4 and 298 K. Change in 
chemical shifts (Δδ, ppm) denoted with • were plotted against D-cellotriose 2 concentration (mM). The 
calculated values for Δδ are overlaid with the observed values, giving Ka = 949 ± 2.9 M-1 (0.3%). 
0 mM D-cellotriose 
0.29 mM D-cellotriose 
0.58 mM D-cellotriose 
0.85 mM D-cellotriose 
1.11 mM D-cellotriose 
1.36 mM D-cellotriose 
1.84 mM D-cellotriose 




















Figure 112 Partial 1H NMR spectra for 1 (0.2 mM) titrated with a combined solution of D-cellotetraose 33 (15 
mM) and 1 (0.2 mM), in D2O with at pH 7.4 and 298 K. Spectra imply binding with intermediate rate of exchange, 
thus no Ka was determinable.  
  
0 mM D-cellotetraose 
0.29 mM D-cellotetraose 
0.58 mM D-cellotetraose 
0.85 mM D-cellotetraose 
1.11 mM D-cellotetraose 
1.36 mM D-cellotetraose 
1.84 mM D-cellotetraose 




















Figure 113 Partial 1H NMR spectra for 1 (0.2 mM) titrated with a combined solution of D-cellopentaose 130 (15 
mM) and 1 (0.2 mM), in D2O with at pH 7.4 and 298 K. Spectra imply binding with intermediate rate of exchange, 
thus no Ka was determinable. 
  
0.29 mM D-cellopentaose 
0.58 mM D-cellopentaose 
0.85 mM D-cellopentaose 
1.11 mM D-cellopentaose 
1.36 mM D-cellopentaose 
1.84 mM D-cellopentaose 
1.61 mM D-cellopentaose 
0 mM D-cellopentaose 
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K a = 15.04 ± 1.78 M-1 (11.84%)
r  = 0.99614
0.0
0.2































Figure 114 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for 1 (0.2 mM) titrated with a 
combined solution of D-maltose 132 (500 mM) and 90 (0.2 mM), in D2O with at pH 7.4 and 298 K. Change in 
chemical shifts (Δδ, ppm) denoted with • were plotted against D-maltose concentration (mM). The calculated 
values for Δδ are overlaid with the observed values, giving Ka = 15 ± 1.8 M-1 (11.8%). 
  
0 mM D-maltose 
9.8 mM D-maltose 
19.2 mM D-maltose 
37.0 mM D-maltose 
53.6 mM D-maltose 
83.3 mM D-maltose 
109.4 mM D-maltose 
132.4 mM D-maltose 
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K a = 20.33 ± 0.67 M-1 (3.31%)
r  = 0.99957
0.0
0.2































Figure 115 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for 1 (0.2 mM) titrated with a 
combined solution of D-maltotriose 133 (500 mM) and 1 (0.2 mM), in D2O with at pH 7.4 and 298 K. Change in 
chemical shifts (Δδ, ppm) denoted with • were plotted against D-maltotriose concentration (mM). The 
calculated values for Δδ are overlaid with the observed values, giving Ka = 20 ± 0.7 M-1 (3.3%). 
  
0 mM D-maltotriose 
9.8 mM D-maltotriose 
19.2 mM D-maltotriose 
37.0 mM D-maltotriose 
53.6 mM D-maltotriose 
83.3 mM D-maltotriose 
109.4 mM D-maltotriose 


























































Ka = 37.58± 2.45 M-1 (6.52%)
r = 0.999102
ΔG =-8.99± -0.59 kJ.mol-1












































Figure 116 ITC binding results for 1 (0.2 mM) titrated with D-cellobiose (200 mM) in water at 298 K, in which: A) 
shows the blank run (addition of substrate into water); B) shows the titration (substrate into receptor); C) shows 
the plotted change in enthalpy vs molar ratio; and D) shows the fit calculated using an Excel spreadsheet (Ka = 













































































Ka = 955.53± 11.17 M-1 (1.17%)
r = 0.999934
ΔG =-17.01± -0.2 kJ.mol-1











































Figure 117 ITC binding results for 1 (0.2 mM) titrated with D-cellotriose 2 (15 mM) in water at 298 K, in which: 
A) shows the blank run (addition of substrate into water); B) shows the titration (substrate into receptor); C) 
shows the plotted change in enthalpy vs molar ratio; and D) shows the fit calculated using an Excel spreadsheet 












K a = 49.77 ± 2.62 M-1 (5.26%)



































Figure 118 Fluorescence titration results for D-cellobiose 31 (150 mM) and receptor 1 (10 µM) in water (pH 7.4) 
at 298 K. Excitation wavelength of 395 nm used, while monitoring emission intensity at 423 nm. Changes in 
emission intensity (Δintensity) at 423 nm were plotted against concentration of D-cellobiose 31. The calculated 
































K a = 6.08 ± 0.48 M-1 (7.84%)





































Figure 119 Fluorescence titration results for D-glucose 4 (700 mM) and receptor 1 (10 µM) in water (pH 7.4) at 
298 K. Excitation wavelength of 395 nm used, while monitoring emission intensity at 480 nm. Changes in 
emission intensity (Δintensity) at 423 nm were plotted against concentration of D-glucose 4. The calculated 




























K a = 6.06 ± 0.21 M-1 (3.49%)


































Figure 120 Fluorescence titration results for methyl β-D-glucoside 14 (400 mM) and receptor 1 (10 µM) in water 
(pH 7.4) at 298 K. Excitation wavelength of 395 nm used, while monitoring emission intensity at 423 nm. Changes 
in emission intensity (Δintensity) at 423 nm were plotted against concentration of D-glucose 4. The calculated 
values for Δintensity are overlaid with the observed values, giving a Ka = 6.1 ± 0.2 M-1 (3.5%).
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9.2 Triethylbenzene receptor (3) 












Figure 121 Numbering system used for the discussion of the conformational and binding properties of receptor 
3.  Triethylbenzene proton designations (blue) are prefixed with “t” (i.e. t1, t1’ etc.), spacer CH protons (red) are 


























































































































































































































































































































































Figure 131 Partial 1H NMR spectra showing receptor 3 at various concentrations in D2O with 10 mM phosphate buffer (pH 7.4). No change in spectra across concentration 






























Figure 132 Partial 1H NMR spectra showing receptor 3 at various temperatures in D2O with 10 mM phosphate buffer (pH 7.4).  Chemical shifts (δ, ppm) relative to proton t1 
(1.18 ppm).  Receptor signals sharpen upon heating, most notably t1/t1’ and t2/t2’ and s3.  Signal for proton t3/t3’ is omitted for clarity due to overlap with the residual 
































Figure 133 Partial 1H NMR spectra showing receptor 3 (0.1 mM) at 25 °C (top) and receptor 3 (0.1 mM) 25 °C after heating at 150 °C for 1 hour in the solid state (bottom), 



















































Figure 134 HeLa cells were incubated with normal cultural medium (control) or medium containing 3 at indicated 
concentrations (10 -1000 µM, dissolved in cultural medium) for 18 hours.  Cell viability was assessed using 
sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-carbonyl]-2H-tetrazolium) (XTT).  Cell 
viability is presented as specific absorbance values normalized to that of control (means ± SEM; n = 20-28 with 
4 replicates per treatment).  There is no significant difference between the cells treated with normal cultural 
medium (orange) and those treated with medium with 3 incorporated at all tested concentrations (blue).  These 
data suggest that receptor 3 at concentrations as high as 1000 µM is without toxic effect. Study performed by 
Dr Hongyu Li. 
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K a = 18026.02 ± 208.63 M-1 (1.04%)
r  = 0.99977



















































Figure 135 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated 
with a combined solution of D-glucose 4 (9.6 mM) and receptor 3 (0.25 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with slow exchange on NMR timescale.  Integrations of the peak 
at 8.19 ppm (denoted with •) versus the region 8.35-7.39 ppm were plotted against D-glucose 4 concentration 
(mM).  The calculated values for the integrals are overlaid with the observed values, giving Ka = 18,026 ± 208 M-
1 (1.04%). 
0 µM D-glc (0 eq) 
57 µM D-glc (0.23 eq) 
114 µM D-glc (0.45 eq) 
179 µM D-glc (0.67 eq) 
225 µM D-glc (0.89 eq) 
280 µM D-glc (1.11 eq) 
334 µM D-glc (1.33 eq) 
387 µM D-glc (1.54 eq) 
440 µM D-glc (1.75 eq) 
492 µM D-glc (1.95 eq) 




















Figure 136 1H NMR spectra for receptor 3 (0.25 mM) titrated with a combined solution of D-glucose 4 (9.6 mM) and receptor 3 (0.25 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K. 
0 µM D-glc (0 eq) 
57 µM D-glc (0.23 eq) 
114 µM D-glc (0.45 eq) 
179 µM D-glc (0.67 eq) 
225 µM D-glc (0.89 eq) 
280 µM D-glc (1.11 eq) 
334 µM D-glc (1.33 eq) 
387 µM D-glc (1.54 eq) 
440 µM D-glc (1.75 eq) 
492 µM D-glc (1.95 eq) 
544 µM D-glc (2.16 eq) 


























Figure 137 ITC binding results for receptor 3 (0.2 mM) titrated with D-glucose 4 (7.5 mM) in 10 mM phosphate 
buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows the titration 
(sugar into receptor 3); C) shows the plotted change in enthalpy vs molar ratio and D) shows the fit calculated 
using a 1:1 binding model (Ka = 18,000 ± 372 M-1). 
Ka = 18048.12± 372.31 M-1 (2.06%)
r = 0.999587
ΔG =-24.3± -0.5 kJ.mol-1




















[G]t  in mM
ΣΔHobs
ΣΔHcalc



































Figure 138 Partial 1H-1H NMR ROESY spectrum of receptor 3 (2 mM) with D-glucose 4 (5 mM, 2.5 equivalents) in D2O at 298 K. Chemical exchange peaks are observed between 
the D-glucose bound to the receptor (whose signals appear more upfield) and free D-glucose.  These exchange signals are labelled accordingly (i.e. β2(f-b) indicates chemical 
exchange between free (“f”) and bound (“b”) β-D-glucose for the proton at position 2).  Exchange peaks are observed for only the β anomer under these conditions (mixing 
time of 100 ms).  Exchange peaks for the α anomer were observed at much longer mixing times (>500 ms).  Quantification of the selectivity of 3 for the α and β anomers could 
not be achieved using this method, however determination of selectivity was achieved using 1H-13C HSQC (see Figure 139Error! Reference source not found. below).  
Comparison of the chemical shifts between the free protons for D-glucose allowed assignment of the 1H NMR chemical shifts for the bound forms of β-D-glucose, which are 



















Figure 139 Partial (1H-13C correlation, one bond) HSQC NMR spectrum of receptor 3 (2 mM) with D-glucose 4 (5 mM, 2.5 equivalents) in D2O at 298 K.  NMR signals for D-
glucose bound to the receptor (whose signals appear more upfield in the 1H (f1) dimension, horizontal axis) and free glucose in solution.  These signals for “free” and “bound” 
states are shown in black for CH protons and red for CH2 protons, and are labelled accordingly (i.e. β2(f) indicates free β-D-glucose and β2(b) indicates the bound form for 
the proton at position 2).  NMR signals corresponding to bound D-glucose are observed for the β anomer only, indicating an expected preference for binding the β anomer.  
The ratio of intensity of signals for bound β-D-glucose and baseline noise is measured as 6:1 (signal:noise).  Assuming the bound signals for the α anomer are at most the 
same intensity as the baseline noise, then it can be assumed the selectivity for β and α-D-glucose is also at least 6:1 (β:α) but could potentially be higher.
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Table 10 Chemical shifts (δ in ppm) of β-D-glucose 4 unbound and bound to receptor 3.  Values obtained in 
D2O/H2O (1:9) at 298 K.  The values for difference in chemical shift (Δδ) upon complexation of glucose with 
receptor 2 are also given, indicating how shielded the CH protons of the carbon skeleton become when bound 








β-D-glucose chemical shifts (δ, ppm) 
H Unbound Bound to 2 Δδ on binding to 2 
1 4.63 3.72 -0.91 
2 3.23 2.34 -0.89 
3 3.47 2.37 -1.10 
4 3.39 1.63, 1.74 -1.76, -1.65 
5 3.45 1.94 -1.51 
6 3.71 3.23 -0.48 
6’ 3.88 3.64 -0.24 
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Ka = 17351.01± 663.56 M-1 (3.82%)
r = 0.996967
ΔG =-24.2± -0.93 kJ.mol-1




















[G]t  in mM
ΣΔHobs
ΣΔHcalc

















































Figure 140 ITC binding results for receptor 3 (0.06 mM) titrated with D-glucose 4 (7 mM) in 10 mM phosphate 
buffered saline solution (pH 7), in which: A) shows the blank run (addition of sugar into water); B) shows the 
titration (sugar into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the fit 












Ka = 17826.22± 985.56 M-1 (5.53%)
r = 0.994074
ΔG =-24.27± -1.34 kJ.mol-1
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Figure 141 ITC binding results for receptor 3 (0.06 mM) titrated with D-glucose 4 (7 mM) in 10 mM phosphate 
buffered saline solution (PBS, pH 6), in which: A) shows the blank run (addition of sugar into water); B) shows 
the titration (sugar into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 












Ka = 18301.3± 332.47 M-1 (1.82%)
r = 0.999244
ΔG =-24.33± -0.44 kJ.mol-1
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Figure 142 ITC binding results for receptor 3 (0.06 mM) titrated with D-glucose 4 (7 mM) in 10 mM phosphate 
buffered saline solution (pH 8), in which: A) shows the blank run (addition of sugar into water); B) shows the 
titration (sugar into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the fit 





































Ka = 5637.65± 118.32 M-1 (2.1%)
r = 0.999855
ΔG =-21.41± -0.45 kJ.mol-1

















































Figure 143 ITC binding results for receptor 3 (0.06 mM) titrated with D-glucose 4 (7 mM) in DMEM Cell Culture 
Medium (no glucose, 10k MWCO, 90% v/v) and 10 mM phosphate buffer solution (pH 7.4), in which: A) shows 
the blank run (addition of sugar into medium); B) shows the titration (sugar into receptor 3); C) shows the plotted 












Ka = 5164.29± 303.82 M-1 (5.88%)
r = 0.995435
ΔG =-21.19± -1.25 kJ.mol-1
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Figure 144  ITC binding results for receptor 3 (0.06 mM) titrated with D-glucose 4 (7 mM) in DMEM salt control 
medium with 10 mM phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate 
into medium); B) shows the titration (substrate into receptor 2); C) shows the plotted change in enthalpy vs 





































Ka = 5214.14± 452.54 M-1 (8.68%)
r = 0.993415
ΔG =-21.22± -1.84 kJ.mol-1




















































Figure 145 ITC binding results for receptor 3 (0.06 mM) titrated with D-glucose 4 (7 mM) in Leibovitz’s L-15 Cell 
Culture Medium (no glucose, 10k MWCO, 90% v/v) and 10 mM phosphate buffer solution (pH 7.4), in which: A) 
shows the blank run (addition of sugar into medium); B) shows the titration (sugar into receptor 3); C) shows the 
plotted change in enthalpy vs molar ratio; and D) shows the fit calculated using an Excel spreadsheet (Ka = 5214 






























Ka = 11300± 270.33 M-1 (2.39%)
r = 0.999496
ΔG =-23.14± -0.55 kJ.mol-1



















































Figure 146 ITC binding results for receptor 3 (0.2 mM) titrated with D-glucose 4 (7 mM) in human serum (90% 
v/v, no glucose) with 10 mM phosphate buffer (pH 7.4) in which: A) shows the blank run (addition of substrate 
into medium); B) shows the titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs 











K a = 7522.19 ± 414.32 M-1 (5.51%)



















































Figure 147 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.07 mM) titrated with a 
combined solution of methyl β-D-glucoside 14 (10 mM) and receptor 3 (0.07 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with slow exchange on NMR timescale.  Integrations of peak at 
8.31 ppm (denoted with •) versus region 8.36-7.36 ppm were plotted against guest concentration (mM).  The 
calculated values for the integrals are overlaid with the observed values, giving Ka = 7522 ± 414 M-1 (5.51%) 
0 µM MBG (0 eq) 
20 µM MBG (0.3 eq) 
40 µM MBG (0.6 eq) 
60 µM MBG (0.9 eq) 
80 µM MBG (1.1 eq) 
100 µM MBG (1.4 eq) 
120 µM MBG (1.7 eq) 
140 µM MBG (2.0 eq) 
160 µM MBG (2.3 eq) 
180 µM MBG (2.6 eq) 
200 µM MBG (2.9 eq) 
234 µM MBG (3.4 eq) 
291 µM MBG (4.2 eq) 
347 µM MBG (5.0 eq) 
440 µM MBG (6.3 eq) 





















Figure 1481H NMR spectra for receptor 3 (0.07 mM) titrated with a combined solution of methyl β-D-glucoside 14 (10 mM) and receptor 3 (0.07 mM), in D2O with 10 mM 
phosphate buffer (pH 7.4) at 298 K 
0 µM MBG (0 eq) 
20 µM MBG (0.3 eq) 
40 µM MBG (0.6 eq) 
60 µM MBG (0.9 eq) 
80 µM MBG (1.1 eq) 
100 µM MBG (1.4 eq) 
120 µM MBG (1.7 eq) 
140 µM MBG (2.0 eq) 
160 µM MBG (2.3 eq) 
180 µM MBG (2.6 eq) 
200 µM MBG (2.9 eq) 
234 µM MBG (3.4 eq) 
291 µM MBG (4.2 eq) 
347 µM MBG (5.0 eq) 
440 µM MBG (6.3 eq) 
620 µM MBG (8.9 eq) 































Ka = 7886.05± 1296.63 M-1 (16.44%)
r = 0.99589
ΔG =-24.4± -4.01 kJ.mol-1


















































Figure 149ITC binding results for receptor 3 (0.06 mM) titrated with methyl β-D-glucoside 14 (7 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows the 
titration (sugar into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the fit 




























Figure 150 Partial 1H NMR spectra for receptor 3 (0.1 mM) titrated with a combined solution of D-glucuronic acid 168 (10 mM) and receptor 3 (0.1 mM), in D2O with 10 mM 
phosphate buffer (pH 7.4) at 298 K.  Spectra imply binding with intermediate rate of exchange (rate between fast and slow exchange rates between H and HG species) on 
NMR timescale.  Due to severe broadening of peaks for receptor 3 upon addition of guest, no Ka was determinable. 
0 µM Glucuronic acid (0 eq) 
40 µM Glucuronic acid (0.40 eq) 
79 µM Glucuronic acid (0.79 eq) 
118 µM Glucuronic acid (1.18 eq) 
157 µM Glucuronic acid (1.57 eq) 
196 µM Glucuronic acid (1.96 eq) 
234 µM Glucuronic acid (2.34 eq) 
272 µM Glucuronic acid (2.72 eq) 
310 µM Glucuronic acid (3.10 eq) 
384 µM Glucuronic acid (3.84 eq) 
476 µM Glucuronic acid (4.76 eq) 
654 µM Glucuronic acid (6.54 eq) 





Ka = 5348.08± 189.39 M-1 (3.54%)
r = 0.999179
ΔG =-21.28± -0.75 kJ.mol-1















































Figure 151 ITC binding results for receptor 3 (0.2 mM) titrated with D-glucuronic acid 168 (5 mM) in 10 mM 
phosphate buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) 
shows the titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) 


















































Figure 152 1H NMR spectra for receptor 3 (0.11 mM) titrated with a combined solution of D-xylose 149 (10 mM) and receptor 3 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) a t 298 K.  Spectra imply binding with intermediate rate of exchange (rate between fast and slow exchange rates between H and HG species) on NMR timescale.  
Due to severe broadening of peaks for receptor 3 upon addition of guest, no Ka was determinable. 
1.07 µM Xylose (9.74 eq) 
740 µM Xylose (6.73 eq) 
560 µM Xylose (5.15 eq) 
380 µM Xylose (3.50 eq) 
290 µM Xylose (2.65 eq) 
200 µM Xylose (1.78 eq) 
160 µM Xylose (1.43 eq) 
120 µM Xylose (1.08 eq) 
80 µM Xylose (0.72 eq) 
40 µM Xylose (0.36 eq) 
0 µM Xylose (0 eq) 







Ka = 5804.55± 174.05 M-1 (3%)
r = 0.999905
ΔG =-21.48± -0.64 kJ.mol-1










































































Figure 153 ITC binding results for receptor 3 (0.1 mM) titrated with D-xylose 149 (5 mM) in 10 mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) shows the 
titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 



















Figure 154 Partial 1H NMR spectra for receptor 3 (0.1 mM) titrated with a combined solution of 2-deoxy-D-glucose 169 (50 mM) and receptor 3 (0.1 mM), in D2O with 10 mM 
phosphate buffer (pH 7.4) at 298 K.  Spectra imply binding with intermediate rate of exchange (rate between fast and slow exchange rates between H and HG species) on 
NMR timescale.  Due to severe broadening of peaks for receptor 3 upon addition of guest, no Ka was determinable. 
0 mM 2DG (0 eq) 
0.2 mM 2DG (2 eq) 
0.4 mM 2DG (4 eq) 
0.6 mM 2DG (6 eq) 
0.8 mM 2DG (8 eq) 






































Ka = 725.88± 41.54 M-1 (5.72%)
r = 0.998134
ΔG =-16.33± -0.93 kJ.mol-1



















































Figure 155 ITC binding results for receptor 3 (0.06 mM) titrated with 2-deoxy-D-glucose 169 (7 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows the 
titration (sugar into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the fit 






K a = 132.34 ± 13.44 M-1 (10.16%)
r  = 0.99580
-0.1


































Figure 156 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.05 mM) titrated 
with a combined solution of D-galactose 5 (250 mM) and receptor 2 (0.05 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with fast/intermediate exchange on NMR timescale.  Changes in 
chemical shift (Δδ ppm) of peak at 7.63ppm (denoted with •) were plotted against increasing guest 
concentration (mM).  The calculated values for the Δδ are overlaid with the observed values giving Ka = 132 ± 13 
M-1 (10.2%). 
0 mM Galactose (0 eq) 
0.5 mM Galactose (10 eq) 
1.0 mM Galactose (20 eq) 
1.5 mM Galactose (30 eq) 
2.0 mM Galactose (40 eq) 
3.0 mM Galactose (60 eq) 
4.0 mM Galactose (80 eq) 
5.0 mM Galactose (100 eq) 
6.0 mM Galactose (120 eq) 
7.8 mM Galactose (150 eq) 





















Figure 157 1H NMR spectra for receptor 3 (0.05 mM) titrated with a combined solution of D-galactose 5 (250 mM) and receptor 3 (0.05 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K 
0 mM Galactose (0 eq) 
0.5 mM Galactose (10 eq) 
1.0 mM Galactose (20 eq) 
1.5 mM Galactose (30 eq) 
2.0 mM Galactose (40 eq) 
3.0 mM Galactose (60 eq) 
4.0 mM Galactose (80 eq) 
5.0 mM Galactose (100 eq) 
6.0 mM Galactose (120 eq) 
7.8 mM Galactose (150 eq) 







Ka = 182.06± 4.24 M-1 (2.33%)
r = 0.999796
ΔG =-12.9± -0.3 kJ.mol-1





















[G]t  in mM
ΣΔHobs
ΣΔHcalc














































Figure 158 ITC binding results for receptor 3 (0.2 mM) titrated with D-galactose 5 (75 mM) in 10 mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) shows the 
titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 











K a = 140.22 ± 1.84 M-1 (1.31%)
r  = 0.99965
-0.1


































Figure 159 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.11 mM) titrated 
with a combined solution of D-mannose 6 (250 mM) and receptor 2 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with fast/intermediate exchange on NMR timescale.  Changes in 
chemical shift (Δδ ppm) of peak at 7.63 ppm (denoted with •) were plotted against increasing guest 
concentration (mM).  The calculated values for the Δδ are overlaid with the observed values giving Ka = 140 ± 2 
M-1 (1.31%) 
0 mM Mannose (0 eq) 
1.0 mM Mannose (9 eq) 
2.0 mM Mannose (18 eq) 
3.0 mM Mannose (27 eq) 
3.9 mM Mannose (36 eq) 
4.9 mM Mannose (44 eq) 
6.8 mM Mannose (62 eq) 
8.7 mM Mannose (78 eq) 
13.3 mM Mannose (120 eq) 





















Figure 160 1H NMR spectra for receptor 3 (0.11 mM) titrated with a combined solution of D-mannose 6 (250 mM) and receptor 3 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K 
0 mM Mannose (0 eq) 
1.0 mM Mannose (9 eq) 
2.0 mM Mannose (18 eq) 
3.0 mM Mannose (27 eq) 
3.9 mM Mannose (36 eq) 
4.9 mM Mannose (44 eq) 
6.8 mM Mannose (62 eq) 
8.7 mM Mannose (78 eq) 
13.3 mM Mannose (120 eq) 








Ka = 143.37± 1.55 M-1 (1.08%)
r = 0.999969
ΔG =-12.31± -0.13 kJ.mol-1























[G]t  in mM
ΣΔHobs
ΣΔHcalc















































Figure 161 ITC binding results for receptor 3 (0.2 mM) titrated with D-mannose 6 (75 mM) in 10 mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) shows the 
titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 






























Figure 162 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.11 mM) titrated 
with a combined solution of D-ribose 170 (250 mM) and receptor 3 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with fast exchange on NMR timescale.  Changes in chemical shift 
(Δδ ppm) of peak at 7.83ppm (denoted with •) were plotted against increasing guest concentration (mM).  The 
calculated values for the Δδ are overlaid with the observed values giving Ka = 264 ± 10 M-1 (3.96%). 
K a = 264.36 ± 10.46 M-1 (3.96%)
r  = 0.99918
0.0
0.2








0 mM Ribose (0 eq) 
1.0 mM Ribose (9 eq) 
2.0 mM Ribose (18 eq) 
3.0 mM Ribose (27 eq) 
3.9 mM Ribose (36 eq) 
5.9 mM Ribose (53 eq) 
7.8 mM Ribose (70 eq) 
9.6 mM Ribose (87 eq) 
13.3 mM Ribose (120 eq) 
16.8 mM Ribose (151 eq) 
25.2 mM Ribose (227 eq) 





















Figure 163 1H NMR spectra for receptor 3 (0.11 mM) titrated with a combined solution of D-ribose 170 (250 mM) and receptor 3 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K 
0 mM Ribose (0 eq) 
1.0 mM Ribose (9 eq) 
2.0 mM Ribose (18 eq) 
3.0 mM Ribose (27 eq) 
3.9 mM Ribose (36 eq) 
5.9 mM Ribose (53 eq) 
7.8 mM Ribose (70 eq) 
9.6 mM Ribose (87 eq) 
13.3 mM Ribose (120 eq) 
16.8 mM Ribose (151 eq) 
25.2 mM Ribose (227 eq) 
33.0 mM Ribose (297 eq) 






Ka = 216.47± 4.05 M-1 (1.87%)
r = 0.999783
ΔG =-13.33± -0.25 kJ.mol-1














































Figure 164 ITC binding results for receptor 3 (0.1 mM) titrated with D-ribose 170 (75 mM) in 10 mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) shows the 
titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 



































K a = 50.89 ± 2.78 M-1 (5.46%)
r  = 0.99837
-0.1
































Figure 165 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.11 mM) titrated 
with a combined solution of D-fructose 20 (250 mM) and receptor 2 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with fast/intermediate exchange on NMR timescale.  Changes in 
chemical shift (Δδ ppm) of peak at 7.63ppm (denoted with •) were plotted against increasing guest 
concentration (mM).  The calculated values for the Δδ are overlaid with the observed values giving Ka = 51 ± 3 
M-1 (5.46%). 
0 mM Fructose (0 eq) 
2.0 mM Fructose (18 eq) 
3.9 mM Fructose (36 eq) 
5.9 mM Fructose (53 eq) 
9.6 mM Fructose (87 eq) 
13.2 mM Fructose (120 eq) 
16.8 mM Fructose (151 eq) 
25.1 mM Fructose (227 eq) 





















Figure 166 1H NMR spectra for receptor 3 (0.11 mM) titrated with a combined solution of D-fructose 20 (250 mM) and receptor 3 (0.11 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K 
t1’ 0 mM Fructose (0 eq) 
2.0 mM Fructose (18 eq) 
3.9 mM Fructose (36 eq) 
5.9 mM Fructose (53 eq) 
9.6 mM Fructose (87 eq) 
13.2 mM Fructose (120 eq) 
16.8 mM Fructose (151 eq) 
25.1 mM Fructose (227 eq) 
33.0 mM Fructose (297 eq) 
s2 s1/s3 t2/t2’ t1/t1’ t3/t3’ 
297 
 
Ka = 60.37± 1.65 M-1 (2.74%)
r = 0.999728
ΔG =-10.17± -0.28 kJ.mol-1

















































Figure 167 ITC binding results for receptor 3 (0.1 mM) titrated with D-fructose 20 (75 mM) in 10 mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) shows the 
titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 

















































Figure 168 Partial 1H NMR spectra for receptor 3 (0.11 mM) titrated with a combined solution of D-cellobiose 31 (250 mM) and receptor 3 (0.11 mM), in D2O with 10 mM 
phosphate buffer (pH 7.4) at 298 K.  Spectra imply binding with slow exchange on NMR timescale.  Integrations of peak at 8.02 ppm (denoted with •) versus region 8.36-7.36 
ppm were used to calculate the Ka (M-1) at each point of addition (see Table S7), an average of these calculated values gives Ka = 31 ± 2.66 (9%). 
0 mM Cellobiose (0 eq) 
s2 s1/s3 
2.0 mM Cellobiose (18 eq) 
3.9 mM Cellobiose (36 eq) 
5.8 mM Cellobiose (54 eq) 
9.6 mM Cellobiose (87 eq) 
13.3 mM Cellobiose (121 eq) 
16.8 mM Cellobiose (153 eq) 
25.2 mM Cellobiose (229 eq) 
33.0 mM Cellobiose (300 eq) 
47.1 mM Cellobiose (428 eq) 
299 
 
Table 11 Calculated values for Ka when titrating cellobiose 31 (250 mM) against receptor 3 (0.11 mM) in D2O 







The integrals of the peak at 8.02 ppm (denoted with •, see Figure 170) were measured relative to the 
region 8.36-7.36.  These values were then compared to that at the end of the titration, when all 
receptor is assumed to be saturated with guest.  Based on this assumption, Ka could be calculated 
from each point in the titration.  An average Ka = 31.1 M-1 ± 2.66 (9%) was obtained in agreement with 
results obtained from ITC studies.  Not all the spectra were used due to baseline distortions resulting 
from the large excess of guest present. 
 
  
 Calculated  





Average Ka / M-1 31.1 
Std Dev (Error) 2.66 (9%) 
300 
 
Ka = 30.91± 4.93 M-1 (15.96%)
r = 0.998979
ΔG =-8.51± -1.36 kJ.mol-1




















[G]t  in mM
ΣΔHobs
ΣΔHcalc
















































Figure 169 ITC binding results for receptor 3 (0.06 mM) titrated with D-cellobiose 31 (250 mM) in 10 mM 
phosphate buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) 
shows the titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) 





































Figure 170 ITC binding results for receptor 3 (0.1 mM) titrated with D-mannitol 173 (500 mM) in 10 mM 
phosphate buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) 












































































Figure 171 ITC binding results for receptor 3 (0.06 mM) titrated with D-gluconic acid 174 (200 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into water); B) shows 



































Figure 172 ITC binding results for receptor 3 (0.06 mM) titrated with methyl α-D-glucoside 171 (500 mM) in 10 
mM phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows 























































Figure 173 ITC binding results for receptor 3 (0.06 mM) titrated with N-acetyl-D-glucosamine 7 (498 mM) in 10 
mM phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows 


























































Figure 174 ITC binding results for receptor 3 (0.06 mM) titrated with maltose 132 (500 mM) in 10 mM phosphate 
buffer solution (pH 7.4), in which: A) shows the blank run (addition of sugar into water); B) shows the titration 


























































Figure 175 ITC binding results for receptor 3 (0.06 mM) titrated with L-fucose 172 (500 mM) in 10 mM phosphate 
buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into water); B) shows the 



























































Figure 176 ITC binding results for receptor 3 (0.06 mM) titrated with ascorbic acid 182 (500 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into water); B) shows 



























































Figure 177 ITC binding results for receptor 3 (0.06 mM) titrated with uracil 176 (5 mM, limit of solubility) in 10 
mM phosphate buffered saline (pH 7.4), in which: A) shows the blank run (addition of uracil into water); B) shows 



























































Figure 178 ITC binding results for receptor 3 (0.06 mM) titrated uric acid 177 (2.34 mM, limit of solubility) in 10 
mM phosphate buffered saline (pH 7.4), in which: A) shows the blank run (addition of uric acid into water); B) 






















































Figure 179 ITC binding results for receptor 3 (0.1 mM) titrated with cytosine 175 (20 mM) in 10 mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) shows the 























































Figure 180 ITC binding results for receptor 3 (0.1 mM) titrated with adenosine 178 (500 mM) in 10 mM 
phosphate buffer solution (pH 7.4) in which: A) shows the blank run (addition of substrate into medium); B) 
shows the titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio. 
  




















































Figure 181 ITC binding results for receptor 3 (0.06 mM) titrated with L-phenylalanine 180 (82 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into medium); B) 
shows the titration (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio. 
  






















































Figure 182 ITC binding results for receptor 3 (0.06 mM) titrated with L-tryptophan 179 (54 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into medium); B) 

























































Figure 183 ITC binding results for receptor 3 (0.06 mM) titrated with paracetamol 181 (87 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into water); B) shows 

































K a = 7328.62 ± 540.94 M-1 (7.38%)












































Figure 184 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.07 mM) titrated with a 
combined solution of myo-inositol 183 (10 mM) and receptor 3 (0.07 mM), in D2O buffered with 10 mM 
phosphate buffer solution (pH 7.4) at 298 K. Spectra imply binding with slow exchange on NMR timescale. 
Integrations of peak at 7.98 ppm (denoted with •) versus region 8.39-7.32 ppm were plotted against guest 
concentration (mM). The calculated values for the integrals are overlaid with the observed values, giving Ka = 
7328 ± 540 M-1 (7.4%) 
0 µM myo inositol (0 eq) 
20 µM myo inositol (0.3 eq) 
40 µM myo inositol (0.6 eq) 
80 µM myo inositol (1.3 eq) 
118 µM myo inositol (1.9 eq) 
157 µM myo inositol (2.6 eq) 
196 µM myo inositol (3.2 eq) 
234 µM myo inositol (3.8 eq) 
272 µM myo inositol (4.4 eq) 
309 µM myo inositol (5.0 eq) 
384 µM myo inositol (6.3 eq) 
458 µM myo inositol (7.5 eq) 
566 µM myo inositol (9.2 eq) 
908 µM myo inositol (14.8 eq) 
1226 µM myo inositol (20.0 eq) 
1524 µM myo inositol (24.8 eq) 
1933 µM myo inositol (31.5 eq) 





















Figure 185 1H NMR spectra for receptor 3 (0.07 mM) titrated with a combined solution of myo-inositol 183 (10 mM) and receptor 3 (0.07 mM), in D2O buffered with 10 mM 
phosphate buffer solution (pH 7.4) at 298 K. 
0 µM myo inositol (0 eq) 
20 µM myo inositol (0.3 eq) 
40 µM myo inositol (0.6 eq) 
80 µM myo inositol (1.3 eq) 
118 µM myo inositol (1.9 eq) 
157 µM myo inositol (2.6 eq) 
196 µM myo inositol (3.2 eq) 
234 µM myo inositol (3.8 eq) 
272 µM myo inositol (4.4 eq) 
309 µM myo inositol (5.0 eq) 
384 µM myo inositol (6.3 eq) 
458 µM myo inositol (7.5 eq) 
566 µM myo inositol (9.2 eq) 
908 µM myo inositol (14.8 eq) 
1226 µM myo inositol (20.0 eq) 
1524 µM myo inositol (24.8 eq) 
1933 µM myo inositol (31.5 eq) 
740 µM myo inositol (12.1 eq) 
317 
 






















Ka = 7562.58± 313.59 M-1 (4.15%)
r = 0.999781
ΔG =-22.14± -0.92 kJ.mol-1














































Figure 186 ITC binding results for receptor 3 (0.1 mM) titrated with myo-inositol 183 (5 mM) in 10mM phosphate 
buffer solution (pH 7.4) in which: A) shows the blank ITC run (addition of substrate into medium); B) shows the 
actual run (substrate into receptor 3); C) shows the plotted change in enthalpy vs molar ratio; and D) shows the 





























Figure 187 Partial 1H NMR spectra (top) and binding analysis curve (bottom) for receptor 3 (0.09 mM) titrated 
with a combined solution of scyllo-inositol 184 (1 mM) and receptor 3 (0.09 mM), in D2O with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Spectra imply binding with slow exchange on NMR timescale.  Integrations of the peak 
at δ 7.85 ppm versus the region δ 7.9-7.25 ppm were plotted against scyllo-inositol 184 concentration (mM).  
The calculated values for the integrals are overlaid with the observed values, giving Ka = 482,000 ± 23,400 M-1 
(4.9%). 
K a = 481959.33 ± 23365.21 M-1 (4.85%)
























0 µM Scyllo-inositol 
10 µM Scyllo-inositol 
19.6 µM Scyllo-inositol 
29.1 µM Scyllo-inositol 
38.5 µM Scyllo-inositol 
47.6 µM Scyllo-inositol 
56.6 µM Scyllo-inositol 
65.4 µM Scyllo-inositol 
74.0 µM Scyllo-inositol 
82.6 µM Scyllo-inositol 
90.9 µM Scyllo-inositol 
99.0 µM Scyllo-inositol 
107 µM Scyllo-inositol 
115 µM Scyllo-inositol 
122 µM Scyllo-inositol 
130 µM Scyllo-inositol 
145 µM Scyllo-inositol 
200 µM Scyllo-inositol 




















Figure 188 1H NMR spectra for receptor 3 (0.09 mM) titrated with a combined solution of scyllo-inositol 184 (1 mM) and receptor 3 (0.09 mM), in D2O buffered with 10 mM 




Ka = 228343.86± 1218.64 M-1 (0.53%)
r = 0.99993
ΔG =-30.59± -0.16 kJ.mol-1























[G]t  in mM
ΣΔHobs
ΣΔHcalc













N 0.989 ±0.0103 Sites
K 3.68E5 ±6.92E4 M
-1








































Figure 189 ITC binding results for receptor 3 (0.2 mM) titrated with scyllo-inositol 184 (2.5 mM) in 10 mM 
phosphate buffer solution (pH 7.4), in which: A) shows the blank run (addition of substrate into water); B) shows 
the titration (substrate into receptor); C) shows the plotted change in enthalpy vs molar ratio and the fit using 
the MicroCal software (Ka = 368,000± 69,200 M-1); and D) shows the fit calculated using an Excel spreadsheet (Ka 





K a = 17171.93 ± 1669.14 M-1 (9.72%)
r  = 0.99660




























































Figure 190 CD spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated with a 
combined solution of D-glucose 4 (10 mM) and receptor 3 (0.25 mM), in water with 10 mM phosphate buffer 
(pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted against increasing 
guest concentration (mM).  The calculated values for the ΔCD are overlaid with the observed values giving Ka = 





















K a = 17177.02 ± 356.19 M-1 (2.07%)






































Figure 191 CD spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated with a 
combined solution of L-glucose 187 (10 mM) and receptor 3 (0.25 mM), in water with 10 mM phosphate buffer 
(pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted against increasing 
guest concentration (mM).  The calculated values for the ΔCD are overlaid with the observed values giving Ka = 




K a = 10332.31 ± 607.24 M-1 (5.88%)



































Figure 192 CD spectra (top) and binding analysis curve (bottom) for receptor 3 (0.15 mM) titrated with a 
combined solution of D-glucose 4 (5 mM) and receptor 3 (0.15 mM), in human serum (90% v/v, D-glucose 
removed) with 10 mM phosphate buffer (pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes in CD 
intensity (ΔCD) were plotted against increasing guest concentration (mM).  The calculated values for the ΔCD 

























Figure 193 CD spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated with a 
combined solution of D-xylose 149 (9 mM) and receptor 3 (0.25 mM), in water with 10 mM phosphate buffer 
(pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted against increasing 
guest concentration (mM).  The calculated values for the ΔCD are overlaid with the observed values giving Ka = 
5000 ± 440 M-1 (8.7%). 
  
K a = 5036.00 ± 439.58 M-1 (8.73%)




















K a = 4360.82 ± 189.05 M-1 (4.34%)


































Figure 194 CD spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated with a 
combined solution of D-glucuronic acid 168 (5 mM) and receptor 3 (0.25 mM), in water with 10 mM phosphate 
buffer (pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted against 
increasing guest concentration (mM).  The calculated values for the ΔCD are overlaid with the observed values 




K a = 679.68 ± 38.99 M-1 (5.74%)





































Figure 195 CD spectra (top) and binding analysis curve (bottom) for receptor 3 (0.25 mM) titrated with a 
combined solution of 2-deoxy-D-glucose 169 (10 mM) and receptor 3 (0.25 mM), in water with 10 mM 
phosphate buffer (pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted 
against increasing guest concentration (mM).  The calculated values for the ΔCD are overlaid with the observed 


































































Figure 196 CD spectra (top) and analysis curve (bottom) for receptor 3 (0.25 mM) saturated with L-glucose 187 
(2.4 mM) titrated with a combined solution of D-glucose 187 (10 mM), L-glucose 187 (2.4 mM) and receptor 3 
(0.25 mM), in water with 10 mM phosphate buffer (pH 7.4) at 298 K.  Monitored intensity at 260 nm. Changes 
in CD intensity (ΔCD) were plotted against increasing ratio of [D-glucose]:[L-glucose], with zero signal observed 
when ratio is equal to one. 
328 
 
Table 12 Raw data obtained from experiment outlined in Figure 196, where CD signal is equal to zero when ratio 
of D-glucose 4 and L-glucose 187 concentrations are equal (highlighted in yellow). 
[D-Glc] / mM CD[mdeg] [DGlc]:[LGlc] 
0.000 18.88 0.00 
0.121 17.847 0.05 
0.242 16.2479 0.10 
0.480 13.3685 0.20 
0.716 11.0832 0.30 
0.950 8.96877 0.40 
1.180 7.12859 0.49 
1.520 4.65307 0.63 
1.744 3.30714 0.73 
1.855 2.77992 0.77 
2.075 1.67586 0.86 
2.292 0.707081 0.96 
2.400 -0.01781 1.00 
2.930 -2.23679 1.22 
3.444 -4.07233 1.44 
3.945 -5.18479 1.64 
4.907 -7.93841 2.04 
6.684 -10.5528 2.78 





















L-glucose (20mM) into TEB (250uM) in human serum
[D-Glc] / M [D-Glc] / mM CD[mdeg]Calc
0.00 0.00 -12.63 -12.63
0.00 0.38 -9.06 -9.46
0.00 0.96 -6.06 -5.93
0.00 1.51 -3.81 -3.62
0.00 2.01 -2.42 -1.99
0.00 2.21 -1.67 -1.47
0.00 2.30 -1.24 -1.24
0.00 2.49 -0.94 -0.80
0.00 2.71 -0.34 -0.31
0.00 3.14 0.35 0.51
0.00 3.92 1.54 1.70
0.00 4.92 2.94 2.85










Figure 197 CD spectra for receptor 3 (0.25 mM) in human serum (50% v/v) saturated with D-glucose already 
present in human serum. L-glucose 187 (20 mM) and receptor 3 (0.25 mM) in human serum (50% v/v) was 
titrated into this medium with 10 mM phosphate buffer (pH 7.4) at 298 K. Monitored intensity at 260 nm. 
Changes in CD intensity (ΔCD) were plotted against increasing ratio of [D-glucose]:[L-glucose], with zero signal 
observed when ratio is equal to one. This is concentration of 50% of the D-glucose in the human serum. 
 
Table 13 Raw data from experiment outlined in Figure 197, where CD signal is equal to zero when ratio of D-
glucose 4 and L-glucose 187 concentrations are equal (highlighted in blue). Extrapolation of this data gives the 
glucose concentration in 50% human serum: 2.85-2.95 mM. Multiplying this by two gives the actual 









































































Figure 198 CD spectra (top) for receptor 3 (0.25 mM) in human serum (D-glucose removed, 50% v/v) saturated 
with L-glucose 187 (2 mM). D-glucose 4 (40 mM), L-glucose 187 (2 mM) and receptor 3 (0.25 mM) in human 
serum (D-glucose removed, 50% v/v) was titrated into this medium with 10 mM phosphate buffer (pH 7.4) at 
298 K. Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted against increasing 
concentration of D-glucose 4 (bottom). A calculated curve was fitted using a non linear least squares regression 
analysis and the resultant equation of the calculated curve was used to measure the concentration of D-glucose 
in a sample of the same human serum with added receptor 3 (see Table 14). 
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Table 14 Measured CD intensity of receptor 3 (0.25 mM) with L-glucose (2mM) in human serum (D-glucose 
present, 50% v/v). This CD intensity was inputted into the equation for the calculated curve outlined in Figure 
198 to obtain the measured concentration of D-glucose in the human serum (50% v/v). This was repeated three 
times and averaged. The final averaged concentration of D-glucose was multiplied by two to obtain the actual 
concentration of D-glucose in the human serum (5.7 mM). 
 
Quantification of DGlc in serum Obs θ [D] / mM 
Run 1 -3.50 2.89 
Run 2 -3.17 2.79 
Run 3 -3.37 2.85 
Average -3.35 2.84 




































































Figure 199 CD spectra (top) for receptor 3 (0.25 mM) in human serum (D-glucose removed, 50% v/v) saturated 
with L-glucose 187 (8 mM). D-glucose 4 (40 mM), L-glucose 187 (8 mM) and receptor 3 (0.25 mM) in human 
serum (D-glucose removed, 50% v/v) was titrated into this medium with 10 mM phosphate buffer (pH 7.4) at 
298 K. Monitored intensity at 260 nm. Changes in CD intensity (ΔCD) were plotted against increasing 
concentration of D-glucose 4 (bottom). A calculated curve was fitted using a non linear least squares regression 
analysis and the resultant equation of the calculated curve was used to measure the concentration of D-glucose 
in a sample of the same human serum with added receptor 3 (see Table 15). 
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Table 15 Measured CD intensity of receptor 3 (0.25 mM) with L-glucose (8mM) in human serum (D-glucose 
present, 50% v/v). This CD intensity was inputted into the equation for the calculated curve outlined in Figure 
199Figure 198 to obtain the measured concentration of D-glucose in the human serum (50% v/v). This was 
repeated three times and averaged. The final averaged concentration of D-glucose was multiplied by two to 
obtain the actual concentration of D-glucose in the human serum (5.8 mM). 
 
Quantification of DGlc in serum Obs θ [D] / mM 
Run 1 8.68 2.94 
Run 2 8.71 2.93 
Run 3 8.93 2.84 
Average 8.77 2.90 
 Final [DGlc] / mM 5.80 
 
 
